
<html lang="en"     class="pb-page"  data-request-id="6646ba06-64e3-4dc8-a818-905ce5334935"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2021.64.issue-4;article:article:10.1021/acs.jmedchem.0c01726;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Design, Structural Optimization, and Characterization of the First Selective Macrocyclic Neurotensin Receptor Type 2 Non-opioid Analgesic" /></meta><meta name="dc.Creator" content="Magali  Chartier" /></meta><meta name="dc.Creator" content="Michael  Desgagné" /></meta><meta name="dc.Creator" content="Marc  Sousbie" /></meta><meta name="dc.Creator" content="Jérôme  Côté" /></meta><meta name="dc.Creator" content="Jean-Michel  Longpré" /></meta><meta name="dc.Creator" content="Eric  Marsault" /></meta><meta name="dc.Creator" content="Philippe  Sarret" /></meta><meta name="dc.Description" content="Neurotensin (NT) receptor type 2 (NTS2) represents an attractive target for the development of new NT-based analgesics. Here, we report the synthesis and functional in vivo characterization of the ..." /></meta><meta name="Description" content="Neurotensin (NT) receptor type 2 (NTS2) represents an attractive target for the development of new NT-based analgesics. Here, we report the synthesis and functional in vivo characterization of the ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 4, 2021" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c01726" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2021 The Authors. Published by American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01726" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c01726" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01726" /></link>
        
    
    

<title>Design, Structural Optimization, and Characterization of the First Selective Macrocyclic Neurotensin Receptor Type 2 Non-opioid Analgesic | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c01726" /></meta><meta property="og:title" content="Design, Structural Optimization, and Characterization of the First Selective Macrocyclic Neurotensin Receptor Type 2 Non-opioid Analgesic" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01726/20210218/images/large/jm0c01726_0009.jpeg" /></meta><meta property="og:description" content="Neurotensin (NT) receptor type 2 (NTS2) represents an attractive target for the development of new NT-based analgesics. Here, we report the synthesis and functional in vivo characterization of the first constrained NTS2-selective macrocyclic NT analog. While most chemical optimization studies rely on the NT(8-13) fragment, we focused on NT(7-12) as a scaffold to design NTS2-selective macrocyclic peptides. Replacement of Ile12 by Leu, and Pro7/Pro10 by allylglycine residues followed by cyclization via ring-closing metathesis led to macrocycle 4, which exhibits good affinity for NTS2 (50 nM), high selectivity over NTS1 (&gt;100 μM), and improved stability compared to NT(8-13). In vivo profiling in rats reveals that macrocycle 4 produces potent analgesia in three distinct rodent pain models, without causing the undesired effects associated with NTS1 activation. We further provide evidence of its non-opioid antinociceptive activity, therefore highlighting the strong therapeutic potential of NTS2-selective analogs for the management of acute and chronic pain." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c01726"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01726">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c01726&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c01726&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c01726&amp;href=/doi/10.1021/acs.jmedchem.0c01726" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2021</span><span class="cit-fg-volume">, 64</span><span class="cit-fg-issue">, 4</span><span class="cit-fg-pageRange">, 2110-2124</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/64/4" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c01717" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.0c01656" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Design, Structural Optimization, and Characterization of the First Selective Macrocyclic Neurotensin Receptor Type 2 Non-opioid Analgesic</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Magali Chartier</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Magali Chartier</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacology and Physiology, Faculty of Medicine and Health Sciences, Institut de Pharmacologie de Sherbrooke, Université de Sherbrooke, 3001 12e Avenue Nord, Sherbrooke, Quebec J1H 5N4, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Magali++Chartier">Magali Chartier</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Michael Desgagné</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michael Desgagné</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacology and Physiology, Faculty of Medicine and Health Sciences, Institut de Pharmacologie de Sherbrooke, Université de Sherbrooke, 3001 12e Avenue Nord, Sherbrooke, Quebec J1H 5N4, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Desgagn%C3%A9">Michael Desgagné</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Marc Sousbie</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Marc Sousbie</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacology and Physiology, Faculty of Medicine and Health Sciences, Institut de Pharmacologie de Sherbrooke, Université de Sherbrooke, 3001 12e Avenue Nord, Sherbrooke, Quebec J1H 5N4, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Marc++Sousbie">Marc Sousbie</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jérôme Côté</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jérôme Côté</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacology and Physiology, Faculty of Medicine and Health Sciences, Institut de Pharmacologie de Sherbrooke, Université de Sherbrooke, 3001 12e Avenue Nord, Sherbrooke, Quebec J1H 5N4, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=J%C3%A9r%C3%B4me++C%C3%B4t%C3%A9">Jérôme Côté</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jean-Michel Longpré</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jean-Michel Longpré</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacology and Physiology, Faculty of Medicine and Health Sciences, Institut de Pharmacologie de Sherbrooke, Université de Sherbrooke, 3001 12e Avenue Nord, Sherbrooke, Quebec J1H 5N4, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jean-Michel++Longpr%C3%A9">Jean-Michel Longpré</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Eric Marsault</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Eric Marsault</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacology and Physiology, Faculty of Medicine and Health Sciences, Institut de Pharmacologie de Sherbrooke, Université de Sherbrooke, 3001 12e Avenue Nord, Sherbrooke, Quebec J1H 5N4, Canada</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#c1a4b3a8a2efaca0b3b2a0b4adb581b4b2a9a4b3a3b3aeaeaaa4efa2a0"><span class="__cf_email__" data-cfemail="3257405b511c5f53404153475e467247415a574050405d5d59571c5153">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Eric++Marsault">Eric Marsault</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5305-8762" title="Orcid link">http://orcid.org/0000-0002-5305-8762</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Philippe Sarret</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Philippe Sarret</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacology and Physiology, Faculty of Medicine and Health Sciences, Institut de Pharmacologie de Sherbrooke, Université de Sherbrooke, 3001 12e Avenue Nord, Sherbrooke, Quebec J1H 5N4, Canada</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#502038393c392020357e23312222352410252338352232223f3f3b357e3331"><span class="__cf_email__" data-cfemail="1e6e767772776e6e7b306d7f6c6c7b6a5e6b6d767b6c7c6c7171757b307d7f">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Philippe++Sarret">Philippe Sarret</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7627-701X" title="Orcid link">http://orcid.org/0000-0002-7627-701X</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01726&amp;href=/doi/10.1021%2Facs.jmedchem.0c01726" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2021</span></span><span class="cit-volume">, 64</span><span class="cit-issue">, 4</span><span class="cit-pageRange">, 2110–2124</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 4, 2021</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>1 October 2020</li><li><span class="item_label"><b>Published</b> online</span>4 February 2021</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 25 February 2021</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c01726" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01726</a></div><div class="article_header-article-copyright"><strong>Copyright © 2021 The Authors. Published by American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2110%26pageCount%3D15%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMagali%2BChartier%252C%2BMichael%2BDesgagn%25C3%25A9%252C%2BMarc%2BSousbie%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D64%26issueNum%3D4%26contentID%3Dacs.jmedchem.0c01726%26title%3DDesign%252C%2BStructural%2BOptimization%252C%2Band%2BCharacterization%2Bof%2Bthe%2BFirst%2BSelective%2BMacrocyclic%2BNeurotensin%2BReceptor%2BType%2B2%2BNon-opioid%2BAnalgesic%26numPages%3D15%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2124%26publicationDate%3DFebruary%2B2021">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c01726"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">745</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">2</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c01726" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Design, Structural Optimization, and Characterization of the First Selective Macrocyclic Neurotensin Receptor Type 2 Non-opioid Analgesic&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Magali&quot;,&quot;last_name&quot;:&quot;Chartier&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Desgagné&quot;},{&quot;first_name&quot;:&quot;Marc&quot;,&quot;last_name&quot;:&quot;Sousbie&quot;},{&quot;first_name&quot;:&quot;Jérôme&quot;,&quot;last_name&quot;:&quot;Côté&quot;},{&quot;first_name&quot;:&quot;Jean-Michel&quot;,&quot;last_name&quot;:&quot;Longpré&quot;},{&quot;first_name&quot;:&quot;Eric&quot;,&quot;last_name&quot;:&quot;Marsault&quot;},{&quot;first_name&quot;:&quot;Philippe&quot;,&quot;last_name&quot;:&quot;Sarret&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2021&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;04&quot;,&quot;issue&quot;:&quot;4&quot;,&quot;volume&quot;:&quot;64&quot;,&quot;pages&quot;:&quot;2110-2124&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c01726&quot;},&quot;abstract&quot;:&quot;Neurotensin (NT) receptor type 2 (NTS2) represents an attractive target for the development of new NT-based analgesics. Here, we report the synthesis and functional in vivo characterization of the first constrained NTS2-selective macrocyclic NT analog. While most chemical optimization studies rely on the NT(8-13) fragment, we focused on NT(7-12) as a scaffold to design NTS2-selective macrocyclic peptides. Replacement of Ile12 by Leu, and Pro7/Pro10 by allylglycine residues followed by cyclization via ring-closing metathesis led to macrocycle 4, which exhibits good affinity for NTS2 (50 nM), high selectivity over NTS1 (&gt;100 μM), and improved stability compared to NT(8-13). In vivo profiling in rats reveals that macrocycle 4 produces potent analgesia in three distinct rodent pain models, without causing the undesired effects associated with NTS1 activation. We further provide evidence of its non-opioid antinociceptive activity, therefore highlighting the strong therapeutic potential of NTS2-selective analogs fo&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01726&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01726" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01726&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01726" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01726&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01726" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01726&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01726&amp;href=/doi/10.1021/acs.jmedchem.0c01726" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c01726" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c01726" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01726&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c01726%26sid%3Dliteratum%253Aachs%26pmid%3D33538583%26genre%3Darticle%26aulast%3DChartier%26date%3D2021%26atitle%3DDesign%252C%2BStructural%2BOptimization%252C%2Band%2BCharacterization%2Bof%2Bthe%2BFirst%2BSelective%2BMacrocyclic%2BNeurotensin%2BReceptor%2BType%2B2%2BNon-opioid%2BAnalgesic%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D64%26issue%3D4%26spage%3D2110%26epage%3D2124%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292461" title="Neurophysiology">Neurophysiology</a>,</li><li><a href="/action/doSearch?ConceptID=290831" title="Monomers">Monomers</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/64/4" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/jmcmar.2021.64.issue-4/20210225/jmcmar.2021.64.issue-4.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01726/20210218/images/medium/jm0c01726_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01726/20210218/images/large/jm0c01726_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01726&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Neurotensin (NT) receptor type 2 (NTS2) represents an attractive target for the development of new NT-based analgesics. Here, we report the synthesis and functional <i>in vivo</i> characterization of the first constrained NTS2-selective macrocyclic NT analog. While most chemical optimization studies rely on the NT(8-13) fragment, we focused on NT(7-12) as a scaffold to design NTS2-selective macrocyclic peptides. Replacement of Ile<sup>12</sup> by Leu, and Pro<sup>7</sup>/Pro<sup>10</sup> by allylglycine residues followed by cyclization via ring-closing metathesis led to macrocycle <b>4</b>, which exhibits good affinity for NTS2 (50 nM), high selectivity over NTS1 (>100 μM), and improved stability compared to NT(8-13). <i>In vivo</i> profiling in rats reveals that macrocycle <b>4</b> produces potent analgesia in three distinct rodent pain models, without causing the undesired effects associated with NTS1 activation. We further provide evidence of its non-opioid antinociceptive activity, therefore highlighting the strong therapeutic potential of NTS2-selective analogs for the management of acute and chronic pain.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80366" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80366" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Opioids are widely used as analgesics for the treatment of various types of pain.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> However, opioids like morphine may not be as effective for the management of neuropathic or bone cancer pain.<a onclick="showRef(event, 'ref3 ref4 ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5 ref6 ref7">(3−7)</a> In addition, long-term use and dose escalation of opioids are associated with numerous adverse effects, namely, constipation, respiratory depression, and tolerance.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8,9)</a> Furthermore, opioid prescribing has the potential to lead to patient abuse and misuse of these medications, which include addiction, overdoses, and death.<a onclick="showRef(event, 'ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12">(10−12)</a> Drug alternatives are therefore needed to provide patients suffering from chronic pain with safe and effective pain medication.</div><div class="NLM_p">Neurotensin (NT), which possesses the sequence pGlu-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Tyr-Ile-Leu-OH, is a tridecapeptide secreted in the brain and gastrointestinal tract and was first isolated in 1973 from bovine hypothalami.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> The hexapeptide C-terminal fragment NT(8-13) was then rapidly identified as the minimal amino acid sequence required for functional activity.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> In recent years, peptide optimization and conjugation strategies have provided direct evidence of the analgesic potency and efficacy of NT(8-13) analogs, including the management of neuropathic pain for which opioid medications have shown limited long-term effectiveness.<a onclick="showRef(event, 'ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref17">(15−17)</a> Of particular importance, NT and its analogs produce opioid-independent antinociceptive responses,<a onclick="showRef(event, 'ref18 ref19 ref20 ref21 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20 ref21 ref22 ref23">(18−23)</a> and their combination with morphine leads to additive or synergistic analgesic actions.<a onclick="showRef(event, 'ref24 ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref24 ref25 ref26">(24−26)</a> Two G protein-coupled receptor (GPCR) subtypes, namely, NTS1 and NTS2, have been shown to mediate the antinociceptive effects of NT.<a onclick="showRef(event, 'ref27 ref28 ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref27 ref28 ref29 ref30">(27−30)</a> Aside its role in pain modulation, activation of NTS1 was also associated with other central or peripheral actions, including hypotension and cardiovascular regulation, hypothermia, and modulation of gastrointestinal motility.<a onclick="showRef(event, 'ref31 ref32 ref33 ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref31 ref32 ref33 ref34 ref35">(31−35)</a> In contrast, the expression of NTS2 is almost exclusively restricted to the central nervous system, which makes this receptor an attractive target for the development of novel analgesic drugs with limited unwanted peripheral effects.<a onclick="showRef(event, 'ref36 ref37 ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref36 ref37 ref38 ref39">(36−39)</a></div><div class="NLM_p">During the past two decades, technological advances in solving the structures of membrane proteins have facilitated the progress in GPCR crystallography, with now over 270 resolved crystal structures of 53 distinct receptors distributed across all four major GPCR classes.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Accordingly, several high-resolution X-ray crystal structures of the rNTS1 receptor have been solved in complex with NT(8-13), delineating the molecular determinants of ligand–receptor interactions.<a onclick="showRef(event, 'ref41 ref42 ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref41 ref42 ref43 ref44">(41−44)</a> In addition, cryo-EM structures of the hNTS1 were recently solved in complex with β-arrestins 1 and 2 or the heterotrimeric Gαi1β1γ2 protein in the presence of NT(8-13) or the homologous synthetic peptide KKPYIL.<a onclick="showRef(event, 'ref45 ref46 ref47'); return false;" href="javascript:void(0);" class="ref ref45 ref46 ref47">(45−47)</a> These structural advances in the field of NT have therefore allowed to optimize the 3D structure of NTS2 by homology modeling and have opened new opportunities to identify novel chemotypes and rationally design NTS2-selective compounds.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a></div><div class="NLM_p">To date, different chemical strategies have been used to improve receptor binding affinity and selectivity toward NTS2 as well as peptide stability and permeability. Among these approaches, substitution of the tyrosine residue in position 11 by natural (lysine) or unnatural amino acids (<span class="smallcaps smallerCapital">d</span>-Trp, <span class="smallcaps smallerCapital">d</span>-Tyr, (<i>R</i>)-Nal, <span class="smallcaps smallerCapital">d</span>-3,1-Nal, 6-OH-Tic, Dmt, <i>m</i>Tyr, N-<i>h</i>Tyr, (<i>R</i>)-FPTyr, and (R<sup>Trans</sup>)TAA(OH)) has been found to favor NTS2 selectivity.<a onclick="showRef(event, 'ref24 ref48 ref49 ref50 ref51 ref52 ref53 ref54 ref55'); return false;" href="javascript:void(0);" class="ref ref24 ref48 ref49 ref50 ref51 ref52 ref53 ref54 ref55">(24,48−55)</a> Accordingly, molecular dynamics simulations revealed that conformational changes and flexibility in Tyr<sup>11</sup> are required for NTS1 activation by NT, thus reinforcing the crucial role played by Tyr<sup>11</sup> in NTS1/NTS2 selectivity.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a></div><div class="NLM_p">Compared to linear peptides, macrocyclic compounds have emerged as an important class of therapeutics by combining favorable properties, such as enhanced conformational rigidity, improved pharmacokinetic properties, and increased target selectivity and binding affinity.<a onclick="showRef(event, 'ref57 ref58 ref59'); return false;" href="javascript:void(0);" class="ref ref57 ref58 ref59">(57−59)</a> Peptide cyclization has shown great success toward generating active NT analogs targeting NTS1 (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). Indeed, head-to-tail (<b>M1</b> and <b>M2</b>), head-to-side-chain (<b>M3</b>, <b>M4</b>, and <b>M5</b>), and side-chain-to-side-chain (<b>M6</b> and <b>M7</b>) peptide cyclization of NT(8-13) have all provided macrocyclic analogs with relatively high affinities for NTS1, ranging from 16 nM to 3.5 μM.<a onclick="showRef(event, 'ref60 ref61 ref62 ref63'); return false;" href="javascript:void(0);" class="ref ref60 ref61 ref62 ref63">(60−63)</a> Of particular note, most of these cyclic analogs of NT(8-13) were found to behave as NTS1 agonists using <i>in vitro</i> functional assays (except <b>M7</b>, which seems to act as an antagonist).<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> Furthermore, <b>M2</b> and its dimeric counterpart <b>M8</b> showing similar binding affinity for both NTS1 and NTS2 (150 nM) were further found to exhibit <i>in vivo</i> biological activity, inducing hypothermic and analgesic effects following systemic administration.<a onclick="showRef(event, 'ref62 ref64'); return false;" href="javascript:void(0);" class="ref ref62 ref64">(62,64)</a> Recently, we searched for optimized macrocyclization sites on NT(8-13) and found that macrocycles formed via ring-closing metathesis (RCM) between the side chains of alkene-functionalized amino acid in position 8 and the <i>ortho</i> allylated tyrosine residue in position 11 of NT(8-13) (<b>M9</b>-<b>M12</b>) showed greatly improved plasma stability, high binding affinity toward both NTS1 and NTS2, and potent analgesic action <i>in vivo</i> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref65 ref66'); return false;" href="javascript:void(0);" class="ref ref65 ref66">(65,66)</a> In the present study, we report the synthesis and <i>in vitro</i> characterization of the first constrained NTS2-selective macrocyclic NT analog. We further provide evidence of its non-opioid antinociceptive properties in different types of pain and lack of hypothermia and hypotensive activity.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01726/20210218/images/medium/jm0c01726_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01726/20210218/images/large/jm0c01726_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Macrocyclic NT(8-13) analogs previously described in the literature. Data taken from ref <a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> (<b>M1</b>, <b>M3</b>, <b>M6</b>, and <b>M7</b>); ref <a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> (<b>M2</b>); ref <a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> (<b>M4</b>); ref <a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> (<b>M5</b>); ref <a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> (<b>M8</b>); ref <a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> (<b>M9</b>), and ref <a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> (<b>M10</b>, <b>M11</b>, and <b>M12</b>). K<sub>i</sub>’s for NTS1 are values reported in the original articles. For NTS2, K<sub>i</sub> values of <b>M9</b> to <b>M12</b> have never been published elsewhere.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01726/20210218/images/large/jm0c01726_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01726&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31561" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31561" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Alanine Scan of NT</h3><div class="NLM_p">In order to investigate which residues of NT(1-13) are important for binding to NTS1 and NTS2 and identify suitable sites for cyclization, an alanine scan was first performed. Alanine scanning has been proven successful in mapping essential amino acids in complex structures<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> and was therefore used here for NT as a way to explore the most important side chains for NTS2 selectivity. Every amino acid was successively replaced by <span class="smallcaps smallerCapital">l</span>-alanine to observe the impact on receptor binding affinity. Binding affinities at the human NT receptors were determined using [<sup>125</sup>I]-Neurotensin competitive radioligand binding assays with membranes from Chinese hamster ovary (CHO) cells stably expressing NTS1 or 1321N1 astrocytoma cells stably expressing NTS2 (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, <a href="/doi/suppl/10.1021/acs.jmedchem.0c01726/suppl_file/jm0c01726_si_002.pdf" class="ext-link">Table S1</a>, and <a href="/doi/suppl/10.1021/acs.jmedchem.0c01726/suppl_file/jm0c01726_si_002.pdf" class="ext-link">Figure S1</a>). According to previous findings showing that NT(8-13) possesses the full binding activity and <i>in vivo</i> potency of NT(1-13),<a onclick="showRef(event, 'ref14 ref68'); return false;" href="javascript:void(0);" class="ref ref14 ref68">(14,68)</a> replacing residues in the 1-7 moiety of NT(1-13) by alanine did not significantly change the binding affinity for either receptor and did not affect selectivity toward NTS2. In contrast, changes in the 8-13 fragment of NT significantly impacted both affinity and selectivity. Indeed, the substitution of amino acids 11, 12, or 13 by Ala decreased binding affinities at both NTS1 and NTS2 by at least 100-fold. In addition, terminal amidation of NT(1-13) showed a 10-fold decrease in receptor binding affinity. In general, these changes seem to affect NTS1 to a greater extent than NTS2, suggesting that the latter exhibits a more permissive binding pocket. These results are in accordance with the literature that shows the importance of residues Tyr<sup>11</sup>, Ile<sup>12</sup>, and Leu<sup>13</sup> for affinity, subtype selectivity, and functional activity.<a onclick="showRef(event, 'ref50 ref68 ref69'); return false;" href="javascript:void(0);" class="ref ref50 ref68 ref69">(50,68,69)</a></div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Alanine Scan of NT(1-13)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">K<sub>i</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">peptide</th><th class="colsep0 rowsep0" align="center">NTS1</th><th class="colsep0 rowsep0" align="center">NTS2</th><th class="colsep0 rowsep0" align="center" char=".">selectivity for NTS2</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NT(1-13)</td><td class="colsep0 rowsep0" align="left">3.3 ± 0.2</td><td class="colsep0 rowsep0" align="left">4.1 ± 0.8</td><td class="colsep0 rowsep0" align="right" char=".">0.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NT(1Ala)</td><td class="colsep0 rowsep0" align="left">2.0 ± 0.5</td><td class="colsep0 rowsep0" align="left">8.7 ± 3.1</td><td class="colsep0 rowsep0" align="right" char=".">0.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NT(2Ala)</td><td class="colsep0 rowsep0" align="left">2.4 ± 1.0</td><td class="colsep0 rowsep0" align="left">6.8 ± 1.6</td><td class="colsep0 rowsep0" align="right" char=".">0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NT(3Ala)</td><td class="colsep0 rowsep0" align="left">2.8 ± 1.0</td><td class="colsep0 rowsep0" align="left">8.7 ± 4.2</td><td class="colsep0 rowsep0" align="right" char=".">0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NT(4Ala)</td><td class="colsep0 rowsep0" align="left">1.8 ± 0.5</td><td class="colsep0 rowsep0" align="left">2.7 ± 1.1</td><td class="colsep0 rowsep0" align="right" char=".">0.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NT(5Ala)</td><td class="colsep0 rowsep0" align="left">2.4 ± 0.7</td><td class="colsep0 rowsep0" align="left">8.8 ± 1.6</td><td class="colsep0 rowsep0" align="right" char=".">0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NT(6Ala)</td><td class="colsep0 rowsep0" align="left">6.0 ± 3.3</td><td class="colsep0 rowsep0" align="left">9.3 ± 4.7</td><td class="colsep0 rowsep0" align="right" char=".">0.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NT(7Ala)</td><td class="colsep0 rowsep0" align="left">2.9 ± 0.7</td><td class="colsep0 rowsep0" align="left">4.6 ± 1.3</td><td class="colsep0 rowsep0" align="right" char=".">0.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NT(8Ala)</td><td class="colsep0 rowsep0" align="left">75 ± 7.9</td><td class="colsep0 rowsep0" align="left">95 ± 44</td><td class="colsep0 rowsep0" align="right" char=".">0.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NT(9Ala)</td><td class="colsep0 rowsep0" align="left">174 ± 21</td><td class="colsep0 rowsep0" align="left">10 ± 3.1</td><td class="colsep0 rowsep0" align="right" char=".">17</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NT(10Ala)</td><td class="colsep0 rowsep0" align="left">161 ± 32</td><td class="colsep0 rowsep0" align="left">16 ± 7.4</td><td class="colsep0 rowsep0" align="right" char=".">9.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NT(11Ala)</td><td class="colsep0 rowsep0" align="left">>10,000</td><td class="colsep0 rowsep0" align="left">590 ± 370</td><td class="colsep0 rowsep0" align="right" char=".">>17</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NT(12Ala)</td><td class="colsep0 rowsep0" align="left">210 ± 49</td><td class="colsep0 rowsep0" align="left">740 ± 270</td><td class="colsep0 rowsep0" align="right" char=".">2.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NT(13Ala)</td><td class="colsep0 rowsep0" align="left">>10,000</td><td class="colsep0 rowsep0" align="left">655 ± 520</td><td class="colsep0 rowsep0" align="right" char=".">>15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NT-NH2</td><td class="colsep0 rowsep0" align="left">43 ± 11</td><td class="colsep0 rowsep0" align="left">36 ± 19</td><td class="colsep0 rowsep0" align="right" char=".">1.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NT(8-12)</td><td class="colsep0 rowsep0" align="left">>100,000</td><td class="colsep0 rowsep0" align="left">620 ± 360</td><td class="colsep0 rowsep0" align="right" char=".">>160</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NT(8-12Leu)</td><td class="colsep0 rowsep0" align="left">>100,000</td><td class="colsep0 rowsep0" align="left">391 ± 87</td><td class="colsep0 rowsep0" align="right" char=".">>255</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Binding affinity and selectivity of NT(1-13) analogs. Results are expressed as Ki values ± SEM, which are the mean of three independent experiments. K<sub>i</sub> values were calculated using the Cheng–Prusoff equation<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> from IC<sub>50</sub> values determined based on displacement curves of [<sup>125</sup>I]-Neurotensin on hNTS1 and hNTS2 membranes shown in <a href="/doi/suppl/10.1021/acs.jmedchem.0c01726/suppl_file/jm0c01726_si_001.csv" class="ext-link">Figure S1</a>. Selectivity was calculated as the ratio of K<sub>i</sub> between hNTS1 and hNTS2.</p></div></div></div><div class="NLM_p last">Following the alanine scan, truncated linear NT analogs were also synthesized with the goal to identify a better scaffold for NTS2 selectivity. Critically, NT(8-12) (K<sub>i</sub> > 100 μM on NTS1 and 620 nM for NTS2) showed no receptor binding to NTS1 while maintaining its ability to bind NTS2 with similar affinity as NT(13Ala) (K<sub>i</sub> 655 nM, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> and <a href="/doi/suppl/10.1021/acs.jmedchem.0c01726/suppl_file/jm0c01726_si_002.pdf" class="ext-link">Figure S1</a>). These results are congruent with previous observations made on NT(1-12)<a onclick="showRef(event, 'ref68 ref69'); return false;" href="javascript:void(0);" class="ref ref68 ref69">(68,69)</a> and with the crystal structure of the NTS1-NT(8-13) complex, which shows that the Leu<sup>13</sup> residue of NT(8-13) is connected to Y324, R327, and R328 through a hydrogen bond network.<a onclick="showRef(event, 'ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref43 ref44">(43,44)</a> This result suggests that removing the C-terminal amino acid therefore emerges as a potential avenue to improve selectivity in favor of NTS2. Furthermore, replacement of Ile<sup>12</sup> by Leu (K<sub>i</sub> 391 nM for NTS2 vs >100 μM for NTS1) also showed a greater effect on receptor selectivity, suggesting a potential role of steric hindrance surrounding the β position of amino acid in position 12. Residues 12 and 13 therefore emerge as a primary target toward the discovery of NT analogs selective for NTS2 since it disproportionally affects NTS1 affinity compared to NTS2. Following the identification of NT(8-12Leu) as a promising scaffold, we designed a series of macrocyclic peptides in order to synthesize constrained NTS2-selective compounds. Contextually, this is a paradigm shift in the field of NT since most optimization studies have been based on the C-terminal fragment 8-13, which is the minimal pharmacophoric element that conserves the pharmacological properties of NT.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> The crucial role played by the tyrosine residue at position 11 in macrocyclic structure will also require further study. Indeed, as previously demonstrated using unnatural amino acids,<a onclick="showRef(event, 'ref24 ref48 ref49 ref50 ref51 ref52 ref53 ref54 ref55'); return false;" href="javascript:void(0);" class="ref ref24 ref48 ref49 ref50 ref51 ref52 ref53 ref54 ref55">(24,48−55)</a> the alanine scan also reveals that modification of NT at Tyr<sup>11</sup> is detrimental for NTS1, thus increasing the selectivity toward NTS2.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Chemistry/Design and Synthesis</h3><div class="NLM_p">Macrocyclic peptides were synthetized using Fmoc-based solid phase peptide synthesis (SPPS) on 2-chlorotrityl chloride resin following standard procedures (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a> and <a href="/doi/suppl/10.1021/acs.jmedchem.0c01726/suppl_file/jm0c01726_si_002.pdf" class="ext-link">Table S1</a>).<a onclick="showRef(event, 'ref65 ref66'); return false;" href="javascript:void(0);" class="ref ref65 ref66">(65,66)</a> Cyclization was performed on resin using ring-closing metathesis (RCM) between two allylglycine residues, using the Hoveyda–Grubbs second-generation catalyst based on its stability and tolerance to diverse functional groups.<a onclick="showRef(event, 'ref65 ref66'); return false;" href="javascript:void(0);" class="ref ref65 ref66">(65,66)</a> Yields for the RCM step were assessed by UPLC-MS to be around 70%.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01726/20210218/images/medium/jm0c01726_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01726/20210218/images/large/jm0c01726_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Solid phase synthesis of the reference compound <b>4</b>. (a) Fmoc-Leu-OH, DIPEA, DCM, rt, 2 h. (b) Piperidine 20% DMF, rt, 2 x 5 min. (c) 1. Fmoc-Tyr(tBu)-OH, DIPEA, DMF, rt, 30 min; 2. Fmoc-AllylGly-OH, DIPEA, DMF, rt, 30 min; 3. Fmoc-Lys(Boc)-OH, DIPEA, DMF, rt, 30 min; 4. Fmoc-Lys(Boc)-OH, DIPEA, DMF, rt, 30 min ;5. Boc-AllylGly-OH, DIPEA, DMF, rt, 30 min. (d) Grubbs–Hoveyda second-generation 0.2 eq, DCE, microwave, 70 °C, 1 h. (e) TFA/TIPS/H<sub>2</sub>O 95/2.5/2.5%, rt, 2 h.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01726/20210218/images/large/jm0c01726_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01726&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Our first approach was to replace turn-inducing proline residues 7 and 10 by allylglycine residues to mediate cyclization. With the presence of these two proline residues, known to induce secondary structure changes in peptides, it was thought that macrocyclic restriction on these positions may similarly mimic turn structures and promote a productive conformation for NTS2 receptor binding.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> Given the results of the alanine scan, which show a retention of selectivity when mutating the C-terminus of the peptide, we kept macrocyclization invariant while varying the C-terminal end. Being the natural amino acids found in NT, leucine and isoleucine residues were either used in positions 12 and 13 or deleted in position 13 (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). The resulting macrocycles <b>1</b> (Ile12 and Leu13) and <b>2</b> (Leu12 and Ile13) did not show any affinity (K<sub>i</sub> > 10 μM) for either receptor. Importantly, compound <b>4</b>, truncated at position 13 and with the Ile12Leu replacement, displayed good affinity for NTS2 and not for NTS1 (K<sub>i</sub> 50 nM for NTS2; selectivity >1600 vs NTS1; <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> and <a href="/doi/suppl/10.1021/acs.jmedchem.0c01726/suppl_file/jm0c01726_si_002.pdf" class="ext-link">Figure S2</a>), congruent with the alanine-scan results of NT(8-12Leu) (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Just as remarkably, its isomer with Ile in position 12 shows no binding to NTS2 (<b>3</b>, K<sub>i</sub> > 10 μM).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Cyclization Sites, Binding Affinity, and Selectivity of Macrocyclic NT(8-13) Peptide Analogs at Both hNTS1 and hNTS2<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01726/20210218/images/medium/jm0c01726_0008.gif" alt="" id="gr7" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Results are expressed as K<sub>i</sub> value ± SEM as the mean of three independent experiments. K<sub>i</sub> values were calculated using the Cheng–Prusoff equation<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> from IC<sub>50</sub> values determined based on displacement curves of [<sup>125</sup>I]-Neurotensin on hNTS1 and hNTS2 membranes shown in <a href="/doi/suppl/10.1021/acs.jmedchem.0c01726/suppl_file/jm0c01726_si_002.pdf" class="ext-link">Figure S2</a>. Selectivity was calculated as the ratio of K<sub>i</sub> between hNTS1 and hNTS2. *Not based on NT notation.</p></div></div><div></div></div><div class="NLM_p">Several additional macrocycles were synthesized with the goal to delineate the structure–activity relationship (SAR) of compound <b>4</b>. Other macrocyclization sites were first explored in order to test whether the secondary structure could be further modulated toward NTS2 selectivity. Newly synthesized compounds <b>5</b> and <b>7</b> did not possess affinity on NTS2 (K<sub>i</sub> > 10 μM), while macrocycle <b>6</b> showed a significant loss but still activated the receptor (K<sub>i</sub> 1.3 μM). Insertion of the proline residue at position 10 at either allylglycine site (<b>8</b> and <b>9</b>) did not improve binding affinity compared to compound <b>4</b>. <b>8</b> showed a modest 4-fold decrease in binding affinity compared to <b>4</b> (K<sub>i</sub> 0.2 μM compared to 0.05 μM), while <b>9</b> exhibited a more drastic 50-fold decrease in affinity (K<sub>i</sub> 2.5 μM). We did not continue investigations on those molecules since their binding affinity was lower than that of compound <b>4</b>.</div><div class="NLM_p">The affinity benefits of macrocyclization in this position could be interpreted as a conformational restriction of the backbone around Lys<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> and Lys<sup>10</sup>. This decrease in entropy could favor a certain sub-population of conformers around Lys<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> and Lys<sup>10</sup>, which could in turn facilitate interactions with residues at the entry of the binding site of NTS2. The absence of binding on NTS1 suggests that the presence of Arg212 in extracellular loop 2 (ECL2) could be of a great importance. Indeed, Arg212 is known to be an important residue for the binding process,<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> but considering the restriction of both lysine residues, it is possible that this interaction becomes detrimental. On the contrary, the same residue in NTS2 is mutated to Glu179, which could positively interact with constrained Lys<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> and Lys<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> and favor binding to NTS2.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> Both lysine residues are known to point toward the entry of the ligand binding site, which could force interactions with the amino acid in position 179 and be beneficial in the case of NTS2.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> In addition, the massive impact of Leu vs Ile in position 12 could possibly be interpreted in terms of steric hindrance and limited rotation of β-branching (Ile) vs γ-branching (Leu).</div><div class="NLM_p last">Additional macrocycles were further synthesized to refine the SAR of macrocycle <b>4</b>. Compounds <b>10</b>–<b>12</b> were prepared using <span class="smallcaps smallerCapital">d</span>-allylglycine on either or both positions 7 and 10 (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Replacement of <span class="smallcaps smallerCapital">l</span>-allyglycine for its <span class="smallcaps smallerCapital">d</span>-stereoisomer in positions 7 and 11 individually and together was detrimental to binding affinity, except in position 7 where it had a less negative impact on NTS2 binding (<b>11</b>, K<sub>i</sub> 0.1 μM vs <b>4</b>, K<sub>i</sub> 0.05 μM), suggesting that <span class="smallcaps smallerCapital">l</span>-allylglycine offers optimal stereochemistry to maximize NTS2 binding (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> and <a href="/doi/suppl/10.1021/acs.jmedchem.0c01726/suppl_file/jm0c01726_si_002.pdf" class="ext-link">Figure S2</a>). Reduction of the linker via hydrogenation (compound <b>13</b>) had a marginal impact on binding (K<sub>i</sub> 90 vs 50 nM), suggesting that linker flexibility is not very important for NTS2 binding. Finally, replacement of <span class="smallcaps smallerCapital">l</span>-allylglycine by <span class="smallcaps smallerCapital">l</span>-cysteine residues macrocyclized via a disulfide bridge produced significant reduction in binding affinity (<b>14</b>, K<sub>i</sub> 1.5 μM vs <b>4</b>, K<sub>i</sub> 50 nM). It could be hypothesized that either lipophilicity or change in steric hindrance may be detrimental for NTS2 receptor binding.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Stability in Plasma and Cerebrospinal Fluid</h3><div class="NLM_p">Metabolic stability of the most promising NTS2-selective macrocycle (compound <b>4</b>) was then assessed at 37 °C in plasma and cerebrospinal fluid (CSF) of naive rats, analyzing compound degradation by UPLC-MS (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a> and <a href="/doi/suppl/10.1021/acs.jmedchem.0c01726/suppl_file/jm0c01726_si_002.pdf" class="ext-link">Figure S3</a>). As previously observed, degradation of the native neurotensin peptide was very fast in plasma, with a half-life estimated of 1.6 ± 0.2 min.<a onclick="showRef(event, 'ref65 ref72'); return false;" href="javascript:void(0);" class="ref ref65 ref72">(65,72)</a> However, its stability in CSF was superior, evaluated at 14.9 ± 3.0 h. This difference in half-life can be explained by the lower proteolytic activity in CSF compared to plasma.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> Compound <b>4</b> showed increased plasma and CSF stability, reaching 15.0 ± 2.6 min and >24 h, respectively. This 15-fold increase in plasma half-life is probably due to macrocyclization, which is thought to induce a different secondary structure than the rapidly degraded beta-strand.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> This cyclization also happens to be surrounding a known dibasic Lys<sup>8</sup>-Lys<sup>9</sup> degradation site,<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> which has already been successfully protected by other chemical approaches, notably amide bond reduction<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> or incorporation of the unnatural amino acid β<sup>3</sup>hLys in position 8.<a onclick="showRef(event, 'ref24 ref77 ref78'); return false;" href="javascript:void(0);" class="ref ref24 ref77 ref78">(24,77,78)</a> However, the stability of compound <b>4</b> is not optimal and can be further improved. Indeed, previous findings demonstrated that NT is rapidly degraded mainly between Arg<sup>8</sup>-Arg<sup>9</sup> but also between Pro<sup>10</sup>-Tyr<sup>11</sup> and Tyr<sup>11</sup>-Ile<sup>12</sup> by a combination of three metalloendopeptidases, EC 3.4.24.11 (also known as neprilysin), EC 3.4.24.15 (Thimet oligopeptidase), and EC 3.4.24.16 (neurolysin).<a onclick="showRef(event, 'ref79 ref80 ref81'); return false;" href="javascript:void(0);" class="ref ref79 ref80 ref81">(79−81)</a> The Pro<sup>10</sup>-Tyr<sup>11</sup> site may already be protected by steric hindrance of the ring, unlike Tyr<sup>11</sup>-Ile<sup>12</sup>. Further work could be done in order to optimize plasma stability of macrocycle <b>4</b>.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Stability in Rat Plasma and Cerebrospinal Fluid (CSF) of Compound <b>4</b><a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center" char="±"><i>t</i><sub>1/2</sub> in plasma (min)</th><th class="colsep0 rowsep0" align="center"><i>t</i><sub>1/2</sub> in CSF (h)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NT(8-13)</td><td class="colsep0 rowsep0" align="char" char="±">1.6 ± 0.2</td><td class="colsep0 rowsep0" align="left">14.9 ± 3.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="char" char="±">15.0 ± 2.6</td><td class="colsep0 rowsep0" align="left">>24</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Half-life (<i>t</i><sub>1/2</sub>) was calculated as the disappearance of half of the compound determined by UPLC-MS.</p></div></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Analgesic Properties</h3><div class="NLM_p">The antinociceptive effect of compound <b>4</b> was first tested in an acute thermal nociceptive test. Measurement of its ability to increase the latency of the tail-flick response to thermal noxious stimuli was observed following intrathecal (i.t.) injection to Sprague-Dawley rats of increasing doses of macrocycle <b>4</b> ranging from 10 to 150 μg/kg (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). We found that i.t. delivery of <b>4</b> elicited a dose-dependent increase in tail-flick latency compared to saline-treated rats, demonstrating its antinociceptive properties (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A). Peak analgesic responses consistently occurred 10 min after injection of <b>4</b>, while the highest doses of 90 and 150 μg/kg induced maximal elevation of the tail-flick threshold, reaching the predetermined 10 s cutoff time. Indeed, the analgesic efficacy of <b>4</b>, expressed as the % of maximal possible effect (MPE), reached 13.1%, 32.5%, 73.1%, 98.6%, and 98.5% at doses of 10, 30, 60, 90, and 150 μg/kg, respectively (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B). The resulting 50% effective dose (ED<sub>50</sub>) was estimated at 43.8 μg/kg (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>C). For comparison purposes, the analgesic potency of macrocycle <b>4</b> was similar to that of other NTS2-selective linear NT(8-13) analogs, such as JMV431 (Boc-Arg-Arg-Pro-Tyr-ψ(CH<sub>2</sub>NH)-Ile-Leu-OH) or NT79 (N<sup>α</sup>MeArg-Arg-Pro-<span class="smallcaps smallerCapital">d</span>-3,1-Nal-tLeu-Leu).<a onclick="showRef(event, 'ref82 ref83'); return false;" href="javascript:void(0);" class="ref ref82 ref83">(82,83)</a> In the same experimental pain paradigm, compound <b>4</b> was, however, less potent than the macrocyclic analog <b>M12</b>, which exhibits an ED50 of 4.6 μg/kg (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> Nevertheless, the analgesic efficacy of <b>4</b> was considerably higher than that of <b>M12</b>, inducing maximal elevation of the tail-flick threshold at the highest dose tested (98.5% MPE) compared to 50% MPE for <b>M12</b>. These differences in analgesic response might be explained by the ability of <b>M12</b> to bind to both NTS1 (K<sub>i</sub> 15 nM) and NTS2 (K<sub>i</sub> 4.5 nM) receptors.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> In the same radiant heat tail-flick test, subcutaneous administration of morphine produced a dose-dependent antinociceptive effect with an ED<sub>50</sub> of 3.6 mg/kg, achieving 83.3% MPE at the highest dose tested (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>D–F). However, the analgesic efficacy of morphine observed at 10 mg/kg was accompanied by unfavorable side effects, such as drowsiness, constipation, and respiratory depression. Importantly, we also found here that the analgesic effect of <b>4</b> was not reversed by the opioid antagonist, naloxone (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>G,H). This is in accordance with previous studies demonstrating that NT-induced analgesia operates independently of opioid receptor activity.<a onclick="showRef(event, 'ref18 ref19 ref22 ref23 ref84'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref22 ref23 ref84">(18,19,22,23,84)</a></div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01726/20210218/images/medium/jm0c01726_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01726/20210218/images/large/jm0c01726_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Analgesic effects of compound <b>4</b> and morphine on tail-flick latencies in Sprague-Dawley rats. (A) Time course of the analgesic effect of an acute intrathecal injection of <b>4</b> from doses ranging from 10 to 150 μg/kg. (B) Percentage of maximal possible effect (%MPE) calculated at the maximal antinociceptive response for each dose. (C) Determination of the analgesic effective dose (ED<sub>50</sub>). (D) Dose–response curve for s.c. morphine from 1 to 10 mg/kg, (E) %MPE, and (F) ED<sub>50</sub>. (G, H) Naloxone’s ability to antagonize (10 mg/kg, intraperitoneal) the analgesic effect of macrocycle <b>4</b>. Results are expressed as mean ± SEM (<i>N</i> = 5/group). For time courses (A, D, G), comparisons between saline and compounds at different doses were performed using a two-way ANOVA with repeated measures followed by multiple comparisons using Dunnett’s correction. For the %MPE (B, E, H), comparisons were performed using a one-way ANOVA with repeated measures followed by multiple comparisons using Dunnett’s correction between saline and compound <b>4</b> or morphine at different doses and nonlinear regression using four parameters. *<i>p</i> < 0.05, **<i>p</i> < 0.01, ***<i>p</i> < 0.001, ****<i>p</i> < 0.0001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01726/20210218/images/large/jm0c01726_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01726&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The antinociceptive effect of compound <b>4</b> was also evaluated in acute (formalin) and chronic inflammatory (complete Freund’s adjuvant, CFA) pain models. Following intraplantar injection of formalin into the right hind paw of saline-pretreated rats, a biphasic nociceptive behavioral response is observed, characterized by an acute phase (0–9 min) followed by a sustained inflammatory phase. Formalin-induced pain-related behaviors were quantified for the two phases by monitoring the duration of the nociceptive behavioral episodes, such as lifting, licking, biting, and shaking of the right injected hind paw.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> Herein, we assessed the ability of compound <b>4</b> in reducing the formalin-evoked lifting behaviors, a stereotypical nociceptive response previously associated to NTS2 activation (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>).<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> Our results revealed that compound <b>4</b> significantly reduced the formalin-induced pain behaviors in both acute and inflammatory phases, as previously shown with either NTS1, NTS2, or non-selective NT receptor agonists.<a onclick="showRef(event, 'ref17 ref24 ref26 ref86 ref87 ref88'); return false;" href="javascript:void(0);" class="ref ref17 ref24 ref26 ref86 ref87 ref88">(17,24,26,86−88)</a></div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01726/20210218/images/medium/jm0c01726_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01726/20210218/images/large/jm0c01726_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Analgesic effect of acute intrathecal injection of 30 to 150 μg/kg compound <b>4</b> or of ziconotide (1 μg/kg) on formalin-evoked pain-related behaviors in Sprague-Dawley rats. The nociceptive response was determined for both acute (A) and inflammatory phases (B). Results are expressed as mean ± SEM (<i>N</i> = 5–6/group). Comparisons between saline, ziconotide, and macrocycle <b>4</b> at different doses were performed using one-way ANOVA with repeated measures followed by multiple comparisons using Dunnett’s correction. *<i>p</i> < 0.05, **<i>p</i> < 0.01.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01726/20210218/images/large/jm0c01726_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01726&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">For comparison purposes, we used the macrocyclic drug ziconotide (also called Prialt or SNX-111), an approved non-opioid analgesic derived from a cone snail (<i>Conus magus</i>) that acts as a selective neuronal N-type voltage-sensitive calcium channel blocker.<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> We have tested this potent and stable cyclic conotoxin since its administration via the intrathecal and epidural routes is used for the management of severe chronic pain, particularly in cancer patients who are intolerant or refractory to systemic analgesics or to intrathecal morphine.<a onclick="showRef(event, 'ref90 ref91 ref92'); return false;" href="javascript:void(0);" class="ref ref90 ref91 ref92">(90−92)</a> At the dose used clinically (1 μg/kg), ziconotide was found here to be as effective as macrocycle <b>4</b> in inhibiting the formalin-induced nociceptive responses (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). As opposed to <b>4</b>, we, however, observed transient and reversible adverse effects following administration of ziconotide, such as dizziness, drowsiness, tremoring, ataxia, abnormal gait, and hyperactivity. These adverse events are also frequently reported in humans. In addition, ziconotide is also contraindicated in patients with pre-existing neuropsychiatric disorders and a history of cardiovascular disease.<a onclick="showRef(event, 'ref91 ref92 ref93 ref94'); return false;" href="javascript:void(0);" class="ref ref91 ref92 ref93 ref94">(91−94)</a></div><div class="NLM_p">We next assessed the antiallodynic effect of compound <b>4</b> in a chronic inflammatory pain model. To this end, mechanical allodynia was monitored using the von Frey test on days 3, 7, and 14 following unilateral injection of CFA into the plantar surface of the rat’s hind paw. Three days after CFA injection, the paw withdrawal threshold was significantly reduced compared to sham animals, indicating the presence of mechanical hypersensitivity (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A). Intrathecal injection of compound <b>4</b> on days 7 and 14 resulted in an increased paw withdrawal threshold compared to saline-treated rats, producing antiallodynic effects up to 45% at 150 μg/kg (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B,C). To our knowledge, this study is the first to demonstrate that activation of NTS2 receptors reduces the nociceptive behaviors to persistent inflammatory pain in a CFA-induced chronic inflammatory pain model.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01726/20210218/images/medium/jm0c01726_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01726/20210218/images/large/jm0c01726_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Antiallodynic effect of intrathecal injection of compound <b>4</b> at 150 μg/kg on days 7 and 14 in a model of chronic inflammatory pain induced by intraplantar injection of complete Freund’s adjuvant (CFA) in Sprague-Dawley rats (A). Percentage of antiallodynic effect was determined at the maximal analgesic effect, 10 min post-injection, on day 7 (B) and 14 (C). Results are expressed as mean ± SEM (<i>N</i> = 6/group). For the time course, comparisons between sham animals and CFA rats treated with saline (#) or between CFA rats receiving either saline or compound <b>4</b> (*) were performed on days 3, 7, and 14 using a two-way analysis of variance for repeated measures followed by multiple comparisons using Dunnett’s correction and comparisons. For the % of antiallodynic effect determined on days 7 and 14, comparisons between sham animals and CFA rats treated with saline (#) or CFA rats receiving either saline or <b>4</b> (*) were performed using one-way analysis of variance for repeated measures followed by multiple comparisons using Dunnett’s correction. **<i>p</i> < 0.01, ****<i>p</i> < 0.0001, ####<i>p</i> < 0.0001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01726/20210218/images/large/jm0c01726_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01726&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Other Physiological Effects</h3><div class="NLM_p">Although NT analogs exert potent analgesic actions, they are also responsible for other physiological effects, which include hypotension, hypothermia, and modulation of gastrointestinal motility.<a onclick="showRef(event, 'ref31 ref32 ref33 ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref31 ref32 ref33 ref34 ref35">(31−35)</a> These peripheral and central effects, shown to be mediated by NTS1 receptors using knockout mice (NTS1<sup>–/–</sup>),<a onclick="showRef(event, 'ref95 ref96 ref97'); return false;" href="javascript:void(0);" class="ref ref95 ref96 ref97">(95−97)</a> could represent serious limitations for the development of novel pain therapies. Here, we thus determined if compound <b>4</b>, selective for the NTS2 receptor subtype, was devoid of these potential adverse effects.</div><div class="NLM_p">We first injected compound <b>4</b> to Sprague-Dawley rats and monitored variations in arterial blood pressure (ΔMABP) via direct and continuous intracarotid measurement (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A). As opposed to NT(8-13), which was found to produce a sharp and sustained drop in blood pressure, reaching up to 50 mmHg at 0.1 mg/kg, intravenous (i.v.) administration of <b>4</b> did not provoke hypotensive action. Even at 1 mg/kg i.v., compound <b>4</b> displayed only a slight and short-lasting hypertensive effect on blood pressure. This reflex response might be due to the stimulation of aortic and carotid baroreceptors of the autonomic nervous system or norepinephrine release in blood vessels, as previously reported following NT administration.<a onclick="showRef(event, 'ref32 ref98'); return false;" href="javascript:void(0);" class="ref ref32 ref98">(32,98)</a> We next investigated whether compound <b>4</b> was able to induce change in body temperature following central administration (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B). In contrast to the NTS1-selective agonist PD149163 (30 μg/kg), which led to strong and persistent hypothermia, with a temperature drop of 3 °C following i.t. delivery, compound <b>4</b> injected at the highest dose (150 μg/kg) did not induce drop in body temperature. Finally, we determined whether compound <b>4</b> was able to modulate the intestinal smooth muscle contractions in isolated organ bath (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>C). No change in <i>ex vivo</i> ileum contractile activity was noticed for compound <b>4</b> compared to NT(8-13), which dose-dependently induced ileum relaxation (EC<sub>50</sub> = 3.9 nM), in accordance with previous findings.<a onclick="showRef(event, 'ref99 ref100'); return false;" href="javascript:void(0);" class="ref ref99 ref100">(99,100)</a></div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01726/20210218/images/medium/jm0c01726_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01726/20210218/images/large/jm0c01726_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effect of compound <b>4</b> on blood pressure, body temperature, and smooth muscle contraction. (A) Delta mean arterial blood pressure (ΔMABP) recorded after intravenous injection of NT(8-13) at 0.1 mg/kg or compound <b>4</b> at 0.01, 0.1, or 1 mg/kg to Sprague-Dawley rats. (B) Variation in body temperature measured after intrathecal injection of saline, NTS1-selective PD149163 at 30 μg/kg or compound <b>4</b> at 150 μg/kg. (C) Percentage of ileum relaxation monitored following incubation with increasing concentrations of NT(8-13) or compound <b>4</b> ranging from 10<sup>–11</sup> to 10<sup>–5</sup> M. Results are expressed as mean ± SEM (<i>N</i> = 5–6/group). For body temperature, comparisons between saline and PD149163 or <b>4</b> were performed using a two-way analysis of variance for repeated measures followed by multiple comparisons using Dunnett’s correction. Nonlinear regression using three parameters was performed for % of ileum relaxation. NT(8-13) EC<sub>50</sub> value was obtained from the resulting dose–response curve. ***<i>p</i> < 0.001, ****<i>p</i> < 0.0001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01726/20210218/images/large/jm0c01726_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01726&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30134" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30134" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In the current study, we thus designed and synthesized a series of new NT macrocyclic analogs in order to explore the chemical space associated with NT receptor binding. Various side chain-to-side chain macrocyclizations were performed, and only the ring closure between the two amino acids surrounding the lysine residues 8 and 9 was effective in retaining high-affinity to NTS2. Moreover, replacement of the C-terminal Ile<sup>12</sup>-Leu<sup>13</sup> residues by Leu<sup>12</sup> was well tolerated by NTS2 while being detrimental to NTS1. This could possibly be interpreted by a more permissive NTS2 binding pocket and a lack of flexibility of the NTS1 receptor around amino acid 12. This is translated by a significant reduction in binding affinity of compound <b>3</b> compared to <b>4</b> and could be attributed to the steric hindrance around the β position of amino acid in position 12. The rigidity induced by macrocyclization also seems to favor the positioning of the lysine residues 8 and 9, which are very important for NT receptor binding, since the reduced form of RCM (i.e., <b>13</b>) did not result in improved NTS2 receptor binding affinity. The use of RCM based on <span class="smallcaps smallerCapital">l</span>-allylglycine was optimal in restraining lysine residues in a suitable position for NTS2 binding since their enantiomers in either position were found to affect NTS2 binding. The conformational changes in the peptide’s secondary structure also protected the dibasic Lys-Lys cleavage site from proteolytic degradation. More analogs will need to be synthesized in order to further explore the implication of β-branching (compound <b>3</b>) compared to γ-branching (compound <b>4</b>) in binding affinity toward NTS2.</div><div class="NLM_p last">Finally, our results demonstrate that this constrained NTS2-selective macrocyclic analog was effective in reversing the thermal, chemical, and mechanical nociceptive behaviors in three distinct rodent pain models, without causing the usual undesired effects associated with NTS1 activation, i.e. hypotension, hypothermia, or ileum relaxation. Importantly, the analgesic effect of compound <b>4</b> was found to be mediated by an opioid-independent mechanism. Further studies are ongoing to more precisely understand the SAR and optimize their pharmacokinetic profile. Indeed, previously published literature suggests that metabolically stable NT analogs could produce central effects, including antinociception and hypothermia, probably through the increased blood circulation time, hence enhancing the blood–brain barrier penetration.<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a> Altogether, we report here the synthesis of the first highly selective constrained macrocyclic NTS2 analog. Our results further highlight the strong therapeutic potential of NTS2-selective analogs, therefore offering a non-opiate pharmacotherapy option for the management of acute and chronic pain.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40761" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40761" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Peptide Synthesis</h3><div class="NLM_p">Peptides were synthesized on solid phase using standard Fmoc chemistry using 200 mg of 2-chlorotrityl chloride resin (100–200 mesh dry, 0.25 mmol/g) from Matrix Innovation. All commercially available Fmoc-protected amino acid were purchased from Chem-Impex and Matrix Innovation at the highest purity available. Other reagents (coupling reagents, base) and solvents were purchased from Chem-Impex, Matrix Innovation, or Sigma-Aldrich and were used as received. Peptide synthesis was performed on an orbital shaker at 150 rpm in 6 mL polypropylene reactors with 20 μm frit purchased from Applied Separations.</div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> Standard Resin Wash Procedures</h4><div class="NLM_p last">After each step, the resin was washed for 1 min using alternating 5 mL volumes of DMF (x2), DCM (x2), <i>i</i>PrOH, DCM (x2), and DMF (x2). When a dried resin was needed, two additional washes with DCM or Et<sub>2</sub>O were performed followed by at least 5 min drying <i>in vacuo</i>.</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> Loading of the First Amino Acid</h4><div class="NLM_p last">The resin and the first amino acid (1 eq. based on nominal loading, typically 0.25 mmol/g) were added to a 6 mL reactor. Five milliliters of DCM was then added and stirred for 5 min or until the amino acid was completely dissolved. 2 eq. of diisopropylethylamine (DIPEA) was added to the mixture, which was then placed on the orbital shaker to react for 2 h or overnight. Unreacted sites on the resin were then capped with 5 mL of a 7/2/1 mixture of DCM/MeOH/DIPEA for 45 min. Standard wash procedure was applied.</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> Fmoc Deprotection</h4><div class="NLM_p last">Fmoc deprotection was performed by adding 5 mL of a 20% solution of piperidine in DMF for 5 min, repeated once. Standard wash procedure was applied.</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> Coupling of Standard Amino Acids</h4><div class="NLM_p last">A 5 eq. solution of Fmoc-protected amino acid and 5 eq. of hexafluorophosphate azabenzotriazole tetramethyluronium (HATU) were added to 5 mL of DMF and allowed to dissolve, sometimes with the help of sonication. The mixture was then added to the washed resin, and 6 eq. of DIPEA was added. The reactor was sealed, the internal pressure was released after gentle hand shaking once or twice, and then it was placed on the orbital shaker for 30–60 min.</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> Coupling of Expensive Amino Acids</h4><div class="NLM_p last">A 2 eq. solution of Fmoc-protected amino acid and 2 eq. of HATU were added to 5 mL of DMF and allowed to dissolve, sometimes with the help of sonication. The mixture was then added to the washed resin, and 3 eq. of DIPEA were added. The reactor was sealed, the internal pressure was released after gentle hand shaking once or twice, and then it was placed on the orbital shaker for at least 2 h, sometimes overnight.</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> Ring-Closing Metathesis</h4><div class="NLM_p last">To a flame-dried microwave vial with a stir bar was added 0.2 eq. of Hoveyda–Grubbs second-generation catalyst, 1 eq. of <i>p</i>-benzoquinone, and the previously dried resin. The solid mixture was then degassed with Ar for 10 min before adding 3 mL of DCE. The mixture was then subjected to microwave irradiation for 1 h at 70 °C on a CEM Discover microwave.</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> Peptide Cleavage</h4><div class="NLM_p last">The previously dried resin was transferred to a glass vial to which was added 4 mL of a solution of TFA, water, and triisopropylsilane (95/2.5/2.5) and then shaken for 2 h. The mixture was filtered over a cotton plug into 30 mL of ice-cold methyl <i>tert</i>-butyl ether (MTBE), resulting in compound precipitation. The mixture was centrifuged at 3000 rpm at 4 °C for 10 min. The remaining supernatant was analyzed by UPLC to confirm the absence of peptides in the organic phase and then was discarded. The crude precipitate was evaporated <i>in vacuo</i>.</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> Lyophilization</h4><div class="NLM_p last">When lyophilized molecules were needed (after final purification, before disulfide bridge formation, etc.), the crude peptide was solubilized in a mix 1:1 of H<sub>2</sub>O:ACN and subsequently frozen in glass or polyethylene (PE) vials. The vials were slightly opened, and the PE tubes were perforated on the cap in order to let the gasses evacuate during lyophilization. The vials were put under vacuum until completely lyophilized, resulting in a solid.</div></div><div id="sec4_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> Disulfide Bridge Formation (Cys-Containing Macrocycles)</h4><div class="NLM_p last">To the previously cleaved and lyophilized peptide was added 1 mL/mg of a 70% AcOH aqueous solution, and the mixture was stirred until full dissolution. To this solution, under stirring, was added dropwise a solution of 10% I<sub>2</sub> in MeOH until the solution remained yellow. The mixture was then frozen and lyophilized twice until a solid was obtained.</div></div><div id="sec4_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> Peptide Purification and HRMS Analysis</h4><div class="NLM_p">To the previously lyophilized peptide was added 1.8 mL of 50% ACN in water. The following solution was then injected on a Waters preparative HPLC-MS (column XSELECTTM CSHTM Prep C18 (19 × 100 mm) packed with 5 μm particles, UV detector 2998, MS SQ Detector 2, Sample manager 2767, and binary gradient module). Eluents used were acetonitrile containing 0.03% aqueous ammonia and water containing 20 mM ammonium carbonate.</div><div class="NLM_p last">A first run was done with the above eluents and the following method: 5% ACN to 95% ACN (0 → 10 min) in order to assess the optimal %ACN for product elution. A second run was made using the following eluent: [(%ACN) – 10 → (%ACN) + 5] (0 → 15 min). Fractions collected were analyzed on a Waters UPLC-MS system (column Acquity UPLC CSHTM C18 (2.1 × 50 mm) packed with 1.7 μm particles) using ACN and water + 0.1% formic acid. The method used was 0 → 0.2 min: 5% ACN; 0.2 → 1.5 min: 5% → 95% ACN; 1.5 → 1.8 min: 95% ACN; 1.8 → 2.0 min: 95% → 5% ACN; 2.0 → 2.5 min: 5% ACN. Pure fractions were pooled and lyophilized. All compounds possess ≥95% purity as determined by UPLC-MS. HRMS spectra of the peptides were recorded using a maXis ESI-Q-TOF with ESI in positive mode.</div></div><div id="sec4_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> Double Bond Reduction (Compound <b>13</b>)</h4><div class="NLM_p last">To the previously purified peptide was added 0.1 mL/mg MeOH. A 1 eq. solution of palladium hydroxide was added. The mixture was then placed in a pressure hydrogen vessel under 100 psi of hydrogen pressure and stirred overnight. The mixture was then evaporated, resolubilized using 50% ACN/H<sub>2</sub>O, filtered, and purified on the previously described prep-MS.</div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Competitive Radioligand Binding Assay on the hNTS1 and hNTS2 Receptors</h3><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> Membrane Cell Preparation</h4><div class="NLM_p last">CHO-K1 cells stably expressing hNTS1 (ES-690-C from PerkinElmer, Montréal, Canada) or 1321N1 cells stably expressing hNTS2 (ES-691-C from PerkinElmer, Montréal, Canada) were cultured in DMEM/F12 culture medium at 37 °C in a humidified chamber under 5% CO<sub>2</sub>. Culture media were supplemented with 10% FBS, 100 U/mL penicillin, 100 μg/mL streptomycin, 20 mM HEPES, and 0.4 mg/mL G418. Cells were frozen upon reaching 80% confluency. Those expressing hNTS1 were scrapped off the dish on ice with 10 mM Tris buffer and 1 mM EDTA at pH 7.5 and centrifuged at 15,000<i>g</i> for 5 min at 4 °C. The pellet was then re-suspended in 1 mL of binding buffer (50 mM Tris-HCl, pH 7.5, 0.2% BSA). Those expressing hNTS2 were scraped off the dish with PBS and 0.5 mM EDTA at pH 7.5 and then sonicated for 5 min (pulse 30 s/5 s off, amplitude 40%) and ultracentrifuged at 100,000<i>g</i> for 60 min at 4 °C. The pellet was re-suspended in 1 mL of ice-cold buffer (PBS, glycerol, 0.5 mM EDTA), sonicated for 1 min (pulse 30 s/5 s off, amplitude 50%), and further diluted in binding buffer.</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> Radioligand Binding Assay</h4><div class="NLM_p last">Competitive radioligand binding experiments were performed by pre-incubating 15 μg of cell membranes expressing the hNTS1 receptor with 45 pM <sup>125</sup>I-[Tyr<sup>3</sup>]-NT (2200 Ci/mmol) or 50 μg of cell membranes expressing the hNTS2 receptor with 300 pM <sup>125</sup>I-[Tyr<sup>3</sup>]-NT in binding buffer in the presence of increasing concentrations of analogs ranging from 10<sup>–11</sup> to 10<sup>–4</sup> M for 60 min at 25 °C. After incubation, the binding mixture was transferred in PEI-coated 96-well filter plates (glass fiber filters GF/B, Millipore, Billerica, MA). The reaction was terminated by filtration, and then plates were washed three times with 200 μL of ice-cold binding buffer. Glass filters were then counted using a γ-counter (2470 Wizard2, PerkinElmer, Mississauga, Ontario, Canada). Non-specific binding was measured in the presence of 10<sup>–5</sup> M unlabeled NT(8-13) and represented less than 5% of total binding. Data were normalized compared to NT(8-13) to control for unwanted source of variation. IC<sub>50</sub> values were determined from competition curves as the unlabeled ligand concentration inhibiting 50% of <sup>125</sup>I-[Tyr<sup>3</sup>]-NT-specific binding. K<sub>i</sub> values were determined using the Cheng–Prusoff equation from IC<sub>50</sub> values.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> Competitive radioligand binding data were plotted using the nonlinear regression One-site-Fit Log(IC<sub>50</sub>) and represented the mean ± SEM of three independent experiments, each performed in triplicate to ensure the reliability of single values.</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Plasma and Cerebrospinal Fluid Stability Assay</h3><div class="NLM_p last">Rats were anesthetized with 2.5% isoflurane for blood collection and with ketamine/xylazine (87 mg/kg: 13 mg/kg, i.m.) for CSF collection. Rat plasma was obtained by centrifugation of rat blood (13,000 rpm, 5 min, 4 °C). Rat CSF was collected from the cisterna magna. Compounds were solubilized in water (10 mM) and diluted to 1/10 ratio (1 mM) using water. Six microliters of the drug solution was incubated in 27 μL of rat plasma at 37 °C for 1, 3, 5, 10, and 20 min or rat CSF at 37 °C for 24 h. Proteolytic degradation was quenched by adding 70 μL of an aqueous solution containing 10% trichloroacetic acid and 0.5% nicotinamide followed by immediate vortexing. Samples were centrifuged (13,000 rpm, 15 min, 4 °C), and the supernatant was filtered on a 4 mm nylon 0.2 μm syringe filter and then analyzed by UPLC-MS (Waters 2695 with ACE C18 column 2.0 × 100 mm, 2.7 μm spherical particle size and Electrospray micromass ZQ-2000 from Waters). Data were analyzed using GraphPad Prism 7 using one-phase decay equation and represented the half-life of an experimental triplicate.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> <i>In Vivo</i> Analgesic Assay</h3><div id="sec4_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> Animals and Housing</h4><div class="NLM_p last">Adult male Sprague-Dawley rats, weighing 225–300 g (Charles River laboratories, St Constant, Canada), were housed two per cage on Aspen shavings in a quiet room and kept on a 12 h light/dark cycle and allowed <i>ad libitum</i> access to food and water. All experimental procedures were approved by the Animal Care Committee of the Université de Sherbrooke in accordance with policies and directives of the Canadian Council on Animal Care. Furthermore, they were performed in agreement with the principles of ARRIVE and United States NIH (Animals in Research: Reporting <i>In Vivo</i> Experiments).<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> Three pain models in rats were selected to assess the antinociceptive effects of the compounds administered intrathecally.</div></div><div id="sec4_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> Intrathecal Administration</h4><div class="NLM_p last">Rats were lightly anesthetized with isoflurane/oxygen (Baxter Corporation, Mississauga, ON, Canada; 2 L/min) flow and injected intrathecally at the L5-L6 intervertebral space with 0.9% saline or doses ranging from 10 to 150 μg/kg tested compounds, diluted in 0.9% saline.</div></div><div id="sec4_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> Acute Pain: Tail-Flick Test</h4><div class="NLM_p last">Acute pain was assessed using the tail-flick test (Tail-Flick Analgesia meter V2.00, Columbus Instruments, Columbus, Ohio, USA), which measures heat-induced pain in animals and reflects the compound’s analgesic efficacy.<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> The test measures the animal sensitivity to a high-intensity light beam focused on the tail. The tail-flick apparatus was set at a light intensity of 6, with a preset cutoff of 10 s to avoid tissue damages. The latency to flick the tail out of the path of the light beam corresponds to the measure of pain sensitivity or analgesia. Before testing, animals were individually acclimatized to manipulations and the behavioral apparatus 5 min/day for three consecutive days. On the test day, latency baseline measure was taken before drug injection. Compound <b>4</b> was injected intrathecally at increasing doses ranging from 10 to 150 μg/kg, while morphine (Medisca, St-Laurent, Canada) was given subcutaneously (doses ranged from 1 to 10 mg/kg). Naloxone was injected intraperitoneally at 10 mg/kg 30 min before administration of macrocycle <b>4</b>. Effects of the tested compounds on thermal nociception were assessed every 10 min for up to 60 min following administration and compared to saline. Tail-flick latencies were converted into the percent maximal possible effect (%MPE) at the time of maximal peak of analgesia. % MPE were calculated according to the following formula: %MPE = [(test latency) – (saline latency)]/[(cutoff) – (saline latency)] × 100. Data are expressed as mean ± SEM of five animals for each dose. The half-maximal effective dose (ED<sub>50</sub>) of the compound was determined on the %MPE, calculated for each dose. Then, ED<sub>50</sub> values were determined using the dose–response stimulation log(agonist) vs response (four parameters).</div></div><div id="sec4_4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> Tonic Pain: Formalin Test</h4><div class="NLM_p last">The analgesic effect was further assessed using the formalin test as a model of persistent pain. Before testing, animals were acclimatized to manipulations and to plexiglass chambers 30 min/day for three consecutive days. On test day, rats received a 50 μL injection of diluted formaldehyde (1.85%; i.e. 5% formalin; Bioshop, Burlington, Ontario) into the plantar surface of the right hind paw, 5 min after intrathecal injection of the tested compound at increasing doses ranging from 30 to 150 μg/kg or ziconotide (Prialt) at 1 μg/kg (Cayman Chemical Co.). Rats were then placed in clear plexiglass chambers (30 × 30 × 30 cm) positioned over a mirror angled at 45° in order to allow an unobstructed view of the paws, and their behaviors were observed for the next 60 min. The intraplantar injection of formalin produced a biphasic nociceptive response typical of this tonic pain model.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> These two distinct phases of spontaneous pain behaviors are proposed to reflect a short and direct effect of formalin on sensory receptors (acute phase, 0–9 min) and a longer lasting effect due to inflammation and central sensitization (inflammatory phase, 21–60 min). Nociceptive behaviors were assessed using a weighted score, as described previously.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> Following injection of formalin, nociceptive mean score was determined for each 3 min block during 60 min by measuring the amount of time spent in each of four behavioral categories: 0, before the formalin injection, the injected paw is similar to the contralateral paw; 1, the injected paw has little weight placed on it; 2, the injected paw is elevated and is not in contact with any surface (lifting); 3, the injected paw is licked, bitten, or shaken.<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a> Reduction in time spent in lifting was chosen to follow the analgesic effectiveness of compound <b>4</b> or ziconotide, as previously described with NTS2-selective agonists.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> Data represents the mean ± SEM of five rats for each dose.</div></div><div id="sec4_4_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> Chronic Pain: CFA Model</h4><div class="NLM_p last">Chronic inflammatory pain was induced with an intraplantar injection of 100 μL of complete Freund’s adjuvant (CFA) in the plantar surface of the left hind paw of rats. The injected volume (injected as a 1:1 emulsion of oil and saline 0.9%) contained the equivalent of 200 μg of lyophilized bacterial membranes (<i>Mycobacterium butyricum</i>) for a final concentration of 8 mg/mL. Intraplantar injection of saline 0.9% was performed on sham animals. CFA injections were performed under isoflurane/oxygen anesthesia. Rats were acclimatized to the plexiglass enclosures, the mesh floor, and the filament for 3 days prior to testing. On test day, rats were given 10 min to habituate to the enclosures. The von Frey test was performed before (day 0) and 3, 7, and 14 days after CFA injection. Allodynia was evaluated using calibrated von Frey hairs. The blunt filaments were applied against the mid-plantar surface of the hind paw. Filaments with increasing resistance were used ranging from 2 to 15 g. Paw withdrawal threshold (PWT) was then determined as previously described.<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a> A 15 g force was considered as the upper cutoff. Five values were taken alternately on both ipsilateral and contralateral hind paws at intervals of 7 s. The effect of 150 μg/kg of the compound or saline on mechanical allodynia was assessed at 15, 30, 60, and 120 min following i.t. administration on days 7 and 14. The percentage of antiallodynic effect was calculated according to the following formula: % antiallodynic effect = 100 × (PWT<sub>compound</sub> – PWT<sub>saline</sub>)/(PWT<sub>sham</sub> – PWT<sub>saline</sub>). Data represents the mean ± SEM of six rats for each condition.</div></div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> Other Physiological Effects</h3><div id="sec4_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> Blood Pressure Measurements</h4><div class="NLM_p last">Rats were anesthetized with ketamine/xylazine (87 mg/kg: 13 mg/kg, i.m.) and placed in supine position on a heating pad. Mean arterial blood pressure (MABP) was measured through a catheter (PE 50 filled with heparinized saline) inserted in the right carotid artery and connected to a Micro-Med transducer (model TDX-300, USA) linked to a blood pressure Micro-Med analyzer (model BPA-100c). Another catheter (PE 10 filled with heparinized saline) was inserted into the left jugular vein for bolus injection of 0.9% saline or the compound at either 0.01, 0.1, or 1 mg/kg (volume 1 mL/kg, 5–10 s). Blood pressure was recorded each second for up to 1000 s following intravenous injection. Changes in mean arterial blood pressure (ΔMABP) were determined from the basal MABP of the animal. Data represents the mean ± SEM of five rats for each dose.</div></div><div id="sec4_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> Body Temperature</h4><div class="NLM_p last">Body temperature was measured using a thermistor probe inserted into the rat’s rectum. Prior to testing, animals were individually acclimatized to manipulations and the thermistor probe for 5 min/day for three consecutive days. Temperatures were then measured before (baseline) and every 10 min for up to 60 min following intrathecal drug administration. The compound was dissolved in 0.9% of saline and injected at the highest analgesic dose of 150 μg/kg. Changes in body temperature (Δbody temperature) were determined from the baseline for each time and each animal. Data represents the mean ± SEM of six rats for each condition.</div></div><div id="sec4_5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> <i>Ex Vivo</i> Ileum Relaxation Assay</h4><div class="NLM_p last">Smooth muscle relaxation assays of distal rat ileum were performed in isolated organ baths. Rats were anesthetized using ketamine/xylazine (87 mg/kg: 13 mg/kg, i.m.) and euthanized by surgical rupture of thoracic aorta. Tissues were rapidly removed, cut into 1 cm-long strips, cleaned of fat, and mounted vertically in 15 mL baths. The baths were filled with oxygenated (95% O<sub>2</sub> and 5% CO<sub>2</sub>) and thermoregulated (37 ̊C) Krebs solution (NaCl 118.1 mmol/L, KCl 4.7 mmol/L, CaCl<sub>2</sub> 2.5 mmol/L, KH<sub>2</sub>PO<sub>4</sub> 1.2 mmol/L, MgSO<sub>4</sub> 1.2 mmol/L, NaHCO<sub>3</sub> 25 mmol/L, and <span class="smallcaps smallerCapital">d</span>-glucose 5.5 mmol/L; pH 7.4). Strips were stretched with a resting tension of 1.0 gram followed by an equilibration period of at least 60 min with replacement of the Krebs solution every 15 min. At the beginning of each experiment, ileum preparations were challenged with 100 nM carbachol until a constant contractile response was achieved, with multiple washing between stimulation. Tissues were then pre-contracted with the same dose of carbachol and tested with analog concentrations ranging from 10<sup>–11</sup> to 10<sup>–5</sup> M. Non-cumulative concentration–response curves for NT analogs were established; thus, analogs were added to the baths as a single addition following washout of the previous dose. Muscular contractions were measured isometrically with force transducers (Radnoti Glass Technology Inc.), recorded on multichannel chart recorders (PowerLab 8/30, ADInstruments) linked to the LabChart Pro software (version 8.1.8). The percentage of ileum relaxation was calculated against each individual contraction. EC<sub>50</sub> values were determined using the dose–response stimulation log(agonist) vs response (four parameters) in GraphPad Prism 7 and presented as mean ± SEM of three different experiments.</div></div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> Statistical Analyses</h3><div class="NLM_p">All experimental protocols, data, and statistical analyses in this study comply with the recommendations on experimental design and analysis in pharmacology.<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a> Animals were randomized to treatment groups. For the behavioral tests, baselines in the tail-flick test, AUCs of the pain scores in the formalin test, and baselines of paw withdrawal threshold on days 7 and 14 in the von Frey test followed a normal (or Gaussian) distribution determined by the Shapiro–Wilk normality test. Parametric tests were thus performed to increase statistical power. Power analysis estimated sample sizes of 2.2 rats per group for the tail-flick and formalin tests and 3.5 rats per group for the von Frey test. For ANOVA analysis, post-hoc tests were conducted only if <i>F</i> was significant and there was no variance in homogeneity. Data are expressed as mean ± standard error of the mean (SEM). All graphs and statistical analyses were performed using GraphPad Prism 7 (GraphPad software, La Jolla, CA, USA). For binding affinities, K<sub>i</sub> values ± SEM were calculated from the IC<sub>50</sub> values, which were derived from the resulting dose–response curves.</div><div class="NLM_p last">A two-way ANOVA followed by Dunnett’s multiple comparison test was used to determine the significance differences in tail-flick latency, paw withdrawal threshold, and changes in body temperature between saline and different doses of compound <b>4</b> or morphine as well as between saline and PD149163 or compound <b>4</b> (*). A two-way ANOVA followed by Dunnett’s multiple comparison test was used to determine significant differences in the paw withdrawal threshold between sham animals and CFA-treated rats receiving saline (#). The %MPE, the time spent in lifting in the formalin test, and the % of antiallodynic effect were analyzed using a one-way ANOVA followed by a Dunnett’s multiple comparison test to compare the effect of different doses of compound <b>4</b> or ziconotide with saline. To determine the half-maximal effective dose (ED<sub>50</sub>) of the compound, the %MPE in acute pain was calculated for each dose of the compound. Then, ED<sub>50</sub> values were determined using the dose–response stimulation log(agonist) vs response (four parameters). Nonlinear regression using three parameters was also performed to determine the half-maximal inhibitory concentration (EC<sub>50</sub>) of neurotensin in the ileum relaxation assay. A difference in response between compound <b>4</b> and saline was considered significant with <i>p</i>-values *<i>p</i> < 0.05, **<i>p</i> < 0.01, ***<i>p</i> < 0.001, and ****<i>p</i> < 0.0001. A difference in response between sham animals and CFA rats treated with saline was considered significant with <i>p</i>-value ####<i>p</i> < 0.0001.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes4"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i41"><a href="/doi/suppl/10.1021/acs.jmedchem.0c01726" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62744" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62744" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c01726?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01726</a>. <ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">SMILES list of compounds NST1 and NST2 (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01726/suppl_file/jm0c01726_si_001.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">(Table S1) Sequences, molecular formula strings, and characterization data of neurotensin analogs; (Figure S1) displacement curves of [<sup>125</sup>I]-Neurotensin for the alascan NT(8-13) peptides on hNTS1 and hNTS2; (Figure S2) displacement curves of [<sup>125</sup>I]-Neurotensin by macrocyclic NT peptides on hNTS1 and hNTS2; and (Figure S3) stability of NT(8-13) and macrocycle <b>4</b> in rat plasma and cerebrospinal fluid (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01726/suppl_file/jm0c01726_si_002.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01726/suppl_file/jm0c01726_si_001.csv">jm0c01726_si_001.csv (6.83 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01726/suppl_file/jm0c01726_si_002.pdf">jm0c01726_si_002.pdf (1.9 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c01726" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45612" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45612" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eric Marsault</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmacology
and Physiology, Faculty of Medicine and Health Sciences, Institut
de Pharmacologie de Sherbrooke, Université
de Sherbrooke, 3001 12e Avenue Nord, Sherbrooke, Quebec J1H 5N4, Canada</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5305-8762" title="Orcid link">http://orcid.org/0000-0002-5305-8762</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#4520372c266b28243736243029310530362d203727372a2a2e206b2624"><span class="__cf_email__" data-cfemail="4623342f25682b27343527332a320633352e2334243429292d23682527">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Philippe Sarret</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmacology
and Physiology, Faculty of Medicine and Health Sciences, Institut
de Pharmacologie de Sherbrooke, Université
de Sherbrooke, 3001 12e Avenue Nord, Sherbrooke, Quebec J1H 5N4, Canada</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7627-701X" title="Orcid link">http://orcid.org/0000-0002-7627-701X</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#64140c0d080d1414014a1705161601102411170c011606160b0b0f014a0705"><span class="__cf_email__" data-cfemail="8fffe7e6e3e6ffffeaa1fceefdfdeafbcffafce7eafdedfde0e0e4eaa1ecee">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Magali Chartier</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmacology
and Physiology, Faculty of Medicine and Health Sciences, Institut
de Pharmacologie de Sherbrooke, Université
de Sherbrooke, 3001 12e Avenue Nord, Sherbrooke, Quebec J1H 5N4, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Desgagné</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmacology
and Physiology, Faculty of Medicine and Health Sciences, Institut
de Pharmacologie de Sherbrooke, Université
de Sherbrooke, 3001 12e Avenue Nord, Sherbrooke, Quebec J1H 5N4, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marc Sousbie</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmacology
and Physiology, Faculty of Medicine and Health Sciences, Institut
de Pharmacologie de Sherbrooke, Université
de Sherbrooke, 3001 12e Avenue Nord, Sherbrooke, Quebec J1H 5N4, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jérôme Côté</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmacology
and Physiology, Faculty of Medicine and Health Sciences, Institut
de Pharmacologie de Sherbrooke, Université
de Sherbrooke, 3001 12e Avenue Nord, Sherbrooke, Quebec J1H 5N4, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jean-Michel Longpré</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmacology
and Physiology, Faculty of Medicine and Health Sciences, Institut
de Pharmacologie de Sherbrooke, Université
de Sherbrooke, 3001 12e Avenue Nord, Sherbrooke, Quebec J1H 5N4, Canada</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>M.G. and M.D. contributed equally to this work.</p><span class="author-information-subsection-header">Author Contributions</span><p>E.M. and P.S. contributed equally to directing this study.</p><span class="author-information-subsection-header">Author Contributions</span><p>All the authors participated in research design. M.D. and M.S. performed compound synthesis and characterization. M.C. performed binding experiments. M.D. and M.S. performed stability experiments. M.C. and J.C. performed and analyzed in vivo studies. M.C. and M.D. wrote the manuscript. J.C., J.M.L., E.M., and P.S. supervised the project and edited the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i45">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47236" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47236" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Funding from the Canadian Institutes of Health Research (FDN-148413 to P.S.), the Natural Sciences and Engineering Research Council of Canada, and the Canadian Foundation for Innovation is gratefully acknowledged. P.S. is the holder of the Canada Research Chair Tier 1 in Neurophysiopharmacology of Chronic Pain and a member of the FRQS-funded Quebec Pain Research Network. E.M. is a member of the FRQNT-funded Proteo and the FRQS-funded Quebec Network for Drug Research networks. M.C.’s Ph.D. is funded by the FRQS-funded Quebec Pain Research Network.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">CFA</td><td class="NLM_def"><p class="first last">complete Freund’s adjuvant</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">CSF</td><td class="NLM_def"><p class="first last">cerebrospinal fluid</p></td></tr><tr><td class="NLM_term">EC<sub>50</sub></td><td class="NLM_def"><p class="first last">half-maximal effective concentration</p></td></tr><tr><td class="NLM_term">ED<sub>50</sub></td><td class="NLM_def"><p class="first last">half-maximal effective dose</p></td></tr><tr><td class="NLM_term">IC<sub>50</sub></td><td class="NLM_def"><p class="first last">concentration inhibiting 50% of binding</p></td></tr><tr><td class="NLM_term">i.m.</td><td class="NLM_def"><p class="first last">intramuscular</p></td></tr><tr><td class="NLM_term">i.t.</td><td class="NLM_def"><p class="first last">intrathecal</p></td></tr><tr><td class="NLM_term">i.v.</td><td class="NLM_def"><p class="first last">intravenous</p></td></tr><tr><td class="NLM_term">MABP</td><td class="NLM_def"><p class="first last">mean arterial blood pressure</p></td></tr><tr><td class="NLM_term">%MPE</td><td class="NLM_def"><p class="first last">% maximal possible effect</p></td></tr><tr><td class="NLM_term">NT</td><td class="NLM_def"><p class="first last">neurotensin</p></td></tr><tr><td class="NLM_term">NTS1</td><td class="NLM_def"><p class="first last">neurotensin receptor type 1</p></td></tr><tr><td class="NLM_term">NTS2</td><td class="NLM_def"><p class="first last">neurotensin receptor type 2</p></td></tr><tr><td class="NLM_term">PWT</td><td class="NLM_def"><p class="first last">paw withdrawal threshold</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">UPLC-MS</td><td class="NLM_def"><p class="first last">ultra-performance liquid chromatography-mass spectrometry</p></td></tr><tr><td class="NLM_term">RCM</td><td class="NLM_def"><p class="first last">ring-closing metathesis</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i48">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77048" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77048" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 107 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
Leon-Casasola, O. A.</span></span> <span> </span><span class="NLM_article-title">Opioids for Chronic Pain: New Evidence, New Strategies, Safe Prescribing</span>. <i>Am. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>126</i></span>,  <span class="NLM_fpage">S3</span>– <span class="NLM_lpage">S11</span>, <span class="refDoi"> DOI: 10.1016/j.amjmed.2012.11.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2Fj.amjmed.2012.11.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=23414718" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjt1Sgsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2013&pages=S3-S11&author=O.+A.+de%0ALeon-Casasola&title=Opioids+for+Chronic+Pain%3A+New+Evidence%2C+New+Strategies%2C+Safe+Prescribing&doi=10.1016%2Fj.amjmed.2012.11.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Opioids for Chronic Pain: New Evidence, New Strategies, Safe Prescribing</span></div><div class="casAuthors">de Leon-Casasola, Oscar A.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">3, Suppl. 1</span>),
    <span class="NLM_cas:pages">S3-S11</span>CODEN:
                <span class="NLM_cas:coden">AJMEAZ</span>;
        ISSN:<span class="NLM_cas:issn">0002-9343</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  In the United States, the prevalence and burden of chronic pain is large and still growing.  Older adults (aged ≥65 years) make up a large portion of the population with chronic pain, and their presentation, diagnosis, and treatment tends to be more complicated because of age-related physiol. changes and comorbidities.  Guidelines on treating patients with severe back pain recommend opioids as an option for those who do not find adequate pain relief from acetaminophen or nonsteroidal anti-inflammatory drugs (NSAIDs).  For older adult patients at higher risk for NSAID-related adverse effects, such as those who have gastrointestinal or cardiovascular disease, diabetes mellitus, or who are taking low-dose aspirin, opioids are recommended instead.  Opioids may also be an appropriate option for patients with neuropathic pain who have not achieved adequate analgesia from max. doses of first- and second-line antineuropathic agents.  Still, opioids are not appropriate for all patients; rather, a differential diagnosis, consideration of other comorbidities, and the potential for opioid-related adverse effects and substance abuse are required to confirm the value of opioid treatment for each individual.  For nonresponders to opioid therapy, opioid rotation should be considered before discontinuation is pursued.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSKzLJyz7UeLVg90H21EOLACvtfcHk0ljdqAi4agWauA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjt1Sgsr8%253D&md5=03d6831cc14515153cf4040a31a053a2</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.amjmed.2012.11.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.amjmed.2012.11.011%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BLeon-Casasola%26aufirst%3DO.%2BA.%26atitle%3DOpioids%2520for%2520Chronic%2520Pain%253A%2520New%2520Evidence%252C%2520New%2520Strategies%252C%2520Safe%2520Prescribing%26jtitle%3DAm.%2520J.%2520Med.%26date%3D2013%26volume%3D126%26spage%3DS3%26epage%3DS11%26doi%3D10.1016%2Fj.amjmed.2012.11.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Balch, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trescot, A.</span></span> <span> </span><span class="NLM_article-title">Extended-Release Morphine Sulfate in Treatment of Severe Acute and Chronic Pain</span>. <i>J. Pain. Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">191</span>– <span class="NLM_lpage">200</span>, <span class="refDoi"> DOI: 10.2147/JPR.S6529</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.2147%2FJPR.S6529" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=21197323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1SksLzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2010&pages=191-200&author=R.+J.+Balchauthor=A.+Trescot&title=Extended-Release+Morphine+Sulfate+in+Treatment+of+Severe+Acute+and+Chronic+Pain&doi=10.2147%2FJPR.S6529"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Extended-release morphine sulfate in treatment of severe acute and chronic pain</span></div><div class="casAuthors">Balch, Robert J.; Trescot, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pain Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">191-200</span>CODEN:
                <span class="NLM_cas:coden">JPROEV</span>;
        ISSN:<span class="NLM_cas:issn">1178-7090</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">A review.  Morphine is the archetypal opioid analgesic.  Because it is a short-acting opioid, its use has been limited to the management of acute pain.  The development of extended-release formulations have resulted in the increased utilization of morphine in chronic pain conditions.  This review documents the history of morphine use in pain treatment, and describes the metab., pharmacodynamics, formulations, and efficacy of the currently available extended-release morphine medications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDpi5M0cwDc7Vg90H21EOLACvtfcHk0lgNUdVTvumYtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1SksLzM&md5=4168f806d9bca0b7511d17102e49ef5c</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.2147%2FJPR.S6529&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FJPR.S6529%26sid%3Dliteratum%253Aachs%26aulast%3DBalch%26aufirst%3DR.%2BJ.%26aulast%3DTrescot%26aufirst%3DA.%26atitle%3DExtended-Release%2520Morphine%2520Sulfate%2520in%2520Treatment%2520of%2520Severe%2520Acute%2520and%2520Chronic%2520Pain%26jtitle%3DJ.%2520Pain.%2520Res.%26date%3D2010%26volume%3D3%26spage%3D191%26epage%3D200%26doi%3D10.2147%2FJPR.S6529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stein, C.</span></span> <span> </span><span class="NLM_article-title">Opioid Analgesia: Recent Developments</span>. <i>Curr. Opin. Supportive Palliative Care</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">112</span>– <span class="NLM_lpage">117</span>, <span class="refDoi"> DOI: 10.1097/SPC.0000000000000495</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1097%2FSPC.0000000000000495" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=32304400" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A280%3ADC%252BB38zms1aruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2020&pages=112-117&author=C.+Stein&title=Opioid+Analgesia%3A+Recent+Developments&doi=10.1097%2FSPC.0000000000000495"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Opioid analgesia: recent developments</span></div><div class="casAuthors">Stein Christoph</div><div class="citationInfo"><span class="NLM_cas:title">Current opinion in supportive and palliative care</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">112-117</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE OF REVIEW:  Opioids are potent drugs for the treatment of severe pain, but they are burdened by detrimental side-effects, such as respiratory depression, addiction, sedation and constipation.  Their clinical application is undisputed in acute (e.g. perioperative) and cancer pain, but their use in chronic nonmalignant pain has met increasing scrutiny and has contributed to the opioid crisis.  Thus, novel analgesics with reduced side-effects are badly needed.  RECENT FINDINGS:  Current research topics include enkephalinase inhibitors, allosteric and multivalent ligands, biased opioid receptor signaling and selective activation of peripheral opioid receptors in injured tissues.  SUMMARY:  Opioids still appear to be most promising among current approaches in the development of analgesics.  Basic knowledge about pathophysiology of clinical pain and novel insights in pharmacology suggest that the most interesting perspectives are augmenting endogenous opioid actions and selectively targeting peripheral opioid receptors.  The latter approach is additionally supported by evidence from clinical studies.  Some biased, multivalent and peripherally selective agonists have advanced to phase III trials, but novel drugs have not become available for clinical application.  Future strategies in analgesic drug development might include public-private partnerships and nonprofit pharmaceutical companies, as exemplified by the AIDS crisis and proposals to combat antibiotic resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcStgl7bjC9fa-vW160gIxP_fW6udTcc2eaLPoZb6RsWY7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB38zms1aruw%253D%253D&md5=4b9674952ab21b82a438efc5299af472</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1097%2FSPC.0000000000000495&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FSPC.0000000000000495%26sid%3Dliteratum%253Aachs%26aulast%3DStein%26aufirst%3DC.%26atitle%3DOpioid%2520Analgesia%253A%2520Recent%2520Developments%26jtitle%3DCurr.%2520Opin.%2520Supportive%2520Palliative%2520Care%26date%3D2020%26volume%3D14%26spage%3D112%26epage%3D117%26doi%3D10.1097%2FSPC.0000000000000495" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fornasari, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allegri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerboni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fanelli, G.</span></span> <span> </span><span class="NLM_article-title">A ″Novel″ Association to Treat Pain: Tramadol/Dexketoprofen. The First Drug of a ″New Pharmacological Class″</span>. <i>Acta Biomed.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">17</span>– <span class="NLM_lpage">24</span>, <span class="refDoi"> DOI: 10.23750/abm.v88i1.6361</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.23750%2Fabm.v88i1.6361" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=28467329" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFOku7rP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2017&pages=17-24&author=D.+Fornasariauthor=M.+Allegriauthor=S.+Gerboniauthor=G.+Fanelli&title=A+%E2%80%B3Novel%E2%80%B3+Association+to+Treat+Pain%3A+Tramadol%2FDexketoprofen.+The+First+Drug+of+a+%E2%80%B3New+Pharmacological+Class%E2%80%B3&doi=10.23750%2Fabm.v88i1.6361"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">A "novel" association to treat pain: tramadol/dexketoprofen. The first drug of a "new pharmacological class"</span></div><div class="casAuthors">Fornasari, D.; Allegri, M.; Gerboni, S.; Fanelli, G.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Bio Medica Atenei Parmensis</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17-24</span>CODEN:
                <span class="NLM_cas:coden">ABMAC3</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Mattioli 1885</span>)
        </div><div class="casAbstract">Acute and chronic pain have an important socio-economical impact.  In order to help physicians to choose the appropriate drug, esp. for cancer pain, in 1986 WHO has developed a three-step analgesic "ladder" for cancer pain relief in adults.  Later it has also been used for acute pain and chronic non-cancer pain.  In step I nonsteroidal anti-inflammatory drugs (NSAIDs) are considered with or without adjuvants, in step II the use of weak opioids for mild-moderate pain, with or without NSAIDs and adjuvant, is suggested, while the step III is reserved to strong opioids for moderate-severe pain with or without non-opioids or adjuvants.  In the last two decades, a better pathophysiol. knowledge has improved pain management shifting our view from the pain ladder to a modern pain pyramid, in which drugs are selected not only on the basis of pain intensity, but mainly according to mechanisms underlying pain, including peripheral and spinal sensitization which is the main trigger of chronic pain.  The best pharmacol. approach has become multimodal, in which drugs belonging to different steps should be combined, matching the mechanisms of action with the type of pain.  An important corollary of combining analgesic drugs with different mechanism of action is that proper matching achieves the same effect with lower doses, better outcome and fewer adverse effects.  In this new perspective, fixed-dose pharmaceutical combinations of different drugs are very useful to fulfil pharmacodynamics, pharmacokinetics and adherence criteria, enriching the pain pyramid of half-steps between the first and second step and between the second and third step.  Hence, a new fixed combination of a NSAID with peripheral and central anti-infilammatory activities, such as dexketoprofen, and a weak opioid, such as tramadol, with double analgesic activity in the spinal cord as an opioid and, at the same time, on the descending modulatory pathways, is expected to cover a wide range of acute and recurrent painful conditions, ranging from nociceptive inflammatory pain to neuropathic pain of moderate/severe intensity.  In this review we evaluate the rationale that justifies its use as new class of pharmacol. modality to treat pain accordingly also to a more update view of WHO pain ladder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGQ5T4GXqRV7Vg90H21EOLACvtfcHk0lgNUdVTvumYtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFOku7rP&md5=7d30261335f53036ff02f116a1ae649f</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.23750%2Fabm.v88i1.6361&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.23750%252Fabm.v88i1.6361%26sid%3Dliteratum%253Aachs%26aulast%3DFornasari%26aufirst%3DD.%26aulast%3DAllegri%26aufirst%3DM.%26aulast%3DGerboni%26aufirst%3DS.%26aulast%3DFanelli%26aufirst%3DG.%26atitle%3DA%2520%25E2%2580%25B3Novel%25E2%2580%25B3%2520Association%2520to%2520Treat%2520Pain%253A%2520Tramadol%252FDexketoprofen.%2520The%2520First%2520Drug%2520of%2520a%2520%25E2%2580%25B3New%2520Pharmacological%2520Class%25E2%2580%25B3%26jtitle%3DActa%2520Biomed.%26date%3D2017%26volume%3D88%26spage%3D17%26epage%3D24%26doi%3D10.23750%2Fabm.v88i1.6361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Finnerup, N. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Attal, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haroutounian, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNicol, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baron, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dworkin, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilron, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haanpää, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamerman, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lund, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raja, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rice, A. S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowbotham, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sena, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siddall, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallace, M.</span></span> <span> </span><span class="NLM_article-title">Pharmacotherapy for Neuropathic Pain in Adults: A Systematic Review and Meta-Analysis</span>. <i>Lancet Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">162</span>– <span class="NLM_lpage">173</span>, <span class="refDoi"> DOI: 10.1016/S1474-4422(14)70251-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2FS1474-4422%2814%2970251-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=25575710" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BC2MXovFygsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=162-173&author=N.+B.+Finnerupauthor=N.+Attalauthor=S.+Haroutounianauthor=E.+McNicolauthor=R.+Baronauthor=R.+H.+Dworkinauthor=I.+Gilronauthor=M.+Haanp%C3%A4%C3%A4author=P.+Hanssonauthor=T.+S.+Jensenauthor=P.+R.+Kamermanauthor=K.+Lundauthor=A.+Mooreauthor=S.+N.+Rajaauthor=A.+S.+C.+Riceauthor=M.+Rowbothamauthor=E.+Senaauthor=P.+Siddallauthor=B.+H.+Smithauthor=M.+Wallace&title=Pharmacotherapy+for+Neuropathic+Pain+in+Adults%3A+A+Systematic+Review+and+Meta-Analysis&doi=10.1016%2FS1474-4422%2814%2970251-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis</span></div><div class="casAuthors">Finnerup, Nanna B.; Attal, Nadine; Haroutounian, Simon; McNicol, Ewan; Baron, Ralf; Dworkin, Robert H.; Gilron, Ian; Haanpaa, Maija; Hansson, Per; Jensen, Troels S.; Kamerman, Peter R.; Lund, Karen; Moore, Andrew; Raja, Srinivasa N.; Rice, Andrew S. C.; Rowbotham, Michael; Sena, Emily; Siddall, Philip; Smith, Blair H.; Wallace, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">162-173</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">New drug treatments, clin. trials, and stds. of quality for assessment of evidence justify an update of evidence-based recommendations for the pharmacol. treatment of neuropathic pain.  Using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE), we revised the Special Interest Group on Neuropathic Pain (NeuPSIG) recommendations for the pharmacotherapy of neuropathic pain based on the results of a systematic review and meta-anal.  Between Apr., 2013, and Jan., 2014, NeuPSIG of the International Assocn. for the Study of Pain did a systematic review and meta-anal. of randomised, double-blind studies of oral and topical pharmacotherapy for neuropathic pain, including studies published in peer-reviewed journals since Jan., 1966, and unpublished trials retrieved from ClinicalTrials.gov and websites of pharmaceutical companies.  We used no. needed to treat (NNT) for 50% pain relief as a primary measure and assessed publication bias; NNT was calcd. with the fixed-effects Mantel-Haenszel method.229 studies were included in the meta-anal.  Anal. of publication bias suggested a 10% overstatement of treatment effects.  Studies published in peer-reviewed journals reported greater effects than did unpublished studies (r2 9·3%, p=0·009).  Trial outcomes were generally modest: in particular, combined NNTs were 6·4 (95% CI 5·2-8·4) for serotonin-noradrenaline reuptake inhibitors, mainly including duloxetine (nine of 14 studies); 7·7 (6·5-9·4) for pregabalin; 7·2 (5·9-9·21) for gabapentin, including gabapentin extended release and enacarbil; and 10·6 (7·4-19·0) for capsaicin high-concn. patches.  NNTs were lower for tricyclic antidepressants, strong opioids, tramadol, and botulinum toxin A, and undetd. for lidocaine patches.  Based on GRADE, final quality of evidence was moderate or high for all treatments apart from lidocaine patches; tolerability and safety, and values and preferences were higher for topical drugs; and cost was lower for tricyclic antidepressants and tramadol.  These findings permitted a strong recommendation for use and proposal as first-line treatment in neuropathic pain for tricyclic antidepressants, serotonin-noradrenaline reuptake inhibitors, pregabalin, and gabapentin; a weak recommendation for use and proposal as second line for lidocaine patches, capsaicin high-concn. patches, and tramadol; and a weak recommendation for use and proposal as third line for strong opioids and botulinum toxin A.  Topical agents and botulinum toxin A are recommended for peripheral neuropathic pain only.  Our results support a revision of the NeuPSIG recommendations for the pharmacotherapy of neuropathic pain.  Inadequate response to drug treatments constitutes a substantial unmet need in patients with neuropathic pain.  Modest efficacy, large placebo responses, heterogeneous diagnostic criteria, and poor phenotypic profiling probably account for moderate trial outcomes and should be taken into account in future studies.  NeuPSIG of the International Assocn. for the Study of Pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGog3lY2ykFKHrVg90H21EOLACvtfcHk0liE5nAuVgu03Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXovFygsw%253D%253D&md5=aaae3dd82ea6896d3977412faedebffd</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2814%2970251-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252814%252970251-0%26sid%3Dliteratum%253Aachs%26aulast%3DFinnerup%26aufirst%3DN.%2BB.%26aulast%3DAttal%26aufirst%3DN.%26aulast%3DHaroutounian%26aufirst%3DS.%26aulast%3DMcNicol%26aufirst%3DE.%26aulast%3DBaron%26aufirst%3DR.%26aulast%3DDworkin%26aufirst%3DR.%2BH.%26aulast%3DGilron%26aufirst%3DI.%26aulast%3DHaanp%25C3%25A4%25C3%25A4%26aufirst%3DM.%26aulast%3DHansson%26aufirst%3DP.%26aulast%3DJensen%26aufirst%3DT.%2BS.%26aulast%3DKamerman%26aufirst%3DP.%2BR.%26aulast%3DLund%26aufirst%3DK.%26aulast%3DMoore%26aufirst%3DA.%26aulast%3DRaja%26aufirst%3DS.%2BN.%26aulast%3DRice%26aufirst%3DA.%2BS.%2BC.%26aulast%3DRowbotham%26aufirst%3DM.%26aulast%3DSena%26aufirst%3DE.%26aulast%3DSiddall%26aufirst%3DP.%26aulast%3DSmith%26aufirst%3DB.%2BH.%26aulast%3DWallace%26aufirst%3DM.%26atitle%3DPharmacotherapy%2520for%2520Neuropathic%2520Pain%2520in%2520Adults%253A%2520A%2520Systematic%2520Review%2520and%2520Meta-Analysis%26jtitle%3DLancet%2520Neurol.%26date%3D2015%26volume%3D14%26spage%3D162%26epage%3D173%26doi%3D10.1016%2FS1474-4422%2814%2970251-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Attal, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouhassira, D.</span></span> <span> </span><span class="NLM_article-title">Pharmacotherapy of Neuropathic Pain: Which Drugs, Which Treatment Algorithms?</span>. <i>Pain</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>156</i></span>,  <span class="NLM_fpage">S104</span>– <span class="NLM_lpage">S114</span>, <span class="refDoi"> DOI: 10.1097/01.j.pain.0000460358.01998.15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1097%2F01.j.pain.0000460358.01998.15" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=25789426" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=2015&pages=S104-S114&author=N.+Attalauthor=D.+Bouhassira&title=Pharmacotherapy+of+Neuropathic+Pain%3A+Which+Drugs%2C+Which+Treatment+Algorithms%3F&doi=10.1097%2F01.j.pain.0000460358.01998.15"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1097%2F01.j.pain.0000460358.01998.15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F01.j.pain.0000460358.01998.15%26sid%3Dliteratum%253Aachs%26aulast%3DAttal%26aufirst%3DN.%26aulast%3DBouhassira%26aufirst%3DD.%26atitle%3DPharmacotherapy%2520of%2520Neuropathic%2520Pain%253A%2520Which%2520Drugs%252C%2520Which%2520Treatment%2520Algorithms%253F%26jtitle%3DPain%26date%3D2015%26volume%3D156%26spage%3DS104%26epage%3DS114%26doi%3D10.1097%2F01.j.pain.0000460358.01998.15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Afsharimani, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kindl, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Good, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardy, J.</span></span> <span> </span><span class="NLM_article-title">Pharmacological Options for the Management of Refractory Cancer Pain-What Is the Evidence?</span>. <i>Support Care Cancer</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1473</span>– <span class="NLM_lpage">1481</span>, <span class="refDoi"> DOI: 10.1007/s00520-015-2678-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1007%2Fs00520-015-2678-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=25749509" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A280%3ADC%252BC2MnitFGktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=1473-1481&author=B.+Afsharimaniauthor=K.+Kindlauthor=P.+Goodauthor=J.+Hardy&title=Pharmacological+Options+for+the+Management+of+Refractory+Cancer+Pain-What+Is+the+Evidence%3F&doi=10.1007%2Fs00520-015-2678-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological options for the management of refractory cancer pain-what is the evidence?</span></div><div class="casAuthors">Afsharimani B; Kindl K; Good P; Hardy J</div><div class="citationInfo"><span class="NLM_cas:title">Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1473-81</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Refractory cancer pain that does not respond to standard opioid and/or co-analgesic therapy occurs in 10-20 % of patients.  Risk factors include young age, neuropathic pain type, incident pain, psychological distress, previous opioid use, high tolerance, a history of addiction and impaired cognition.  The management of patients with refractory pain remains a challenge.  Treatment options include opioid manipulation (parenteral delivery, rotation, combination, methadone and buprenorphine), non-opioids and co-analgesics (paracetamol, non-steroidal anti-inflammatory agents, antidepressants and anticonvulsants), NMDA receptor antagonists, cannabinoids, lignocaine and corticosteroids.  The evidence of benefit for any of these agents is weak, and each additional agent increases the risk of adverse events.  Evidence-based guidelines cannot, therefore, be developed at present.  New approaches are recommended including targeted opioid therapy, multimodal analgesia, a goal-oriented approach to pain management and increasing use of the multidisciplinary team and support services.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS5Ma1donXoAijiVMCqkKxVfW6udTcc2eZoNFI8A3pu87ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MnitFGktg%253D%253D&md5=7a437a90f384fba6f4615d181cd120e2</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1007%2Fs00520-015-2678-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00520-015-2678-9%26sid%3Dliteratum%253Aachs%26aulast%3DAfsharimani%26aufirst%3DB.%26aulast%3DKindl%26aufirst%3DK.%26aulast%3DGood%26aufirst%3DP.%26aulast%3DHardy%26aufirst%3DJ.%26atitle%3DPharmacological%2520Options%2520for%2520the%2520Management%2520of%2520Refractory%2520Cancer%2520Pain-What%2520Is%2520the%2520Evidence%253F%26jtitle%3DSupport%2520Care%2520Cancer%26date%3D2015%26volume%3D23%26spage%3D1473%26epage%3D1481%26doi%3D10.1007%2Fs00520-015-2678-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Benyamin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trescot, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Datta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buenaventura, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adlaka, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sehgal, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glaser, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vallejo, R.</span></span> <span> </span><span class="NLM_article-title">Opioid Complications and Side Effects</span>. <i>Pain Physician</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">S105</span>– <span class="NLM_lpage">S120</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=18443635" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A280%3ADC%252BD1czosVSjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2008&pages=S105-S120&author=R.+Benyaminauthor=A.+M.+Trescotauthor=S.+Dattaauthor=R.+Buenaventuraauthor=R.+Adlakaauthor=N.+Sehgalauthor=S.+E.+Glaserauthor=R.+Vallejo&title=Opioid+Complications+and+Side+Effects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Opioid complications and side effects</span></div><div class="casAuthors">Benyamin Ramsin; Trescot Andrea M; Datta Sukdeb; Buenaventura Ricardo; Adlaka Rajive; Sehgal Nalini; Glaser Scott E; Vallejo Ricardo</div><div class="citationInfo"><span class="NLM_cas:title">Pain physician</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2 Suppl</span>),
    <span class="NLM_cas:pages">S105-20</span>
        ISSN:<span class="NLM_cas:issn">1533-3159</span>.
    </div><div class="casAbstract">Medications which bind to opioid receptors are increasingly being prescribed for the treatment of multiple and diverse chronic painful conditions.  Their use for acute pain or terminal pain is well accepted.  Their role in the long-term treatment of chronic noncancer pain is, however, controversial for many reasons.  One of the primary reasons is the well-known phenomenon of psychological addiction that can occur with the use of these medications.  Abuse and diversion of these medications is a growing problem as the availability of these medications increases and this public health issue confounds their clinical utility.  Also, the extent of their efficacy in the treatment of pain when utilized on a chronic basis has not been definitively proven.  Lastly, the role of opioids in the treatment of chronic pain is also influenced by the fact that these potent analgesics are associated with a significant number of side effects and complications.  It is these phenomena that are the focus of this review.  Common side effects of opioid administration include sedation, dizziness, nausea, vomiting, constipation, physical dependence, tolerance, and respiratory depression.  Physical dependence and addiction are clinical concerns that may prevent proper prescribing and in turn inadequate pain management.  Less common side effects may include delayed gastric emptying, hyperalgesia, immunologic and hormonal dysfunction, muscle rigidity, and myoclonus.  The most common side effects of opioid usage are constipation (which has a very high incidence) and nausea.  These 2 side effects can be difficult to manage and frequently tolerance to them does not develop; this is especially true for constipation.  They may be severe enough to require opioid discontinuation, and contribute to under-dosing and inadequate analgesia.  Several clinical trials are underway to identify adjunct therapies that may mitigate these side effects.  Switching opioids and/or routes of administration may also provide benefits for patients.  Proper patient screening, education, and preemptive treatment of potential side effects may aid in maximizing effectiveness while reducing the severity of side effects and adverse events.  Opioids can be considered broad spectrum analgesic agents, affecting a wide number of organ systems and influencing a large number of body functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRS-eBn7Ppy6vx2phytoz6_fW6udTcc2eblEfwmCYo_LLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1czosVSjsQ%253D%253D&md5=26196f3cc302b1cad86e32477bb52e18</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBenyamin%26aufirst%3DR.%26aulast%3DTrescot%26aufirst%3DA.%2BM.%26aulast%3DDatta%26aufirst%3DS.%26aulast%3DBuenaventura%26aufirst%3DR.%26aulast%3DAdlaka%26aufirst%3DR.%26aulast%3DSehgal%26aufirst%3DN.%26aulast%3DGlaser%26aufirst%3DS.%2BE.%26aulast%3DVallejo%26aufirst%3DR.%26atitle%3DOpioid%2520Complications%2520and%2520Side%2520Effects%26jtitle%3DPain%2520Physician%26date%3D2008%26volume%3D11%26spage%3DS105%26epage%3DS120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chu, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angst, M. S.</span></span> <span> </span><span class="NLM_article-title">Opioid Tolerance and Hyperalgesia in Chronic Pain Patients after One Month of Oral Morphine Therapy: A Preliminary Prospective Study</span>. <i>J. Pain</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">43</span>– <span class="NLM_lpage">48</span>, <span class="refDoi"> DOI: 10.1016/j.jpain.2005.08.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2Fj.jpain.2005.08.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=16414554" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BD28Xls1Wgtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=43-48&author=L.+F.+Chuauthor=D.+J.+Clarkauthor=M.+S.+Angst&title=Opioid+Tolerance+and+Hyperalgesia+in+Chronic+Pain+Patients+after+One+Month+of+Oral+Morphine+Therapy%3A+A+Preliminary+Prospective+Study&doi=10.1016%2Fj.jpain.2005.08.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Opioid Tolerance and Hyperalgesia in Chronic Pain Patients After One Month of Oral Morphine Therapy: A Preliminary Prospective Study</span></div><div class="casAuthors">Chu, Larry F.; Clark, David J.; Angst, Martin S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pain</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43-48</span>CODEN:
                <span class="NLM_cas:coden">JPOAB5</span>;
        ISSN:<span class="NLM_cas:issn">1526-5900</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">There is accumulating evidence that opioid therapy might not only be assocd. with the development of tolerance but also with an increased sensitivity to pain, a condition referred to as opioid-induced hyperalgesia (OIH).  However, there are no prospective studies documenting the development of opioid tolerance or OIH in patients with chronic pain.  This preliminary study in 6 patients with chronic low back pain prospectively evaluated the development of tolerance and OIH.  Patients were assessed before and 1 mo after initiating oral morphine therapy.  The cold pressor test and exptl. heat pain were used to measure pain sensitivity before and during a target-controlled infusion with the short-acting μ opioid agonist remifentanil.  In the cold pressor test, all patients became hyperalgesic as well as tolerant after 1 mo of oral morphine therapy.  In a model of heat pain, patients exhibited no hyperalgesia, although tolerance could not be evaluated.  These results provide the first prospective evidence for the development of analgesic tolerance and OIH by using exptl. pain in patients with chronic back pain.  This study also validated methodol. for prospectively studying these phenomena in larger populations of pain patients.  Perspective: Exptl. evidence suggests that opioid tolerance and opioid-induced hyperalgesia might limit the clin. utility of opioids in controlling chronic pain.  This study validates a pharmacol. approach to study these phenomena prospectively in chronic pain patients and suggests that both conditions do occur within 1 mo of initiating opioid therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_c1PCwa3EzrVg90H21EOLACvtfcHk0lgX-0lRu5FQkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xls1Wgtg%253D%253D&md5=1aec558cf8dc6754af4dea1370cdcfb0</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.jpain.2005.08.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpain.2005.08.001%26sid%3Dliteratum%253Aachs%26aulast%3DChu%26aufirst%3DL.%2BF.%26aulast%3DClark%26aufirst%3DD.%2BJ.%26aulast%3DAngst%26aufirst%3DM.%2BS.%26atitle%3DOpioid%2520Tolerance%2520and%2520Hyperalgesia%2520in%2520Chronic%2520Pain%2520Patients%2520after%2520One%2520Month%2520of%2520Oral%2520Morphine%2520Therapy%253A%2520A%2520Preliminary%2520Prospective%2520Study%26jtitle%3DJ.%2520Pain%26date%3D2006%26volume%3D7%26spage%3D43%26epage%3D48%26doi%3D10.1016%2Fj.jpain.2005.08.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Munzing, T.</span></span> <span> </span><span class="NLM_article-title">Physician Guide to Appropriate Opioid Prescribing for Noncancer Pain</span>. <i>Perm. J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">16</span>– <span class="NLM_lpage">169</span>, <span class="refDoi"> DOI: 10.7812/TPP/16-169</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.7812%2FTPP%2F16-169" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=28488993" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A280%3ADC%252BC1crlslGrtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2017&pages=16-169&author=T.+Munzing&title=Physician+Guide+to+Appropriate+Opioid+Prescribing+for+Noncancer+Pain&doi=10.7812%2FTPP%2F16-169"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Physician Guide to Appropriate Opioid Prescribing for Noncancer Pain</span></div><div class="casAuthors">Munzing Timothy</div><div class="citationInfo"><span class="NLM_cas:title">The Permanente journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">16-169</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Prescription opioid use for relief of noncancer pain has risen dramatically in the last 15 years, contributing to a quadrupling of opioid overdoses and prescription opioid-related deaths.  This crisis is resulting in heightened attention by health care professionals and organizations, law enforcement, and the government.  In this article, I highlight key topics in the management of patients using opioids (or potentially needing opioids) in outpatient clinical practice; federal and state law enforcement actions regarding physicians' illegal prescribing of opioids; multimodal approaches to pain control; nonmedication management of pain; response strategies when suspecting a patient of diverting or misusing opioids; and warning signs for abuse or diversion.  For those patients for whom opioids are appropriate, I describe key elements for prescribing, including documentation of a detailed history and examination, appropriate evaluation to arrive at a specific diagnosis, individualizing management, and ongoing monitoring (including the use of urine drug screening and a prescription drug monitoring program).  In addition to individual action, when possible, the initiation of systemwide and clinicwide safe prescribing practices supports the physician and patient such that the patient's well-being is at the heart of all pain management decisions.  Physicians are encouraged to further educate themselves to treat pain safely and effectively; to screen patients for opioid use disorder and, when diagnosed, to connect them with evidence-based treatment; and to follow Centers for Disease Control and Prevention guidelines whenever possible.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS_P31OZw-1AS6Ufuk_1xoTfW6udTcc2eblEfwmCYo_LLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1crlslGrtg%253D%253D&md5=6dae0a55c50da02aa9a36858cefdd746</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.7812%2FTPP%2F16-169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7812%252FTPP%252F16-169%26sid%3Dliteratum%253Aachs%26aulast%3DMunzing%26aufirst%3DT.%26atitle%3DPhysician%2520Guide%2520to%2520Appropriate%2520Opioid%2520Prescribing%2520for%2520Noncancer%2520Pain%26jtitle%3DPerm.%2520J.%26date%3D2017%26volume%3D21%26spage%3D16%26epage%3D169%26doi%3D10.7812%2FTPP%2F16-169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coyle, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pratt, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ocran-Appiah, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Secora, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornegay, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staffa, J.</span></span> <span> </span><span class="NLM_article-title">Opioid Analgesic Dose and the Risk of Misuse, Overdose, and Death: A Narrative Review</span>. <i>Pharmacoepidemiol. Drug. Saf.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">464</span>– <span class="NLM_lpage">472</span>, <span class="refDoi"> DOI: 10.1002/pds.4366</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1002%2Fpds.4366" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=29243305" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A280%3ADC%252BC1MzhslCksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2018&pages=464-472&author=D.+T.+Coyleauthor=C.+Y.+Prattauthor=J.+Ocran-Appiahauthor=A.+Secoraauthor=C.+Kornegayauthor=J.+Staffa&title=Opioid+Analgesic+Dose+and+the+Risk+of+Misuse%2C+Overdose%2C+and+Death%3A+A+Narrative+Review&doi=10.1002%2Fpds.4366"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Opioid analgesic dose and the risk of misuse, overdose, and death: A narrative review</span></div><div class="casAuthors">Coyle David Tyler; Pratt Chih-Ying; Ocran-Appiah Josephine; Secora Alex; Kornegay Cynthia; Staffa Judy</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacoepidemiology and drug safety</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">464-472</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE:  Despite the rise in serious adverse events paralleling increased prescription opioid analgesic use in the United States over the past 2 decades, the association between opioid analgesic dose and the risk of serious adverse health outcomes is incompletely characterized.  We sought to synthesize the medical literature for observational studies examining the association between opioid analgesic dose and the risk of serious adverse health outcomes, with particular attention to the outcomes of misuse, abuse, addiction, overdose, and death.  METHODS:  Searching MEDLINE using PubMed and bibliography review, we identified 22 observational studies published between 2000 and 2015 that assessed the association between opioid analgesic dose and the risk of serious adverse health outcomes.  Some of these studies had significant methodological limitations.  Twelve reviewed studies examined the outcomes of misuse, overdose, or death; no studies examining the risk of addiction or abuse met our criteria for inclusion.  RESULTS:  The results of multiple studies clearly indicate an increasing risk of serious adverse health outcomes associated with increasing opioid analgesic dose.  In particular, the risk of misuse, overdose, and death increases with increasing opioid analgesic dose.  However, there is no opioid dose inflection point beyond which the risk of these adverse health outcomes increases.  No opioid analgesic dose is without risk.  CONCLUSIONS:  The reviewed studies show an increasing risk of serious adverse health outcomes-including misuse, overdose, and death-associated with increasing opioid analgesic dose.  Further research is needed to characterize the relationship between opioid analgesic dose and the risk of addiction and abuse.  This analysis could inform policy actions for regulators and clinical decision making for providers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQM96_mwUR2KtyzdcP07UmufW6udTcc2eblEfwmCYo_LLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MzhslCksg%253D%253D&md5=5f4018cbcfb30e6fce04293d427d8b79</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1002%2Fpds.4366&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpds.4366%26sid%3Dliteratum%253Aachs%26aulast%3DCoyle%26aufirst%3DD.%2BT.%26aulast%3DPratt%26aufirst%3DC.%2BY.%26aulast%3DOcran-Appiah%26aufirst%3DJ.%26aulast%3DSecora%26aufirst%3DA.%26aulast%3DKornegay%26aufirst%3DC.%26aulast%3DStaffa%26aufirst%3DJ.%26atitle%3DOpioid%2520Analgesic%2520Dose%2520and%2520the%2520Risk%2520of%2520Misuse%252C%2520Overdose%252C%2520and%2520Death%253A%2520A%2520Narrative%2520Review%26jtitle%3DPharmacoepidemiol.%2520Drug.%2520Saf.%26date%3D2018%26volume%3D27%26spage%3D464%26epage%3D472%26doi%3D10.1002%2Fpds.4366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lutfy, K.</span></span> <span> </span><span class="NLM_article-title">Opioid Crisis-an Emphasis on Fentanyl Analogs</span>. <i>Brain Sci.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_fpage">10</span>, <span class="refDoi"> DOI: 10.3390/brainsci10080485</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.3390%2Fbrainsci10080485" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&pages=10&author=K.+Lutfy&title=Opioid+Crisis-an+Emphasis+on+Fentanyl+Analogs&doi=10.3390%2Fbrainsci10080485"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.3390%2Fbrainsci10080485&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fbrainsci10080485%26sid%3Dliteratum%253Aachs%26aulast%3DLutfy%26aufirst%3DK.%26atitle%3DOpioid%2520Crisis-an%2520Emphasis%2520on%2520Fentanyl%2520Analogs%26jtitle%3DBrain%2520Sci.%26date%3D2020%26spage%3D10%26doi%3D10.3390%2Fbrainsci10080485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carraway, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leeman, S. E.</span></span> <span> </span><span class="NLM_article-title">The Isolation of a New Hypotensive Peptide, Neurotensin, from Bovine Hypothalami</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1973</span>,  <span class="NLM_volume"><i>248</i></span>,  <span class="NLM_fpage">6854</span>– <span class="NLM_lpage">6861</span>, <span class="refDoi"> DOI: 10.1016/S0021-9258(19)43429-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2FS0021-9258%2819%2943429-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=4745447" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADyaE2cXps1U%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=248&publication_year=1973&pages=6854-6861&author=R.+Carrawayauthor=S.+E.+Leeman&title=The+Isolation+of+a+New+Hypotensive+Peptide%2C+Neurotensin%2C+from+Bovine+Hypothalami&doi=10.1016%2FS0021-9258%2819%2943429-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami</span></div><div class="casAuthors">Carraway, Robert; Leeman, Susan E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1973</span>),
    <span class="NLM_cas:volume">248</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6854-61</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">A hypotensive peptide, designated neurotensin, was isolated in pure form from acid-Me2CO exts. of bovine hypothalami by column chromatog. and paper electrophoresis.  Amino acid anal. of material recovered after paper electrophoresis at pH 3.5, 6.5, and 8.9 and chromatog. anal. of the dansylated material indicated that the peptide isolated by this procedure was homogenous.  Its amino acid compn. and apparent mol. wt. estd. by chromatog. on Sephadex G-25 indicated that neurotensin is a tridecapeptide composed of Lys, Arg2, Asx, Glx2, Pro2, Ileu, Leu2, Tyr2.  Neurotensin lacks a free N-terminus; however, it possesses a free C-terminus which can be acted upon by carboxypeptidase A.  Neurotensin induced hypotension in the rat and stimulated the contraction of guinea pig ileum and rat uterus; however, it produced relaxation of the rat duodenum.  These pharmacol. properties classify it as a kinin, yet its chem. compn. distinguishes it from any known peptide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGUMbGcmJyBrVg90H21EOLACvtfcHk0lhCeqxjEBdf_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2cXps1U%253D&md5=717f2fac48338b8403ea764e6e59db00</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2FS0021-9258%2819%2943429-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0021-9258%252819%252943429-7%26sid%3Dliteratum%253Aachs%26aulast%3DCarraway%26aufirst%3DR.%26aulast%3DLeeman%26aufirst%3DS.%2BE.%26atitle%3DThe%2520Isolation%2520of%2520a%2520New%2520Hypotensive%2520Peptide%252C%2520Neurotensin%252C%2520from%2520Bovine%2520Hypothalami%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1973%26volume%3D248%26spage%3D6854%26epage%3D6861%26doi%3D10.1016%2FS0021-9258%2819%2943429-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Granier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Rietschoten, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitabgi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poustis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freychet, P.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Characterization of Neurotensin Analogues for Structure/Activity Relationship Studies. Acetyl-Neurotensin-(8–13) Is the Shortest Analogue with Full Binding and Pharmacological Activities</span>. <i>Eur. J. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>124</i></span>,  <span class="NLM_fpage">117</span>– <span class="NLM_lpage">125</span>, <span class="refDoi"> DOI: 10.1111/j.1432-1033.1982.tb05913.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1111%2Fj.1432-1033.1982.tb05913.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=7084220" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADyaL38XktFOgtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=1982&pages=117-125&author=C.+Granierauthor=J.+Van+Rietschotenauthor=P.+Kitabgiauthor=C.+Poustisauthor=P.+Freychet&title=Synthesis+and+Characterization+of+Neurotensin+Analogues+for+Structure%2FActivity+Relationship+Studies.+Acetyl-Neurotensin-%288%E2%80%9313%29+Is+the+Shortest+Analogue+with+Full+Binding+and+Pharmacological+Activities&doi=10.1111%2Fj.1432-1033.1982.tb05913.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and characterization of neurotensin analogs for structure/activity relationship studies.  Acetyl-neurotensin-(8-13) is the shortest analogue with full binding and pharmacological activities</span></div><div class="casAuthors">Granier, Claude; Van Rietschoten, Jurphaas; Kitabgi, Patrick; Poustis, Claudine; Freychet, Pierre</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">117-24</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    </div><div class="casAbstract">neurotensin  [39379-15-2] And several sequence analogs were synthesized using solid-phase technol. and tested for binding competition with [3H]neurotensin on the specific fixation sites of rat brain synaptosomal membranes and on those of HT 29 cells.  In addn. to these radioreceptor assays on neural and extraneural targets, a pharmacol. test (contraction of guinea pig ileum in the presence of neostigmine) was used to compare the behavior of the synthetic analogs.  A good parallel was obsd. between the degree of fixation and pharmacol. effects for entire neurotensin and for C-terminal region analogs up to the size of neurotensin-(8-13)  [60482-95-3].  The two peptides neurotensin-(6-13)  [60482-94-2] and neurotensin-(4-13)  [60482-93-1] had abnormally high affinities for rat brain synaptic membrane binding sites, combined with relatively low contracting activities.  The C-terminal peptide -Arg-Arg-Pro-Tyr-Ile-Leu fulfills all the structural requirements for mimicking the entire sequence, provided its α-amino end is protected by acetylation.  The guanidinium structure of residues 8 and 9 are not of vital importance, since they could be efficiently replaced by amino groups of lysyl side chains.  xenopsin  [51827-01-1], Which can be considered as a natural analog of neurotensin-(8-13), acts similarly to acetyl-neurotensin-(8-13)  [74853-69-3].  Removal of the phenolic function of residue 11 induces a decrease in neurotensin effects.  The C-terminal isoleucyl and leucyl residues could not be replaced by alanine without complete loss of the 3 activities tested.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZYG17WWqZtLVg90H21EOLACvtfcHk0lhCeqxjEBdf_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38XktFOgtbg%253D&md5=b48e23ddb8244691644b4b8ae5ceb70c</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1111%2Fj.1432-1033.1982.tb05913.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1432-1033.1982.tb05913.x%26sid%3Dliteratum%253Aachs%26aulast%3DGranier%26aufirst%3DC.%26aulast%3DVan%2BRietschoten%26aufirst%3DJ.%26aulast%3DKitabgi%26aufirst%3DP.%26aulast%3DPoustis%26aufirst%3DC.%26aulast%3DFreychet%26aufirst%3DP.%26atitle%3DSynthesis%2520and%2520Characterization%2520of%2520Neurotensin%2520Analogues%2520for%2520Structure%252FActivity%2520Relationship%2520Studies.%2520Acetyl-Neurotensin-%25288%25E2%2580%259313%2529%2520Is%2520the%2520Shortest%2520Analogue%2520with%2520Full%2520Binding%2520and%2520Pharmacological%2520Activities%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D1982%26volume%3D124%26spage%3D117%26epage%3D125%26doi%3D10.1111%2Fj.1432-1033.1982.tb05913.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guillemette, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dansereau, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaudet, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richelson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarret, P.</span></span> <span> </span><span class="NLM_article-title">Intrathecal Administration of Nts1 Agonists Reverses Nociceptive Behaviors in a Rat Model of Neuropathic Pain</span>. <i>Eur. J. Pain</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">473</span>– <span class="NLM_lpage">484</span>, <span class="refDoi"> DOI: 10.1016/j.ejpain.2011.07.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2Fj.ejpain.2011.07.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=22396077" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BC38XjsVSqt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2012&pages=473-484&author=A.+Guillemetteauthor=M.+A.+Dansereauauthor=N.+Beaudetauthor=E.+Richelsonauthor=P.+Sarret&title=Intrathecal+Administration+of+Nts1+Agonists+Reverses+Nociceptive+Behaviors+in+a+Rat+Model+of+Neuropathic+Pain&doi=10.1016%2Fj.ejpain.2011.07.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Intrathecal administration of NTS1 agonists reverses nociceptive behaviors in a rat model of neuropathic pain</span></div><div class="casAuthors">Guillemette, A.; Dansereau, M. A.; Beaudet, N.; Richelson, E.; Sarret, P.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pain (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">473-484</span>CODEN:
                <span class="NLM_cas:coden">EJPAFJ</span>;
        ISSN:<span class="NLM_cas:issn">1090-3801</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Chronic neuropathic pain arising from peripheral nerve damage is a severe clin. issue where there is a major unmet medical need.  We previously demonstrated that both neurotensin (NT) receptor subtypes 1 (NTS1) and 2 (NTS2) are involved in mediating the naloxone-insensitive antinociceptive effects of neurotensin in different analgesic tests including hotplate, tail-flick, and tonic pain.  However, the role of these receptors in neuropathic pain management has been poorly investigated.  In the present study, we therefore examd. whether intrathecal delivery of NTS1 agonists was effective in reducing neuropathic pain symptoms in rats.  Neuropathy was induced by sciatic nerve constriction (CCI model), and the development of mech. allodynia and thermal hyperalgesia on the ipsi- and contralateral hind paws was examd. 3, 7, 14, 21, and 28 days post-surgery.  CCI-operated rats exhibited significant increases in thermal and mech. hypersensitivities over a 28-day testing period.  Spinal injection of NT to CCI rats alleviated the behavioral responses to radiant heat and mech. stimuli, with a maximal reversal of 91% of allodynia at 6 μg/kg.  Intrathecal administration of the NTS1-selective agonist, PD149163 (30-90 μg/kg) also produced potent anti-allodynic and anti-hyperalgesic effects in nerve-injured rats.  Likewise, heat hyperalgesia and tactile allodynia produced by CCI of the sciatic nerve were fully reversed by the NTS1 agonist, NT69L (5-25 μg/kg).  Altogether, these results support the idea that the NTS1 receptor subtype is involved in pain modulation, and the potential use of NTS1 agonists for the treatment of painful neuropathies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriQDJyQci3e7Vg90H21EOLACvtfcHk0lhCeqxjEBdf_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjsVSqt7w%253D&md5=837122c56b6ee87613fff9b5c10e9797</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.ejpain.2011.07.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejpain.2011.07.008%26sid%3Dliteratum%253Aachs%26aulast%3DGuillemette%26aufirst%3DA.%26aulast%3DDansereau%26aufirst%3DM.%2BA.%26aulast%3DBeaudet%26aufirst%3DN.%26aulast%3DRichelson%26aufirst%3DE.%26aulast%3DSarret%26aufirst%3DP.%26atitle%3DIntrathecal%2520Administration%2520of%2520Nts1%2520Agonists%2520Reverses%2520Nociceptive%2520Behaviors%2520in%2520a%2520Rat%2520Model%2520of%2520Neuropathic%2520Pain%26jtitle%3DEur.%2520J.%2520Pain%26date%3D2012%26volume%3D16%26spage%3D473%26epage%3D484%26doi%3D10.1016%2Fj.ejpain.2011.07.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
Vega, M. J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrer-Montiel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">González-Muñiz, R.</span></span> <span> </span><span class="NLM_article-title">Recent Progress in Non-Opioid Analgesic Peptides</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>660</i></span>,  <span class="NLM_fpage">36</span>– <span class="NLM_lpage">52</span>, <span class="refDoi"> DOI: 10.1016/j.abb.2018.10.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2Fj.abb.2018.10.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=30342013" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=660&publication_year=2018&pages=36-52&author=M.+J.+P.+de%0AVegaauthor=A.+Ferrer-Montielauthor=R.+Gonz%C3%A1lez-Mu%C3%B1iz&title=Recent+Progress+in+Non-Opioid+Analgesic+Peptides&doi=10.1016%2Fj.abb.2018.10.011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.abb.2018.10.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.abb.2018.10.011%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BVega%26aufirst%3DM.%2BJ.%2BP.%26aulast%3DFerrer-Montiel%26aufirst%3DA.%26aulast%3DGonz%25C3%25A1lez-Mu%25C3%25B1iz%26aufirst%3DR.%26atitle%3DRecent%2520Progress%2520in%2520Non-Opioid%2520Analgesic%2520Peptides%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2018%26volume%3D660%26spage%3D36%26epage%3D52%26doi%3D10.1016%2Fj.abb.2018.10.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tétreault, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaudet, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perron, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belleville, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">René, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavelier, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stroh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobi, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behlke, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarret, P.</span></span> <span> </span><span class="NLM_article-title">Spinal Nts2 Receptor Activation Reverses Signs of Neuropathic Pain</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">3741</span>– <span class="NLM_lpage">3752</span>, <span class="refDoi"> DOI: 10.1096/fj.12-225540</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1096%2Ffj.12-225540" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=23756650" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVaitLrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2013&pages=3741-3752&author=P.+T%C3%A9treaultauthor=N.+Beaudetauthor=A.+Perronauthor=K.+Bellevilleauthor=A.+Ren%C3%A9author=F.+Cavelierauthor=J.+Martinezauthor=T.+Strohauthor=A.+M.+Jacobiauthor=S.+D.+Roseauthor=M.+A.+Behlkeauthor=P.+Sarret&title=Spinal+Nts2+Receptor+Activation+Reverses+Signs+of+Neuropathic+Pain&doi=10.1096%2Ffj.12-225540"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Spinal NTS2 receptor activation reverses signs of neuropathic pain</span></div><div class="casAuthors">Tetreault, Pascal; Beaudet, Nicolas; Perron, Amelie; Belleville, Karine; Rene, Adeline; Cavelier, Florine; Martinez, Jean; Stroh, Thomas; Jacobi, Ashley M.; Rose, Scott D.; Behlke, Mark A.; Sarret, Philippe</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3741-3752, 10.1096/fj.12-225540</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">Management of painful peripheral neuropathies remains challenging, since patients with chronic pain respond poorly to the available pharmacopeia.  In recent years, the G-protein-coupled receptor neurotensin (NT) type 2 (NTS2) emerged as an attractive target for treating transitory pain states.  To date, however, there is no evidence for its role in the regulation of chronic peripheral neuropathies.  Here, we found that NTS2 receptors were largely localized to primary afferent fibers and superficial dorsal horns.  Changes in the time course of the gene expression profile of NT, NTS1, and NTS2 were obsd. over a 28-d period following the sciatic nerve constriction [chronic constriction injury (CCI) model].  We next detd. the effects of central delivery of selective-NTS2 agonists to CCI-treated rats on both mech. allodynia (evoked withdrawal responses) and wt.-bearing deficits (discomfort and quality-of-life proxies).  The NTS2 analogs JMV431, levocabastine, and β-lactotensin were all effective in reducing ongoing tactile allodynia in CCI-treated rats.  Likewise, amitriptyline, pregabalin, and morphine significantly attenuated CCI-induced mech. hypersensitivity.  NTS2 agonists were also efficient in reversing wt.-bearing and postural deficits caused by nerve damage, unlike ref. analgesics currently used in the clinic.  Thus, NTS2 agonists may offer new treatment avenues for limiting pain assocd. with peripheral neuropathies and improve functional rehabilitation and well-being.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquJJpzef1xT7Vg90H21EOLACvtfcHk0lg5GMZqYcfinQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVaitLrJ&md5=10a111da88716e123c03c6b89df248a1</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1096%2Ffj.12-225540&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.12-225540%26sid%3Dliteratum%253Aachs%26aulast%3DT%25C3%25A9treault%26aufirst%3DP.%26aulast%3DBeaudet%26aufirst%3DN.%26aulast%3DPerron%26aufirst%3DA.%26aulast%3DBelleville%26aufirst%3DK.%26aulast%3DRen%25C3%25A9%26aufirst%3DA.%26aulast%3DCavelier%26aufirst%3DF.%26aulast%3DMartinez%26aufirst%3DJ.%26aulast%3DStroh%26aufirst%3DT.%26aulast%3DJacobi%26aufirst%3DA.%2BM.%26aulast%3DRose%26aufirst%3DS.%2BD.%26aulast%3DBehlke%26aufirst%3DM.%2BA.%26aulast%3DSarret%26aufirst%3DP.%26atitle%3DSpinal%2520Nts2%2520Receptor%2520Activation%2520Reverses%2520Signs%2520of%2520Neuropathic%2520Pain%26jtitle%3DFASEB%2520J.%26date%3D2013%26volume%3D27%26spage%3D3741%26epage%3D3752%26doi%3D10.1096%2Ffj.12-225540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Behbehani, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pert, A.</span></span> <span> </span><span class="NLM_article-title">A Mechanism for the Analgesic Effect of Neurotensin as Revealed by Behavioral and Electrophysiological Techniques</span>. <i>Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>324</i></span>,  <span class="NLM_fpage">35</span>– <span class="NLM_lpage">42</span>, <span class="refDoi"> DOI: 10.1016/0006-8993(84)90619-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2F0006-8993%2884%2990619-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=6518391" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADyaL2MXptVeiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=324&publication_year=1984&pages=35-42&author=M.+M.+Behbehaniauthor=A.+Pert&title=A+Mechanism+for+the+Analgesic+Effect+of+Neurotensin+as+Revealed+by+Behavioral+and+Electrophysiological+Techniques&doi=10.1016%2F0006-8993%2884%2990619-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">A mechanism for the analgesic effect of neurotensin as revealed by behavioral and electrophysiological techniques</span></div><div class="casAuthors">Behbehani, M. M.; Pert, A.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">324</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">35-42</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    </div><div class="casAbstract">Behavioral and electrophysiol. techniques were used to examine the effects of local injections of neurotensin (NT)  [39379-15-2] into the periaqueductal gray (PAG) of rats.  Injection of NT into the PAG produced dose-dependent analgesia that lasted for as long as 60 min and was not blocked by naloxone.  However, electrolytic lesions of the nucleus raphe magnus (NRM) and its surrounding area abolished the analgesic effect of NT.  Electrophysiol. expts. indicated that micro-pressure application of NT onto neurons in the PAG had a predominantly excitatory effect.  Furthermore, injection of NT into the PAG produced excitation of the NRM neurons.  NT produces its analgesic effect by excitation of PAG neurons which leads to activation of the pain inhibitory system that originates from the NRM and its surrounding areas in the medulla.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoD8Jc99x3wk7Vg90H21EOLACvtfcHk0lg5GMZqYcfinQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXptVeiug%253D%253D&md5=cc6759f013c5fbad15c1f0ab3e1935fe</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2F0006-8993%2884%2990619-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-8993%252884%252990619-X%26sid%3Dliteratum%253Aachs%26aulast%3DBehbehani%26aufirst%3DM.%2BM.%26aulast%3DPert%26aufirst%3DA.%26atitle%3DA%2520Mechanism%2520for%2520the%2520Analgesic%2520Effect%2520of%2520Neurotensin%2520as%2520Revealed%2520by%2520Behavioral%2520and%2520Electrophysiological%2520Techniques%26jtitle%3DBrain%2520Res.%26date%3D1984%26volume%3D324%26spage%3D35%26epage%3D42%26doi%3D10.1016%2F0006-8993%2884%2990619-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bredeloux, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costentin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubuc, I.</span></span> <span> </span><span class="NLM_article-title">Interactions between Nts2 Neurotensin and Opioid Receptors on Two Nociceptive Responses Assessed on the Hot Plate Test in Mice</span>. <i>Behav. Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>175</i></span>,  <span class="NLM_fpage">399</span>– <span class="NLM_lpage">407</span>, <span class="refDoi"> DOI: 10.1016/j.bbr.2006.09.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2Fj.bbr.2006.09.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=17074405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1ersr%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=175&publication_year=2006&pages=399-407&author=P.+Bredelouxauthor=J.+Costentinauthor=I.+Dubuc&title=Interactions+between+Nts2+Neurotensin+and+Opioid+Receptors+on+Two+Nociceptive+Responses+Assessed+on+the+Hot+Plate+Test+in+Mice&doi=10.1016%2Fj.bbr.2006.09.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Interactions between NTS2 neurotensin and opioid receptors on two nociceptive responses assessed on the hot plate test in mice</span></div><div class="casAuthors">Bredeloux, Pierre; Costentin, Jean; Dubuc, Isabelle</div><div class="citationInfo"><span class="NLM_cas:title">Behavioural Brain Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">175</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">399-407</span>CODEN:
                <span class="NLM_cas:coden">BBREDI</span>;
        ISSN:<span class="NLM_cas:issn">0166-4328</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The intracerebroventricular administration of the tridecapeptide neurotensin (NT) produces strong analgesic effects in tests evaluating acute pain.  We investigated whether these effects are mediated by the opioid receptors.  In the hot plate test, the NT receptors agonist NT1 (NαMe-Arg-Lys-Pro-Trp-Tle-Leu), s.c. injected (0.3-3 mg/kg), increased paw licking and jump latencies.  These effects were inhibited by the NTS2 antagonist levocabastine (2.5 mg/kg, i.p.) but not by the selective NTS1 antagonist SR48692 (3 mg/kg, i.p.).  The opioid receptor antagonist naloxone did not modify (up to the dose of 4.5 mg/kg, s.c.) the NT1 effect on licking, but abolished the increase in the jump latency (from the dose of 1.5 mg/kg).  In mice made tolerant to the analgesic effect of morphine (2 mg/kg, s.c.) by previous morphine injections (32 mg/kg, s.c., twice a day, 4 days), NT1 maintained its effect on licking, but its effect on jump latency was suppressed.  Levocabastine (up to the dose of 4.5 mg/kg) failed to antagonize the effects of morphine (2 mg/kg, s.c.) on both licking and jump latencies.  In mice made tolerant to the analgesic effect of NT1 (0.3 mg/kg, s.c.) by previous NT1 injections (3 mg/kg, s.c., twice a day, 4 days) morphine maintained its analgesic effects both on licking and jumping latencies.  We can conclude that neurotensinergic and opioidergic transmissions are functionally independent as regards the licking response.  However, in the jump response, neurotensinergic transmission seems to regulate opioidergic transmission, inducing its stimulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCzDMc2RrThLVg90H21EOLACvtfcHk0liRgHKOXyGWYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1ersr%252FF&md5=10582997fbcd6fb16bb39de279237205</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.bbr.2006.09.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbr.2006.09.016%26sid%3Dliteratum%253Aachs%26aulast%3DBredeloux%26aufirst%3DP.%26aulast%3DCostentin%26aufirst%3DJ.%26aulast%3DDubuc%26aufirst%3DI.%26atitle%3DInteractions%2520between%2520Nts2%2520Neurotensin%2520and%2520Opioid%2520Receptors%2520on%2520Two%2520Nociceptive%2520Responses%2520Assessed%2520on%2520the%2520Hot%2520Plate%2520Test%2520in%2520Mice%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2006%26volume%3D175%26spage%3D399%26epage%3D407%26doi%3D10.1016%2Fj.bbr.2006.09.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clineschmidt, B. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGuffin, J. C.</span></span> <span> </span><span class="NLM_article-title">Neurotensin Administered Intracisternally Inhibits Responsiveness of Mice to Noxious Stimuli</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1977</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">395</span>– <span class="NLM_lpage">396</span>, <span class="refDoi"> DOI: 10.1016/0014-2999(77)90236-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2F0014-2999%2877%2990236-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=201475" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADyaE1cXhtlWht7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1977&pages=395-396&author=B.+V.+Clineschmidtauthor=J.+C.+McGuffin&title=Neurotensin+Administered+Intracisternally+Inhibits+Responsiveness+of+Mice+to+Noxious+Stimuli&doi=10.1016%2F0014-2999%2877%2990236-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Neurotensin administered intracisternally inhibits responsiveness of mice to noxious stimuli</span></div><div class="casAuthors">Clineschmidt, Bradley V.; McGuffin, Jodie C.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">395-6</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">In female mice, neurotensin (I)  [39379-15-2] injected intracisternally caused a dose-related increase in reaction time upon exposure to a hot plate and a decrease in the frequency of writhing subsequent to the injection of acetic acid.  The minimally ED in the hot plate test was 0.025-0.25 ng/mouse.  In both cases, the max. antinocisponsive effect occurred at 250 ng/mouse, a 10-fold increase in dose caused little, if any addnl. action.  I (2.5 μg) did not have an antinocisponsive effect.  The antinocisponsive effect of I following the max. ED (250 ng/mouse) lasted for ∼ 1 h and for ∼2 h after 10-times this dose.  With dose of I of 25 ng/mouse (hot plate) or 2.5 ng/mouse (writhing), naloxone was not effective as an antagonist of the antinocisponsive action of I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqChpxrp802KrVg90H21EOLACvtfcHk0liRgHKOXyGWYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1cXhtlWht7Y%253D&md5=c50fa14e8a4d40d4ef72a155508ab302</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2877%2990236-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252877%252990236-9%26sid%3Dliteratum%253Aachs%26aulast%3DClineschmidt%26aufirst%3DB.%2BV.%26aulast%3DMcGuffin%26aufirst%3DJ.%2BC.%26atitle%3DNeurotensin%2520Administered%2520Intracisternally%2520Inhibits%2520Responsiveness%2520of%2520Mice%2520to%2520Noxious%2520Stimuli%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1977%26volume%3D46%26spage%3D395%26epage%3D396%26doi%3D10.1016%2F0014-2999%2877%2990236-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clineschmidt, B. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGuffin, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunting, P. B.</span></span> <span> </span><span class="NLM_article-title">Neurotensin: Antinocisponsive Action in Rodents</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1979</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">129</span>– <span class="NLM_lpage">139</span>, <span class="refDoi"> DOI: 10.1016/0014-2999(79)90415-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2F0014-2999%2879%2990415-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=421735" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADyaE1MXhsVKhsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1979&pages=129-139&author=B.+V.+Clineschmidtauthor=J.+C.+McGuffinauthor=P.+B.+Bunting&title=Neurotensin%3A+Antinocisponsive+Action+in+Rodents&doi=10.1016%2F0014-2999%2879%2990415-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Neurotensin:  antinocisponsive action in rodents</span></div><div class="casAuthors">Clineschmidt, Bradley V.; McGuffin, Jodie C.; Bunting, Patricia A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">129-39</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">Neurotensin  [39379-15-2] administered intracisternally in mice increased reaction time in the hot plate test (min. ED = 25 ng) and decreased writhing induced by acetic acid (min. ED = 0.25 ng).  At the max. ED of 250 ng, the antinocisponsive action of neurotensin lasted for ∼1 h.  In the hot plate test, neurotensin, [Gln4]-neurotensin  [61445-54-3], and [D-Ala2, Met5]enkephalinamide  [61090-95-7] were all equiactive at the 3 dose levels examd., 0.00015, 0.015, and 1.5 nmoles/mouse.  At antinocisponsive doses, mice treated intracisternally with neurotensin also were hypothermic and had decreased locomotor activity.  Neurotensin (2500 ng) administered i.v. did not produce any of the effects described above.  DL-5-Hydroxytryptophan, oxotremorine, and chlorpromazine given systemically caused hypothermia but did not change reaction time in the hot plate procedure.  Neurotensin, even at doses as high as 2500 ng given intracisternally, did not disrupt coordinated motor control or change the current-response relation for electroshock-induced seizures.  The antinocisponsive action of neurotensin in mice (hot plate test) was not antagonized by naloxone, cyproheptadine, methergoline, atropine, benzotropine, mecamylamine, chlorpheniramine, pyribenzamine, cimetidine, BE 2254, propranolol, phenoxybenzamine, haloperidol, or indomethacin.  Neurotensin administered intracisternally was also an effective antinocisponsive agent in rats, as assessed in the hot plate procedure, but not in the tail-flick test.  Naloxone did not antagonize this action of neurotensin in the rat.  The antinocisponsive effect of neurotensin may result from interaction of the peptide with neurotensin-specific receptor sites in the central nervous system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTrJmNLec117Vg90H21EOLACvtfcHk0liRgHKOXyGWYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1MXhsVKhsrs%253D&md5=c05fcc516f529cfaf3e190a59be2f301</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2879%2990415-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252879%252990415-1%26sid%3Dliteratum%253Aachs%26aulast%3DClineschmidt%26aufirst%3DB.%2BV.%26aulast%3DMcGuffin%26aufirst%3DJ.%2BC.%26aulast%3DBunting%26aufirst%3DP.%2BB.%26atitle%3DNeurotensin%253A%2520Antinocisponsive%2520Action%2520in%2520Rodents%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1979%26volume%3D54%26spage%3D129%26epage%3D139%26doi%3D10.1016%2F0014-2999%2879%2990415-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Osbahr, A. J. D.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nemeroff, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luttinger, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prange, A. J.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Neurotensin-Induced Antinociception in Mice: Antagonism by Thyrotropin-Releasing Hormone</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1981</span>,  <span class="NLM_volume"><i>217</i></span>,  <span class="NLM_fpage">645</span>– <span class="NLM_lpage">651</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=6112261" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADyaL3MXitVeis7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=217&publication_year=1981&pages=645-651&author=A.+J.+D.+Osbahrauthor=C.+B.+Nemeroffauthor=D.+Luttingerauthor=G.+A.+Masonauthor=A.+J.+Prange&title=Neurotensin-Induced+Antinociception+in+Mice%3A+Antagonism+by+Thyrotropin-Releasing+Hormone"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Neurotensin-induced antinociception in mice:  antagonism by thyrotropin-releasing hormone</span></div><div class="casAuthors">Osbahr, Albert J., III; Nemeroff, Charles B.; Luttinger, Daniel; Mason, George A.; Prange, Arthur J., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">217</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">645-51</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">Neurotensin (NT)  [39379-15-2] administered intracisternally to mice produced dose-dependent antinociception in 3 analgesic tests: tail immersion, hot-plate, and acetic acid writhing.  Naloxone, administered i.p. before NT, did not alter NT-induced antinociception in any of these tests but did reverse β-endorphin  [60617-12-1]-induced antinociception.  Centrally and peripherally administered TRH  [24305-27-9] antagonized NT-induced (but not β-endorphin-induced) antinociception.  Equimolar doses of melanostatin  [9083-38-9] did not alter the effects of NT.  NT and TRH apparently are functional antagonists in the central nervous system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJY7ke2pY_WbVg90H21EOLACvtfcHk0liRgHKOXyGWYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXitVeis7o%253D&md5=2169b298a15b35041301b74a46a2a36e</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOsbahr%26aufirst%3DA.%2BJ.%2BD.%26aulast%3DNemeroff%26aufirst%3DC.%2BB.%26aulast%3DLuttinger%26aufirst%3DD.%26aulast%3DMason%26aufirst%3DG.%2BA.%26aulast%3DPrange%26aufirst%3DA.%2BJ.%26atitle%3DNeurotensin-Induced%2520Antinociception%2520in%2520Mice%253A%2520Antagonism%2520by%2520Thyrotropin-Releasing%2520Hormone%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1981%26volume%3D217%26spage%3D645%26epage%3D651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wustrow, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akunne, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corbin, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiley, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wise, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heffner, T. G.</span></span> <span> </span><span class="NLM_article-title">Reduced Amide Bond Neurotensin 8-13 Mimetics with Potent in Vivo Activity</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">997</span>– <span class="NLM_lpage">1002</span>, <span class="refDoi"> DOI: 10.1016/0960-894X(95)00155-M</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2F0960-894X%2895%2900155-M" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADyaK2MXlslegu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1995&pages=997-1002&author=D.+J.+Wustrowauthor=M.+D.+Davisauthor=H.+C.+Akunneauthor=A.+E.+Corbinauthor=J.+N.+Wileyauthor=L.+D.+Wiseauthor=T.+G.+Heffner&title=Reduced+Amide+Bond+Neurotensin+8-13+Mimetics+with+Potent+in+Vivo+Activity&doi=10.1016%2F0960-894X%2895%2900155-M"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Reduced amide bond neurotensin 8-13 mimetics with potent in vivo activity</span></div><div class="casAuthors">Wustrow, D. J.; Davis, M. D.; Akunne, H. C.; Corbin, A. E.; Wiley, J. N.; Wise, L. D.; Heffner, T. G.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">997-1002</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Appropriately substituted 8-9 (ψCH2NY) isosteres of neurotensin (NT) 8-13 have been found which are active as NT agonists in vitro and in vivo.  SAR studies suggest that preventing amide bond hydrolysis at the 8-9 and 11-12 positions of NT(8-13) mimetics is important for producing compds. with potent activity in vivo.  Other simplified replacements for the Arg-Arg portion of NT(8-13) are reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolczgZFDR_9rVg90H21EOLACvtfcHk0liqo3I_5I_prQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXlslegu7Y%253D&md5=827c72b0a113b17bfcf7594cbf57cef8</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2F0960-894X%2895%2900155-M&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0960-894X%252895%252900155-M%26sid%3Dliteratum%253Aachs%26aulast%3DWustrow%26aufirst%3DD.%2BJ.%26aulast%3DDavis%26aufirst%3DM.%2BD.%26aulast%3DAkunne%26aufirst%3DH.%2BC.%26aulast%3DCorbin%26aufirst%3DA.%2BE.%26aulast%3DWiley%26aufirst%3DJ.%2BN.%26aulast%3DWise%26aufirst%3DL.%2BD.%26aulast%3DHeffner%26aufirst%3DT.%2BG.%26atitle%3DReduced%2520Amide%2520Bond%2520Neurotensin%25208-13%2520Mimetics%2520with%2520Potent%2520in%2520Vivo%2520Activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1995%26volume%3D5%26spage%3D997%26epage%3D1002%26doi%3D10.1016%2F0960-894X%2895%2900155-M" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eiselt, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chartier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Betti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Longpré, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavelier, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tourwé, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gendron, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballet, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarret, P.</span></span> <span> </span><span class="NLM_article-title">Neurotensin Analogues Containing Cyclic Surrogates of Tyrosine at Position 11 Improve Nts2 Selectivity Leading to Analgesia without Hypotension and Hypothermia</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">4535</span>– <span class="NLM_lpage">4544</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.9b00390</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.9b00390" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvFWltLvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=4535-4544&author=E.+Eiseltauthor=S.+Gonzalezauthor=C.+Martinauthor=M.+Chartierauthor=C.+Bettiauthor=J.-M.+Longpr%C3%A9author=F.+Cavelierauthor=D.+Tourw%C3%A9author=L.+Gendronauthor=S.+Balletauthor=P.+Sarret&title=Neurotensin+Analogues+Containing+Cyclic+Surrogates+of+Tyrosine+at+Position+11+Improve+Nts2+Selectivity+Leading+to+Analgesia+without+Hypotension+and+Hypothermia&doi=10.1021%2Facschemneuro.9b00390"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Neurotensin Analogues Containing Cyclic Surrogates of Tyrosine at Position 11 Improve NTS2 Selectivity Leading to Analgesia without Hypotension and Hypothermia</span></div><div class="casAuthors">Eiselt, Emilie; Gonzalez, Simon; Martin, Charlotte; Chartier, Magali; Betti, Cecilia; Longpre, Jean-Michel; Cavelier, Florine; Tourwe, Dirk; Gendron, Louis; Ballet, Steven; Sarret, Philippe</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4535-4544</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Neurotensin (NT) exerts its analgesic effects through activation of the G protein-coupled receptors NTS1 and NTS2.  This opioid-independent antinociception represents a potential alternative for pain management.  While activation of NTS1 also induces a drop in blood pressure and body temp., NTS2 appears to be an analgesic target free of these adverse effects.  Here, we report modifications of NT at Tyr11 to increase selectivity toward NTS2, complemented by modifications at the N-terminus to impair proteolytic degrdn. of the biol. active NT(8-13) sequence.  Replacement of Tyr11 by either 6-OH-Tic or 7-OH-Tic resulted in a significant loss of binding affinity to NTS1 and subsequent NTS2 selectivity.  Incorporation of the unnatural amino acid β3hLys at position 8 increased the half-life to over 24 h in plasma.  Simultaneous integration of both β3hLys8 and 6-OH-Tic11 into NT(8-13) produced a potent and NTS2-selective analog with strong analgesic action after intrathecal delivery in the rat formalin-induced pain model with an ED50 of 1.4 nmol.  Addnl., i.v. administration of this NT analog did not produce persistent hypotension or hypothermia.  These results demonstrate that NT analogs harboring unnatural amino acids at positions 8 and 11 can enhance crucial pharmacokinetic and pharmacodynamic features for NT(8-13) analogs, i.e., proteolytic stability, NTS2 selectivity, and improved analgesic/adverse effect ratio.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1tutNP5uFw7Vg90H21EOLACvtfcHk0liqo3I_5I_prQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvFWltLvM&md5=66a2f7f94056744d2d6de0a91314017d</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.9b00390&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.9b00390%26sid%3Dliteratum%253Aachs%26aulast%3DEiselt%26aufirst%3DE.%26aulast%3DGonzalez%26aufirst%3DS.%26aulast%3DMartin%26aufirst%3DC.%26aulast%3DChartier%26aufirst%3DM.%26aulast%3DBetti%26aufirst%3DC.%26aulast%3DLongpr%25C3%25A9%26aufirst%3DJ.-M.%26aulast%3DCavelier%26aufirst%3DF.%26aulast%3DTourw%25C3%25A9%26aufirst%3DD.%26aulast%3DGendron%26aufirst%3DL.%26aulast%3DBallet%26aufirst%3DS.%26aulast%3DSarret%26aufirst%3DP.%26atitle%3DNeurotensin%2520Analogues%2520Containing%2520Cyclic%2520Surrogates%2520of%2520Tyrosine%2520at%2520Position%252011%2520Improve%2520Nts2%2520Selectivity%2520Leading%2520to%2520Analgesia%2520without%2520Hypotension%2520and%2520Hypothermia%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2019%26volume%3D10%26spage%3D4535%26epage%3D4544%26doi%3D10.1021%2Facschemneuro.9b00390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boules, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbut, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richelson, E.</span></span> <span> </span><span class="NLM_article-title">Nt69l, a Novel Analgesic, Shows Synergy with Morphine</span>. <i>Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>1294</i></span>,  <span class="NLM_fpage">22</span>– <span class="NLM_lpage">28</span>, <span class="refDoi"> DOI: 10.1016/j.brainres.2009.07.086</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2Fj.brainres.2009.07.086" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=19651107" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFGlurrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1294&publication_year=2009&pages=22-28&author=M.+Boulesauthor=A.+Shawauthor=Y.+Liangauthor=D.+Barbutauthor=E.+Richelson&title=Nt69l%2C+a+Novel+Analgesic%2C+Shows+Synergy+with+Morphine&doi=10.1016%2Fj.brainres.2009.07.086"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">NT69L, a novel analgesic, shows synergy with morphine</span></div><div class="casAuthors">Boules, M.; Shaw, A.; Liang, Y.; Barbut, D.; Richelson, E.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">1294</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">22-28</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Background: Neurotensin (NT) is a neuropeptide with antinociceptive effects that are mediated through NT receptors, of which there are three known subtypes (NTS1, NTS2, and NTS3).  Morphine is a μ-opioid receptor agonist commonly used for pain treatment but is assocd. with side effects that can be serious.  We hypothesize that selective NT receptor agonists may represent a novel class of analgesics and their use in conjunction with morphine will have synergistic properties which may reduce the dose of morphine administered and its side effects.  Methods: The antinociceptive activity of an NT agonist (NT69L) and morphine was studied in rats using the hot plate test to det. if there is synergism between the two drugs in reducing pain.  The NTS2 receptor antagonist, levocabastine, was used to det. the receptor subtype involved in the analgesic effect of NT69L and morphine.  Results: The administration of both NT69L and morphine resulted in a dose-dependent analgesic effect.  The isobolog. anal. demonstrated that the combination of sub-analgesic doses of NT69L and morphine was synergistic in the hot plate test.  Pretreatment with the NTS2 receptor antagonist, levocabastine attenuated the antinociceptive effect of NT69L and the combined effect of NT69L and morphine in the hot plate test.  Conclusion: The results support the hypothesis that the synergistic combination of NT69L and morphine would improve the pharmacol. treatment of pain while minimizing specific adverse effects of each of the drugs at a higher dose.  NTS2 is important for the antinociceptive effect of NT69L and morphine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrE7jkwCFETorVg90H21EOLACvtfcHk0liqo3I_5I_prQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFGlurrM&md5=15d6faf03877137b20b911f8aa7b6a64</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2009.07.086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2009.07.086%26sid%3Dliteratum%253Aachs%26aulast%3DBoules%26aufirst%3DM.%26aulast%3DShaw%26aufirst%3DA.%26aulast%3DLiang%26aufirst%3DY.%26aulast%3DBarbut%26aufirst%3DD.%26aulast%3DRichelson%26aufirst%3DE.%26atitle%3DNt69l%252C%2520a%2520Novel%2520Analgesic%252C%2520Shows%2520Synergy%2520with%2520Morphine%26jtitle%3DBrain%2520Res.%26date%3D2009%26volume%3D1294%26spage%3D22%26epage%3D28%26doi%3D10.1016%2Fj.brainres.2009.07.086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boules, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnston, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tozy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richelson, E.</span></span> <span> </span><span class="NLM_article-title">Analgesic Synergy of Neurotensin Receptor Subtype 2 Agonist Nt79 and Morphine</span>. <i>Behav. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">573</span>– <span class="NLM_lpage">581</span>, <span class="refDoi"> DOI: 10.1097/FBP.0b013e3283474a3a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1097%2FFBP.0b013e3283474a3a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=21691202" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVWnu7%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2011&pages=573-581&author=M.+Boulesauthor=H.+Johnstonauthor=J.+Tozyauthor=K.+Smithauthor=Z.+Liauthor=E.+Richelson&title=Analgesic+Synergy+of+Neurotensin+Receptor+Subtype+2+Agonist+Nt79+and+Morphine&doi=10.1097%2FFBP.0b013e3283474a3a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Analgesic synergy of neurotensin receptor subtype 2 agonist NT79 and morphine</span></div><div class="casAuthors">Boules, Mona; Johnston, Hannah; Tozy, Jessica; Smith, Kristin; Li, Zhimin; Richelson, Elliott</div><div class="citationInfo"><span class="NLM_cas:title">Behavioural Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">5&6</span>),
    <span class="NLM_cas:pages">573-581</span>CODEN:
                <span class="NLM_cas:coden">BPHAEL</span>;
        ISSN:<span class="NLM_cas:issn">0955-8810</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Neurotensin (NT) is a tridecapeptide with naloxone-independent analgesic action.  NT exerts its effects through three molecularly cloned receptor subtypes, NTS1, NTS2, and NTS3.  The analgesic efficacy of NT agonists depends on their activation of NTS1 and/or NTS2.  NT79 is an NTS2-selective agonist without hypothermic and hypotensive effects, produces analgesic effects in animal models of visceral (writhing), but not thermal (hot plate) pain.  This study extends previous study with NT79 to test its efficacy in an animal model of persistent pain (formalin test) and to det. whether there is analgesic synergy between NT79 and morphine on visceral and persistent pain.  NT79 enhanced the analgesic potency of morphine in the writhing test.  In the persistent pain model, NT79 and morphine attenuated formalin-induced lifting and biting during the inflammatory phase.  NT79 and morphine alone significantly blocked the lifting but not the biting response, which involves the activity of spinal nociceptive circuits.  However, the combination of NT79 and morphine attenuated both lifting and biting responses, results indicating both spinal and supraspinal modulation of persistent nociception.  Isobolog. analyses show analgesic synergism between NT79 and morphine in persistent pain, thus providing a promise of therapy for pain while minimizing adverse effects assocd. with morphine use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRLp-c6yI_KrVg90H21EOLACvtfcHk0liFz77QwUklEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVWnu7%252FP&md5=ed83630de3fce2bd7391d16b9f601bf1</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1097%2FFBP.0b013e3283474a3a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FFBP.0b013e3283474a3a%26sid%3Dliteratum%253Aachs%26aulast%3DBoules%26aufirst%3DM.%26aulast%3DJohnston%26aufirst%3DH.%26aulast%3DTozy%26aufirst%3DJ.%26aulast%3DSmith%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DRichelson%26aufirst%3DE.%26atitle%3DAnalgesic%2520Synergy%2520of%2520Neurotensin%2520Receptor%2520Subtype%25202%2520Agonist%2520Nt79%2520and%2520Morphine%26jtitle%3DBehav.%2520Pharmacol.%26date%3D2011%26volume%3D22%26spage%3D573%26epage%3D581%26doi%3D10.1097%2FFBP.0b013e3283474a3a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dobner, P. R.</span></span> <span> </span><span class="NLM_article-title">Neurotensin and Pain Modulation</span>. <i>Peptides</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">2405</span>– <span class="NLM_lpage">2414</span>, <span class="refDoi"> DOI: 10.1016/j.peptides.2006.04.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2Fj.peptides.2006.04.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=16870306" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BD28XpvV2gsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2006&pages=2405-2414&author=P.+R.+Dobner&title=Neurotensin+and+Pain+Modulation&doi=10.1016%2Fj.peptides.2006.04.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Neurotensin and pain modulation</span></div><div class="casAuthors">Dobner, Paul R.</div><div class="citationInfo"><span class="NLM_cas:title">Peptides (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2405-2414</span>CODEN:
                <span class="NLM_cas:coden">PPTDD5</span>;
        ISSN:<span class="NLM_cas:issn">0196-9781</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Neurotensin (NT) can produce a profound analgesia or enhance pain responses, depending on the circumstances.  Recent evidence suggests that this may be due to a dose-dependent recruitment of distinct populations of pain modulatory neurons.  NT knockout mice display defects in both basal nociceptive responses and stress-induced analgesia.  Stress-induced antinociception is absent in these mice and instead stress induces a hyperalgesic response, suggesting that NT plays a key role in the stress-induced suppression of pain.  Cold water swim stress results in increased NT mRNA expression in hypothalamic regions known to project to periaqueductal gray, a key region involved in pain modulation.  Thus, stress-induced increases in NT signaling in pain modulatory regions may be responsible for the transition from pain facilitation to analgesia.  This review focuses on recent advances that have provided insights into the role of NT in pain modulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdK5ae3Tc9lbVg90H21EOLACvtfcHk0liFz77QwUklEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpvV2gsro%253D&md5=b36dae07e063430ad827ac3ed489d616</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.peptides.2006.04.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.peptides.2006.04.025%26sid%3Dliteratum%253Aachs%26aulast%3DDobner%26aufirst%3DP.%2BR.%26atitle%3DNeurotensin%2520and%2520Pain%2520Modulation%26jtitle%3DPeptides%26date%3D2006%26volume%3D27%26spage%3D2405%26epage%3D2414%26doi%3D10.1016%2Fj.peptides.2006.04.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Y.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Y.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.-Q.</span></span> <span> </span><span class="NLM_article-title">The Roles of Neurotensin and Its Analogues in Pain</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">840</span>– <span class="NLM_lpage">848</span>, <span class="refDoi"> DOI: 10.2174/1381612820666141027124915</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.2174%2F1381612820666141027124915" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=840-848&author=Y.-P.+Fengauthor=J.+Wangauthor=Y.-L.+Dongauthor=Y.-Y.+Wangauthor=Y.-Q.+Li&title=The+Roles+of+Neurotensin+and+Its+Analogues+in+Pain&doi=10.2174%2F1381612820666141027124915"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.2174%2F1381612820666141027124915&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612820666141027124915%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DY.-P.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DDong%26aufirst%3DY.-L.%26aulast%3DWang%26aufirst%3DY.-Y.%26aulast%3DLi%26aufirst%3DY.-Q.%26atitle%3DThe%2520Roles%2520of%2520Neurotensin%2520and%2520Its%2520Analogues%2520in%2520Pain%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2014%26volume%3D21%26spage%3D840%26epage%3D848%26doi%3D10.2174%2F1381612820666141027124915" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kleczkowska, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lipkowski, A. W.</span></span> <span> </span><span class="NLM_article-title">Neurotensin and Neurotensin Receptors: Characteristic, Structure-Activity Relationship and Pain Modulation--a Review</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>716</i></span>,  <span class="NLM_fpage">54</span>– <span class="NLM_lpage">60</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2013.03.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2Fj.ejphar.2013.03.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=23500196" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BC3sXltVCrsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=716&publication_year=2013&pages=54-60&author=P.+Kleczkowskaauthor=A.+W.+Lipkowski&title=Neurotensin+and+Neurotensin+Receptors%3A+Characteristic%2C+Structure-Activity+Relationship+and+Pain+Modulation%2D%2Da+Review&doi=10.1016%2Fj.ejphar.2013.03.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Neurotensin and neurotensin receptors: Characteristic, structure-activity relationship and pain modulation-A review</span></div><div class="casAuthors">Kleczkowska, Patrycja; Lipkowski, Andrzej W.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">716</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">54-60</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Neurotensin (NT) is a tridecapeptide, which - since its discovery in 1973 - has been demonstrated to be involved in the control of various physiol. activities in both the central nervous system and in the periphery.  Its biol. effects are mediated by four receptor types.  Exogenously administered NT exerts different behavioral effects, including antinociception.  Structure-activity relationship studies performed in recent years resulted in development of several peptidomimetic receptor agonists and non-peptidic receptor antagonists that are useful tools for studies of NT mechanisms in tissue and on cellular level.  This may result in design of new generation of analgesics based on neurotensin.  NT antinociceptive effects are distinct from opioid analgesia.  This creates opportunity of development of hybrid analgesics that may simultaneously activate both opioid and NT antinociceptive pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtIxYXK-5X-bVg90H21EOLACvtfcHk0lg5_o_lsxXRtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXltVCrsbY%253D&md5=1797d1b66db6924f7bf0bfdc1fe1a1e3</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2013.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2013.03.004%26sid%3Dliteratum%253Aachs%26aulast%3DKleczkowska%26aufirst%3DP.%26aulast%3DLipkowski%26aufirst%3DA.%2BW.%26atitle%3DNeurotensin%2520and%2520Neurotensin%2520Receptors%253A%2520Characteristic%252C%2520Structure-Activity%2520Relationship%2520and%2520Pain%2520Modulation--a%2520Review%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2013%26volume%3D716%26spage%3D54%26epage%3D60%26doi%3D10.1016%2Fj.ejphar.2013.03.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sarret, P.</span>; <span class="NLM_string-name">Cavelier, F.</span></span> <span> </span><span class="NLM_article-title">Neurotensin and Its Receptors</span>. In  <i>Reference Module in Neuroscience and Biobehavioral Psychology</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stein, J.</span></span>, Ed.; <span class="NLM_publisher-name">Elsevier</span>, <span class="NLM_year">2018</span>; pp.  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">17</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&pages=1-17&author=P.+Sarret&author=F.+Cavelierauthor=J.+Stein&title=Reference+Module+in+Neuroscience+and+Biobehavioral+Psychology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DSarret%26aufirst%3DP.%26atitle%3DNeurotensin%2520and%2520Its%2520Receptors%26btitle%3DReference%2520Module%2520in%2520Neuroscience%2520and%2520Biobehavioral%2520Psychology%26aulast%3DStein%26aufirst%3DJ.%26pub%3DElsevier%26date%3D2018%26spage%3D1%26epage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fantegrossi, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, M. C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woods, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richelson, E.</span></span> <span> </span><span class="NLM_article-title">Antinociceptive, Hypothermic, Hypotensive, and Reinforcing Effects of a Novel Neurotensin Receptor Agonist, Nt69l, in Rhesus Monkeys</span>. <i>Pharmacol. Biochem. Behav.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">341</span>– <span class="NLM_lpage">349</span>, <span class="refDoi"> DOI: 10.1016/j.pbb.2004.12.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2Fj.pbb.2004.12.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=15680187" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmvFGrug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2005&pages=341-349&author=W.+E.+Fantegrossiauthor=M.+C.+H.+Koauthor=J.+H.+Woodsauthor=E.+Richelson&title=Antinociceptive%2C+Hypothermic%2C+Hypotensive%2C+and+Reinforcing+Effects+of+a+Novel+Neurotensin+Receptor+Agonist%2C+Nt69l%2C+in+Rhesus+Monkeys&doi=10.1016%2Fj.pbb.2004.12.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Antinociceptive, hypothermic, hypotensive, and reinforcing effects of a novel neurotensin receptor agonist, NT69L, in rhesus monkeys</span></div><div class="casAuthors">Fantegrossi, W. E.; Ko, M. C. H.; Woods, J. H.; Richelson, E.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology, Biochemistry and Behavior</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">341-349</span>CODEN:
                <span class="NLM_cas:coden">PBBHAU</span>;
        ISSN:<span class="NLM_cas:issn">0091-3057</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Neurotensin (NT) is a tridecapeptide found in the nervous system, as well as elsewhere in the body.  It has anatomical and functional relationships to dopaminergic neurons in brain.  NT was implicated in the actions of antipsychotic drugs and psychostimulants, and animal studies suggest that neurotensin directly injected into brain has reinforcing effects.  Previously, the authors showed that 1 of the authors' brain-penetrating analogs of neurotensin, NT69L (N-methyl-L-Arg, L-Lys, L-Pro, L-neo-Trp, L-tert-Leu, L-Leu), has many pharmacol. effects in rats including antinociception, hypothermia, and blockade of the hyperactivity caused by psychostimulants (cocaine, D-amphetamine, and nicotine).  Since these studies in rats suggest that this compd. may have clin. use in humans, the authors were interested to know what effects NT69L had in primates.  NT69L caused a potent antinociceptive effect against capsaicin (0.1 mg)-induced allodynia in 46 °C water in rhesus monkeys, inducing 40% of the maximal possible effect at an i.v. dosage of 0.03 mg/kg; its hypotensive effects precluded evaluation of higher dosages.  Core temp. measured by rectal probe was modestly reduced at 0.01 and 0.03 mg/kg.  In an i.v. self-administration procedure, NT69L was without reinforcing effects at any dose, including those that caused other pharmacol. effects, and did not alter cocaine-maintained behavior when administered as a pretreatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCNrUc_FsYRLVg90H21EOLACvtfcHk0lg5_o_lsxXRtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmvFGrug%253D%253D&md5=fda03e02c91b0664aa96ab367a95f855</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.pbb.2004.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pbb.2004.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DFantegrossi%26aufirst%3DW.%2BE.%26aulast%3DKo%26aufirst%3DM.%2BC.%2BH.%26aulast%3DWoods%26aufirst%3DJ.%2BH.%26aulast%3DRichelson%26aufirst%3DE.%26atitle%3DAntinociceptive%252C%2520Hypothermic%252C%2520Hypotensive%252C%2520and%2520Reinforcing%2520Effects%2520of%2520a%2520Novel%2520Neurotensin%2520Receptor%2520Agonist%252C%2520Nt69l%252C%2520in%2520Rhesus%2520Monkeys%26jtitle%3DPharmacol.%2520Biochem.%2520Behav.%26date%3D2005%26volume%3D80%26spage%3D341%26epage%3D349%26doi%3D10.1016%2Fj.pbb.2004.12.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Osadchii, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodiwiss, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deftereos, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norton, G.</span></span> <span> </span><span class="NLM_article-title">Neurotensin-Induced Myocardial Noradrenergic Effects in Spontaneously Hypertensive Rats</span>. <i>J. Cardiovasc. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">221</span>– <span class="NLM_lpage">227</span>, <span class="refDoi"> DOI: 10.1097/01.fjc.0000200988.85868.f8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1097%2F01.fjc.0000200988.85868.f8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=16495759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhs12ns78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2006&pages=221-227&author=O.+Osadchiiauthor=A.+Woodiwissauthor=D.+Deftereosauthor=G.+Norton&title=Neurotensin-Induced+Myocardial+Noradrenergic+Effects+in+Spontaneously+Hypertensive+Rats&doi=10.1097%2F01.fjc.0000200988.85868.f8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Neurotensin-Induced Myocardial Noradrenergic Effects in Spontaneously Hypertensive Rats</span></div><div class="casAuthors">Osadchii, Oleg; Woodiwiss, Angela; Deftereos, Dawn; Norton, Gavin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cardiovascular Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">221-227</span>CODEN:
                <span class="NLM_cas:coden">JCPCDT</span>;
        ISSN:<span class="NLM_cas:issn">0160-2446</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Although increases in myocardial synaptic norepinephrine concns. contribute toward the progression to heart failure in hypertension, the stimuli for norepinephrine release are unclear.  In this study we explored whether neurotensin, a neuropeptide found in heart tissue, could modify myocardial norepinephrine release in spontaneously hypertensive rats (SHR).  Prior to the development of cardiac decompensation, baseline coronary effluent norepinephrine concns. were higher in isolated heart prepns. of spontaneously hypertensive rats than in Wistar Kyoto (WKY) control rat hearts.  Neurotensin increased coronary effluent norepinephrine concns. and induced pos. inotropic responses, effects that were enhanced in spontaneously hypertensive rats compared with Wistar Kyoto rats.  Although the neurotensin receptor antagonist, SR 48692, did not modify either baseline coronary effluent norepinephrine concns. or left ventricular systolic function in spontaneously hypertensive rats, it dose dependently abolished neurotensin-induced cardiac norepinephrine release and contractile responses.  Neurotensin-mediated inotropic responses were also abolished by co-administration of the β-adrenoreceptor blockers, propranolol and atenolol.  Inotropic responses to exogenous norepinephrine were similar in SHR and WKY rats.  In summary, in the hypertensive heart there is an increased sensitivity to neurotensin's actions on myocardial norepinephrine release and subsequent contractile changes.  Therefore, neurotensin receptor blockade may represent a novel therapeutic target in preventing the progression to heart failure in hypertension.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJHNV_QfvqebVg90H21EOLACvtfcHk0lg5_o_lsxXRtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhs12ns78%253D&md5=e5f0720a9cd1e84534f14c089cd9a060</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1097%2F01.fjc.0000200988.85868.f8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F01.fjc.0000200988.85868.f8%26sid%3Dliteratum%253Aachs%26aulast%3DOsadchii%26aufirst%3DO.%26aulast%3DWoodiwiss%26aufirst%3DA.%26aulast%3DDeftereos%26aufirst%3DD.%26aulast%3DNorton%26aufirst%3DG.%26atitle%3DNeurotensin-Induced%2520Myocardial%2520Noradrenergic%2520Effects%2520in%2520Spontaneously%2520Hypertensive%2520Rats%26jtitle%3DJ.%2520Cardiovasc.%2520Pharmacol.%26date%3D2006%26volume%3D47%26spage%3D221%26epage%3D227%26doi%3D10.1097%2F01.fjc.0000200988.85868.f8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Previti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vivancos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rémond, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaulieu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Longpré, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballet, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarret, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavelier, F.</span></span> <span> </span><span class="NLM_article-title">Insightful Backbone Modifications Preventing Proteolytic Degradation of Neurotensin Analogs Improve Nts1-Induced Protective Hypothermia</span>. <i>Front. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">406</span>, <span class="refDoi"> DOI: 10.3389/fchem.2020.00406</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.3389%2Ffchem.2020.00406" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=32582624" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitVWgt7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2020&pages=406&author=S.+Previtiauthor=M.+Vivancosauthor=E.+R%C3%A9mondauthor=S.+Beaulieuauthor=J.+M.+Longpr%C3%A9author=S.+Balletauthor=P.+Sarretauthor=F.+Cavelier&title=Insightful+Backbone+Modifications+Preventing+Proteolytic+Degradation+of+Neurotensin+Analogs+Improve+Nts1-Induced+Protective+Hypothermia&doi=10.3389%2Ffchem.2020.00406"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Insightful backbone modifications preventing proteolytic degradation of neurotensin analogs improve NTS1-induced protective hypothermia</span></div><div class="casAuthors">Previti, Santo; Vivancos, Melanie; Remond, Emmanuelle; Beaulieu, Sabrina; Longpre, Jean-Michel; Ballet, Steven; Sarret, Philippe; Cavelier, Florine</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Chemistry (Lausanne, Switzerland)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">00406</span>CODEN:
                <span class="NLM_cas:coden">FCLSAA</span>;
        ISSN:<span class="NLM_cas:issn">2296-2646</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Therapeutic hypothermia represents a brain-protective strategy for multiple emergency situations, such as stroke or traumatic injury.  Neurotensin (NT), which exerts its effects through activation of two G protein-coupled receptors, namely NTS1 and NTS2, induces a strong and long-lasting decrease in core body temp. after its central administration.  Growing evidence demonstrates that NTS1 is the receptor subtype mediating the hypothermic action of NT.  As such, potent NTS1 agonists designed on the basis of the minimal C-terminal NT(8-13) bioactive fragment have been shown to produce mild hypothermia and exert neuroprotective effects under various clin. relevant conditions.  The high susceptibility of NT(8-13) to protease degrdn. (half-life <2 min) represents, however, a serious limitation for its use in pharmacol. therapy.  In light of this, we report here a structure-activity relationship study in which pairs of NT(8-13) analogs have been developed, based on the incorporation of a reduced Lys8-Lys9 bond.  To further stabilize the peptide bonds, a panel of backbone modifications was also inserted along the peptide sequence, including Sip10, D-Trp11, Dmt11, Tle12, and TMSAla13.  Our results revealed that the combination of appropriate chem. modifications leads to compds. exhibiting improved resistance to proteolytic cleavages (>24 h; 16).  Among them, the NT(8-13) analogs harboring the reduced amine bond combined with the unnatural amino acids TMSAla13 (4) and Sip10 (6) or the di-substitution Lys11 - TMSAla13 (12), D-Trp11-TMSAla13 (14), and Dmt11-Tle12 (16) produced sustained hypothermic effects (-3°C for at least 1 h).  Importantly, we obsd. that hypothermia was mainly driven by the increased stability of the NT(8-13) derivs., instead of the high binding-affinity at NTS1.  Altogether, these results reveal the importance of the reduced amine bond in optimizing the metabolic properties of the NT(8-13) peptide and support the development of stable NTS1 agonists as first drug candidate in neuroprotective hypothermia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotOch_UfGOS7Vg90H21EOLACvtfcHk0lg6k3Tn5KUzzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitVWgt7rE&md5=0be0d4fedfa9f73fab18af39aa2c6b41</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.3389%2Ffchem.2020.00406&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffchem.2020.00406%26sid%3Dliteratum%253Aachs%26aulast%3DPreviti%26aufirst%3DS.%26aulast%3DVivancos%26aufirst%3DM.%26aulast%3DR%25C3%25A9mond%26aufirst%3DE.%26aulast%3DBeaulieu%26aufirst%3DS.%26aulast%3DLongpr%25C3%25A9%26aufirst%3DJ.%2BM.%26aulast%3DBallet%26aufirst%3DS.%26aulast%3DSarret%26aufirst%3DP.%26aulast%3DCavelier%26aufirst%3DF.%26atitle%3DInsightful%2520Backbone%2520Modifications%2520Preventing%2520Proteolytic%2520Degradation%2520of%2520Neurotensin%2520Analogs%2520Improve%2520Nts1-Induced%2520Protective%2520Hypothermia%26jtitle%3DFront.%2520Chem.%26date%3D2020%26volume%3D8%26spage%3D406%26doi%3D10.3389%2Ffchem.2020.00406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bissette, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luttinger, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loosen, P. T.</span></span> <span> </span><span class="NLM_article-title">Neurotensin and Thermoregulation</span>. <i>Ann. N. Y. Acad. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>400</i></span>,  <span class="NLM_fpage">268</span>– <span class="NLM_lpage">282</span>, <span class="refDoi"> DOI: 10.1111/j.1749-6632.1982.tb31575.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1111%2Fj.1749-6632.1982.tb31575.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=6820243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADyaL3sXhslehsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=400&publication_year=1982&pages=268-282&author=G.+Bissetteauthor=D.+Luttingerauthor=G.+A.+Masonauthor=D.+E.+Hernandezauthor=P.+T.+Loosen&title=Neurotensin+and+Thermoregulation&doi=10.1111%2Fj.1749-6632.1982.tb31575.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Neurotensin and thermoregulation</span></div><div class="casAuthors">Bissette, Garth; Luttinger, Daniel; Mason, George A.; Hernandez, Daniel E.; Loosen, Peter T.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the New York Academy of Sciences</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">400</span>
        (<span class="NLM_cas:issue">Neurotensin, Brain Gastrointest. Pept.</span>),
    <span class="NLM_cas:pages">268-82</span>CODEN:
                <span class="NLM_cas:coden">ANYAA9</span>;
        ISSN:<span class="NLM_cas:issn">0077-8923</span>.
    </div><div class="casAbstract">A review with 35 refs. on neurotensin  [39379-15-2] and thermoregulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUUchvqZVhyrVg90H21EOLACvtfcHk0lg6k3Tn5KUzzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXhslehsrs%253D&md5=6595b225d1f3d3e9bfc47de52e2fe2f1</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1111%2Fj.1749-6632.1982.tb31575.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1749-6632.1982.tb31575.x%26sid%3Dliteratum%253Aachs%26aulast%3DBissette%26aufirst%3DG.%26aulast%3DLuttinger%26aufirst%3DD.%26aulast%3DMason%26aufirst%3DG.%2BA.%26aulast%3DHernandez%26aufirst%3DD.%2BE.%26aulast%3DLoosen%26aufirst%3DP.%2BT.%26atitle%3DNeurotensin%2520and%2520Thermoregulation%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D1982%26volume%3D400%26spage%3D268%26epage%3D282%26doi%3D10.1111%2Fj.1749-6632.1982.tb31575.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pothoulakis, C.</span></span> <span> </span><span class="NLM_article-title">Effects of Nt on Gastrointestinal Motility and Secretion, and Role in Intestinal Inflammation</span>. <i>Peptides</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">2434</span>– <span class="NLM_lpage">2444</span>, <span class="refDoi"> DOI: 10.1016/j.peptides.2005.12.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2Fj.peptides.2005.12.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=16872719" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BD28XpvV2gsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2006&pages=2434-2444&author=D.+Zhaoauthor=C.+Pothoulakis&title=Effects+of+Nt+on+Gastrointestinal+Motility+and+Secretion%2C+and+Role+in+Intestinal+Inflammation&doi=10.1016%2Fj.peptides.2005.12.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of NT on gastrointestinal motility and secretion, and role in intestinal inflammation</span></div><div class="casAuthors">Zhao, Dezheng; Pothoulakis, Charalabos</div><div class="citationInfo"><span class="NLM_cas:title">Peptides (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2434-2444</span>CODEN:
                <span class="NLM_cas:coden">PPTDD5</span>;
        ISSN:<span class="NLM_cas:issn">0196-9781</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  It is well established that interactions of neuropeptides with several cell types at various parts of the intestine are critically involved in intestinal pathophysiol.  Among them, neurotensin has been identified as an important mediator in the development and progress of several gastrointestinal functions and disease conditions, exerting its effects by interacting with specific receptors that exert direct and indirect effects on nerves, epithelial cells, and cells of the immune and inflammatory systems.  This review summarizes our recent understanding on the participation of neurotensin in the physiol. and pathophysiol. of the small and large intestine, and discusses various mechanisms that could be involved in these actions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCfvwYdNLG37Vg90H21EOLACvtfcHk0lg6k3Tn5KUzzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpvV2gsrk%253D&md5=64c00c033c59f7c0aa72c1cdaec0a82b</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.peptides.2005.12.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.peptides.2005.12.016%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DD.%26aulast%3DPothoulakis%26aufirst%3DC.%26atitle%3DEffects%2520of%2520Nt%2520on%2520Gastrointestinal%2520Motility%2520and%2520Secretion%252C%2520and%2520Role%2520in%2520Intestinal%2520Inflammation%26jtitle%3DPeptides%26date%3D2006%26volume%3D27%26spage%3D2434%26epage%3D2444%26doi%3D10.1016%2Fj.peptides.2005.12.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Asselin, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubuc, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coquerel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costentin, J.</span></span> <span> </span><span class="NLM_article-title">Localization of Neurotensin Nts2 Receptors in Rat Brain, Using [3h]Levocabastine</span>. <i>Neuroreport</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1087</span>– <span class="NLM_lpage">1091</span>, <span class="refDoi"> DOI: 10.1097/00001756-200104170-00044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1097%2F00001756-200104170-00044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=11303751" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjtVWgsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2001&pages=1087-1091&author=M.+L.+Asselinauthor=I.+Dubucauthor=A.+Coquerelauthor=J.+Costentin&title=Localization+of+Neurotensin+Nts2+Receptors+in+Rat+Brain%2C+Using+%5B3h%5DLevocabastine&doi=10.1097%2F00001756-200104170-00044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Localization of neurotensin NTS2 receptors in rat brain, using [3H]levocabastine</span></div><div class="casAuthors">Asselin, Marie-Liesse; Dubuc, Isabelle; Coquerel, Antoine; Costentin, Jean</div><div class="citationInfo"><span class="NLM_cas:title">NeuroReport</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1087-1091</span>CODEN:
                <span class="NLM_cas:coden">NERPEZ</span>;
        ISSN:<span class="NLM_cas:issn">0959-4965</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">The brain localization of the neurotensin receptor NTS2 was studied with [3H]levocabastine, using an autoradiog. procedure.  This study suggests that NTS2 receptors are mainly intracellular.  High densities of binding sites were obsd. in the cingulate, insular, temporal, occipital, entorhinal cortex, amygdaloid complex, septohippocampal nuclei, medial thalamus, mammillary bodies and superior colliculi; a moderate labeling was obsd. in the anterior and medial hippocampus, olfactory tubercle, hypothalamus, periaqueductal gray matter, caudate putamen, nucleus accumbens, septum, lateral thalamus, dorsal raphe nucleus and cerebellum; finally, a low labeling was apparent in the ventral tegmentum area and substantia nigra.  Thus it appears that NTS2 receptors are particularly abundant in the cerebral cortex, the limbic areas and some areas involved in pain perception.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKospzSy6FeLVg90H21EOLACvtfcHk0lheZNs8E1uYnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjtVWgsLw%253D&md5=dcf68024e457bb6e687babb2a5fb7021</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1097%2F00001756-200104170-00044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00001756-200104170-00044%26sid%3Dliteratum%253Aachs%26aulast%3DAsselin%26aufirst%3DM.%2BL.%26aulast%3DDubuc%26aufirst%3DI.%26aulast%3DCoquerel%26aufirst%3DA.%26aulast%3DCostentin%26aufirst%3DJ.%26atitle%3DLocalization%2520of%2520Neurotensin%2520Nts2%2520Receptors%2520in%2520Rat%2520Brain%252C%2520Using%2520%255B3h%255DLevocabastine%26jtitle%3DNeuroreport%26date%3D2001%26volume%3D12%26spage%3D1087%26epage%3D1091%26doi%3D10.1097%2F00001756-200104170-00044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sarret, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaudet, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazella, J.</span></span> <span> </span><span class="NLM_article-title">Regional and Cellular Distribution of Low Affinity Neurotensin Receptor Mrna in Adult and Developing Mouse Brain</span>. <i>J. Comp. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>394</i></span>,  <span class="NLM_fpage">344</span>– <span class="NLM_lpage">356</span>, <span class="refDoi"> DOI: 10.1002/(SICI)1096-9861(19980511)394:3<344::AID-CNE6>3.0.CO;2-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1002%2F%28SICI%291096-9861%2819980511%29394%3A3%3C344%3A%3AAID-CNE6%3E3.0.CO%3B2-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=9579398" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADyaK1cXjt1KjsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=394&publication_year=1998&pages=344-356&author=P.+Sarretauthor=A.+Beaudetauthor=J.+P.+Vincentauthor=J.+Mazella&title=Regional+and+Cellular+Distribution+of+Low+Affinity+Neurotensin+Receptor+Mrna+in+Adult+and+Developing+Mouse+Brain&doi=10.1002%2F%28SICI%291096-9861%2819980511%29394%3A3%3C344%3A%3AAID-CNE6%3E3.0.CO%3B2-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Regional and cellular distribution of low affinity neurotensin receptor mRNA in adult and developing mouse brain</span></div><div class="casAuthors">Sarret, Philippe; Beaudet, Alain; Vincent, Jean-Pierre; Mazellai, Jean</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Comparative Neurology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">394</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">344-356</span>CODEN:
                <span class="NLM_cas:coden">JCNEAM</span>;
        ISSN:<span class="NLM_cas:issn">0021-9967</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Levocabastine-sensitive neurotensin receptor (NTRL) mRNAs were localized by in situ hybridization in adult and developing mouse brain.  NTRL hybridization signal was widely distributed throughout the neuraxis.  The highest concns. of NTRL mRNA were detected in the olfactory system, olfactory tubercle, cerebral and cerebellar cortices, hippocampal formation, and selective hypothalamic nuclei.  Moderate to dense hybridization signal was also obsd. in assocn. with a variety of auditory, visual, and somatosensory relay nuclei, suggesting that the NTRL might be involved in a widespread modulation of primary afferent pathways.  Finally a high expression of NTRL was evident in brainstem structures implicated in descending antinociceptive influences (e.g., the periaqueductal gray, nucleus raphe magnus, gigantocellular reticular nucleus, pars alpha, and lateral paragigantocellular nucleus) consistent with the proposed mediation of NT-induced analgesia by the NTRL.  Although most of the regions found here to express NTRL mRNA were previously reported to be devoid of mRNA encoding the high affinity NT receptor (NTRH), a few areas (e.g., the anterior olfactory nucleus, medial septum, diagonal band of Broca, reticular thalamic nucleus, suprachiasmatic hypothalamic nucleus, and pontine nucleus) were enriched in both receptor subtypes, suggesting a possible coexpression of these receptors by the same cells.  Ontogenic studies revealed that in the mouse brain, NTRL mRNA was detected only from postnatal day 14 and did not reach adulthood concns. before day 30.  In cerebral cortex, the developmental increase in NTRL expression was correlated over time with the decrease in NTRH expression previously documented in the rat, suggesting a progressive takeover of the latter by the former for transduction of the effects of NT in this structure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo750VMxJ8UfrVg90H21EOLACvtfcHk0lheZNs8E1uYnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjt1KjsbY%253D&md5=08e46a043a96e0d2e48ff9ecc5596d7b</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291096-9861%2819980511%29394%3A3%3C344%3A%3AAID-CNE6%3E3.0.CO%3B2-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291096-9861%252819980511%2529394%253A3%253C344%253A%253AAID-CNE6%253E3.0.CO%253B2-1%26sid%3Dliteratum%253Aachs%26aulast%3DSarret%26aufirst%3DP.%26aulast%3DBeaudet%26aufirst%3DA.%26aulast%3DVincent%26aufirst%3DJ.%2BP.%26aulast%3DMazella%26aufirst%3DJ.%26atitle%3DRegional%2520and%2520Cellular%2520Distribution%2520of%2520Low%2520Affinity%2520Neurotensin%2520Receptor%2520Mrna%2520in%2520Adult%2520and%2520Developing%2520Mouse%2520Brain%26jtitle%3DJ.%2520Comp.%2520Neurol.%26date%3D1998%26volume%3D394%26spage%3D344%26epage%3D356%26doi%3D10.1002%2F%28SICI%291096-9861%2819980511%29394%3A3%3C344%3A%3AAID-CNE6%3E3.0.CO%3B2-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sarret, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perron, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stroh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaudet, A.</span></span> <span> </span><span class="NLM_article-title">Immunohistochemical Distribution of Nts2 Neurotensin Receptors in the Rat Central Nervous System</span>. <i>J. Comp. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>461</i></span>,  <span class="NLM_fpage">520</span>– <span class="NLM_lpage">538</span>, <span class="refDoi"> DOI: 10.1002/cne.10718</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1002%2Fcne.10718" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=12746866" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BD3sXltFGlurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=461&publication_year=2003&pages=520-538&author=P.+Sarretauthor=A.+Perronauthor=T.+Strohauthor=A.+Beaudet&title=Immunohistochemical+Distribution+of+Nts2+Neurotensin+Receptors+in+the+Rat+Central+Nervous+System&doi=10.1002%2Fcne.10718"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Immunohistochemical distribution of NTS2 neurotensin receptors in the rat central nervous system</span></div><div class="casAuthors">Sarret, Philippe; Perron, Amelie; Stroh, Thomas; Beaudet, Alain</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Comparative Neurology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">461</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">520-538</span>CODEN:
                <span class="NLM_cas:coden">JCNEAM</span>;
        ISSN:<span class="NLM_cas:issn">0021-9967</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">We localized the levocabastine-sensitive neurotensin receptor (NTS2) protein in adult rat brain by using an N-terminally-directed antibody.  NTS2-like immunoreactivity was broadly distributed throughout the rat brain.  At the cellular level, the reaction product was exclusively assocd. with neurons and predominantly, although not exclusively, with their dendritic arbors.  No NTS2 signal was obsd. over astrocytes, as confirmed by dual confocal microscopic immunofluorescence studies using the astrocytic marker S100β.  High densities of NTS2-like immunoreactive nerve cell bodies and/or processes were detected in many regions documented to receive a dense neurotensinergic innervation, such as the olfactory bulb, bed nucleus of the stria terminalis, magnocellular preoptic nucleus, amygdaloid complex, anterodorsal thalamic nucleus, substantia nigra, ventral tegmental area, and several brainstem nuclei.  Most conspicuous among the latter were structures implicated in the descending control of nociceptive inputs (e.g., the periaqueductal gray, dorsal raphe, gigantocellular reticular nucleus, pars alpha, lateral paragigantocellular, and raphe magnus), in keeping with the postulated role of NTS2 receptors in the mediation of neurotensin's supraspinal antinociceptive actions.  However, the distribution of NTS2-like immunoreactivity largely exceeded that of neurotensin terminal fields, and some of the highest concns. of the receptor were found in areas devoid of neurotensinergic inputs such as the cerebral cortex, hippocampus, and cerebellum, suggesting that neurotensin may not be the exclusive endogenous ligand for this receptor subtype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsW0j3O468YLVg90H21EOLACvtfcHk0lheZNs8E1uYnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXltFGlurg%253D&md5=2ffe69b294f8ccc75ef2a5d3ea8d108b</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1002%2Fcne.10718&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcne.10718%26sid%3Dliteratum%253Aachs%26aulast%3DSarret%26aufirst%3DP.%26aulast%3DPerron%26aufirst%3DA.%26aulast%3DStroh%26aufirst%3DT.%26aulast%3DBeaudet%26aufirst%3DA.%26atitle%3DImmunohistochemical%2520Distribution%2520of%2520Nts2%2520Neurotensin%2520Receptors%2520in%2520the%2520Rat%2520Central%2520Nervous%2520System%26jtitle%3DJ.%2520Comp.%2520Neurol.%26date%3D2003%26volume%3D461%26spage%3D520%26epage%3D538%26doi%3D10.1002%2Fcne.10718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lépée-Lorgeoux, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Betancur, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rostène, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pélaprat, D.</span></span> <span> </span><span class="NLM_article-title">Differential Ontogenetic Patterns of Levocabastine-Sensitive Neurotensin Nt2 Receptors and of Nt1 Receptors in the Rat Brain Revealed by in Situ Hybridization</span>. <i>Brain Res. Dev. Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">115</span>– <span class="NLM_lpage">131</span>, <span class="refDoi"> DOI: 10.1016/S0165-3806(99)00009-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2FS0165-3806%2899%2900009-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10064881" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADyaK1MXht1OhtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=1999&pages=115-131&author=I.+L%C3%A9p%C3%A9e-Lorgeouxauthor=C.+Betancurauthor=W.+Rost%C3%A8neauthor=D.+P%C3%A9laprat&title=Differential+Ontogenetic+Patterns+of+Levocabastine-Sensitive+Neurotensin+Nt2+Receptors+and+of+Nt1+Receptors+in+the+Rat+Brain+Revealed+by+in+Situ+Hybridization&doi=10.1016%2FS0165-3806%2899%2900009-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Differential ontogenetic patterns of levocabastine-sensitive neurotensin NT2 receptors and of NT1 receptors in the rat brain revealed by in situ hybridization</span></div><div class="casAuthors">Lepee-Lorgeoux, Isabelle; Betancur, Catalina; Rostene, William; Pelaprat, Didier</div><div class="citationInfo"><span class="NLM_cas:title">Developmental Brain Research</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">1,2</span>),
    <span class="NLM_cas:pages">115-131</span>CODEN:
                <span class="NLM_cas:coden">DBRRDB</span>;
        ISSN:<span class="NLM_cas:issn">0165-3806</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The postnatal ontogeny of the levocabastine-sensitive neurotensin receptor (NT2) mRNA was studied by in situ hybridization in the rat brain and compared with the distribution of the levocabastine-insensitive NT1 receptor.  NT2 receptor mRNA was absent at birth from all brain structures except the ependymal cell layer lining the ventricles.  The development of NT2 receptor mRNA followed three ontogenetic patterns.  The first pattern, involving the majority of the cerebral gray matter, was characterized by a continuous increase from postnatal day 5 (P5) to P30.  The second one, involving regions rich in myelinated fibers such as the corpus callosum and lacunosum moleculare layer of the hippocampus, exhibited a pronounced increase between P5 and P10, peaked at P15 and was followed by a plateau or a slight decrease.  The third pattern was obsd. in the ependymal cell layer lining the olfactory and lateral ventricles, where the high labeling already present at birth continued to increase during development.  These different developmental patterns could reflect the variety of cells expressing NT2 receptor mRNA, including neurons, protoplasmic astrocytes in gray matter, fibrous astrocytes present in myelinated fibers tracts, and ependymal cells.  In contrast, NT1 receptor mRNA, which seems to be assocd. only with neurons, was highly and transiently expressed during the perinatal period in the cerebral cortex, hippocampus and striatal neuroepithelium.  Other regions, notably the ventral tegmental area and substantia nigra compacta, exhibited a gradual increase in NT1 receptor signal, reaching adult levels by P21.  Both the differential localization and ontogenetic profiles of NT1 and NT2 receptor mRNAs suggest different involvement of these two receptors in brain functions and development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUfer4c8glILVg90H21EOLACvtfcHk0lheZNs8E1uYnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXht1OhtbY%253D&md5=a17ff07d795f5953642b572f1ef8e3b3</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2FS0165-3806%2899%2900009-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0165-3806%252899%252900009-7%26sid%3Dliteratum%253Aachs%26aulast%3DL%25C3%25A9p%25C3%25A9e-Lorgeoux%26aufirst%3DI.%26aulast%3DBetancur%26aufirst%3DC.%26aulast%3DRost%25C3%25A8ne%26aufirst%3DW.%26aulast%3DP%25C3%25A9laprat%26aufirst%3DD.%26atitle%3DDifferential%2520Ontogenetic%2520Patterns%2520of%2520Levocabastine-Sensitive%2520Neurotensin%2520Nt2%2520Receptors%2520and%2520of%2520Nt1%2520Receptors%2520in%2520the%2520Rat%2520Brain%2520Revealed%2520by%2520in%2520Situ%2520Hybridization%26jtitle%3DBrain%2520Res.%2520Dev.%2520Brain%2520Res.%26date%3D1999%26volume%3D113%26spage%3D115%26epage%3D131%26doi%3D10.1016%2FS0165-3806%2899%2900009-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Munk, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mutt, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isberg, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolajsen, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bibbe, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flock, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deupi, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gloriam, D. E.</span></span> <span> </span><span class="NLM_article-title">An Online Resource for Gpcr Structure Determination and Analysis</span>. <i>Nat. Methods</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">151</span>– <span class="NLM_lpage">162</span>, <span class="refDoi"> DOI: 10.1038/s41592-018-0302-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1038%2Fs41592-018-0302-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=30664776" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BC1MXmtFGru74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2019&pages=151-162&author=C.+Munkauthor=E.+Muttauthor=V.+Isbergauthor=L.+F.+Nikolajsenauthor=J.+M.+Bibbeauthor=T.+Flockauthor=M.+A.+Hansonauthor=R.+C.+Stevensauthor=X.+Deupiauthor=D.+E.+Gloriam&title=An+Online+Resource+for+Gpcr+Structure+Determination+and+Analysis&doi=10.1038%2Fs41592-018-0302-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">An online resource for GPCR structure determination and analysis</span></div><div class="casAuthors">Munk, Christian; Mutt, Eshita; Isberg, Vignir; Nikolajsen, Louise F.; Bibbe, Janne M.; Flock, Tilman; Hanson, Michael A.; Stevens, Raymond C.; Deupi, Xavier; Gloriam, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Methods</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">151-162</span>CODEN:
                <span class="NLM_cas:coden">NMAEA3</span>;
        ISSN:<span class="NLM_cas:issn">1548-7091</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">G-protein-coupled receptors (GPCRs) transduce physiol. and sensory stimuli into appropriate cellular responses and mediate the actions of one-third of drugs.  GPCR structural studies have revealed the general bases of receptor activation, signaling, drug action and allosteric modulation, but so far cover only 13% of nonolfactory receptors.  We broadly surveyed the receptor modifications/engineering and methods used to produce all available GPCR crystal and cryo-electron microscopy (cryo-EM) structures, and present an interactive resource integrated in GPCRdb (http://www.gpcrdb.org) to assist users in designing constructs and browsing appropriate exptl. conditions for structure studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnhlg2FyHfTLVg90H21EOLACvtfcHk0lgexKmtfOqjDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXmtFGru74%253D&md5=a0e1ffb48671b58a63764ed4cff86901</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1038%2Fs41592-018-0302-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41592-018-0302-x%26sid%3Dliteratum%253Aachs%26aulast%3DMunk%26aufirst%3DC.%26aulast%3DMutt%26aufirst%3DE.%26aulast%3DIsberg%26aufirst%3DV.%26aulast%3DNikolajsen%26aufirst%3DL.%2BF.%26aulast%3DBibbe%26aufirst%3DJ.%2BM.%26aulast%3DFlock%26aufirst%3DT.%26aulast%3DHanson%26aufirst%3DM.%2BA.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DDeupi%26aufirst%3DX.%26aulast%3DGloriam%26aufirst%3DD.%2BE.%26atitle%3DAn%2520Online%2520Resource%2520for%2520Gpcr%2520Structure%2520Determination%2520and%2520Analysis%26jtitle%3DNat.%2520Methods%26date%3D2019%26volume%3D16%26spage%3D151%26epage%3D162%26doi%3D10.1038%2Fs41592-018-0302-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krumm, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Botos, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaidehi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grisshammer, R.</span></span> <span> </span><span class="NLM_article-title">Structure and Dynamics of a Constitutively Active Neurotensin Receptor</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">38564</span>, <span class="refDoi"> DOI: 10.1038/srep38564</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1038%2Fsrep38564" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=27924846" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFCqtbbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=38564&author=B.+E.+Krummauthor=S.+Leeauthor=S.+Bhattacharyaauthor=I.+Botosauthor=C.+F.+Whiteauthor=H.+Duauthor=N.+Vaidehiauthor=R.+Grisshammer&title=Structure+and+Dynamics+of+a+Constitutively+Active+Neurotensin+Receptor&doi=10.1038%2Fsrep38564"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and dynamics of a constitutively active neurotensin receptor</span></div><div class="casAuthors">Krumm, Brian E.; Lee, Sangbae; Bhattacharya, Supriyo; Botos, Istvan; White, Courtney F.; Du, Haijuan; Vaidehi, Nagarajan; Grisshammer, Reinhard</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">38564</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Many G protein-coupled receptors show constitutive activity, resulting in the prodn. of a second messenger in the absence of an agonist; and naturally occurring constitutively active mutations in receptors have been implicated in diseases.  To gain insight into mechanistic aspects of constitutive activity, we report here the 3.3 Å crystal structure of a constitutively active, agonist-bound neurotensin receptor (NTSR1) and mol. dynamics simulations of agonist-occupied and ligand-free receptor.  Comparison with the structure of a NTSR1 variant that has little constitutive activity reveals uncoupling of the ligand-binding domain from conserved connector residues, that effect conformational changes during GPCR activation.  Furthermore, mol. dynamics simulations show strong contacts between connector residue side chains and increased flexibility at the intracellular receptor face as features that coincide with robust signalling in cells.  The loss of correlation between the binding pocket and conserved connector residues, combined with altered receptor dynamics, possibly explains the reduced neurotensin efficacy in the constitutively active NTSR1 and a facilitated initial engagement with G protein in the absence of agonist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1DeeNHmoaMLVg90H21EOLACvtfcHk0lgexKmtfOqjDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFCqtbbI&md5=c14f5ada49ba23c241dc547a0c502ba8</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1038%2Fsrep38564&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep38564%26sid%3Dliteratum%253Aachs%26aulast%3DKrumm%26aufirst%3DB.%2BE.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DBhattacharya%26aufirst%3DS.%26aulast%3DBotos%26aufirst%3DI.%26aulast%3DWhite%26aufirst%3DC.%2BF.%26aulast%3DDu%26aufirst%3DH.%26aulast%3DVaidehi%26aufirst%3DN.%26aulast%3DGrisshammer%26aufirst%3DR.%26atitle%3DStructure%2520and%2520Dynamics%2520of%2520a%2520Constitutively%2520Active%2520Neurotensin%2520Receptor%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D38564%26doi%3D10.1038%2Fsrep38564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Egloff, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hillenbrand, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klenk, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batyuk, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heine, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balada, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlinkmann, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schütz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plückthun, A.</span></span> <span> </span><span class="NLM_article-title">Structure of Signaling-Competent Neurotensin Receptor 1 Obtained by Directed Evolution in Escherichia Coli</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">E655</span>– <span class="NLM_lpage">E662</span>, <span class="refDoi"> DOI: 10.1073/pnas.1317903111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1073%2Fpnas.1317903111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=24453215" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisFOntrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=E655-E662&author=P.+Egloffauthor=M.+Hillenbrandauthor=C.+Klenkauthor=A.+Batyukauthor=P.+Heineauthor=S.+Baladaauthor=K.+M.+Schlinkmannauthor=D.+J.+Scottauthor=M.+Sch%C3%BCtzauthor=A.+Pl%C3%BCckthun&title=Structure+of+Signaling-Competent+Neurotensin+Receptor+1+Obtained+by+Directed+Evolution+in+Escherichia+Coli&doi=10.1073%2Fpnas.1317903111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of signaling-competent neurotensin receptor 1 obtained by directed evolution in Escherichia coli</span></div><div class="casAuthors">Egloff, Pascal; Hillenbrand, Matthias; Klenk, Christoph; Batyuk, Alexander; Heine, Philipp; Balada, Stefanie; Schlinkmann, Karola M.; Scott, Daniel J.; Schutz, Marco; Pluckthun, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">E655-E662</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Crystallog. has advanced our understanding of G protein-coupled receptors, but low expression levels and instability in soln. have limited structural insights to very few selected members of this large protein family.  Using neurotensin receptor 1 (NTR1) as a proof of principle, we show that two directed evolution technologies that we recently developed have the potential to overcome these problems.  We purified three neurotensin-bound NTR1 variants from Escherichia coli and detd. their x-ray structures at up to 2.75 Å resoln. using vapor diffusion crystn. expts.  A crystd. construct was pharmacol. characterized and exhibited ligand-dependent signaling, internalization, and wild-type-like agonist and antagonist affinities.  Our structures are fully consistent with all biochem. defined ligand-contacting residues, and they represent an inactive NTR1 state at the cytosolic side.  They exhibit significant differences to a previously detd. NTR1 structure (Protein Data Bank ID code 4GRV) in the ligand-binding pocket and by the presence of the amphipathic helix 8.  A comparison of helix 8 stability determinants between NTR1 and other crystd. G protein-coupled receptors suggests that the occupancy of the canonical position of the amphipathic helix is reduced to various extents in many receptors, and we have elucidated the sequence determinants for a stable helix 8.  Our anal. also provides a structural rationale for the long-known effects of C-terminal palmitoylation reactions on G protein-coupled receptor signaling, receptor maturation, and desensitization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEqfddVgyHFLVg90H21EOLACvtfcHk0lgexKmtfOqjDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisFOntrc%253D&md5=036230389cacc05a6462cf7b6a55278b</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1317903111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1317903111%26sid%3Dliteratum%253Aachs%26aulast%3DEgloff%26aufirst%3DP.%26aulast%3DHillenbrand%26aufirst%3DM.%26aulast%3DKlenk%26aufirst%3DC.%26aulast%3DBatyuk%26aufirst%3DA.%26aulast%3DHeine%26aufirst%3DP.%26aulast%3DBalada%26aufirst%3DS.%26aulast%3DSchlinkmann%26aufirst%3DK.%2BM.%26aulast%3DScott%26aufirst%3DD.%2BJ.%26aulast%3DSch%25C3%25BCtz%26aufirst%3DM.%26aulast%3DPl%25C3%25BCckthun%26aufirst%3DA.%26atitle%3DStructure%2520of%2520Signaling-Competent%2520Neurotensin%2520Receptor%25201%2520Obtained%2520by%2520Directed%2520Evolution%2520in%2520Escherichia%2520Coli%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26spage%3DE655%26epage%3DE662%26doi%3D10.1073%2Fpnas.1317903111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">White, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noinaj, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Love, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kloss, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gvozdenovic-Jeremic, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiloach, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grisshammer, R.</span></span> <span> </span><span class="NLM_article-title">Structure of the Agonist-Bound Neurotensin Receptor</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>490</i></span>,  <span class="NLM_fpage">508</span>– <span class="NLM_lpage">513</span>, <span class="refDoi"> DOI: 10.1038/nature11558</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1038%2Fnature11558" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=23051748" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVykt7%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=490&publication_year=2012&pages=508-513&author=J.+F.+Whiteauthor=N.+Noinajauthor=Y.+Shibataauthor=J.+Loveauthor=B.+Klossauthor=F.+Xuauthor=J.+Gvozdenovic-Jeremicauthor=P.+Shahauthor=J.+Shiloachauthor=C.+G.+Tateauthor=R.+Grisshammer&title=Structure+of+the+Agonist-Bound+Neurotensin+Receptor&doi=10.1038%2Fnature11558"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the agonist-bound neurotensin receptor</span></div><div class="casAuthors">White, Jim F.; Noinaj, Nicholas; Shibata, Yoko; Love, James; Kloss, Brian; Xu, Feng; Gvozdenovic-Jeremic, Jelena; Shah, Priyanka; Shiloach, Joseph; Tate, Christopher G.; Grisshammer, Reinhard</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">490</span>
        (<span class="NLM_cas:issue">7421</span>),
    <span class="NLM_cas:pages">508-513</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Neurotensin (NTS) is a 13-amino-acid peptide that functions as both a neurotransmitter and a hormone through the activation of the neurotensin receptor NTSR1, a G-protein-coupled receptor (GPCR).  In the brain, NTS modulates the activity of dopaminergic systems, opioid-independent analgesia, and the inhibition of food intake; in the gut, NTS regulates a range of digestive processes.  Here we present the structure at 2.8 Å resoln. of Rattus norvegicus NTSR1 in an active-like state, bound to NTS8-13, the carboxy-terminal portion of NTS responsible for agonist-induced activation of the receptor.  The peptide agonist binds to NTSR1 in an extended conformation nearly perpendicular to the membrane plane, with the C terminus oriented towards the receptor core.  Our findings provide, to our knowledge, the first insight into the binding mode of a peptide agonist to a GPCR and may support the development of non-peptide ligands that could be useful in the treatment of neurol. disorders, cancer and obesity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMGexg96PiObVg90H21EOLACvtfcHk0liawGMCfKvqNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVykt7%252FP&md5=c55a071640dec7edae7a69d715bea675</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1038%2Fnature11558&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11558%26sid%3Dliteratum%253Aachs%26aulast%3DWhite%26aufirst%3DJ.%2BF.%26aulast%3DNoinaj%26aufirst%3DN.%26aulast%3DShibata%26aufirst%3DY.%26aulast%3DLove%26aufirst%3DJ.%26aulast%3DKloss%26aufirst%3DB.%26aulast%3DXu%26aufirst%3DF.%26aulast%3DGvozdenovic-Jeremic%26aufirst%3DJ.%26aulast%3DShah%26aufirst%3DP.%26aulast%3DShiloach%26aufirst%3DJ.%26aulast%3DTate%26aufirst%3DC.%2BG.%26aulast%3DGrisshammer%26aufirst%3DR.%26atitle%3DStructure%2520of%2520the%2520Agonist-Bound%2520Neurotensin%2520Receptor%26jtitle%3DNature%26date%3D2012%26volume%3D490%26spage%3D508%26epage%3D513%26doi%3D10.1038%2Fnature11558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krumm, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grisshammer, R.</span></span> <span> </span><span class="NLM_article-title">Structural Prerequisites for G-Protein Activation by the Neurotensin Receptor</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">7895</span>, <span class="refDoi"> DOI: 10.1038/ncomms8895</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1038%2Fncomms8895" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=26205105" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlWgsr%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=7895&author=B.+E.+Krummauthor=J.+F.+Whiteauthor=P.+Shahauthor=R.+Grisshammer&title=Structural+Prerequisites+for+G-Protein+Activation+by+the+Neurotensin+Receptor&doi=10.1038%2Fncomms8895"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Structural prerequisites for G-protein activation by the neurotensin receptor</span></div><div class="casAuthors">Krumm, Brian E.; White, Jim F.; Shah, Priyanka; Grisshammer, Reinhard</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">7895</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We previously detd. the structure of neurotensin receptor NTSR1 in an active-like conformation with six thermostabilizing mutations bound to the peptide agonist neurotensin.  This receptor was unable to activate G proteins, indicating that the mutations restricted NTSR1 to relate agonist binding to G-protein activation.  Here we analyze the effect of three of those mutations (E166A3.49, L310A6.37, F358A7.42) and present two structures of NTSR1 able to catalyze nucleotide exchange at Gα.  The presence of F3587.42 causes the conserved W3216.48 to adopt a side chain orientation parallel to the lipid bilayer sealing the collapsed Na+ ion pocket and linking the agonist with residues in the lower receptor part implicated in GPCR activation.  In the intracellular receptor half, the bulkier L3106.37 side chain dictates the position of R1673.50 of the highly conserved D/ERY motif.  These residues, together with the presence of E1663.49 provide determinants for G-protein activation by NTSR1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCIT6IdiZypLVg90H21EOLACvtfcHk0liawGMCfKvqNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlWgsr%252FP&md5=d190d8d1194ec776c628729c7c7ad368</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1038%2Fncomms8895&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms8895%26sid%3Dliteratum%253Aachs%26aulast%3DKrumm%26aufirst%3DB.%2BE.%26aulast%3DWhite%26aufirst%3DJ.%2BF.%26aulast%3DShah%26aufirst%3DP.%26aulast%3DGrisshammer%26aufirst%3DR.%26atitle%3DStructural%2520Prerequisites%2520for%2520G-Protein%2520Activation%2520by%2520the%2520Neurotensin%2520Receptor%26jtitle%3DNat.%2520Commun.%26date%3D2015%26volume%3D6%26spage%3D7895%26doi%3D10.1038%2Fncomms8895" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yin, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Waal, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pal, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melcher, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edward Zhou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eric Xu, H.</span></span> <span> </span><span class="NLM_article-title">A Complex Structure of Arrestin-2 Bound to a G Protein-Coupled Receptor</span>. <i>Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">971</span>– <span class="NLM_lpage">983</span>, <span class="refDoi"> DOI: 10.1038/s41422-019-0256-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1038%2Fs41422-019-0256-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=31776446" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlOmsbjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2019&pages=971-983&author=W.+Yinauthor=Z.+Liauthor=M.+Jinauthor=Y.+L.+Yinauthor=P.+W.+de+Waalauthor=K.+Palauthor=Y.+Yinauthor=X.+Gaoauthor=Y.+Heauthor=J.+Gaoauthor=X.+Wangauthor=Y.+Zhangauthor=H.+Zhouauthor=K.+Melcherauthor=Y.+Jiangauthor=Y.+Congauthor=X.+Edward+Zhouauthor=X.+Yuauthor=H.+Eric+Xu&title=A+Complex+Structure+of+Arrestin-2+Bound+to+a+G+Protein-Coupled+Receptor&doi=10.1038%2Fs41422-019-0256-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">A complex structure of arrestin-2 bound to a G protein-coupled receptor</span></div><div class="casAuthors">Yin, Wanchao; Li, Zhihai; Jin, Mingliang; Yin, Yu-Ling; de Waal, Parker W.; Pal, Kuntal; Yin, Yanting; Gao, Xiang; He, Yuanzheng; Gao, Jing; Wang, Xiaoxi; Zhang, Yan; Zhou, Hu; Melcher, Karsten; Jiang, Yi; Cong, Yao; Edward Zhou, X.; Yu, Xuekui; Eric Xu, H.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">971-983</span>CODEN:
                <span class="NLM_cas:coden">CREEB6</span>;
        ISSN:<span class="NLM_cas:issn">1001-0602</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Arrestins comprise a family of signal regulators of G-protein-coupled receptors (GPCRs), which include arrestins 1 to 4.  While arrestins 1 and 4 are visual arrestins dedicated to rhodopsin, arrestins 2 and 3 (Arr2 and Arr3) are β-arrestins known to regulate many nonvisual GPCRs.  The dynamic and promiscuous coupling of Arr2 to nonvisual GPCRs has posed tech. challenges to tackle the basis of arrestin binding to GPCRs.  Here we report the structure of Arr2 in complex with neurotensin receptor 1 (NTSR1), which reveals an overall assembly that is strikingly different from the visual arrestin-rhodopsin complex by a 90° rotation of Arr2 relative to the receptor.  In this new configuration, intracellular loop 3 (ICL3) and transmembrane helix 6 (TM6) of the receptor are oriented toward the N-terminal domain of the arrestin, making it possible for GPCRs that lack the C-terminal tail to couple Arr2 through their ICL3.  Mol. dynamics simulation and crosslinking data further support the assembly of the Arr2-NTSR1 complex.  Sequence anal. and homol. modeling suggest that the Arr2-NTSR1 complex structure may provide an alternative template for modeling arrestin-GPCR interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOGw5ZDnRsp7Vg90H21EOLACvtfcHk0liawGMCfKvqNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlOmsbjL&md5=4083a3c2c00ad32fe37bda69c61aa0c0</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1038%2Fs41422-019-0256-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41422-019-0256-2%26sid%3Dliteratum%253Aachs%26aulast%3DYin%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DJin%26aufirst%3DM.%26aulast%3DYin%26aufirst%3DY.%2BL.%26aulast%3Dde%2BWaal%26aufirst%3DP.%2BW.%26aulast%3DPal%26aufirst%3DK.%26aulast%3DYin%26aufirst%3DY.%26aulast%3DGao%26aufirst%3DX.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DMelcher%26aufirst%3DK.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DCong%26aufirst%3DY.%26aulast%3DEdward%2BZhou%26aufirst%3DX.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DEric%2BXu%26aufirst%3DH.%26atitle%3DA%2520Complex%2520Structure%2520of%2520Arrestin-2%2520Bound%2520to%2520a%2520G%2520Protein-Coupled%2520Receptor%26jtitle%3DCell%2520Res.%26date%3D2019%26volume%3D29%26spage%3D971%26epage%3D983%26doi%3D10.1038%2Fs41422-019-0256-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masureel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janetzko, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glenn, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skiniotis, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobilka, B. K.</span></span> <span> </span><span class="NLM_article-title">Structure of the Neurotensin Receptor 1 in Complex with β-Arrestin 1</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>579</i></span>,  <span class="NLM_fpage">303</span>– <span class="NLM_lpage">308</span>, <span class="refDoi"> DOI: 10.1038/s41586-020-1953-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1038%2Fs41586-020-1953-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=31945771" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BB3cXjvFygu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=579&publication_year=2020&pages=303-308&author=W.+Huangauthor=M.+Masureelauthor=Q.+Quauthor=J.+Janetzkoauthor=A.+Inoueauthor=H.+E.+Katoauthor=M.+J.+Robertsonauthor=K.+C.+Nguyenauthor=J.+S.+Glennauthor=G.+Skiniotisauthor=B.+K.+Kobilka&title=Structure+of+the+Neurotensin+Receptor+1+in+Complex+with+%CE%B2-Arrestin+1&doi=10.1038%2Fs41586-020-1953-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the neurotensin receptor 1 in complex with β-arrestin 1</span></div><div class="casAuthors">Huang, Weijiao; Masureel, Matthieu; Qu, Qianhui; Janetzko, John; Inoue, Asuka; Kato, Hideaki E.; Robertson, Michael J.; Nguyen, Khanh C.; Glenn, Jeffrey S.; Skiniotis, Georgios; Kobilka, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">579</span>
        (<span class="NLM_cas:issue">7798</span>),
    <span class="NLM_cas:pages">303-308</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Arrestin proteins bind to active, phosphorylated G-protein-coupled receptors (GPCRs), thereby preventing G-protein coupling, triggering receptor internalization and affecting various downstream signaling pathways.  Although there is a wealth of structural information detailing the interactions between GPCRs and G proteins, less is known about how arrestins engage GPCRs.  Here we report a cryo-electron microscopy structure of full-length human neurotensin receptor 1 (NTSR1) in complex with truncated human β-arrestin 1 (βarr1(ΔCT)).  We find that phosphorylation of NTSR1 is crit. for the formation of a stable complex with βarr1(ΔCT), and identify phosphorylated sites in both the third intracellular loop and the C terminus that may promote this interaction.  In addn., we observe a phosphatidylinositol-4,5-bisphosphate mol. forming a bridge between the membrane side of NTSR1 transmembrane segments 1 and 4 and the C-lobe of arrestin.  Compared with a structure of a rhodopsin-arrestin-1 complex, in our structure arrestin is rotated by approx. 85° relative to the receptor.  These findings highlight both conserved aspects and plasticity among arrestin-receptor interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOIs9dTKOA37Vg90H21EOLACvtfcHk0lh63esLHva8bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXjvFygu7w%253D&md5=1c0c8f151295a59694dd27bec054495d</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1038%2Fs41586-020-1953-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41586-020-1953-1%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DMasureel%26aufirst%3DM.%26aulast%3DQu%26aufirst%3DQ.%26aulast%3DJanetzko%26aufirst%3DJ.%26aulast%3DInoue%26aufirst%3DA.%26aulast%3DKato%26aufirst%3DH.%2BE.%26aulast%3DRobertson%26aufirst%3DM.%2BJ.%26aulast%3DNguyen%26aufirst%3DK.%2BC.%26aulast%3DGlenn%26aufirst%3DJ.%2BS.%26aulast%3DSkiniotis%26aufirst%3DG.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26atitle%3DStructure%2520of%2520the%2520Neurotensin%2520Receptor%25201%2520in%2520Complex%2520with%2520%25CE%25B2-Arrestin%25201%26jtitle%3DNature%26date%3D2020%26volume%3D579%26spage%3D303%26epage%3D308%26doi%3D10.1038%2Fs41586-020-1953-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kato, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suomivuori, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kadji, F. M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishna
Kumar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fonseca, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hilger, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Latorraca, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dror, R. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobilka, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skiniotis, G.</span></span> <span> </span><span class="NLM_article-title">Conformational Transitions of a Neurotensin Receptor 1-Gi1 Complex</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>572</i></span>,  <span class="NLM_fpage">80</span>– <span class="NLM_lpage">85</span>, <span class="refDoi"> DOI: 10.1038/s41586-019-1337-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1038%2Fs41586-019-1337-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=31243364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BC1MXht1yktL%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=572&publication_year=2019&pages=80-85&author=H.+E.+Katoauthor=Y.+Zhangauthor=H.+Huauthor=C.+M.+Suomivuoriauthor=F.+M.+N.+Kadjiauthor=J.+Aokiauthor=K.+Krishna%0AKumarauthor=R.+Fonsecaauthor=D.+Hilgerauthor=W.+Huangauthor=N.+R.+Latorracaauthor=A.+Inoueauthor=R.+O.+Drorauthor=B.+K.+Kobilkaauthor=G.+Skiniotis&title=Conformational+Transitions+of+a+Neurotensin+Receptor+1-Gi1+Complex&doi=10.1038%2Fs41586-019-1337-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Conformational transitions of a neurotensin receptor 1-Gi1 complex</span></div><div class="casAuthors">Kato, Hideaki E.; Zhang, Yan; Hu, Hongli; Suomivuori, Carl-Mikael; Kadji, Francois Marie Ngako; Aoki, Junken; Krishna Kumar, Kaavya; Fonseca, Rasmus; Hilger, Daniel; Huang, Weijiao; Latorraca, Naomi R.; Inoue, Asuka; Dror, Ron O.; Kobilka, Brian K.; Skiniotis, Georgios</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">572</span>
        (<span class="NLM_cas:issue">7767</span>),
    <span class="NLM_cas:pages">80-85</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Neurotensin receptor 1 (NTSR1) is a G-protein-coupled receptor (GPCR) that engages multiple subtypes of G protein, and is involved in the regulation of blood pressure, body temp., wt. and the response to pain.  Here we present structures of human NTSR1 in complex with the agonist JMV449 and the heterotrimeric Gi1 protein, at a resoln. of 3 Å.  We identify two conformations: a canonical-state complex that is similar to recently reported GPCR-Gi/o complexes (in which the nucleotide-binding pocket adopts more flexible conformations that may facilitate nucleotide exchange), and a non-canonical state in which the G protein is rotated by about 45 degrees relative to the receptor and exhibits a more rigid nucleotide-binding pocket.  In the non-canonical state, NTSR1 exhibits features of both active and inactive conformations, which suggests that the structure may represent an intermediate form along the activation pathway of G proteins.  This structural information, complemented by mol. dynamics simulations and functional studies, provides insights into the complex process of G-protein activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7W5VFHU7QCbVg90H21EOLACvtfcHk0lh63esLHva8bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXht1yktL%252FL&md5=0ce265e5a9dc353e69d2c04032803399</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1038%2Fs41586-019-1337-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41586-019-1337-6%26sid%3Dliteratum%253Aachs%26aulast%3DKato%26aufirst%3DH.%2BE.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DHu%26aufirst%3DH.%26aulast%3DSuomivuori%26aufirst%3DC.%2BM.%26aulast%3DKadji%26aufirst%3DF.%2BM.%2BN.%26aulast%3DAoki%26aufirst%3DJ.%26aulast%3DKrishna%2BKumar%26aufirst%3DK.%26aulast%3DFonseca%26aufirst%3DR.%26aulast%3DHilger%26aufirst%3DD.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DLatorraca%26aufirst%3DN.%2BR.%26aulast%3DInoue%26aufirst%3DA.%26aulast%3DDror%26aufirst%3DR.%2BO.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26aulast%3DSkiniotis%26aufirst%3DG.%26atitle%3DConformational%2520Transitions%2520of%2520a%2520Neurotensin%2520Receptor%25201-Gi1%2520Complex%26jtitle%3DNature%26date%3D2019%26volume%3D572%26spage%3D80%26epage%3D85%26doi%3D10.1038%2Fs41586-019-1337-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fanelli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Floquet, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besserer-Offroy, É.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delort, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vivancos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Longpré, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renault, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarret, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavelier, F.</span></span> <span> </span><span class="NLM_article-title">Use of Molecular Modeling to Design Selective Nts2 Neurotensin Analogues</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">3303</span>– <span class="NLM_lpage">3313</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01848</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01848" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlsVyntrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=3303-3313&author=R.+Fanelliauthor=N.+Floquetauthor=%C3%89.+Besserer-Offroyauthor=B.+Delortauthor=M.+Vivancosauthor=J.+M.+Longpr%C3%A9author=P.+Renaultauthor=J.+Martinezauthor=P.+Sarretauthor=F.+Cavelier&title=Use+of+Molecular+Modeling+to+Design+Selective+Nts2+Neurotensin+Analogues&doi=10.1021%2Facs.jmedchem.6b01848"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Use of Molecular Modeling to Design Selective NTS2 Neurotensin Analogues</span></div><div class="casAuthors">Fanelli, Roberto; Floquet, Nicolas; Besserer-Offroy, Elie; Delort, Bartholome; Vivancos, Melanie; Longpre, Jean-Michel; Renault, Pedro; Martinez, Jean; Sarret, Philippe; Cavelier, Florine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3303-3313</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Neurotensin exerts potent analgesia by acting at both NTS1 and NTS2 receptors, whereas NTS1 activation also results in other physiol. effects such as hypotension and hypothermia.  Here, we used mol. modeling approach to design highly selective NTS2 ligands by investigating the docking of novel NT[8-13] compds. at both NTS1 and NTS2 sites.  Mol. dynamics simulations revealed an interaction of the Tyr11 residue of NT[8-13] with an acidic residue (Glu179) located in the ECL2 of hNTS2 or with a basic residue (Arg212) at the same position in hNTS1.  The importance of the residue at position 11 for NTS1/NTS2 selectivity was further demonstrated by the design of new NT analogs bearing basic (Lys, Orn) or acid (Asp or Glu) function.  As predicted by the mol. dynamics simulations, binding of NT[8-13] analogs harboring a Lys11 exhibited higher affinity toward the hNTS1-R212E mutant receptor, in which Arg212 was substituted by the neg. charged Glu residue.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIqa126BbiC7Vg90H21EOLACvtfcHk0lh63esLHva8bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlsVyntrg%253D&md5=32fc41daeb4c5f0f8219765a7c1e9c12</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01848&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01848%26sid%3Dliteratum%253Aachs%26aulast%3DFanelli%26aufirst%3DR.%26aulast%3DFloquet%26aufirst%3DN.%26aulast%3DBesserer-Offroy%26aufirst%3D%25C3%2589.%26aulast%3DDelort%26aufirst%3DB.%26aulast%3DVivancos%26aufirst%3DM.%26aulast%3DLongpr%25C3%25A9%26aufirst%3DJ.%2BM.%26aulast%3DRenault%26aufirst%3DP.%26aulast%3DMartinez%26aufirst%3DJ.%26aulast%3DSarret%26aufirst%3DP.%26aulast%3DCavelier%26aufirst%3DF.%26atitle%3DUse%2520of%2520Molecular%2520Modeling%2520to%2520Design%2520Selective%2520Nts2%2520Neurotensin%2520Analogues%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D3303%26epage%3D3313%26doi%3D10.1021%2Facs.jmedchem.6b01848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boules, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briody, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fauq, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliveros, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khaniyev, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katovich, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richelson, E.</span></span> <span> </span><span class="NLM_article-title">Nt79: A Novel Neurotensin Analog with Selective Behavioral Effects</span>. <i>Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1308</i></span>,  <span class="NLM_fpage">35</span>– <span class="NLM_lpage">46</span>, <span class="refDoi"> DOI: 10.1016/j.brainres.2009.10.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2Fj.brainres.2009.10.050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=19874804" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFanu7vO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1308&publication_year=2010&pages=35-46&author=M.+Boulesauthor=Y.+Liangauthor=S.+Briodyauthor=T.+Miuraauthor=I.+Fauqauthor=A.+Oliverosauthor=M.+Wilsonauthor=S.+Khaniyevauthor=K.+Williamsauthor=Z.+Liauthor=Y.+Qiauthor=M.+Katovichauthor=E.+Richelson&title=Nt79%3A+A+Novel+Neurotensin+Analog+with+Selective+Behavioral+Effects&doi=10.1016%2Fj.brainres.2009.10.050"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">NT79: A novel neurotensin analog with selective behavioral effects</span></div><div class="casAuthors">Boules, Mona; Liang, Yanqi; Briody, Siobhan; Miura, Tomofumi; Fauq, Irfan; Oliveros, Alfredo; Wilson, Mina; Khaniyev, Shaheen; Williams, Katrina; Li, Zhimin; Qi, Yanfei; Katovich, Michael; Richelson, Elliott</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1308</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">35-46</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Neurotensin, a tridecapeptide, is widely distributed in the brain and gastrointestinal tract.  It possesses analgesic, hypothermic, and antipsychotic-like properties.  Neurotensin's effects are mediated mainly through two receptor subtypes, NTS1 and NTS2.  Activation of NTS1 has been implicated in most of the pharmacol. effects of neurotensin but is assocd. with hypothermia and hypotension.  The authors report on a novel neurotensin analog with higher selectivity to NTS2, namely, NT79, which exhibits selective behavioral effects.  NT79 was tested in animal models for pain (thermal-hot plate test; visceral-acetic acid-induced writhing test), and in animal models that are predictive of antipsychotic-like effects (apomorphine-induced climbing; d-amphetamine-induced hyperactivity; disruption of prepulse inhibition).  Its effects on body temp. and on blood pressure were also detd.  Neurochem. changes in extracellular neurotransmitters were measured using in vivo microdialysis while the rats were simultaneously evaluated for acetic acid-induced writhing with and without pretreatment with NT79.  Binding data at molecularly cloned hNTS1 and hNTS2 suggest selectivity for hNTS2.  NT79 blocked the acetic acid-induced writhing with an ED50 of 0.14 μg/kg while having no effect on thermal nociception.  The writhing was paralleled by an increase in 5-HT which was attenuated by NT79.  NT79 demonstrated antipsychotic-like effects by blocking apomorphine-induced climbing, d-amphetamine-induced hyperactivity, and reducing d-amphetamine- and DOI-induced disruption of prepulse inhibition.  Uniquely, it caused no significant hypothermia and was without effect on blood pressure.  NT79, with its higher selectivity to NTS2, may be potentially useful to treat visceral pain, and psychosis without concomitant side effects of hypothermia or hypotension.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvdV6rKFt287Vg90H21EOLACvtfcHk0lhMcEFzIsS5zg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFanu7vO&md5=212ac7646f691aeec397282b1782876a</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2009.10.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2009.10.050%26sid%3Dliteratum%253Aachs%26aulast%3DBoules%26aufirst%3DM.%26aulast%3DLiang%26aufirst%3DY.%26aulast%3DBriody%26aufirst%3DS.%26aulast%3DMiura%26aufirst%3DT.%26aulast%3DFauq%26aufirst%3DI.%26aulast%3DOliveros%26aufirst%3DA.%26aulast%3DWilson%26aufirst%3DM.%26aulast%3DKhaniyev%26aufirst%3DS.%26aulast%3DWilliams%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DQi%26aufirst%3DY.%26aulast%3DKatovich%26aufirst%3DM.%26aulast%3DRichelson%26aufirst%3DE.%26atitle%3DNt79%253A%2520A%2520Novel%2520Neurotensin%2520Analog%2520with%2520Selective%2520Behavioral%2520Effects%26jtitle%3DBrain%2520Res.%26date%3D2010%26volume%3D1308%26spage%3D35%26epage%3D46%26doi%3D10.1016%2Fj.brainres.2009.10.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Einsiedel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Held, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hervet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plomer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tschammer, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span> <span> </span><span class="NLM_article-title">Discovery of Highly Potent and Neurotensin Receptor 2 Selective Neurotensin Mimetics</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">2915</span>– <span class="NLM_lpage">2923</span>, <span class="refDoi"> DOI: 10.1021/jm200006c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200006c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvV2hurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2915-2923&author=J.+Einsiedelauthor=C.+Heldauthor=M.+Hervetauthor=M.+Plomerauthor=N.+Tschammerauthor=H.+H%C3%BCbnerauthor=P.+Gmeiner&title=Discovery+of+Highly+Potent+and+Neurotensin+Receptor+2+Selective+Neurotensin+Mimetics&doi=10.1021%2Fjm200006c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Highly Potent and Neurotensin Receptor 2 Selective Neurotensin Mimetics</span></div><div class="casAuthors">Einsiedel, Jurgen; Held, Cornelia; Hervet, Maud; Plomer, Manuel; Tschammer, Nuska; Hubner, Harald; Gmeiner, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2915-2923</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The neurotensin receptor subtype 2 (NTS2) is involved in the modulation of tonic pain sensitivity and psychiatric diseases and is, therefore, regarded as a highly attractive pharmacol. target protein.  Aiming to discover NTS2 selective ligands, we herein describe the identification of screening hits and the chem. synthesis of structural variants leading to the highly potent and NTS2 selective peptide-peptoid hybrids of type 3.  The neurotensin mimetics 3a and 3e-g incorporating an N-(4-hydroxyphenethyl)glycine substructure exhibit single digit nanomolar affinity (Ki = 4.3-8.8 nM) and 1900-12000 fold selectivity over the neurotensin receptor subtype 1 (NTS1).  According to functional expts., the test compds. 3a and 3e-g displayed an inhibition of constitutive mitogen-activated protein kinase (MAPK) activity exceeding 2.6-4.6 times the inverse agonist activity of the endogenous ligand neurotensin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgosdwSBrpXbVg90H21EOLACvtfcHk0lhMcEFzIsS5zg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvV2hurc%253D&md5=d6b755f092b2073e6c38f6663c8b81b4</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fjm200006c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200006c%26sid%3Dliteratum%253Aachs%26aulast%3DEinsiedel%26aufirst%3DJ.%26aulast%3DHeld%26aufirst%3DC.%26aulast%3DHervet%26aufirst%3DM.%26aulast%3DPlomer%26aufirst%3DM.%26aulast%3DTschammer%26aufirst%3DN.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DDiscovery%2520of%2520Highly%2520Potent%2520and%2520Neurotensin%2520Receptor%25202%2520Selective%2520Neurotensin%2520Mimetics%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2915%26epage%3D2923%26doi%3D10.1021%2Fjm200006c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Richard, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barroso, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labbé-Jullié, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitabgi, P.</span></span> <span> </span><span class="NLM_article-title">Agonism, Inverse Agonism, and Neutral Antagonism at the Constitutively Active Human Neurotensin Receptor 2</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1392</span>– <span class="NLM_lpage">1398</span>, <span class="refDoi"> DOI: 10.1124/mol.60.6.1392</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1124%2Fmol.60.6.1392" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=11723247" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BD3MXovVOitLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2001&pages=1392-1398&author=F.+Richardauthor=S.+Barrosoauthor=J.+Martinezauthor=C.+Labb%C3%A9-Julli%C3%A9author=P.+Kitabgi&title=Agonism%2C+Inverse+Agonism%2C+and+Neutral+Antagonism+at+the+Constitutively+Active+Human+Neurotensin+Receptor+2&doi=10.1124%2Fmol.60.6.1392"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Agonism, inverse agonism, and neutral antagonism at the constitutively active human neurotensin receptor 2</span></div><div class="casAuthors">Richard, Francoise; Barroso, Severine; Martinez, Jean; Labbe-Jullie, Catherine; Kitabgi, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1392-1398</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Two G protein-coupled neurotensin (NT) receptors, termed NTR1 and NTR2, have been identified so far.  In contrast to the NTR1, which has been extensively studied, little is known about the pharmacol. and biol. properties of the NTR2.  In the course of characterizing NT analogs that exhibited binding selectivity for the NTR2, the authors discovered that this receptor constitutively activated inositol phosphate (IP) prodn.  Here, the authors report on the constitutive activity of the human NTR2 (hNTR2) transfected in COS cells and on compds. that exhibit agonism, inverse agonism, and neutral antagonism at this receptor.  IP levels increased linearly with time, whereas they remained const. in mock-transfected cells.  Furthermore, IP prodn. was proportional to the amt. of hNTR2 present at the cell membrane.  SR 48692, a nonpeptide antagonist of the NTR1, stimulated IP prodn., whereas levocabastine, a nonpeptide histamine H1 antagonist that binds the NTR2 but not the NTR1, behaved as a weak partial inverse agonist.  NT analogs modified at position 11 of the NT mol., in particular by the introduction of bulky arom. D amino acids, exhibited binding selectivity at the hNTR2 and also behaved as partial inverse agonists, reversing constitutive IP prodn. up to 50%.  Finally, NT barely affected constitutive IP prodn. but antagonized the effects of both agonist and inverse agonist compds., thus behaving as a neutral antagonist.  The unique pharmacol. profile of the hNTR2 is discussed in the light of its sequence similarity with the NTR1 and the known binding site topol. of NT and SR 48692 in the NTR1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPUX-dsvlE67Vg90H21EOLACvtfcHk0lhMcEFzIsS5zg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXovVOitLY%253D&md5=da4ffe26782a9a0d0ec9c6d6a76de91f</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1124%2Fmol.60.6.1392&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.60.6.1392%26sid%3Dliteratum%253Aachs%26aulast%3DRichard%26aufirst%3DF.%26aulast%3DBarroso%26aufirst%3DS.%26aulast%3DMartinez%26aufirst%3DJ.%26aulast%3DLabb%25C3%25A9-Julli%25C3%25A9%26aufirst%3DC.%26aulast%3DKitabgi%26aufirst%3DP.%26atitle%3DAgonism%252C%2520Inverse%2520Agonism%252C%2520and%2520Neutral%2520Antagonism%2520at%2520the%2520Constitutively%2520Active%2520Human%2520Neurotensin%2520Receptor%25202%26jtitle%3DMol.%2520Pharmacol.%26date%3D2001%26volume%3D60%26spage%3D1392%26epage%3D1398%26doi%3D10.1124%2Fmol.60.6.1392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dubuc, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarret, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labbé-Jullié, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Botto, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honoré, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourdel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costentin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitabgi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazella, J.</span></span> <span> </span><span class="NLM_article-title">Identification of the Receptor Subtype Involved in the Analgesic Effect of Neurotensin</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">503</span>– <span class="NLM_lpage">510</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.19-01-00503.1999</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1523%2FJNEUROSCI.19-01-00503.1999" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=9870978" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADyaK1MXltVWitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1999&pages=503-510&author=I.+Dubucauthor=P.+Sarretauthor=C.+Labb%C3%A9-Julli%C3%A9author=J.-M.+Bottoauthor=E.+Honor%C3%A9author=E.+Bourdelauthor=J.+Martinezauthor=J.+Costentinauthor=J.-P.+Vincentauthor=P.+Kitabgiauthor=J.+Mazella&title=Identification+of+the+Receptor+Subtype+Involved+in+the+Analgesic+Effect+of+Neurotensin&doi=10.1523%2FJNEUROSCI.19-01-00503.1999"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of the receptor subtype involved in the analgesic effect of neurotensin</span></div><div class="casAuthors">Dubuc, Isabelle; Sarret, Philippe; Labbe-Jullie, Catherine; Botto, Jean-Marie; Honore, Eric; Bourdel, Elisabeth; Martinez, Jean; Costentin, Jean; Vincent, Jean-Pierre; Kitabgi, Patrick; Mazella, Jean</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">503-510</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The neuropeptide neurotensin (NT) elicits hypothermic and naloxone-insensitive analgesic responses after brain injection.  Recent pharmacol. evidence obtained with NT agonists and antagonists suggests that these effects are mediated by a receptor distinct from the initially cloned high-affinity NT receptor (NTR1).  The recent cloning of a second NT receptor (NTR2) prompted the authors to evaluate its role in NT-induced analgesia.  Intracerebroventricular injections in mice of two different antisense oligodeoxynucleotides from the NTR2 markedly decreased NTR2 mRNA and protein and reduced NT-induced analgesia.  This effect was specific, because NTR1 levels were unaffected, and sense or scramble oligodeoxynucleotides had no effect.  Structure-activity studies revealed a close correlation between the analgesic potency of NT analogs and their affinity for the NTR2 and disclosed potent and selective agonists of this receptor.  These data confirm that NTR1 is involved in the NT-elicited turning behavior and demonstrate that the NTR2 mediates NT-induced analgesia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIvLUmowYy_bVg90H21EOLACvtfcHk0lgqimNptOH1pA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXltVWitQ%253D%253D&md5=5c95936473e8adb8566bfe72bcea5668</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.19-01-00503.1999&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.19-01-00503.1999%26sid%3Dliteratum%253Aachs%26aulast%3DDubuc%26aufirst%3DI.%26aulast%3DSarret%26aufirst%3DP.%26aulast%3DLabb%25C3%25A9-Julli%25C3%25A9%26aufirst%3DC.%26aulast%3DBotto%26aufirst%3DJ.-M.%26aulast%3DHonor%25C3%25A9%26aufirst%3DE.%26aulast%3DBourdel%26aufirst%3DE.%26aulast%3DMartinez%26aufirst%3DJ.%26aulast%3DCostentin%26aufirst%3DJ.%26aulast%3DVincent%26aufirst%3DJ.-P.%26aulast%3DKitabgi%26aufirst%3DP.%26aulast%3DMazella%26aufirst%3DJ.%26atitle%3DIdentification%2520of%2520the%2520Receptor%2520Subtype%2520Involved%2520in%2520the%2520Analgesic%2520Effect%2520of%2520Neurotensin%26jtitle%3DJ.%2520Neurosci.%26date%3D1999%26volume%3D19%26spage%3D503%26epage%3D510%26doi%3D10.1523%2FJNEUROSCI.19-01-00503.1999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Held, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plomer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meltretter, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pischetsrieder, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span> <span> </span><span class="NLM_article-title">Development of a Metabolically Stable Neurotensin Receptor 2 (Nts2) Ligand</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">75</span>– <span class="NLM_lpage">81</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201200376</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1002%2Fcmdc.201200376" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=23097347" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFGqu7%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=75-81&author=C.+Heldauthor=M.+Plomerauthor=H.+H%C3%BCbnerauthor=J.+Meltretterauthor=M.+Pischetsriederauthor=P.+Gmeiner&title=Development+of+a+Metabolically+Stable+Neurotensin+Receptor+2+%28Nts2%29+Ligand&doi=10.1002%2Fcmdc.201200376"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a Metabolically Stable Neurotensin Receptor 2 (NTS2) Ligand</span></div><div class="casAuthors">Held, Cornelia; Plomer, Manuel; Huebner, Harald; Meltretter, Jasmin; Pischetsrieder, Monika; Gmeiner, Peter</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">75-81</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Subtype-selective neurotensin receptor 2 (NTS2) ligands can be used as mol. probes to investigate the physiol. role of neurotensinergic systems and serve as lead compds. to initiate the development of drugs for the treatment of tonic pain.  Starting from the authors' recently described NTS2 ligand (I, H-Arg-Arg-Pro-(N-homo-Tyr)-Ile-Leu-OH), structural variants of type (II, H-X-Y-Pro-(N-homo-Tyr)-Ile-Leu-OH where X = N-Me-Arg or Nlys and Y = Arg or Lys) were synthesized to further improve binding affinity and selectivity to gain metabolic stability.  The peptide-peptoid hybrid (III, N-Me-Arg-Arg-Pro-(N-homo-Tyr)-Ile-Leu-OH) showed excellent NTS2 binding affinity (Ki=2.8 nM) and 22,000-fold selectivity over NTS1, as well as metabolic stability over 32 h in a serum degrdn. assay.  Employing a MAPK-driven luciferase reporter gene assay and an IP accumulation assay, the neurotensin mimetic (III) displayed resp. inhibitions of constitutive activity exceeding 4.3- and 3.9-fold that of the inverse agonist activity of the endogenous ligand neurotensin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFWayShMb1J7Vg90H21EOLACvtfcHk0lgqimNptOH1pA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFGqu7%252FN&md5=c7f08d11405351b2dc5a81dfc81bff35</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201200376&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201200376%26sid%3Dliteratum%253Aachs%26aulast%3DHeld%26aufirst%3DC.%26aulast%3DPlomer%26aufirst%3DM.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DMeltretter%26aufirst%3DJ.%26aulast%3DPischetsrieder%26aufirst%3DM.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DDevelopment%2520of%2520a%2520Metabolically%2520Stable%2520Neurotensin%2520Receptor%25202%2520%2528Nts2%2529%2520Ligand%26jtitle%3DChemMedChem%26date%3D2013%26volume%3D8%26spage%3D75%26epage%3D81%26doi%3D10.1002%2Fcmdc.201200376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pratsch, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unfried, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Einsiedel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plomer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinrich, M. R.</span></span> <span> </span><span class="NLM_article-title">Radical Arylation of Tyrosine and Its Application in the Synthesis of a Highly Selective Neurotensin Receptor 2 Ligand</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">3746</span>– <span class="NLM_lpage">3752</span>, <span class="refDoi"> DOI: 10.1039/c1ob05292f</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1039%2Fc1ob05292f" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=21472182" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlt1Ght7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2011&pages=3746-3752&author=G.+Pratschauthor=J.+F.+Unfriedauthor=J.+Einsiedelauthor=M.+Plomerauthor=H.+H%C3%BCbnerauthor=P.+Gmeinerauthor=M.+R.+Heinrich&title=Radical+Arylation+of+Tyrosine+and+Its+Application+in+the+Synthesis+of+a+Highly+Selective+Neurotensin+Receptor+2+Ligand&doi=10.1039%2Fc1ob05292f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Radical arylation of tyrosine and its application in the synthesis of a highly selective neurotensin receptor 2 ligand</span></div><div class="casAuthors">Pratsch, Gerald; Unfried, Johannes F.; Einsiedel, Juergen; Plomer, Manuel; Huebner, Harald; Gmeiner, Peter; Heinrich, Markus R.</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3746-3752</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A small library of Fmoc-protected 3-arylated tyrosines was created by radical arylation.  The new building blocks were successfully applied in the synthesis of two novel neurotensin receptor ligands, H-Arg-Arg-Pro-FPTyr-Ile-Leu-OH [FPTyr = (S)- and (R)-3-(4-fluorophenyl)tyrosine].  Both isomers showed high affinity for the human NTS2 receptor with Ki values in the nanomolar range.  Interestingly, subtype selectivity strongly depends on the configuration of the peptide in position 11.  Peptide contg. (R)-3-(4-fluorophenyl)tyrosine displayed an excellent preference for NTS2 compared to NTS1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrY1iBZYuIrkrVg90H21EOLACvtfcHk0lgqimNptOH1pA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlt1Ght7c%253D&md5=a7d9030ecc421c22ae1c343fd8f2c04e</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1039%2Fc1ob05292f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc1ob05292f%26sid%3Dliteratum%253Aachs%26aulast%3DPratsch%26aufirst%3DG.%26aulast%3DUnfried%26aufirst%3DJ.%2BF.%26aulast%3DEinsiedel%26aufirst%3DJ.%26aulast%3DPlomer%26aufirst%3DM.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DGmeiner%26aufirst%3DP.%26aulast%3DHeinrich%26aufirst%3DM.%2BR.%26atitle%3DRadical%2520Arylation%2520of%2520Tyrosine%2520and%2520Its%2520Application%2520in%2520the%2520Synthesis%2520of%2520a%2520Highly%2520Selective%2520Neurotensin%2520Receptor%25202%2520Ligand%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2011%26volume%3D9%26spage%3D3746%26epage%3D3752%26doi%3D10.1039%2Fc1ob05292f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Simeth, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bause, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobmeier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kling, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lachmann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Einsiedel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">König, B.</span></span> <span> </span><span class="NLM_article-title">Nts2-Selective Neurotensin Mimetics with Tetrahydrofuran Amino Acids</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">350</span>– <span class="NLM_lpage">359</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2016.10.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2Fj.bmc.2016.10.039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=27842797" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVGgtrjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=350-359&author=N.+A.+Simethauthor=M.+Bauseauthor=M.+Dobmeierauthor=R.+C.+Klingauthor=D.+Lachmannauthor=H.+H%C3%BCbnerauthor=J.+Einsiedelauthor=P.+Gmeinerauthor=B.+K%C3%B6nig&title=Nts2-Selective+Neurotensin+Mimetics+with+Tetrahydrofuran+Amino+Acids&doi=10.1016%2Fj.bmc.2016.10.039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">NTS2-selective neurotensin mimetics with tetrahydrofuran amino acids</span></div><div class="casAuthors">Simeth, Nadja A.; Bause, Manuel; Dobmeier, Michael; Kling, Ralf C.; Lachmann, Daniel; Huebner, Harald; Einsiedel, Juergen; Gmeiner, Peter; Koenig, Burkhard</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">350-359</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Stimulation of the NTS2 neurotensin receptor causes antipsychotic effects and leads to a promotion of the μ-opioid-independent antinociception, which is important in the modulation of tonic pain sensitivity.  We report the synthesis and properties of a small library of peptidic agonists based on the active neurotensin fragment NT(8-13).  Two THF amino acid derivs. were synthesized to replace Tyr11 in NT(8-13).  Addnl., Arg8, Arg9, and Ile12 of the lead peptide were exchanged by Lys, Lys, and Gly, resp.  The new compds. showed substantial NTS2 binding affinity and up to 1000-fold selectivity over NTS1.  The highest selectivity (Ki(NTS2): 29 nM, Ki(NTS1): 35,000 nM) was obsd. for the peptide analog 17Rtrans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNyZX8W7v-TbVg90H21EOLACvtfcHk0lg0HL11bnJ-ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVGgtrjJ&md5=071e1b20ff943a826abedadebab5851a</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.10.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.10.039%26sid%3Dliteratum%253Aachs%26aulast%3DSimeth%26aufirst%3DN.%2BA.%26aulast%3DBause%26aufirst%3DM.%26aulast%3DDobmeier%26aufirst%3DM.%26aulast%3DKling%26aufirst%3DR.%2BC.%26aulast%3DLachmann%26aufirst%3DD.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DEinsiedel%26aufirst%3DJ.%26aulast%3DGmeiner%26aufirst%3DP.%26aulast%3DK%25C3%25B6nig%26aufirst%3DB.%26atitle%3DNts2-Selective%2520Neurotensin%2520Mimetics%2520with%2520Tetrahydrofuran%2520Amino%2520Acids%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2017%26volume%3D25%26spage%3D350%26epage%3D359%26doi%3D10.1016%2Fj.bmc.2016.10.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bumbak, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noonan-Williams, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaid, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitehead, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kocan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bathgate, R. A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chalmers, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gooley, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, D. J.</span></span> <span> </span><span class="NLM_article-title">Conformational Changes in Tyrosine 11 of Neurotensin Are Required to Activate the Neurotensin Receptor 1</span>. <i>ACS Pharmacol. Trans. l Sci.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">690</span>– <span class="NLM_lpage">705</span>, <span class="refDoi"> DOI: 10.1021/acsptsci.0c00026</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsptsci.0c00026" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2020&pages=690-705&author=F.+Bumbakauthor=T.+Thomasauthor=B.+J.+Noonan-Williamsauthor=T.+M.+Vaidauthor=F.+Yanauthor=A.+R.+Whiteheadauthor=S.+Bruellauthor=M.+Kocanauthor=X.+Tanauthor=M.+A.+Johnsonauthor=R.+A.+D.+Bathgateauthor=D.+K.+Chalmersauthor=P.+R.+Gooleyauthor=D.+J.+Scott&title=Conformational+Changes+in+Tyrosine+11+of+Neurotensin+Are+Required+to+Activate+the+Neurotensin+Receptor+1&doi=10.1021%2Facsptsci.0c00026"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Facsptsci.0c00026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsptsci.0c00026%26sid%3Dliteratum%253Aachs%26aulast%3DBumbak%26aufirst%3DF.%26aulast%3DThomas%26aufirst%3DT.%26aulast%3DNoonan-Williams%26aufirst%3DB.%2BJ.%26aulast%3DVaid%26aufirst%3DT.%2BM.%26aulast%3DYan%26aufirst%3DF.%26aulast%3DWhitehead%26aufirst%3DA.%2BR.%26aulast%3DBruell%26aufirst%3DS.%26aulast%3DKocan%26aufirst%3DM.%26aulast%3DTan%26aufirst%3DX.%26aulast%3DJohnson%26aufirst%3DM.%2BA.%26aulast%3DBathgate%26aufirst%3DR.%2BA.%2BD.%26aulast%3DChalmers%26aufirst%3DD.%2BK.%26aulast%3DGooley%26aufirst%3DP.%2BR.%26aulast%3DScott%26aufirst%3DD.%2BJ.%26atitle%3DConformational%2520Changes%2520in%2520Tyrosine%252011%2520of%2520Neurotensin%2520Are%2520Required%2520to%2520Activate%2520the%2520Neurotensin%2520Receptor%25201%26jtitle%3DACS%2520Pharmacol.%2520Trans.%2520l%2520Sci.%26date%3D2020%26volume%3D3%26spage%3D690%26epage%3D705%26doi%3D10.1021%2Facsptsci.0c00026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marsault, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, M. L.</span></span> <span> </span><span class="NLM_article-title">Macrocycles Are Great Cycles: Applications, Opportunities, and Challenges of Synthetic Macrocycles in Drug Discovery</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">1961</span>– <span class="NLM_lpage">2004</span>, <span class="refDoi"> DOI: 10.1021/jm1012374</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1012374" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BC3MXivVSjtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1961-2004&author=E.+Marsaultauthor=M.+L.+Peterson&title=Macrocycles+Are+Great+Cycles%3A+Applications%2C+Opportunities%2C+and+Challenges+of+Synthetic+Macrocycles+in+Drug+Discovery&doi=10.1021%2Fjm1012374"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Macrocycles Are Great Cycles: Applications, Opportunities, and Challenges of Synthetic Macrocycles in Drug Discovery</span></div><div class="casAuthors">Marsault, Eric; Peterson, Mark L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1961-2004</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Macrocycles occupy a unique segment of chem. space.  In the past decade, their chem. diversity expanded significantly, supported by advances in bioinformatics and synthetic methodol.  As a consequence, this structural type has now been successfully tested on most biol. target classes.  The goal of this article is to put into perspective the current applications, opportunities, and challenges assocd. with synthetic macrocycles in drug discovery.  Accordingly, the first part of this article is dedicated to the drug discovery aspects of macrocycles and highlights salient features of their medicinal chem.  This section is organized by target class, a choice aimed at providing the reader an appreciation of the structural diversity generated for each class.  To give the reader an appreciation of the tools available to construct macrocyclic scaffolds, the site and method of the pivotal macrocyclization step are indicated in the figures.  Readers are referred to the source articles for further details.  In the second part, the technologies and synthetic approaches that already have demonstrated utility or possess a high potential for macrocycle-based drug discovery are discussed.  Finally, a perspective on the future of synthetic macrocycles in medicinal chem. is offered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrygQLE6JraHrVg90H21EOLACvtfcHk0lg0HL11bnJ-ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXivVSjtbo%253D&md5=97c1120896e90a85790a9ac1274259f3</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fjm1012374&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1012374%26sid%3Dliteratum%253Aachs%26aulast%3DMarsault%26aufirst%3DE.%26aulast%3DPeterson%26aufirst%3DM.%2BL.%26atitle%3DMacrocycles%2520Are%2520Great%2520Cycles%253A%2520Applications%252C%2520Opportunities%252C%2520and%2520Challenges%2520of%2520Synthetic%2520Macrocycles%2520in%2520Drug%2520Discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1961%26epage%3D2004%26doi%3D10.1021%2Fjm1012374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marsault, E.</span>; <span class="NLM_string-name">Peterson, M. L.</span></span> <i>Practical Medicinal Chemistry with Macrocycles: Design, Synthesis, and Case Studies</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsault, E.</span>; <span class="NLM_string-name">Peterson, M. L.</span></span>, Eds.; <span class="NLM_publisher-name">John Wiley & Sons, Incorporated</span>, <span class="NLM_year">2017</span>; p  <span class="NLM_fpage">624</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1002%2F9781119092599" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&pages=624&author=E.+Marsault&author=M.+L.+Petersonauthor=E.+Marsault&author=M.+L.+Peterson&title=Practical+Medicinal+Chemistry+with+Macrocycles%3A+Design%2C+Synthesis%2C+and+Case+Studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1002%2F9781119092599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9781119092599%26sid%3Dliteratum%253Aachs%26aulast%3DMarsault%26aufirst%3DE.%26btitle%3DPractical%2520Medicinal%2520Chemistry%2520with%2520Macrocycles%253A%2520Design%252C%2520Synthesis%252C%2520and%2520Case%2520Studies%26aulast%3DMarsault%26aufirst%3DE.%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Incorporated%26date%3D2017%26spage%3D624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mallinson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, I.</span></span> <span> </span><span class="NLM_article-title">Macrocycles in New Drug Discovery</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1409</span>– <span class="NLM_lpage">1438</span>, <span class="refDoi"> DOI: 10.4155/fmc.12.93</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.4155%2Ffmc.12.93" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=22857532" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFCht7rO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=1409-1438&author=J.+Mallinsonauthor=I.+Collins&title=Macrocycles+in+New+Drug+Discovery&doi=10.4155%2Ffmc.12.93"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Macrocycles in new drug discovery</span></div><div class="casAuthors">Mallinson, Jamie; Collins, Ian</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1409-1438</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  The use of drug-like macrocycles is emerging as an exciting area of medicinal chem., with several recent examples highlighting the favorable changes in biol. and physicochem. properties that macrocyclization can afford.  Natural product macrocycles and their synthetic derivs. have long been clin. useful and attention is now being focused on the wider use of macrocyclic scaffolds in medicinal chem. in the search for new drugs for increasingly challenging targets.  With the increasing awareness of concepts of drug-likeness and the dangers of mol. obesity', functionalized macrocyclic scaffolds could provide a way to generate ligand-efficient mols. with enhanced properties.  In this review we will sep. discuss the effects of macrocyclization upon potency, selectivity and physicochem. properties, concg. on recent case histories in oncol. drug discovery.  Addnl., we will highlight selected advances in the synthesis of macrocycles and provide an outlook on the future use of macrocyclic scaffolds in medicinal chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSrzcbKW7Tc7Vg90H21EOLACvtfcHk0lg0HL11bnJ-ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFCht7rO&md5=63ad275af92ac89ae6b36c5071b578f8</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.4155%2Ffmc.12.93&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.12.93%26sid%3Dliteratum%253Aachs%26aulast%3DMallinson%26aufirst%3DJ.%26aulast%3DCollins%26aufirst%3DI.%26atitle%3DMacrocycles%2520in%2520New%2520Drug%2520Discovery%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2012%26volume%3D4%26spage%3D1409%26epage%3D1438%26doi%3D10.4155%2Ffmc.12.93" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sefler, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawyer, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holub, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Omecinsky, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reily, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thanabal, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akunne, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cody, W. L.</span></span> <span> </span><span class="NLM_article-title">Design and Structure-Activity Relationships of C-Terminal Cyclic Neurotensin Fragment Analogues</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">249</span>– <span class="NLM_lpage">257</span>, <span class="refDoi"> DOI: 10.1021/jm00002a006</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00002a006" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADyaK2MXivFOqtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1995&pages=249-257&author=A.+M.+Seflerauthor=J.+X.+Heauthor=T.+K.+Sawyerauthor=K.+E.+Holubauthor=D.+O.+Omecinskyauthor=M.+D.+Reilyauthor=V.+Thanabalauthor=H.+C.+Akunneauthor=W.+L.+Cody&title=Design+and+Structure-Activity+Relationships+of+C-Terminal+Cyclic+Neurotensin+Fragment+Analogues&doi=10.1021%2Fjm00002a006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Structure-Activity Relationships of C-Terminal Cyclic Neurotensin Fragment Analogs</span></div><div class="casAuthors">Sefler, Andrea M.; He, John X.; Sawyer, Tomi K.; Holub, Katherine E.; Omecinsky, Diana O.; Reily, Michael D.; Thanabal, Venkataraman; Akunne, Hyacinth C.; Cody, Wayne L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">249-57</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Neurotensin (NT) is a linear tridecapeptide with a broad range of central and peripheral pharmacol. effects.  The C-terminal hexapeptide of NT (NT8-13) has been shown to possess similar properties to NT itself, and in fact, an analog of NT8-13 (NαMeArg8-Lys-Pro-Trp-Tle-Leu13, Tle = tert-leucine) has been reported to possess central activity after peripheral administration.  Cyclic derivs. of this hexapeptide were synthesized by a combination of soln. and solid-phase peptide synthetic methodologies, and several analogs had low nanomolar binding affinity for the NT receptor.  In particular, cyclo[Arg-Lys-Pro-Trp-Glu]-Leu (cyclized between the α amine of Arg and the γ carboxylate of Glu) possessed 16 nM NT receptor affinity and was detd. to be an agonist in vitro.  1H-NMR and 13C-edited 1H-NMR spectroscopy were performed on this and related cyclic analogs to help identify structural properties which may be important for receptor recognition.  These cyclic peptides represent novel mol. probes to further investigate NT receptor pharmacol., as well as to advance the authors understanding of the structural/conformational relationships of NT and to help establish a working basis for addnl. pharmacophore mapping studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_fpGulb0q87Vg90H21EOLACvtfcHk0liSml_vQnspPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXivFOqtLw%253D&md5=65c62b9e868acaab3fa75954891c119d</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1021%2Fjm00002a006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00002a006%26sid%3Dliteratum%253Aachs%26aulast%3DSefler%26aufirst%3DA.%2BM.%26aulast%3DHe%26aufirst%3DJ.%2BX.%26aulast%3DSawyer%26aufirst%3DT.%2BK.%26aulast%3DHolub%26aufirst%3DK.%2BE.%26aulast%3DOmecinsky%26aufirst%3DD.%2BO.%26aulast%3DReily%26aufirst%3DM.%2BD.%26aulast%3DThanabal%26aufirst%3DV.%26aulast%3DAkunne%26aufirst%3DH.%2BC.%26aulast%3DCody%26aufirst%3DW.%2BL.%26atitle%3DDesign%2520and%2520Structure-Activity%2520Relationships%2520of%2520C-Terminal%2520Cyclic%2520Neurotensin%2520Fragment%2520Analogues%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1995%26volume%3D38%26spage%3D249%26epage%3D257%26doi%3D10.1021%2Fjm00002a006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Akunne, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zoski, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sefler, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawyer, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pugsley, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cody, W. L.</span></span> <span> </span><span class="NLM_article-title">Functional Activity of New C-Terminal Cyclic-Neurotensin Fragment Analogs</span>. <i>Neuropeptides</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">213</span>– <span class="NLM_lpage">218</span>, <span class="refDoi"> DOI: 10.1016/S0143-4179(96)90066-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2FS0143-4179%2896%2990066-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=8819144" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADyaK28XksFSltrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1996&pages=213-218&author=H.+C.+Akunneauthor=S.+Darlingauthor=K.+Zoskiauthor=A.+M.+Seflerauthor=J.+X.+Heauthor=T.+K.+Sawyerauthor=T.+A.+Pugsleyauthor=W.+L.+Cody&title=Functional+Activity+of+New+C-Terminal+Cyclic-Neurotensin+Fragment+Analogs&doi=10.1016%2FS0143-4179%2896%2990066-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Functional activity of new C-terminal cyclic-neurotensin fragment analogs</span></div><div class="casAuthors">Akunne, H. C.; Darling, S.; Zoski, K.; Sefler, A. M.; He, J. X.; Sawyer, T. K.; Pugsley, T. A.; Cody, W. L.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropeptides (Edinburgh)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">213-218</span>CODEN:
                <span class="NLM_cas:coden">NRPPDD</span>;
        ISSN:<span class="NLM_cas:issn">0143-4179</span>.
    
            (<span class="NLM_cas:orgname">Churchill Livingstone</span>)
        </div><div class="casAbstract">Neurotensin (NT, pGlu-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Tyr-Ile-Leu) is a tridecapeptide that displays a wide spectrum of biol. actions.  Cyclic derivs. of a hexapeptide NT [(8-13)] (NαMeArg-Lys-Pro-Trp-Tle-Leu, Tle = tert-leucine) were designed and prepd. by a combination of soln. and solid-phase peptide synthetic methodologies.  As reported previously, several analogs possessed nanomolar binding affinities for NT receptors in newborn (10-day-old) mouse brain membrane prepns.  In this study, the authors detd. the functional ability of these analogs to mobilize intracellular free calcium, [Ca2+]i, in HT-29 cells (human colonic adenocarcinoma).  Of greatest interest were the cyclic compds. 2, 6 and 9 that had Ki values of 0.19, 3.50 and 4.18 μM for [3H]NT-labeled receptors in the HT-29 cell membrane assay, resp.  In the functional assay, compds. 2 and 6 mobilized [Ca2+]i with EC50 values of 0.13 and 20 μM, resp.  In comparison, Compd. 9 blocked the NT-induced mobilization of [Ca2+]i, with an IC50 of 1.70 μM.  The present findings indicate that small mol. cyclic analogs, that possess functional activity, can be designed and may have therapeutic utility in the treatment of schizophrenia and possibly other neurol. disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocKbW8FBlwMLVg90H21EOLACvtfcHk0liSml_vQnspPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XksFSltrg%253D&md5=479a060eb7bead57ce3155d118e6e91e</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2FS0143-4179%2896%2990066-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0143-4179%252896%252990066-9%26sid%3Dliteratum%253Aachs%26aulast%3DAkunne%26aufirst%3DH.%2BC.%26aulast%3DDarling%26aufirst%3DS.%26aulast%3DZoski%26aufirst%3DK.%26aulast%3DSefler%26aufirst%3DA.%2BM.%26aulast%3DHe%26aufirst%3DJ.%2BX.%26aulast%3DSawyer%26aufirst%3DT.%2BK.%26aulast%3DPugsley%26aufirst%3DT.%2BA.%26aulast%3DCody%26aufirst%3DW.%2BL.%26atitle%3DFunctional%2520Activity%2520of%2520New%2520C-Terminal%2520Cyclic-Neurotensin%2520Fragment%2520Analogs%26jtitle%3DNeuropeptides%26date%3D1996%26volume%3D30%26spage%3D213%26epage%3D218%26doi%3D10.1016%2FS0143-4179%2896%2990066-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Van
Kemmel, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubuc, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourdel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fehrentz, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costentin, J.</span></span> <span> </span><span class="NLM_article-title">A C-Terminal Cyclic 8-13 Neurotensin Fragment Analog Appears Less Exposed to Neprilysin When It Crosses the Blood-Brain Barrier Than the Cerebrospinal Fluid-Brain Barrier in Mice</span>. <i>Neurosci. Lett.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>217</i></span>,  <span class="NLM_fpage">58</span>– <span class="NLM_lpage">60</span>, <span class="refDoi"> DOI: 10.1016/0304-3940(96)13074-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2F0304-3940%2896%2913074-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=8905739" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADyaK28XmsFGltrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=217&publication_year=1996&pages=58-60&author=F.+M.+Van%0AKemmelauthor=I.+Dubucauthor=E.+Bourdelauthor=J.+A.+Fehrentzauthor=J.+Martinezauthor=J.+Costentin&title=A+C-Terminal+Cyclic+8-13+Neurotensin+Fragment+Analog+Appears+Less+Exposed+to+Neprilysin+When+It+Crosses+the+Blood-Brain+Barrier+Than+the+Cerebrospinal+Fluid-Brain+Barrier+in+Mice&doi=10.1016%2F0304-3940%2896%2913074-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">A C-terminal cyclic 8-13 neurotensin fragment analog appears less exposed to neprilysin when it crosses the blood-brain barrier than the cerebrospinal fluid-brain barrier in mice</span></div><div class="casAuthors">Van Kemmel, F.-M.; Dubuc, I.; Bourdel, E.; Fehrentz, J.-A.; Martinez, J.; Costentin, J.</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience Letters</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">217</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">58-60</span>CODEN:
                <span class="NLM_cas:coden">NELED5</span>;
        ISSN:<span class="NLM_cas:issn">0304-3940</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A C-terminal cyclic 8-13 neurotensin fragment analog, JMV 1193, a direct agonist of central neurotensin receptors, is able to cross both the cerebrospinal fluid-brain barrier and the blood-brain barrier.  When administered intracerebroventricularly (i.c.v.), its hypothermic effect was potentiated by the enkephalinase inhibition induced either by thiorphan (simultaneous intracerebroventricular administration of 10 μg) or by the thiorphan prodrug, acetorphan (10 mg/kg, i.v.).  Such a potentiation was not obsd. with both JMV 1193 and acetorphan were administered i.v.  Therefore it appears that the sensitivity of JMV 1193 to enkephalinase depends on its route of administration.  It is exposed to this peptidase after i.c.v. injection (when crossing the cerebrospinal fluid-brain barrier), while it is not after i.v. administration (when crossing the blood-brain barrier).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowxyL91WEvvbVg90H21EOLACvtfcHk0liSml_vQnspPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XmsFGltrY%253D&md5=e5d4de8c2099863ca865722a0cef7c28</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2F0304-3940%2896%2913074-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0304-3940%252896%252913074-3%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BKemmel%26aufirst%3DF.%2BM.%26aulast%3DDubuc%26aufirst%3DI.%26aulast%3DBourdel%26aufirst%3DE.%26aulast%3DFehrentz%26aufirst%3DJ.%2BA.%26aulast%3DMartinez%26aufirst%3DJ.%26aulast%3DCostentin%26aufirst%3DJ.%26atitle%3DA%2520C-Terminal%2520Cyclic%25208-13%2520Neurotensin%2520Fragment%2520Analog%2520Appears%2520Less%2520Exposed%2520to%2520Neprilysin%2520When%2520It%2520Crosses%2520the%2520Blood-Brain%2520Barrier%2520Than%2520the%2520Cerebrospinal%2520Fluid-Brain%2520Barrier%2520in%2520Mice%26jtitle%3DNeurosci.%2520Lett.%26date%3D1996%26volume%3D217%26spage%3D58%26epage%3D60%26doi%3D10.1016%2F0304-3940%2896%2913074-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lundquist, J. T.,  IV</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dix, T. A.</span></span> <span> </span><span class="NLM_article-title">Preparation and Receptor Binding Affinities of Cyclic C-Terminal Neurotensin (8-13) and (9-13) Analogues</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">2579</span>– <span class="NLM_lpage">2582</span>, <span class="refDoi"> DOI: 10.1016/S0960-894X(99)00420-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2FS0960-894X%2899%2900420-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10498212" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADyaK1MXmtFCitr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1999&pages=2579-2582&author=J.+T.+Lundquistauthor=T.+A.+Dix&title=Preparation+and+Receptor+Binding+Affinities+of+Cyclic+C-Terminal+Neurotensin+%288-13%29+and+%289-13%29+Analogues&doi=10.1016%2FS0960-894X%2899%2900420-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation and receptor binding affinities of cyclic C-terminal neurotensin (8-13) and (9-13) analogues</span></div><div class="casAuthors">Lundquist, Joseph T., IV; Dix, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2579-2582</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Cyclic analogs of neurotensin (NT) C-terminal fragments NT(8-13) and NT(9-13) were produced via intramol. nucleophilic substitution of the Tyr(11) phenoxide anion on a 6-bromohexanoyl side chain substituted at position 8 or 9 and tested for NT receptor binding affinity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSuH8va3kk_rVg90H21EOLACvtfcHk0lgaXdFrURc86A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmtFCitr4%253D&md5=418fde68195607c0d0048b41ebe612ef</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2899%2900420-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252899%252900420-5%26sid%3Dliteratum%253Aachs%26aulast%3DLundquist%26aufirst%3DJ.%2BT.%26aulast%3DDix%26aufirst%3DT.%2BA.%26atitle%3DPreparation%2520and%2520Receptor%2520Binding%2520Affinities%2520of%2520Cyclic%2520C-Terminal%2520Neurotensin%2520%25288-13%2529%2520and%2520%25289-13%2529%2520Analogues%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1999%26volume%3D9%26spage%3D2579%26epage%3D2582%26doi%3D10.1016%2FS0960-894X%2899%2900420-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bredeloux, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavelier, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubuc, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vivet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costentin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, J.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Biological Effects of C(Lys-Lys-Pro-Tyr-Ile-Leu-Lys-Lys-Pro-Tyr-Ile-Leu) (Jmv2012), a New Analogue of Neurotensin That Crosses the Blood-Brain Barrier</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">1610</span>– <span class="NLM_lpage">1616</span>, <span class="refDoi"> DOI: 10.1021/jm700925k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm700925k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BD1cXivV2gsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=1610-1616&author=P.+Bredelouxauthor=F.+Cavelierauthor=I.+Dubucauthor=B.+Vivetauthor=J.+Costentinauthor=J.+Martinez&title=Synthesis+and+Biological+Effects+of+C%28Lys-Lys-Pro-Tyr-Ile-Leu-Lys-Lys-Pro-Tyr-Ile-Leu%29+%28Jmv2012%29%2C+a+New+Analogue+of+Neurotensin+That+Crosses+the+Blood-Brain+Barrier&doi=10.1021%2Fjm700925k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological effects of c(Lys-Lys-Pro-Tyr-Ile-Leu-Lys-Lys-Pro-Tyr-Ile-Leu) (JMV2012), a new analogue of neurotensin that crosses the blood-brain barrier</span></div><div class="casAuthors">Bredeloux, Pierre; Cavelier, Florine; Dubuc, Isabelle; Vivet, Bertrand; Costentin, Jean; Martinez, Jean</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1610-1616</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The central administration of neurotensin (NT) or of its C-terminal hexapeptide fragment NT(8-13), produces strong analgesic effects in tests evaluating acute pain.  The use of NT-derived peptides as pharmaceutical agents to relief severe pain in patients could be of great interest.  Unfortunately, peptides do not readily penetrate the blood-brain barrier.  It was obsd. that the cyclic NT(8-13) analog, c(Lys-Lys-Pro-Tyr-Ile-Leu-Lys-Lys-Pro-Tyr-Ile-Leu) (JMV2012), when peripherally administered to mice produced analgesic and hypothermic effects, suggesting the peptide penetrates the blood-brain barrier and functions effectively like a drug.  Moreover, dimeric compds. show increased potency compared to their corresponding monomer.  The synthesis of the cyclic dimer JMV2012 is reported.  In mice, JMV2012 induced a profound hypothermia and a potent analgesia, even when peripherally administered.  JMV2012 appears to be an ideal lead compd. for the development of bioactive NT analogs as analgesics drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC6JSqhCBUzrVg90H21EOLACvtfcHk0lgaXdFrURc86A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXivV2gsLk%253D&md5=cfc20f6b9efea2d1be988eccfdef4c92</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Fjm700925k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm700925k%26sid%3Dliteratum%253Aachs%26aulast%3DBredeloux%26aufirst%3DP.%26aulast%3DCavelier%26aufirst%3DF.%26aulast%3DDubuc%26aufirst%3DI.%26aulast%3DVivet%26aufirst%3DB.%26aulast%3DCostentin%26aufirst%3DJ.%26aulast%3DMartinez%26aufirst%3DJ.%26atitle%3DSynthesis%2520and%2520Biological%2520Effects%2520of%2520C%2528Lys-Lys-Pro-Tyr-Ile-Leu-Lys-Lys-Pro-Tyr-Ile-Leu%2529%2520%2528Jmv2012%2529%252C%2520a%2520New%2520Analogue%2520of%2520Neurotensin%2520That%2520Crosses%2520the%2520Blood-Brain%2520Barrier%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D1610%26epage%3D1616%26doi%3D10.1021%2Fjm700925k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sousbie, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besserer-Offroy, É.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brouillette, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Longpré, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leduc, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarret, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsault, É.</span></span> <span> </span><span class="NLM_article-title">In Search of the Optimal Macrocyclization Site for Neurotensin</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">227</span>– <span class="NLM_lpage">232</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.7b00500</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.7b00500" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslyqsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=227-232&author=M.+Sousbieauthor=%C3%89.+Besserer-Offroyauthor=R.+L.+Brouilletteauthor=J.-M.+Longpr%C3%A9author=R.+Leducauthor=P.+Sarretauthor=%C3%89.+Marsault&title=In+Search+of+the+Optimal+Macrocyclization+Site+for+Neurotensin&doi=10.1021%2Facsmedchemlett.7b00500"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">In Search of the Optimal Macrocyclization Site for Neurotensin</span></div><div class="casAuthors">Sousbie, Marc; Besserer-Offroy, Elie; Brouillette, Rebecca L.; Longpre, Jean-Michel; Leduc, Richard; Sarret, Philippe; Marsault, Eric</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">227-232</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Neurotensin exerts potent analgesic effects following activation of its cognate GPCRs.  In this study, the authors describe a systematic exploration, using structure-based design, of conformationally constraining neurotensin (8-13) with the help of macrocyclization and the resulting impacts on binding affinity, signaling, and proteolytic stability.  This exploratory study led to a macrocyclic scaffold with submicromolar binding affinity, agonist activity, and greatly improved plasma stability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKgRzZ0YvF3LVg90H21EOLACvtfcHk0lgaXdFrURc86A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslyqsbg%253D&md5=7a81d21142ea26f1b85b4f43283ed509</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.7b00500&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.7b00500%26sid%3Dliteratum%253Aachs%26aulast%3DSousbie%26aufirst%3DM.%26aulast%3DBesserer-Offroy%26aufirst%3D%25C3%2589.%26aulast%3DBrouillette%26aufirst%3DR.%2BL.%26aulast%3DLongpr%25C3%25A9%26aufirst%3DJ.-M.%26aulast%3DLeduc%26aufirst%3DR.%26aulast%3DSarret%26aufirst%3DP.%26aulast%3DMarsault%26aufirst%3D%25C3%2589.%26atitle%3DIn%2520Search%2520of%2520the%2520Optimal%2520Macrocyclization%2520Site%2520for%2520Neurotensin%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D9%26spage%3D227%26epage%3D232%26doi%3D10.1021%2Facsmedchemlett.7b00500" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sousbie, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vivancos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brouillette, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besserer-Offroy, É.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Longpré, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leduc, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarret, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsault, É.</span></span> <span> </span><span class="NLM_article-title">Structural Optimization and Characterization of Potent Analgesic Macrocyclic Analogues of Neurotensin (8-13)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">7103</span>– <span class="NLM_lpage">7115</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00175</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00175" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlKms7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=7103-7115&author=M.+Sousbieauthor=M.+Vivancosauthor=R.+L.+Brouilletteauthor=%C3%89.+Besserer-Offroyauthor=J.-M.+Longpr%C3%A9author=R.+Leducauthor=P.+Sarretauthor=%C3%89.+Marsault&title=Structural+Optimization+and+Characterization+of+Potent+Analgesic+Macrocyclic+Analogues+of+Neurotensin+%288-13%29&doi=10.1021%2Facs.jmedchem.8b00175"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Optimization and Characterization of Potent Analgesic Macrocyclic Analogues of Neurotensin (8-13)</span></div><div class="casAuthors">Sousbie, Marc; Vivancos, Melanie; Brouillette, Rebecca L.; Besserer-Offroy, Elie; Longpre, Jean-Michel; Leduc, Richard; Sarret, Philippe; Marsault, Eric</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7103-7115</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The neurotensin receptors are attractive targets for the development of new analgesic compds.  They represent potential alternatives or adjuvants to opioids.  Herein, we report the structural optimization of our recently reported macrocyclic peptide analogs of NT (8-13).  The macrocycle was formed via ring-closing metathesis (RCM) between an ortho allylated tyrosine residue in position 11 and the side chain of alkene-functionalized amino acid in position 8 of NT (8-13).  Minute modifications led to significant binding affinity improvement (Ki improved from 5600 nM to 15 nM) with greatly improved plasma stability compared to NT (8-13).  This study also delineates the structural features influencing these parameters.  The signaling profiles of the new macrocycles were detd. on the NTS1 receptor and the physiol. effects of the two most potent and stable analogs were assessed in vivo using rodent models.  Both compds. displayed strong analgesic effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiJNnGkZ2klrVg90H21EOLACvtfcHk0lhfvC5cbUYYGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlKms7fK&md5=0dc826bb5712cb3910ecb51f7bf88d28</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00175&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00175%26sid%3Dliteratum%253Aachs%26aulast%3DSousbie%26aufirst%3DM.%26aulast%3DVivancos%26aufirst%3DM.%26aulast%3DBrouillette%26aufirst%3DR.%2BL.%26aulast%3DBesserer-Offroy%26aufirst%3D%25C3%2589.%26aulast%3DLongpr%25C3%25A9%26aufirst%3DJ.-M.%26aulast%3DLeduc%26aufirst%3DR.%26aulast%3DSarret%26aufirst%3DP.%26aulast%3DMarsault%26aufirst%3D%25C3%2589.%26atitle%3DStructural%2520Optimization%2520and%2520Characterization%2520of%2520Potent%2520Analgesic%2520Macrocyclic%2520Analogues%2520of%2520Neurotensin%2520%25288-13%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D7103%26epage%3D7115%26doi%3D10.1021%2Facs.jmedchem.8b00175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, J. A.</span></span> <span> </span><span class="NLM_article-title">High-Resolution Epitope Mapping of Hgh-Receptor Interactions by Alanine-Scanning Mutagenesis</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>244</i></span>,  <span class="NLM_fpage">1081</span>– <span class="NLM_lpage">1085</span>, <span class="refDoi"> DOI: 10.1126/science.2471267</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1126%2Fscience.2471267" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=2471267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADyaL1MXltV2it7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=244&publication_year=1989&pages=1081-1085&author=B.+C.+Cunninghamauthor=J.+A.+Wells&title=High-Resolution+Epitope+Mapping+of+Hgh-Receptor+Interactions+by+Alanine-Scanning+Mutagenesis&doi=10.1126%2Fscience.2471267"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">High-resolution epitope mapping of hGH-receptor interactions by alanine-scanning mutagenesis</span></div><div class="casAuthors">Cunningham, Brian C.; Wells, James A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">244</span>
        (<span class="NLM_cas:issue">4908</span>),
    <span class="NLM_cas:pages">1081-5</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">A strategy, called alanine-scanning mutagenesis, was used to identify specific side chains in human growth hormone (hGH) that strongly modulate binding to the hGH receptor cloned from human liver.  Single alanine mutations (62 in total) were introduced at every residue contained within the 3 discontinuous segments of hGH (residues 2-19, 54-74, and 167-191) that have been implicated in receptor recognition.  The alanine scan revealed a cluster of a dozen large side chains that when mutated to alanine each showed >4-fold lower binding affinity to the hGH receptor.  Many of these residues that promote binding to the hGH receptor are altered in homologs of hGH (such as placental lactogens and prolactins) that do not bind tightly to the hGH receptor.  The overall folding of these mutant proteins was indistinguishable from that of the wild-type hGH, as detd. by strong cross-reactivities with 7 different conformationally sensitive monoclonal antibodies.  The alanine scan also identified at least one side chain, Glu174, that hindered binding because when it was mutated to alanine the receptor affinity increased by >4-fold.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6zoDe8YESIrVg90H21EOLACvtfcHk0lhfvC5cbUYYGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXltV2it7c%253D&md5=b88aa28886f1716c85f8beb76e7e7100</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1126%2Fscience.2471267&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.2471267%26sid%3Dliteratum%253Aachs%26aulast%3DCunningham%26aufirst%3DB.%2BC.%26aulast%3DWells%26aufirst%3DJ.%2BA.%26atitle%3DHigh-Resolution%2520Epitope%2520Mapping%2520of%2520Hgh-Receptor%2520Interactions%2520by%2520Alanine-Scanning%2520Mutagenesis%26jtitle%3DScience%26date%3D1989%26volume%3D244%26spage%3D1081%26epage%3D1085%26doi%3D10.1126%2Fscience.2471267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">St-Pierre, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lalonde, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gendreau, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quirion, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regoli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rioux, F.</span></span> <span> </span><span class="NLM_article-title">Synthesis of peptides by the solid-phase method. 6. Neurotensin, fragments, and analogs</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1981</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">370</span>– <span class="NLM_lpage">376</span>, <span class="refDoi"> DOI: 10.1021/jm00136a004</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00136a004" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADyaL3MXhtlarsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1981&pages=370-376&author=S.+St-Pierreauthor=J.+M.+Lalondeauthor=M.+Gendreauauthor=R.+Quirionauthor=D.+Regoliauthor=F.+Rioux&title=Synthesis+of+peptides+by+the+solid-phase+method.+6.+Neurotensin%2C+fragments%2C+and+analogs&doi=10.1021%2Fjm00136a004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of peptides by the solid-phase method.  6.  Neurotensin, fragments, and analogs</span></div><div class="casAuthors">St-Pierre, S.; Lalonde, J. M.; Gendreau, M.; Quirion, R.; Regoli, D.; Rioux, F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">370-6</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">Neurotensin acetate  [76398-90-8] and 24 related compds., including fragments or analogs modified at the C-terminal end of the parent mol., have been prepd. by the solid-phase method.  After purifn. by cation-exchange chromatog., the compds. were characterized by thin-layer chromatog., amino acid anal., elemental anal., and high-pressure liq. chromatog.  The stimulating effects of the peptides were evaluated in rat stomach strips, in isolated spontaneously beating atria of guinea pigs, and in the coronaries of perfused rat hearts.  9-13-Neurotensin acetate  [76381-84-5] was the smallest C-terminal fragment possessing full intrinsic activity in all 3 assays.  The 11-tyrosine residue was important for biol. activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKtkueJKmzxLVg90H21EOLACvtfcHk0lhfvC5cbUYYGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXhtlarsL8%253D&md5=a2ab2e0b743c5ad17b713c8a2f83693e</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1021%2Fjm00136a004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00136a004%26sid%3Dliteratum%253Aachs%26aulast%3DSt-Pierre%26aufirst%3DS.%26aulast%3DLalonde%26aufirst%3DJ.%2BM.%26aulast%3DGendreau%26aufirst%3DM.%26aulast%3DQuirion%26aufirst%3DR.%26aulast%3DRegoli%26aufirst%3DD.%26aulast%3DRioux%26aufirst%3DF.%26atitle%3DSynthesis%2520of%2520peptides%2520by%2520the%2520solid-phase%2520method.%25206.%2520Neurotensin%252C%2520fragments%252C%2520and%2520analogs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1981%26volume%3D24%26spage%3D370%26epage%3D376%26doi%3D10.1021%2Fjm00136a004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Henry, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horwell, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meecham, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, D. C.</span></span> <span> </span><span class="NLM_article-title">A Structure-Affinity Study of the Amino Acid Side-Chains in Neurotensin: N and C Terminal Deletions and Ala-Scan</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">949</span>– <span class="NLM_lpage">952</span>, <span class="refDoi"> DOI: 10.1016/S0960-894X(00)80698-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2FS0960-894X%2800%2980698-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADyaK3sXlslCgs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1993&pages=949-952&author=J.+A.+Henryauthor=D.+C.+Horwellauthor=K.+G.+Meechamauthor=D.+C.+Rees&title=A+Structure-Affinity+Study+of+the+Amino+Acid+Side-Chains+in+Neurotensin%3A+N+and+C+Terminal+Deletions+and+Ala-Scan&doi=10.1016%2FS0960-894X%2800%2980698-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">A structure-affinity study of the amino acid side-chains in neurotensin: N and C terminal deletions and Ala-scan</span></div><div class="casAuthors">Henry, Jenny A.; Horwell, David C.; Meecham, Kenneth G.; Rees, David C.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">949-52</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    </div><div class="casAbstract">A systematic N- and C-terminal deletion and Ala-scan (sequential replacement of amino acid moieties in active peptide fragment with Ala) study was used to quantify the involvement of each neurotensin amino acid side-chain for the in vitro binding interaction with the neurotensin receptor.  The hexapeptide neurotensin-(8-13) retained receptor binding affinity similar to that of the intact hormone, indicating that neither the amino acid side-chains on residues 1-7 nor their amide backbone contributed to receptor binding.  Tyr11 and Leu13 were the most important residues, and there appeared to be some synergy between the binding interactions of these two side-chains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCeNxU4Tuos7Vg90H21EOLACvtfcHk0lhfvC5cbUYYGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXlslCgs7w%253D&md5=143e3b4b4ccd74a7db6175e14e42531b</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2800%2980698-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252800%252980698-8%26sid%3Dliteratum%253Aachs%26aulast%3DHenry%26aufirst%3DJ.%2BA.%26aulast%3DHorwell%26aufirst%3DD.%2BC.%26aulast%3DMeecham%26aufirst%3DK.%2BG.%26aulast%3DRees%26aufirst%3DD.%2BC.%26atitle%3DA%2520Structure-Affinity%2520Study%2520of%2520the%2520Amino%2520Acid%2520Side-Chains%2520in%2520Neurotensin%253A%2520N%2520and%2520C%2520Terminal%2520Deletions%2520and%2520Ala-Scan%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1993%26volume%3D3%26spage%3D949%26epage%3D952%26doi%3D10.1016%2FS0960-894X%2800%2980698-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prusoff, W. H.</span></span> <span> </span><span class="NLM_article-title">Relationship between the Inhibition Constant (K1) and the Concentration of Inhibitor Which Causes 50 Per Cent Inhibition (I50) of an Enzymatic Reaction</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1973</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">3099</span>– <span class="NLM_lpage">3108</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(73)90196-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2F0006-2952%2873%2990196-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=4202581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADyaE2cXhtVGgs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1973&pages=3099-3108&author=Y.+Chengauthor=W.+H.+Prusoff&title=Relationship+between+the+Inhibition+Constant+%28K1%29+and+the+Concentration+of+Inhibitor+Which+Causes+50+Per+Cent+Inhibition+%28I50%29+of+an+Enzymatic+Reaction&doi=10.1016%2F0006-2952%2873%2990196-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Relation between the inhibition constant K1) and the concentration of inhibitor which causes fifty per cent inhibition (I50) of an enzymic reaction</span></div><div class="casAuthors">Cheng, Yung-Chi; Prusoff, William H.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1973</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">3099-108</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">The Ki and I50 values are equal where the kinetics are non- or uncompetitive, but not where they are competitive.  The relation between the 2 values was analyzed for non- and uncompetitive bi- and monosubstrate reactions and for competitive bisubstrate reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqodFY_8msz57Vg90H21EOLACvtfcHk0lgWaK_w589d9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2cXhtVGgs7c%253D&md5=fe7175ca300d8f4085df87af37f8656c</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2873%2990196-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252873%252990196-2%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DPrusoff%26aufirst%3DW.%2BH.%26atitle%3DRelationship%2520between%2520the%2520Inhibition%2520Constant%2520%2528K1%2529%2520and%2520the%2520Concentration%2520of%2520Inhibitor%2520Which%2520Causes%252050%2520Per%2520Cent%2520Inhibition%2520%2528I50%2529%2520of%2520an%2520Enzymatic%2520Reaction%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1973%26volume%3D22%26spage%3D3099%26epage%3D3108%26doi%3D10.1016%2F0006-2952%2873%2990196-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">MacArthur, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thornton, J. M.</span></span> <span> </span><span class="NLM_article-title">Influence of Proline Residues on Protein Conformation</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>218</i></span>,  <span class="NLM_fpage">397</span>– <span class="NLM_lpage">412</span>, <span class="refDoi"> DOI: 10.1016/0022-2836(91)90721-H</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2F0022-2836%2891%2990721-H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=2010917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADyaK3MXit1eru7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=218&publication_year=1991&pages=397-412&author=M.+W.+MacArthurauthor=J.+M.+Thornton&title=Influence+of+Proline+Residues+on+Protein+Conformation&doi=10.1016%2F0022-2836%2891%2990721-H"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Influence of proline residues on protein conformation</span></div><div class="casAuthors">MacArthur, Malcolm W.; Thornton, Janet M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">218</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">397-412</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    </div><div class="casAbstract">To study the influence of proline residues on three-dimensional structure, an anal. has been made of all proline residues and their local conformations extd. from the Brookhaven Protein Data bank.  The conformation of the proline itself, the relative occurrence of cis and trans peptides preceding proline residues, the influence of proline on the conformation of the preceding residue and the conformations of various proline patters (Pro-Pro, Pro-X-Pro, etc.) were considered.  The results highlight the unique role of proline in detg. local conformation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9BHG_P_K9ubVg90H21EOLACvtfcHk0lgWaK_w589d9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXit1eru7g%253D&md5=65644520cd10a3ef7e68ebbe6d8a2cf7</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2F0022-2836%2891%2990721-H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0022-2836%252891%252990721-H%26sid%3Dliteratum%253Aachs%26aulast%3DMacArthur%26aufirst%3DM.%2BW.%26aulast%3DThornton%26aufirst%3DJ.%2BM.%26atitle%3DInfluence%2520of%2520Proline%2520Residues%2520on%2520Protein%2520Conformation%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1991%26volume%3D218%26spage%3D397%26epage%3D412%26doi%3D10.1016%2F0022-2836%2891%2990721-H" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uttenthal, L. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bloom, S. R.</span></span> <span> </span><span class="NLM_article-title">In Vitro Degradation of Neurotensin in Human Plasma</span>. <i>Peptides</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">383</span>– <span class="NLM_lpage">387</span>, <span class="refDoi"> DOI: 10.1016/0196-9781(86)90002-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2F0196-9781%2886%2990002-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=3774585" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADyaL28Xls1Grt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1986&pages=383-387&author=Y.+C.+Leeauthor=L.+O.+Uttenthalauthor=H.+A.+Smithauthor=S.+R.+Bloom&title=In+Vitro+Degradation+of+Neurotensin+in+Human+Plasma&doi=10.1016%2F0196-9781%2886%2990002-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro degradation of neurotensin in human plasma</span></div><div class="casAuthors">Lee, Y. C.; Uttenthal, L. O.; Smith, H. A.; Bloom, S. R.</div><div class="citationInfo"><span class="NLM_cas:title">Peptides (New York, NY, United States)</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">383-7</span>CODEN:
                <span class="NLM_cas:coden">PPTDD5</span>;
        ISSN:<span class="NLM_cas:issn">0196-9781</span>.
    </div><div class="casAbstract">Fresh human plasma was incubated with neurotensin  [39379-15-2] in the presence and absence of the peptidase  [9031-96-3] inhibitors pepstatin A, EDTA  [60-00-4], phenylmethylsulfonylfluoride, and aprotinin.  The half-time of disappearance of neurotensin at 37° was 226 min in vitro as opposed to 1.4 min in vivo when measured by RIA with a C-terminally directed neurotensin antiserum.  Both gel filtration and reversed-phase HPLC showed that the main degrdn. product of neurotensin in human plasma in vitro was chromatog. and immunol. identical to neurotensin 1-8  [80887-44-1] and HPLC also demonstrated the formation of neurotensin 1-11  [74032-89-6].  The loss of neurotensin incubated in human plasma in vitro was greatly reduced by EDTA but not by the other peptidase inhibitors tested.  In this respect peptidase(s) responsible for the degrdn. of neurotensin in plasma differ from those present in brain homogenates.  EDTA may be of importance in the preservation of neurotensin in plasma samples.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0PLTSBw-bb7Vg90H21EOLACvtfcHk0lgWaK_w589d9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28Xls1Grt7Y%253D&md5=24cda7de23fcd0b1c755ab9782967696</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1016%2F0196-9781%2886%2990002-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0196-9781%252886%252990002-1%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DY.%2BC.%26aulast%3DUttenthal%26aufirst%3DL.%2BO.%26aulast%3DSmith%26aufirst%3DH.%2BA.%26aulast%3DBloom%26aufirst%3DS.%2BR.%26atitle%3DIn%2520Vitro%2520Degradation%2520of%2520Neurotensin%2520in%2520Human%2520Plasma%26jtitle%3DPeptides%26date%3D1986%26volume%3D7%26spage%3D383%26epage%3D387%26doi%3D10.1016%2F0196-9781%2886%2990002-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stern, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cullen, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barber, V. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richer, R.</span></span> <span> </span><span class="NLM_article-title">Peptidases in the Cerebrospinal Fluid</span>. <i>Can. Med. Assoc. J.</i> <span class="NLM_year" style="font-weight: bold;">1950</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">473</span>– <span class="NLM_lpage">475</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=14778097" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADyaG38XhsFagsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1950&pages=473-475&author=K.+Sternauthor=A.+M.+Cullenauthor=V.+T.+Barberauthor=R.+Richer&title=Peptidases+in+the+Cerebrospinal+Fluid"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Peptidases in the cerebrospinal fluid</span></div><div class="casAuthors">Stern, Karl; Cullen, Andrea M.; Barber, Virginia T.; Richer, Ruth</div><div class="citationInfo"><span class="NLM_cas:title">Canadian Medical Association Journal</span>
        (<span class="NLM_cas:date">1950</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">473-5</span>CODEN:
                <span class="NLM_cas:coden">CMAJAX</span>;
        ISSN:<span class="NLM_cas:issn">0008-4409</span>.
    </div><div class="casAbstract">Cerebrospinal fluid, obtained from 21 patients suffering from various pathol. conditions, generally had considerably less peptidase activity than blood serum.  Those spinal fluids with high peptidase activity also contained numerous leucocytes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpX9dtVNy_wPbVg90H21EOLACvtfcHk0licH2E4tinYOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG38XhsFagsA%253D%253D&md5=48436da2324c08180a6f61bde20b7ab0</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStern%26aufirst%3DK.%26aulast%3DCullen%26aufirst%3DA.%2BM.%26aulast%3DBarber%26aufirst%3DV.%2BT.%26aulast%3DRicher%26aufirst%3DR.%26atitle%3DPeptidases%2520in%2520the%2520Cerebrospinal%2520Fluid%26jtitle%3DCan.%2520Med.%2520Assoc.%2520J.%26date%3D1950%26volume%3D63%26spage%3D473%26epage%3D475" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tyndall, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nall, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlie, D. P.</span></span> <span> </span><span class="NLM_article-title">Proteases Universally Recognize Beta Strands in Their Active Sites</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">973</span>– <span class="NLM_lpage">1000</span>, <span class="refDoi"> DOI: 10.1021/cr040669e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr040669e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlSqtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2005&pages=973-1000&author=J.+D.+Tyndallauthor=T.+Nallauthor=D.+P.+Fairlie&title=Proteases+Universally+Recognize+Beta+Strands+in+Their+Active+Sites&doi=10.1021%2Fcr040669e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Proteases universally recognize beta strands in their active sites</span></div><div class="casAuthors">Tyndall, Joel D. A.; Nall, Tessa; Fairlie, David P.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">973-999</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Proteases account for a significant proportion (∼2%) of the human genome with >550 defined members and a further ∼100 predicted human proteases.  Proteases also represent 1-5% of the genomes of infectious organisms such as bacteria, parasites, and viruses.  They are categorized by the nature of their active site catalytic residue(s) as metallo (34%), serine (30%), cysteine (26%), aspartic (4%), and the less characterized threonine (5%).  Mammalian proteases, of which ∼20% are membrane-bound, are aberrantly expressed or underregulated during many disease conditions, suggesting that inhibitors of specific proteases might be able to control irregular mammalian physiol.  Alternatively, since there are now >50 human proteases where one or more genetic mutations have been found to lead to hereditary diseases, gene therapy may be a useful approach when it eventually becomes technol. feasible.  The goal of protease inhibitor design is to develop potent inhibitors of the offending or mammalian protease but with accompanying selectivity to avoid inhibiting very similar host proteases required for normal host physiol.  This review summarizes an anal. of >1500 3-dimensional crystal (x-ray) and soln. (NMR) structures from the Protein Data Bank of substrates, products, and inhibitors bound in the active sites of all 5 protease classes.  Most of the active sites, with few exceptions, have been found to recognize peptidic and non-peptidic ligands in an extended β-strand conformation.  Such conformational selection of ligands explains the resistance of folded/structured regions of proteins to proteolytic degrdn., the susceptibility of denatured proteins to processing, and the higher affinity of conformationally constrained 'extended' inhibitors/substrates for proteases.  On the basis of the results presented by the authors, one would predict that the use of various approaches to fix an extended β-strand ligand conformation should produce high-affinity inhibitors even for proteases of unknown structure, provided that the substrate specificity and protease type is known.  This inference should be extremely valuable, particularly when the structure of a protease is not known and inhibitor design has to be based solely on substrate preferences.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8uFIrmHewBrVg90H21EOLACvtfcHk0licH2E4tinYOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlSqtLo%253D&md5=67da540a9c260f7c80d9a2f7128dfc15</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1021%2Fcr040669e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr040669e%26sid%3Dliteratum%253Aachs%26aulast%3DTyndall%26aufirst%3DJ.%2BD.%26aulast%3DNall%26aufirst%3DT.%26aulast%3DFairlie%26aufirst%3DD.%2BP.%26atitle%3DProteases%2520Universally%2520Recognize%2520Beta%2520Strands%2520in%2520Their%2520Active%2520Sites%26jtitle%3DChem.%2520Rev.%26date%3D2005%26volume%3D105%26spage%3D973%26epage%3D1000%26doi%3D10.1021%2Fcr040669e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McDermott, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwardson, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffiths, E. C.</span></span> <span> </span><span class="NLM_article-title">Mechanism of Neurotensin Degradation by Rat Brain Peptidases</span>. <i>Regul. Pept.</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">397</span>– <span class="NLM_lpage">404</span>, <span class="refDoi"> DOI: 10.1016/0167-0115(82)90062-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2F0167-0115%2882%2990062-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=7051196" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADyaL38Xlt1Wju70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1982&pages=397-404&author=J.+R.+McDermottauthor=A.+I.+Smithauthor=J.+A.+Edwardsonauthor=E.+C.+Griffiths&title=Mechanism+of+Neurotensin+Degradation+by+Rat+Brain+Peptidases&doi=10.1016%2F0167-0115%2882%2990062-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of neurotensin degradation by rat brain peptidases</span></div><div class="casAuthors">McDermott, J. R.; Smith, A. I.; Edwardson, J. A.; Griffiths, E. C.</div><div class="citationInfo"><span class="NLM_cas:title">Regulatory Peptides</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5-6</span>),
    <span class="NLM_cas:pages">397-404</span>CODEN:
                <span class="NLM_cas:coden">REPPDY</span>;
        ISSN:<span class="NLM_cas:issn">0167-0115</span>.
    </div><div class="casAbstract">neurotensin  [39379-15-2] Is degraded by peptidases present in sol. and particulate (25,000 × g) fractions of rat hypothalamus, thalamus, cortex, and pituitary, the sol. fraction of the hypothalamus having the highest activity.  High performance liq. chromatog. and amino acid anal. were used to identify the degrdn. pathway.  The main product in both fractions was neurotensin  [80887-44-1] and the corresponding C-terminal fragment [9-13]neurotensin  [60482-96-4] was identified.  [1-10]neurotensin  [63524-00-5] Was also identified, proportionately more of this peptide being produced by the particulate rather than the sol. fraction.  In the presence of dithiothreitol, neurotensin  [82882-13-1] and [1-10]neurotensin were major products particularly in the sol. fraction.  Results suggest that the main sites of cleavage of neurotensin by rat brain peptidases are the Arg8-Arg9, Pro10-Tyr11, and Pro7-Arg8 bonds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdUOHHs82TCbVg90H21EOLACvtfcHk0licH2E4tinYOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38Xlt1Wju70%253D&md5=e947215b328ec497f4e849b50bfbf632</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1016%2F0167-0115%2882%2990062-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0167-0115%252882%252990062-3%26sid%3Dliteratum%253Aachs%26aulast%3DMcDermott%26aufirst%3DJ.%2BR.%26aulast%3DSmith%26aufirst%3DA.%2BI.%26aulast%3DEdwardson%26aufirst%3DJ.%2BA.%26aulast%3DGriffiths%26aufirst%3DE.%2BC.%26atitle%3DMechanism%2520of%2520Neurotensin%2520Degradation%2520by%2520Rat%2520Brain%2520Peptidases%26jtitle%3DRegul.%2520Pept.%26date%3D1982%26volume%3D3%26spage%3D397%26epage%3D404%26doi%3D10.1016%2F0167-0115%2882%2990062-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lugrin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vecchini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doulut, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitabgi, P.</span></span> <span> </span><span class="NLM_article-title">Reduced Peptide Bond Pseudopeptide Analogues of Neurotensin: Binding and Biological Activities, and in Vitro Metabolic Stability</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>205</i></span>,  <span class="NLM_fpage">191</span>– <span class="NLM_lpage">198</span>, <span class="refDoi"> DOI: 10.1016/0014-2999(91)90819-C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2F0014-2999%2891%2990819-C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1812009" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADyaK38XpvFCksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=205&publication_year=1991&pages=191-198&author=D.+Lugrinauthor=F.+Vecchiniauthor=S.+Doulutauthor=M.+Rodriguezauthor=J.+Martinezauthor=P.+Kitabgi&title=Reduced+Peptide+Bond+Pseudopeptide+Analogues+of+Neurotensin%3A+Binding+and+Biological+Activities%2C+and+in+Vitro+Metabolic+Stability&doi=10.1016%2F0014-2999%2891%2990819-C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Reduced peptide bond pseudopeptide analogs of neurotensin:  binding and biological activities, and in vitro metabolic stability</span></div><div class="casAuthors">Lugrin, Didier; Vecchini, Francoise; Doulut, Sylvie; Rodriguez, Marc; Martinez, Jean; Kitabgi, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">205</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">191-8</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">A series of pseudopeptide analogs of neurotensin was produced by systematically replacing the 5 peptide bonds in neurotensin-(8-13) with CH2NH (ψ, reduced) bonds.  All these analogs were synthesized with a free amino terminus (H derivs.) and with a N-terminal tert-butyloxycarbonyl group (Boc derivs.).  The compds. were screened in vitro for agonist or antagonist activity and for metabolic stability by testing their ability to inhibit the binding of radiolabeled neurotensin to homogenates of newborn mouse brain; their ability to contract isolated guinea pig ileum prepns.; and their degrdn. in the presence of rat brain homogenates.  All the analogs bound to the mouse brain neurotensin receptor and all exhibited agonist activity in the guinea pig ileum assay.  Only the H- and Boc[ψ8,9] derivs. were at least as potent as their parent compds. neurotensin (8-13) and Boc-neurotensin-(8-13) in the binding and biol. assays.  All the other pseudopeptide analogs with reduced bonds at position 9-10, 10-11, 11-12 and 12-13 showed a marked redn. in potency ranging from 2 to 4 orders of magnitude.  All the derivs. that were protected at their N terminus either by the presence of a Boc group or by the presence of a reduced bond at position 8-9 and 9-10 were slowly degraded by rat brain homogenates.  The other derivs. were, in contrast, quite rapidly degraded.  There was a good correlation between binding and biol. potencies for those analogs that were resistant to degrdn.  Interestingly, the degrdn.-resistant H-[ψ8,9] compd. exhibited higher binding and biol. potency than neurotensin.  It is therefore expected that this analog will produce highly potent and long-lasting neurotensin-like effects in vivo, and preliminary expts. indicate that this is indeed the case.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMrU2Z_xnLOrVg90H21EOLACvtfcHk0lgaIXUFDEYjkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XpvFCksg%253D%253D&md5=de57511a94a2224ce09f8624fdda79ac</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2891%2990819-C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252891%252990819-C%26sid%3Dliteratum%253Aachs%26aulast%3DLugrin%26aufirst%3DD.%26aulast%3DVecchini%26aufirst%3DF.%26aulast%3DDoulut%26aufirst%3DS.%26aulast%3DRodriguez%26aufirst%3DM.%26aulast%3DMartinez%26aufirst%3DJ.%26aulast%3DKitabgi%26aufirst%3DP.%26atitle%3DReduced%2520Peptide%2520Bond%2520Pseudopeptide%2520Analogues%2520of%2520Neurotensin%253A%2520Binding%2520and%2520Biological%2520Activities%252C%2520and%2520in%2520Vitro%2520Metabolic%2520Stability%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1991%26volume%3D205%26spage%3D191%26epage%3D198%26doi%3D10.1016%2F0014-2999%2891%2990819-C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seebach, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lukaszuk, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patora-Komisarska, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Podwysocka, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardiner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebert, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reubi, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cescato, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waser, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rougeot, C.</span></span> <span> </span><span class="NLM_article-title">On the Terminal Homologation of Physiologically Active Peptides as a Means of Increasing Stability in Human Serum--Neurotensin, Opiorphin, B27-Kk10 Epitope, Npy</span>. <i>Chem. Biodivers.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">711</span>– <span class="NLM_lpage">739</span>, <span class="refDoi"> DOI: 10.1002/cbdv.201100093</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1002%2Fcbdv.201100093" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=21560227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A280%3ADC%252BC3MrgtVGmug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2011&pages=711-739&author=D.+Seebachauthor=A.+Lukaszukauthor=K.+Patora-Komisarskaauthor=D.+Podwysockaauthor=J.+Gardinerauthor=M.+O.+Ebertauthor=J.+C.+Reubiauthor=R.+Cescatoauthor=B.+Waserauthor=P.+Gmeinerauthor=H.+H%C3%BCbnerauthor=C.+Rougeot&title=On+the+Terminal+Homologation+of+Physiologically+Active+Peptides+as+a+Means+of+Increasing+Stability+in+Human+Serum%2D%2DNeurotensin%2C+Opiorphin%2C+B27-Kk10+Epitope%2C+Npy&doi=10.1002%2Fcbdv.201100093"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">On the terminal homologation of physiologically active peptides as a means of increasing stability in human serum--neurotensin, opiorphin, B27-KK10 epitope, NPY</span></div><div class="casAuthors">Seebach Dieter; Lukaszuk Aneta; Patora-Komisarska Krystyna; Podwysocka Dominika; Gardiner James; Ebert Marc-Olivier; Reubi Jean Claude; Cescato Renzo; Waser Beatrice; Gmeiner Peter; Hubner Harald; Rougeot Catherine</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & biodiversity</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">711-39</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The terminal homologation by CH(2) insertion into the peptides mentioned in the title is described.  This involves replacement of the N-terminal amino acid residue by a β(2) - and of the C-terminal amino acid residue by a β(3) -homo-amino acid moiety (β(2) hXaa and β(3) hXaa, resp.; Fig. 1).  In this way, the structure of the peptide chain from the N-terminal to the C-terminal stereogenic center is identical, and the modified peptide is protected against cleavage by exopeptidases (Figs. 2 and 3).  Neurotensin (NT; 1) and its C-terminal fragment NT(8-13) are ligands of the G-protein-coupled receptors (GPCR) NT1, NT2, NT3, and NT analogs are promising tools to be used in cancer diagnostics and therapy.  The affinities of homologated NT analogs, 2b-2e, for NT1 and NT2 receptors were determined by using cell homogenates and tumor tissues (Table 1); in the latter experiments, the affinities for the NT1 receptor are more or less the same as those of NT (0.5-1.3 vs. 0.6 nM).  At the same time, one of the homologated NT analogs, 2c, survives in human plasma for 7 days at 37° (Fig. 6).  An NMR analysis of NT(8-13) (Tables 2 and 4, and Fig. 8) reveals that this N-terminal NT fragment folds to a turn in CD(3) OH. - In the case of the human analgesic opiorphin (3a), a pentapeptide, and of the HIV-derived B27-KK10 (4a), a decapeptide, terminal homologation (→3b and 4b, resp.) led to a 7- and 70-fold half-life increase in plasma (Fig. 9).  With N-terminally homologated NPY, 5c, we were not able to determine serum stability; the peptide consisting of 36 amino acid residues is subject to cleavage by endopetidases.  Three of the homologated compounds, 2b, 2c, and 5c, were shown to be agonists (Fig. 7 and 11).  A comparison of terminal homologation with other stability-increasing terminal modifications of peptides is performed (Fig. 5), and possible applications of the neurotensin analogs, described herein, are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTXSIxo7OLTmbjnyZkbE8yXfW6udTcc2eZCZU5X4kk8oLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MrgtVGmug%253D%253D&md5=9280069bdab6a3f7a034f917241e0c81</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1002%2Fcbdv.201100093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbdv.201100093%26sid%3Dliteratum%253Aachs%26aulast%3DSeebach%26aufirst%3DD.%26aulast%3DLukaszuk%26aufirst%3DA.%26aulast%3DPatora-Komisarska%26aufirst%3DK.%26aulast%3DPodwysocka%26aufirst%3DD.%26aulast%3DGardiner%26aufirst%3DJ.%26aulast%3DEbert%26aufirst%3DM.%2BO.%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26aulast%3DCescato%26aufirst%3DR.%26aulast%3DWaser%26aufirst%3DB.%26aulast%3DGmeiner%26aufirst%3DP.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DRougeot%26aufirst%3DC.%26atitle%3DOn%2520the%2520Terminal%2520Homologation%2520of%2520Physiologically%2520Active%2520Peptides%2520as%2520a%2520Means%2520of%2520Increasing%2520Stability%2520in%2520Human%2520Serum--Neurotensin%252C%2520Opiorphin%252C%2520B27-Kk10%2520Epitope%252C%2520Npy%26jtitle%3DChem.%2520Biodivers.%26date%3D2011%26volume%3D8%26spage%3D711%26epage%3D739%26doi%3D10.1002%2Fcbdv.201100093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Einsiedel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hervet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Härterich, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koschatzky, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span> <span> </span><span class="NLM_article-title">Peptide Backbone Modifications on the C-Terminal Hexapeptide of Neurotensin</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">2013</span>– <span class="NLM_lpage">2018</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2008.01.110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2Fj.bmcl.2008.01.110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=18276136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjtlymtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=2013-2018&author=J.+Einsiedelauthor=H.+H%C3%BCbnerauthor=M.+Hervetauthor=S.+H%C3%A4rterichauthor=S.+Koschatzkyauthor=P.+Gmeiner&title=Peptide+Backbone+Modifications+on+the+C-Terminal+Hexapeptide+of+Neurotensin&doi=10.1016%2Fj.bmcl.2008.01.110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Peptide backbone modifications on the C-terminal hexapeptide of neurotensin</span></div><div class="casAuthors">Einsiedel, Juergen; Huebner, Harald; Hervet, Maud; Haerterich, Steffen; Koschatzky, Susanne; Gmeiner, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2013-2018</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">To compare backbone-induced susceptibilities with affinity changes that are caused by side-chain modifications in the resp. positions, structure activity relationship studies on a series of NT(8-13) analogs were performed providing valuable insights into the major requirement for neurotensin receptor recognition and activation.  The data led the authors to highly potent NTR1 ligands and the generation of a pharmacophore model that will be helpful for the discovery of therapeutically relevant non-peptidic NTR1 agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDAmdNBALiOrVg90H21EOLACvtfcHk0lgaIXUFDEYjkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjtlymtr8%253D&md5=279fe25841915ac7da128234fb412083</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.01.110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.01.110%26sid%3Dliteratum%253Aachs%26aulast%3DEinsiedel%26aufirst%3DJ.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DHervet%26aufirst%3DM.%26aulast%3DH%25C3%25A4rterich%26aufirst%3DS.%26aulast%3DKoschatzky%26aufirst%3DS.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DPeptide%2520Backbone%2520Modifications%2520on%2520the%2520C-Terminal%2520Hexapeptide%2520of%2520Neurotensin%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D2013%26epage%3D2018%26doi%3D10.1016%2Fj.bmcl.2008.01.110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Checler, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emson, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitabgi, P.</span></span> <span> </span><span class="NLM_article-title">Inactivation of Neurotensin by Rat Brain Synaptic Membranes. Cleavage at the Pro10-Tyr11 Bond by Endopeptidase 24.11 (Enkephalinase) and a Peptidase Different from Proline-Endopeptidase</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">1295</span>– <span class="NLM_lpage">1301</span>, <span class="refDoi"> DOI: 10.1111/j.1471-4159.1984.tb05386.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1111%2Fj.1471-4159.1984.tb05386.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=6387047" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADyaL2MXhtVyk" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1984&pages=1295-1301&author=F.+Checlerauthor=P.+C.+Emsonauthor=J.+P.+Vincentauthor=P.+Kitabgi&title=Inactivation+of+Neurotensin+by+Rat+Brain+Synaptic+Membranes.+Cleavage+at+the+Pro10-Tyr11+Bond+by+Endopeptidase+24.11+%28Enkephalinase%29+and+a+Peptidase+Different+from+Proline-Endopeptidase&doi=10.1111%2Fj.1471-4159.1984.tb05386.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Inactivation of neurotensin by rat brain synaptic membranes.  Cleavage at the Pro10-Tyr11 bond by endopeptidase 24.11 (enkephalinase) and a peptidase different from proline-endopeptidase</span></div><div class="casAuthors">Checler, Frederic; Emson, P. C.; Vincent, J. P.; Kitabgi, P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1295-301</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    </div><div class="casAbstract">It was shown previously that the tridecapeptide neurotensin (NT)  [55508-42-4] is inactivated by rat brain synaptic membranes, with one of the primary inactivating cleavages occurring at the Pro10-Tyr11 peptide bond and leading to the formation of NT1-10  [63524-00-5] and NT11-13  [60482-98-6].  A study was designed to investigate the possibility that this cleavage was catalyzed by proline endopeptidase  [72162-84-6] and(or) endopeptidase 24.11 (enkephalinase)  [82707-54-8].  The cleavage of neurotensin at the Pro10-Tyr11 bond by synaptic membranes was not affected by an inhibitor of proline endopeptidase or an antiserum to this enzyme, and thiorphan (a potent endopeptidase 24.11 inhibitor only partially decreased the formation of NT1-10 and NT11-13 by synaptic membranes.  Thus, proline endopeptidase (although it is present in synaptic membranes) is not involved in the cleavage of neurotensin at the Pro10-Tyr11 bond, and endopeptidase 24.11 only partially contributes to this cleavage.  Apparently, there exists in rat brain synaptic membranes a peptidase  [9031-96-3] different from proline endopeptidase and endopeptidase 24.11 that is mainly responsible for inactivating neurotensin by cleaving at the Pro10-Tyr11 bond.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9F4TCRFk_2rVg90H21EOLACvtfcHk0lg2XrO9Bcxbeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXhtVyk&md5=785137dffca396859ffd6cd5dd3c64ea</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.1984.tb05386.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.1984.tb05386.x%26sid%3Dliteratum%253Aachs%26aulast%3DChecler%26aufirst%3DF.%26aulast%3DEmson%26aufirst%3DP.%2BC.%26aulast%3DVincent%26aufirst%3DJ.%2BP.%26aulast%3DKitabgi%26aufirst%3DP.%26atitle%3DInactivation%2520of%2520Neurotensin%2520by%2520Rat%2520Brain%2520Synaptic%2520Membranes.%2520Cleavage%2520at%2520the%2520Pro10-Tyr11%2520Bond%2520by%2520Endopeptidase%252024.11%2520%2528Enkephalinase%2529%2520and%2520a%2520Peptidase%2520Different%2520from%2520Proline-Endopeptidase%26jtitle%3DJ.%2520Neurochem.%26date%3D1984%26volume%3D43%26spage%3D1295%26epage%3D1301%26doi%3D10.1111%2Fj.1471-4159.1984.tb05386.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Checler, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitabgi, P.</span></span> <span> </span><span class="NLM_article-title">Inactivation of Neurotensin by Rat Brain Synaptic Membranes Partly Occurs through Cleavage at the Arg8-Arg9 Peptide Bond by a Metalloendopeptidase</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">1509</span>– <span class="NLM_lpage">1513</span>, <span class="refDoi"> DOI: 10.1111/j.1471-4159.1985.tb07220.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1111%2Fj.1471-4159.1985.tb07220.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=3900293" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADyaL2MXmtVOgt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1985&pages=1509-1513&author=F.+Checlerauthor=J.+P.+Vincentauthor=P.+Kitabgi&title=Inactivation+of+Neurotensin+by+Rat+Brain+Synaptic+Membranes+Partly+Occurs+through+Cleavage+at+the+Arg8-Arg9+Peptide+Bond+by+a+Metalloendopeptidase&doi=10.1111%2Fj.1471-4159.1985.tb07220.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Inactivation of neurotensin by rat brain synaptic membranes partly occurs through cleavage at the Arg8-Arg9 peptide bond by a metalloendopeptidase</span></div><div class="casAuthors">Checler, Frederic; Vincent, J. P.; Kitabgi, P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1509-13</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    </div><div class="casAbstract">One of the primary inactivating cleavages of neurotensin (NT)  [39379-15-2] by rat brain synaptic membranes occurs at the Arg8-Arg9 peptide bond, leading to the formation of NT1-8 and NT9-13.  The involvement at this site of a metalloendopeptidase  [149371-24-4] was demonstrated by the use of its specific inhibitor, N-[1(R,S)-carboxy-2-phenylethyl]-alanylalanylphenylalanine-p-aminobenzoate  [90991-75-6], which exerts an inhibition on NT1-8 formation with a concn. for half maximal inhibition of 0.6 μM, close to its Ki for the purified metalloendopeptidase (1.94 μM).  Furthermore, the role of a postproline dipeptidyl-aminopeptidase  [54249-88-6] in the secondary processing of NT9-13 formation was established.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovxsOWtXge67Vg90H21EOLACvtfcHk0lg2XrO9Bcxbeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXmtVOgt7Y%253D&md5=b1b7fca2bd7117b2de9ee02ce44fe002</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.1985.tb07220.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.1985.tb07220.x%26sid%3Dliteratum%253Aachs%26aulast%3DChecler%26aufirst%3DF.%26aulast%3DVincent%26aufirst%3DJ.%2BP.%26aulast%3DKitabgi%26aufirst%3DP.%26atitle%3DInactivation%2520of%2520Neurotensin%2520by%2520Rat%2520Brain%2520Synaptic%2520Membranes%2520Partly%2520Occurs%2520through%2520Cleavage%2520at%2520the%2520Arg8-Arg9%2520Peptide%2520Bond%2520by%2520a%2520Metalloendopeptidase%26jtitle%3DJ.%2520Neurochem.%26date%3D1985%26volume%3D45%26spage%3D1509%26epage%3D1513%26doi%3D10.1111%2Fj.1471-4159.1985.tb07220.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Checler, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitabgi, P.</span></span> <span> </span><span class="NLM_article-title">Purification and Characterization of a Novel Neurotensin-Degrading Peptidase from Rat Brain Synaptic Membranes</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>261</i></span>,  <span class="NLM_fpage">11274</span>– <span class="NLM_lpage">11281</span>, <span class="refDoi"> DOI: 10.1016/S0021-9258(18)67379-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2FS0021-9258%2818%2967379-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=3525564" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADyaL28XlvVKgu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=261&publication_year=1986&pages=11274-11281&author=F.+Checlerauthor=J.+P.+Vincentauthor=P.+Kitabgi&title=Purification+and+Characterization+of+a+Novel+Neurotensin-Degrading+Peptidase+from+Rat+Brain+Synaptic+Membranes&doi=10.1016%2FS0021-9258%2818%2967379-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Purification and characterization of a novel neurotensin-degrading peptidase from rat brain synaptic membranes</span></div><div class="casAuthors">Checler, Frederic; Vincent, Jean Pierre; Kitabgi, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">261</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">11274-81</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">A peptidase that cleaved neurotensin at the Pro10-Tyr11 peptide bond, leading to the formation of neurotensin-(1-10) and neurotensin-(11-13), was purified nearly to homogeneity from rat brain synaptic membranes.  The enzyme appeared to be monomeric with a mol. wt. of ∼70,000-75,000 as detd. by SDS-PAGE and HPLC.  Isoelectrofocusing indicated a pI of 5.9-6.  The purified peptidase could be classified as a neutral metallopeptidase with respect to its sensitivity to pH and metal chelators.  SH group-blocking agents and acidic and serine protease inhibitors had no effect.  Studies with specific peptidase inhibitors clearly indicated that the purified enzyme was distinct from enzymes capable of cleaving neurotensin at the Pro10-Tyr11 bond, such as proline endopeptidase and endopeptidase 24-11.  The enzyme was also distinct from other neurotensin-degrading peptidases, such as angiotensin-converting enzyme and a recently purified rat brain sol. metalloendopeptidase.  The peptidase displayed a high affinity for neurotensin (Km = 2.6 μM).  Studies on its specificity revealed that neurotensin-(9-13) was the shortest neurotensin partial sequence that was able to fully inhibit [3H]neurotensin degrdn.  Shortening the C-terminal end of the neurotensin mol. as well as substitutions in positions 8, 9, and 11 by D-amino acids strongly decreased the inhibitory potency of neurotensin.  Among 20 natural peptides, only angiotensin I and the neurotensin-related peptides xenopsin and neuromedin N were found as potent as unlabeled neurotensin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKlR1_uEkky7Vg90H21EOLACvtfcHk0li3CuaKWVT2Ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XlvVKgu74%253D&md5=209457f889b7d8f9c90270160b136be3</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1016%2FS0021-9258%2818%2967379-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0021-9258%252818%252967379-X%26sid%3Dliteratum%253Aachs%26aulast%3DChecler%26aufirst%3DF.%26aulast%3DVincent%26aufirst%3DJ.%2BP.%26aulast%3DKitabgi%26aufirst%3DP.%26atitle%3DPurification%2520and%2520Characterization%2520of%2520a%2520Novel%2520Neurotensin-Degrading%2520Peptidase%2520from%2520Rat%2520Brain%2520Synaptic%2520Membranes%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1986%26volume%3D261%26spage%3D11274%26epage%3D11281%26doi%3D10.1016%2FS0021-9258%2818%2967379-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sarret, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esdaile, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perron, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stroh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaudet, A.</span></span> <span> </span><span class="NLM_article-title">Potent Spinal Analgesia Elicited through Stimulation of Nts2 Neurotensin Receptors</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">8188</span>– <span class="NLM_lpage">8196</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.0810-05.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1523%2FJNEUROSCI.0810-05.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=16148226" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVaktL%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=8188-8196&author=P.+Sarretauthor=M.+J.+Esdaileauthor=A.+Perronauthor=J.+Martinezauthor=T.+Strohauthor=A.+Beaudet&title=Potent+Spinal+Analgesia+Elicited+through+Stimulation+of+Nts2+Neurotensin+Receptors&doi=10.1523%2FJNEUROSCI.0810-05.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Potent spinal analgesia elicited through stimulation of NTS2 neurotensin receptors</span></div><div class="casAuthors">Sarret, Philippe; Esdaile, Michael J.; Perron, Amelie; Martinez, Jean; Stroh, Thomas; Beaudet, Alain</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">8188-8196</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Intrathecal administration of the neuropeptide neurotensin (NT) was shown previously to exert antinociceptive effects in a variety of acute spinal pain paradigms including hot-plate, tail-flick, and writhing tests.  In the present study, we sought to det. whether some of these antinociceptive effects might be elicited via stimulation of low-affinity NTS2 receptors.  We first established, using immunoblotting and immunohistochem. techniques, that NTS2 receptors were extensively assocd. with putative spinal nociceptive pathways, both at the level of the dorsal root ganglia and of the superficial layers of the dorsal horn of the spinal cord.  We then examd. the effects of intrathecal administration of NT or selective NTS2 agonists on acute thermal pain.  Both NT and NTS2 agonists, levocabastine and JMV-431, induced dose-dependent antinociceptive responses in the tail-flick test.  The effects of levocabastine and of JMV-431 were unaffected by coadministration of the NTS1-specific antagonist SR 48692, confirming that they were NTS2 mediated.  In contrast, the antinociceptive effects of NT were partly abolished by coadministration of SR 48692, indicating that NTS1 and NTS2 receptors were both involved.  These results suggest that NTS2 receptors play a role in the regulation of spinal nociceptive inputs and that selective NTS2 agonists may offer new avenues for the treatment of acute pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFtoMm6lyDKrVg90H21EOLACvtfcHk0li3CuaKWVT2Ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVaktL%252FK&md5=1cf6d25f21e5c86e87b14a40f219a9fd</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.0810-05.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.0810-05.2005%26sid%3Dliteratum%253Aachs%26aulast%3DSarret%26aufirst%3DP.%26aulast%3DEsdaile%26aufirst%3DM.%2BJ.%26aulast%3DPerron%26aufirst%3DA.%26aulast%3DMartinez%26aufirst%3DJ.%26aulast%3DStroh%26aufirst%3DT.%26aulast%3DBeaudet%26aufirst%3DA.%26atitle%3DPotent%2520Spinal%2520Analgesia%2520Elicited%2520through%2520Stimulation%2520of%2520Nts2%2520Neurotensin%2520Receptors%26jtitle%3DJ.%2520Neurosci.%26date%3D2005%26volume%3D25%26spage%3D8188%26epage%3D8196%26doi%3D10.1523%2FJNEUROSCI.0810-05.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vivancos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giddings, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiethe, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warner, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murza, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besserer-Offroy, É.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Longpré, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Runyon, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decker, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilmour, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarret, P.</span></span> <span> </span><span class="NLM_article-title">Identification of 2-({[1-(4-Fluorophenyl)-5-(2-Methoxyphenyl)-1h-Pyrazol-3-Yl]Carbonyl}Amino)Tricyc Lo[3.3.1.13,7]Decane-2-Carboxylic Acid (Ntrc-844) as a Selective Antagonist for the Rat Neurotensin Receptor Type 2</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1225</span>– <span class="NLM_lpage">1231</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.6b00097</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.6b00097" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVyitrfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=1225-1231&author=J.+B.+Thomasauthor=M.+Vivancosauthor=A.+M.+Giddingsauthor=R.+W.+Wietheauthor=K.+R.+Warnerauthor=A.+Murzaauthor=%C3%89.+Besserer-Offroyauthor=J.-M.+Longpr%C3%A9author=S.+P.+Runyonauthor=A.+M.+Deckerauthor=B.+P.+Gilmourauthor=P.+Sarret&title=Identification+of+2-%28%7B%5B1-%284-Fluorophenyl%29-5-%282-Methoxyphenyl%29-1h-Pyrazol-3-Yl%5DCarbonyl%7DAmino%29Tricyc+Lo%5B3.3.1.13%2C7%5DDecane-2-Carboxylic+Acid+%28Ntrc-844%29+as+a+Selective+Antagonist+for+the+Rat+Neurotensin+Receptor+Type+2&doi=10.1021%2Facschemneuro.6b00097"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of 2-({[1-(4-Fluorophenyl)-5-(2-methoxyphenyl)-1H-pyrazol-3-yl]carbonyl}amino)tricyclo[3.3.1.13,7]decane-2-carboxylic Acid (NTRC-844) as a Selective Antagonist for the Rat Neurotensin Receptor Type 2</span></div><div class="casAuthors">Thomas, James B.; Vivancos, Melanie; Giddings, Angela M.; Wiethe, Robert W.; Warner, Keith R.; Murza, Alexandre; Besserer-Offroy, Elie; Longpre, Jean-Michel; Runyon, Scott P.; Decker, Ann M.; Gilmour, Brian P.; Sarret, Philippe</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1225-1231</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Neurotensin receptor type 2 (NTS2) compds. display analgesic activity in animal pain models.  We have identified the first high-affinity NTS2-selective antagonist (8) that is active in vivo.  This study also revealed that the NTS2 FLIPR assay designation for a compd., agonist, partial agonist, and so forth, did not correlate with its in vivo activity as obsd. in the thermal tail-flick acute model of pain.  This suggests that calcium mobilization is not the signaling pathway involved in NTS2-mediated analgesia as assessed by the thermal tail-flick model.  Finally, we found a significant bias between rat and human for compd. 9 in the NTS2 binding assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmiVSjAuzSlbVg90H21EOLACvtfcHk0li3CuaKWVT2Ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVyitrfP&md5=f2e3c54fc60f9a905588d16ba7381323</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.6b00097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.6b00097%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DJ.%2BB.%26aulast%3DVivancos%26aufirst%3DM.%26aulast%3DGiddings%26aufirst%3DA.%2BM.%26aulast%3DWiethe%26aufirst%3DR.%2BW.%26aulast%3DWarner%26aufirst%3DK.%2BR.%26aulast%3DMurza%26aufirst%3DA.%26aulast%3DBesserer-Offroy%26aufirst%3D%25C3%2589.%26aulast%3DLongpr%25C3%25A9%26aufirst%3DJ.-M.%26aulast%3DRunyon%26aufirst%3DS.%2BP.%26aulast%3DDecker%26aufirst%3DA.%2BM.%26aulast%3DGilmour%26aufirst%3DB.%2BP.%26aulast%3DSarret%26aufirst%3DP.%26atitle%3DIdentification%2520of%25202-%2528%257B%255B1-%25284-Fluorophenyl%2529-5-%25282-Methoxyphenyl%2529-1h-Pyrazol-3-Yl%255DCarbonyl%257DAmino%2529Tricyc%2520Lo%255B3.3.1.13%252C7%255DDecane-2-Carboxylic%2520Acid%2520%2528Ntrc-844%2529%2520as%2520a%2520Selective%2520Antagonist%2520for%2520the%2520Rat%2520Neurotensin%2520Receptor%2520Type%25202%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2016%26volume%3D7%26spage%3D1225%26epage%3D1231%26doi%3D10.1021%2Facschemneuro.6b00097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coquerel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubuc, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitaegi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costentin, J.</span></span> <span> </span><span class="NLM_article-title">Potentiation by Thiorphan and Bestatin of the Naloxone-Insensitive Analgesic Effects of Neurotensin and Neuromedin N</span>. <i>Neurochem. Int.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">361</span>– <span class="NLM_lpage">366</span>, <span class="refDoi"> DOI: 10.1016/0197-0186(88)90175-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2F0197-0186%2888%2990175-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=20501239" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADyaL1cXktFOgsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1988&pages=361-366&author=A.+Coquerelauthor=I.+Dubucauthor=P.+Kitaegiauthor=J.+Costentin&title=Potentiation+by+Thiorphan+and+Bestatin+of+the+Naloxone-Insensitive+Analgesic+Effects+of+Neurotensin+and+Neuromedin+N&doi=10.1016%2F0197-0186%2888%2990175-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Potentiation by thiorphan and bestatin of the naloxone-insensitive analgesic effects of neurotensin and neuromedin N</span></div><div class="casAuthors">Coquerel, A.; Dubuc, I.; Kitabgi, P.; Costentin, J.</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemistry International</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">361-6</span>CODEN:
                <span class="NLM_cas:coden">NEUIDS</span>;
        ISSN:<span class="NLM_cas:issn">0197-0186</span>.
    </div><div class="casAbstract">Neurotensin induced antinociceptive activity as measured in a variety of nociceptive tests 10 and 30 min following intracerebroventricular (i.c.v.) injection in mice.  The lowest effective peptide doses were 25 ng in the writhing test, 25-50 ng in the tail-flick test, 50-100 ng in the hot-plate test, and 2000 ng in the tail elec. stimulation test.  The neurotensin-related hexapeptide neuromedin N also displayed antinociceptive properties but only in the writhing and tail-flick tests.  Furthermore, as compared to neurotensin, the neuromedin effects required higher doses.  The 50% EDs for neurotensin and neuromedin in the writhing test were 70 and 1070 ng, resp.  Sep. or combined injections of the endopeptidase 24.11 (enkephalinase) inhibitor thiorphan (10 μg) and the aminopeptidase inhibitor bestatin (50 μg) did not affect tail-flick latencies.  In contrast i.c.v. injection or thiorphan together with an ineffective dose of neurotensin (25 ng) resulted in an antinociceptive effect.  Bestatin did not modify tail-flick latencies in neurotensin-treated mice whether in the absence or presence of thiorphan.  On the contrary, each of these peptidase inhibitors promoted antinociceptive effects of subthreshold doses of neuromedin (1 μg) in the tail-flick test.  Maximal antinociception was obtained by combining both inhibitors, thus conferring antinociceptive effects to neuromedin doses that were as low as 10 ng.  Naloxone (0.5-2 mg/kg, s.c.) did not reduced the antinociceptive effects of combinations of neurotensin and thiorphan and of neuromedin, thiorphan, and bestatin.  Both neurotensin and neuromedin elicit analgesia in mice through an opiate-independent mechanism.  Furthermore, like enkephalin, neuromedin is readily degraded by brain endopeptidase 24.11 and bestatin sensitive aminopeptidase(s), whereas the resistance of neurotensin to aminopeptidase attack confers to this peptide a broader spectrum and longer duration of action than its congener neuromedin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvycSr-IkCzbVg90H21EOLACvtfcHk0ljASuB3C_-iGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXktFOgsLg%253D&md5=b902afe03f7e7c6c75e9a485f9c67149</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1016%2F0197-0186%2888%2990175-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0197-0186%252888%252990175-1%26sid%3Dliteratum%253Aachs%26aulast%3DCoquerel%26aufirst%3DA.%26aulast%3DDubuc%26aufirst%3DI.%26aulast%3DKitaegi%26aufirst%3DP.%26aulast%3DCostentin%26aufirst%3DJ.%26atitle%3DPotentiation%2520by%2520Thiorphan%2520and%2520Bestatin%2520of%2520the%2520Naloxone-Insensitive%2520Analgesic%2520Effects%2520of%2520Neurotensin%2520and%2520Neuromedin%2520N%26jtitle%3DNeurochem.%2520Int.%26date%3D1988%26volume%3D12%26spage%3D361%26epage%3D366%26doi%3D10.1016%2F0197-0186%2888%2990175-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tjølsen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berge, O. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunskaar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosland, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hole, K.</span></span> <span> </span><span class="NLM_article-title">The Formalin Test: An Evaluation of the Method</span>. <i>Pain</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">5</span>– <span class="NLM_lpage">17</span>, <span class="refDoi"> DOI: 10.1016/0304-3959(92)90003-T</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2F0304-3959%2892%2990003-T" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1454405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A280%3ADyaK3s%252FoslSnsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1992&pages=5-17&author=A.+Tj%C3%B8lsenauthor=O.+G.+Bergeauthor=S.+Hunskaarauthor=J.+H.+Roslandauthor=K.+Hole&title=The+Formalin+Test%3A+An+Evaluation+of+the+Method&doi=10.1016%2F0304-3959%2892%2990003-T"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">The formalin test: an evaluation of the method</span></div><div class="casAuthors">Tjolsen Arne; Berge Odd-Geir; Hunskaar Steinar; Rosland Jan Henrik; Hole Kjell</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5-17</span>
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    </div><div class="casAbstract">The formalin test for nociception, which is predominantly used with rats and mice, involves moderate, continuous pain generated by injured tissue.  In this way it differs from most traditional tests of nociception which rely upon brief stimuli of threshold intensity.  In this article we describe the main features of the formalin test, including the characteristics of the stimulus and how changes in nociceptive behaviour may be measured and interpreted.  The response to formalin shows an early and a late phase.  The early phase seems to be caused predominantly by C-fibre activation due to the peripheral stimulus, while the late phase appears to be dependent on the combination of an inflammatory reaction in the peripheral tissue and functional changes in the dorsal horn of the spinal cord.  These functional changes seem to be initiated by the C-fibre barrage during the early phase.  In mice, the behavioural response in the late phase depends on the ambient temperature.  We argue that the peripheral tissue temperature as well as other factors influencing the peripheral inflammation may affect the response, possibly confounding the results obtained with the test.  Furthermore, we discuss the methods of recording the response and the value of observing more than one aspect of behaviour.  Scoring of several behavioural variables provides a means of assessing motor or sensorimotor function as possible causes for changes in behaviour.  In conclusion, the formalin test is a valuable addition to the battery of methods available to study nociception.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSEPstJUQcfvkEksK8CslK8fW6udTcc2eZnMj2y8JBJtrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3s%252FoslSnsA%253D%253D&md5=d56dc5eb88d109dd30d319dcf580c781</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1016%2F0304-3959%2892%2990003-T&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0304-3959%252892%252990003-T%26sid%3Dliteratum%253Aachs%26aulast%3DTj%25C3%25B8lsen%26aufirst%3DA.%26aulast%3DBerge%26aufirst%3DO.%2BG.%26aulast%3DHunskaar%26aufirst%3DS.%26aulast%3DRosland%26aufirst%3DJ.%2BH.%26aulast%3DHole%26aufirst%3DK.%26atitle%3DThe%2520Formalin%2520Test%253A%2520An%2520Evaluation%2520of%2520the%2520Method%26jtitle%3DPain%26date%3D1992%26volume%3D51%26spage%3D5%26epage%3D17%26doi%3D10.1016%2F0304-3959%2892%2990003-T" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roussy, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dansereau, M.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baudisson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ezzoubaa, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belleville, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaudet, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richelson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarret, P.</span></span> <span> </span><span class="NLM_article-title">Evidence for a Role of Nts2 Receptors in the Modulation of Tonic Pain Sensitivity</span>. <i>Mol. Pain</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1744-8069-5-38</span>, <span class="refDoi"> DOI: 10.1186/1744-8069-5-38</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1186%2F1744-8069-5-38" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=1744-8069-5-38&author=G.+Roussyauthor=M.-A.+Dansereauauthor=S.+Baudissonauthor=F.+Ezzoubaaauthor=K.+Bellevilleauthor=N.+Beaudetauthor=J.+Martinezauthor=E.+Richelsonauthor=P.+Sarret&title=Evidence+for+a+Role+of+Nts2+Receptors+in+the+Modulation+of+Tonic+Pain+Sensitivity&doi=10.1186%2F1744-8069-5-38"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1186%2F1744-8069-5-38&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1744-8069-5-38%26sid%3Dliteratum%253Aachs%26aulast%3DRoussy%26aufirst%3DG.%26aulast%3DDansereau%26aufirst%3DM.-A.%26aulast%3DBaudisson%26aufirst%3DS.%26aulast%3DEzzoubaa%26aufirst%3DF.%26aulast%3DBelleville%26aufirst%3DK.%26aulast%3DBeaudet%26aufirst%3DN.%26aulast%3DMartinez%26aufirst%3DJ.%26aulast%3DRichelson%26aufirst%3DE.%26aulast%3DSarret%26aufirst%3DP.%26atitle%3DEvidence%2520for%2520a%2520Role%2520of%2520Nts2%2520Receptors%2520in%2520the%2520Modulation%2520of%2520Tonic%2520Pain%2520Sensitivity%26jtitle%3DMol.%2520Pain%26date%3D2009%26volume%3D5%26spage%3D1744-8069-5-38%26doi%3D10.1186%2F1744-8069-5-38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brouillette, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besserer-Offroy, É.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mona, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chartier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavenus, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sousbie, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belleville, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Longpré, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsault, É.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grandbois, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarret, P.</span></span> <span> </span><span class="NLM_article-title">Cell-Penetrating Pepducins Targeting the Neurotensin Receptor Type 1 Relieve Pain</span>. <i>Pharmacol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>155</i></span>,  <span class="NLM_fpage">104750</span>, <span class="refDoi"> DOI: 10.1016/j.phrs.2020.104750</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2Fj.phrs.2020.104750" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=32151680" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BB3cXlsFaqtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=155&publication_year=2020&pages=104750&author=R.+L.+Brouilletteauthor=%C3%89.+Besserer-Offroyauthor=C.+E.+Monaauthor=M.+Chartierauthor=S.+Lavenusauthor=M.+Sousbieauthor=K.+Bellevilleauthor=J.+M.+Longpr%C3%A9author=%C3%89.+Marsaultauthor=M.+Grandboisauthor=P.+Sarret&title=Cell-Penetrating+Pepducins+Targeting+the+Neurotensin+Receptor+Type+1+Relieve+Pain&doi=10.1016%2Fj.phrs.2020.104750"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Cell-penetrating pepducins targeting the neurotensin receptor type 1 relieve pain</span></div><div class="casAuthors">Brouillette, Rebecca L.; Besserer-Offroy, Elie; Mona, Christine E.; Chartier, Magali; Lavenus, Sandrine; Sousbie, Marc; Belleville, Karine; Longpre, Jean-Michel; Marsault, Eric; Grandbois, Michel; Sarret, Philippe</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">155</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">104750</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Pepducins are cell-penetrating, membrane-tethered lipopeptides designed to target the intracellular region of a G protein-coupled receptor (GPCR) in order to allosterically modulate the receptor's signaling output.  In this proof-of-concept study, we explored the pain-relief potential of a pepducin series derived from the first intracellular loop of neurotensin receptor type 1 (NTS1), a class A GPCR that mediates many of the effects of the neurotensin (NT) tridecapeptide, including hypothermia, hypotension and analgesia.  We used BRET-based biosensors to det. the pepducins' ability to engage G protein signaling pathways assocd. with NTS1 activation.  We obsd. partial Gαq and Gα13 activation at a 10 μM concn., indicating that these pepducins may act as allosteric agonists of NTS1.  Addnl., we used surface plasmon resonance (SPR) as a label-free assay to monitor pepducin-induced responses in CHO-K1 cells stably expressing hNTS1.  This whole-cell integrated assay enabled us to subdivide our pepducin series into three profile response groups.  In order to det. the pepducins' antinociceptive potential, we then screened the series in an acute pain model (tail-flick test) by measuring tail withdrawal latencies to a thermal nociceptive stimulus, following intrathecal (i.t.) pepducin administration (275 nmol/kg).  We further evaluated promising pepducins in a tonic pain model (formalin test), as well as in neuropathic (Chronic Constriction Injury) and inflammatory (Complete Freund's Adjuvant) chronic pain models.  We report one pepducin, PP-001, that consistently reduced rat nociceptive behaviors, even in chronic pain paradigms.  Finally, we designed a TAMRA-tagged version of PP-001 and found by confocal microscopy that the pepducin reached the rat dorsal root ganglia post i.t. injection, thus potentially modulating the activity of NTS1 at this location to produce its analgesic effect.  Altogether, these results suggest that NTS1-derived pepducins may represent a promising strategy in pain-relief.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquiZ7ZgL1QoLVg90H21EOLACvtfcHk0ljASuB3C_-iGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXlsFaqtbw%253D&md5=7ac6b5b2c35737f185a963e75c882af1</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2020.104750&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2020.104750%26sid%3Dliteratum%253Aachs%26aulast%3DBrouillette%26aufirst%3DR.%2BL.%26aulast%3DBesserer-Offroy%26aufirst%3D%25C3%2589.%26aulast%3DMona%26aufirst%3DC.%2BE.%26aulast%3DChartier%26aufirst%3DM.%26aulast%3DLavenus%26aufirst%3DS.%26aulast%3DSousbie%26aufirst%3DM.%26aulast%3DBelleville%26aufirst%3DK.%26aulast%3DLongpr%25C3%25A9%26aufirst%3DJ.%2BM.%26aulast%3DMarsault%26aufirst%3D%25C3%2589.%26aulast%3DGrandbois%26aufirst%3DM.%26aulast%3DSarret%26aufirst%3DP.%26atitle%3DCell-Penetrating%2520Pepducins%2520Targeting%2520the%2520Neurotensin%2520Receptor%2520Type%25201%2520Relieve%2520Pain%26jtitle%3DPharmacol.%2520Res.%26date%3D2020%26volume%3D155%26spage%3D104750%26doi%3D10.1016%2Fj.phrs.2020.104750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roussy, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dansereau, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doré-Savard, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belleville, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaudet, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richelson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarret, P.</span></span> <span> </span><span class="NLM_article-title">Spinal Nts1 Receptors Regulate Nociceptive Signaling in a Rat Formalin Tonic Pain Model</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">1100</span>– <span class="NLM_lpage">1114</span>, <span class="refDoi"> DOI: 10.1111/j.1471-4159.2007.05205.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1111%2Fj.1471-4159.2007.05205.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=18182046" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmsVOlsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=1100-1114&author=G.+Roussyauthor=M.+A.+Dansereauauthor=L.+Dor%C3%A9-Savardauthor=K.+Bellevilleauthor=N.+Beaudetauthor=E.+Richelsonauthor=P.+Sarret&title=Spinal+Nts1+Receptors+Regulate+Nociceptive+Signaling+in+a+Rat+Formalin+Tonic+Pain+Model&doi=10.1111%2Fj.1471-4159.2007.05205.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Spinal NTS1 receptors regulate nociceptive signaling in a rat formalin tonic pain model</span></div><div class="casAuthors">Roussy, Genevieve; Dansereau, Marc-Andre; Dore-Savard, Louis; Belleville, Karine; Beaudet, Nicolas; Richelson, Elliott; Sarret, Philippe</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1100-1114</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Central administration of the neuropeptide neurotensin (NT) was shown to induce antinociceptive responses both spinally and supraspinally.  Although NTS2 receptors play an important role in modulating the activity of spinal neurons, we have recently implicated NTS1 receptors in NT's analgesic effects in acute spinal pain paradigms.  The current expts. were thus designed to examine the antinociceptive effects of intrathecal administration of NTS1 agonists in formalin-induced tonic pain in rats.  We first established, using immunoblotting and immunohistochem. approaches, that NTS1 receptors were present in small- and medium-sized dorsal root ganglion cells and localized in the superficial layers of the dorsal horn of the spinal cord.  We then examd. the effects of intrathecal injection of NT (1-15 μg/kg) or NTS1 preferring agonists on the nocifensive response to intraplantar formalin.  Both NTS1-agonists, PD149163 (10-120 μg/kg) and NT69L (1-100 μg/kg), dose-dependently attenuated the formalin-induced behaviors.  Accordingly, NTS1 agonists markedly suppressed pain-evoked c-fos expression in the superficial, nucleus proprius and neck regions of the spinal dorsal horn.  The concomitant administration of PD149163 with the NTS1 antagonist SR48692 (3 μg/kg) significantly reversed PD149163-induced antinociception, confirming the implication of NTS1 in tonic pain.  In contrast, NT69L's analgesic effects were partly abolished by co-administration of SR48692, indicating that NT69L-induced effects may also be exerted through interaction with NTS2.  These results demonstrate that NTS1 receptors play a key role in the mediation of the analgesic effects of NT in persistent pain and suggest that NTS1-selective agonists may represent a new line of analgesic compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrD9lHFE_J6YLVg90H21EOLACvtfcHk0lgEICptW3wLPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmsVOlsrk%253D&md5=f1b36a2cb157800ef7b98f628517c73c</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2007.05205.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2007.05205.x%26sid%3Dliteratum%253Aachs%26aulast%3DRoussy%26aufirst%3DG.%26aulast%3DDansereau%26aufirst%3DM.%2BA.%26aulast%3DDor%25C3%25A9-Savard%26aufirst%3DL.%26aulast%3DBelleville%26aufirst%3DK.%26aulast%3DBeaudet%26aufirst%3DN.%26aulast%3DRichelson%26aufirst%3DE.%26aulast%3DSarret%26aufirst%3DP.%26atitle%3DSpinal%2520Nts1%2520Receptors%2520Regulate%2520Nociceptive%2520Signaling%2520in%2520a%2520Rat%2520Formalin%2520Tonic%2520Pain%2520Model%26jtitle%3DJ.%2520Neurochem.%26date%3D2008%26volume%3D105%26spage%3D1100%26epage%3D1114%26doi%3D10.1111%2Fj.1471-4159.2007.05205.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Williams, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heavner, J. E.</span></span> <span> </span><span class="NLM_article-title">Ziconotide: An Update and Review</span>. <i>Expert Opin. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1575</span>– <span class="NLM_lpage">1583</span>, <span class="refDoi"> DOI: 10.1517/14656566.9.9.1575</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1517%2F14656566.9.9.1575" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=18518786" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BD1cXms1Wlu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=1575-1583&author=J.+A.+Williamsauthor=M.+Dayauthor=J.+E.+Heavner&title=Ziconotide%3A+An+Update+and+Review&doi=10.1517%2F14656566.9.9.1575"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Ziconotide: an update and review</span></div><div class="casAuthors">Williams, Jason A.; Day, Miles; Heavner, James E.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Pharmacotherapy</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1575-1583</span>CODEN:
                <span class="NLM_cas:coden">EOPHF7</span>;
        ISSN:<span class="NLM_cas:issn">1465-6566</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Background: Ziconotide is the only N-type calcium channel blocker approved by the US FDA for the treatment of chronic pain.  The approved indication is for the management of severe chronic pain in patients for whom intrathecal therapy is warranted and who are intolerant of or refractory to other treatments such as systemic analgesics, adjunctive therapies or intrathecal morphine.  Objective: The purpose of this article was to review the available safety, efficacy and dosing information for ziconotide.  Methods: The sources searched for literature from 1980 to Jan. 2008 included Pub Med, MEDLINE and PREMEDLINE using the words ziconotide, conotoxins and pain.  Results/conclusion: Ziconotide is administered intrathecally by infusion pump to block nociceptive signal transmission in the spinal cord.  It is a synthetic neuroactive peptide equiv. to the omega conotoxin MVIIA, a constituent of the venom of the fish-hunting marine snail Conus magus.  It is highly potent, has a steep dose-response curve, a slow onset of action and a narrow margin of safety and responses to dose adjustments are slow.  Patients receiving ziconotide should be under the care of physicians experienced in the management of intrathecal infusion therapy for pain control and should have convenient access to medical facilities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6JGTrlDxukbVg90H21EOLACvtfcHk0lgEICptW3wLPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXms1Wlu78%253D&md5=9b652d1492d000acfb2db5aff1039ae5</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1517%2F14656566.9.9.1575&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14656566.9.9.1575%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DJ.%2BA.%26aulast%3DDay%26aufirst%3DM.%26aulast%3DHeavner%26aufirst%3DJ.%2BE.%26atitle%3DZiconotide%253A%2520An%2520Update%2520and%2520Review%26jtitle%3DExpert%2520Opin.%2520Pharmacother.%26date%3D2008%26volume%3D9%26spage%3D1575%26epage%3D1583%26doi%3D10.1517%2F14656566.9.9.1575" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deer, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pope, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanes, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDowell, G. C.</span></span> <span> </span><span class="NLM_article-title">Intrathecal Therapy for Chronic Pain: A Review of Morphine and Ziconotide as Firstline Options</span>. <i>Pain Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">784</span>– <span class="NLM_lpage">798</span>, <span class="refDoi"> DOI: 10.1093/pm/pny132</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1093%2Fpm%2Fpny132" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=30137539" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A280%3ADC%252BB3c3htVOgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2019&pages=784-798&author=T.+R.+Deerauthor=J.+E.+Popeauthor=M.+C.+Hanesauthor=G.+C.+McDowell&title=Intrathecal+Therapy+for+Chronic+Pain%3A+A+Review+of+Morphine+and+Ziconotide+as+Firstline+Options&doi=10.1093%2Fpm%2Fpny132"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Intrathecal Therapy for Chronic Pain: A Review of Morphine and Ziconotide as Firstline Options</span></div><div class="casAuthors">Deer Timothy R; Pope Jason E; Hanes Michael C; McDowell Gladstone C</div><div class="citationInfo"><span class="NLM_cas:title">Pain medicine (Malden, Mass.)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">784-798</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVES:  To evaluate the evidence for morphine and ziconotide as firstline intrathecal (IT) analgesia agents for patients with chronic pain.  METHODS:  Medline was searched (through July 2017) for "ziconotide" or "morphine" AND "intrathecal" AND "chronic pain," with results limited to studies in human populations.  RESULTS:  The literature supports the use of morphine (based primarily on noncontrolled, prospective, and retrospective studies) and ziconotide (based on randomized controlled trials and prospective observational studies) as first-choice IT therapies.  The 2016 Polyanalgesic Consensus Conference (PACC) guidelines recommended both morphine and ziconotide as firstline IT monotherapy for localized and diffuse chronic pain of cancer-related and non-cancer-related etiologies; however, one consensus point emphasized ziconotide use, unless contraindicated, as firstline IT therapy in patients with chronic non-cancer-related pain.  Initial IT therapy choice should take into consideration individual patient characteristics (e.g., pain location, response to previous therapies, comorbid medical conditions, psychiatric history).  Trialing is recommended to assess medication efficacy and tolerability.  For both morphine and ziconotide, the PACC guidelines recommend conservative initial dosing strategies.  Due to its narrow therapeutic window, ziconotide requires careful dose titration.  Ziconotide is contraindicated in patients with a history of psychosis.  IT morphine administration may be associated with serious side effects (e.g., respiratory depression, catheter tip granuloma), require dose increases, and cause dependence over time.  CONCLUSION:  Based on the available evidence, morphine and ziconotide are recommended as firstline IT monotherapy for cancer-related and non-cancer-related pain.  The choice of first-in-pump therapy should take into consideration patient characteristics and the advantages and disadvantages of each medication.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQSR0OHYEK4ucuCWE5mhx1RfW6udTcc2ebs8Jr8F_DFM7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c3htVOgtw%253D%253D&md5=79f97446d9bd1b18da18549d58ac9466</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1093%2Fpm%2Fpny132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fpm%252Fpny132%26sid%3Dliteratum%253Aachs%26aulast%3DDeer%26aufirst%3DT.%2BR.%26aulast%3DPope%26aufirst%3DJ.%2BE.%26aulast%3DHanes%26aufirst%3DM.%2BC.%26aulast%3DMcDowell%26aufirst%3DG.%2BC.%26atitle%3DIntrathecal%2520Therapy%2520for%2520Chronic%2520Pain%253A%2520A%2520Review%2520of%2520Morphine%2520and%2520Ziconotide%2520as%2520Firstline%2520Options%26jtitle%3DPain%2520Med.%26date%3D2019%26volume%3D20%26spage%3D784%26epage%3D798%26doi%3D10.1093%2Fpm%2Fpny132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Báckryd, E.</span></span> <span> </span><span class="NLM_article-title">Do the Potential Benefits Outweigh the Risks? An Update on the Use of Ziconotide in Clinical Practice</span>. <i>Eur. J. Pain</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1193</span>– <span class="NLM_lpage">1202</span>, <span class="refDoi"> DOI: 10.1002/ejp.1229</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1002%2Fejp.1229" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=29635804" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A280%3ADC%252BC1MjgslCqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2018&pages=1193-1202&author=E.+B%C3%A1ckryd&title=Do+the+Potential+Benefits+Outweigh+the+Risks%3F+An+Update+on+the+Use+of+Ziconotide+in+Clinical+Practice&doi=10.1002%2Fejp.1229"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Do the potential benefits outweigh the risks? An update on the use of ziconotide in clinical practice</span></div><div class="casAuthors">Backryd E</div><div class="citationInfo"><span class="NLM_cas:title">European journal of pain (London, England)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1193-1202</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Ziconotide is a selective and potent blocker of N-type voltage-gated calcium channels.  It was approved by the Food and Drug Administration in 2004 and by the European Medicines Agency in 2005 for the treatment of severe chronic pain in patients needing intrathecal analgesia (ITA).  The aim of this paper is to provide a practitioner-oriented, educational, narrative, up-to-date review on the use of ziconotide in clinical pain medicine.  Of special concern regarding safety is the partial incongruity between dosing statements in the Summary of Product Characteristics and novel low-dosage, slow uptitration recommendations.  Even though ziconotide has obvious advantages compared to opioids, pain practitioners pondering the use of ziconotide nonetheless have to balance its proved potential analgesic effect against its neurological side effects, with special consideration being given to dosing and neuropsychiatric dangers.  Using a seesaw analogy, the paper discusses what factors pain physicians should weigh in when considering ziconotide as ITA drug, the non-opioid advantages of ziconotide being counterbalanced by its potential psychiatric side effects.  Ziconotide is an important part of the armamentarium of modern interventional pain medicine.  If ITA is deemed necessary, ziconotide is a rational alternative, at least in chronic (neuropathic) non-cancer pain.  However, in many European countries, ziconotide treatment is only available in a few (if any) centres.  The safety profile of ziconotide is not fundamentally more worrying than that of opioids or cannabinoids; it is just different.  This paper provides a concise, up-to-date and clinically-oriented summary of the use of ziconotide in clinical practice, not least concerning safety and dosage issues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTsBIVt11XjsUh5eUSa2oe_fW6udTcc2eYetVtPMajQh7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MjgslCqsQ%253D%253D&md5=4b2cb469a3048d1de7021b44619409aa</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1002%2Fejp.1229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fejp.1229%26sid%3Dliteratum%253Aachs%26aulast%3DB%25C3%25A1ckryd%26aufirst%3DE.%26atitle%3DDo%2520the%2520Potential%2520Benefits%2520Outweigh%2520the%2520Risks%253F%2520An%2520Update%2520on%2520the%2520Use%2520of%2520Ziconotide%2520in%2520Clinical%2520Practice%26jtitle%3DEur.%2520J.%2520Pain%26date%3D2018%26volume%3D22%26spage%3D1193%26epage%3D1202%26doi%3D10.1002%2Fejp.1229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schmidtko, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lótsch, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freynhagen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geisslinger, G.</span></span> <span> </span><span class="NLM_article-title">Ziconotide for Treatment of Severe Chronic Pain</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>375</i></span>,  <span class="NLM_fpage">1569</span>– <span class="NLM_lpage">1577</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(10)60354-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2FS0140-6736%2810%2960354-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=20413151" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsVOnt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=375&publication_year=2010&pages=1569-1577&author=A.+Schmidtkoauthor=J.+L%C3%B3tschauthor=R.+Freynhagenauthor=G.+Geisslinger&title=Ziconotide+for+Treatment+of+Severe+Chronic+Pain&doi=10.1016%2FS0140-6736%2810%2960354-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Ziconotide for treatment of severe chronic pain</span></div><div class="casAuthors">Schmidtko, Achim; Loetsch, Joern; Freynhagen, Rainer; Geisslinger, Gerd</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">375</span>
        (<span class="NLM_cas:issue">9725</span>),
    <span class="NLM_cas:pages">1569-1577</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Summary: Pharmacol. management of severe chronic pain is difficult to achieve with currently available analgesic drugs, and remains a large unmet therapeutic need.  The synthetic peptide ziconotide has been approved by the US Food and Drug Administration and the European Medicines Agency for intrathecal treatment of patients with severe chronic pain that is refractory to other treatment modalities.  Ziconotide is the first member in the new drug class of selective N-type voltage-sensitive calcium-channel blockers.  The ziconotide-induced blockade of N-type calcium channels in the spinal cord inhibits release of pain-relevant neurotransmitters from central terminals of primary afferent neurons.  By this mechanism, ziconotide can effectively reduce pain.  However, ziconotide has a narrow therapeutic window because of substantial CNS side-effects, and thus treatment with ziconotide is appropriate for only a small subset of patients with severe chronic pain.  We provide an overview of the benefits and limitations of intrathecal ziconotide treatment and review potential future developments in this new drug class.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpp8ap2seTMHbVg90H21EOLACvtfcHk0lgS-5Kx5ZlkqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsVOnt7w%253D&md5=3823cf9b9116bb02f898a3bf01848dc2</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2810%2960354-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252810%252960354-6%26sid%3Dliteratum%253Aachs%26aulast%3DSchmidtko%26aufirst%3DA.%26aulast%3DL%25C3%25B3tsch%26aufirst%3DJ.%26aulast%3DFreynhagen%26aufirst%3DR.%26aulast%3DGeisslinger%26aufirst%3DG.%26atitle%3DZiconotide%2520for%2520Treatment%2520of%2520Severe%2520Chronic%2520Pain%26jtitle%3DLancet%26date%3D2010%26volume%3D375%26spage%3D1569%26epage%3D1577%26doi%3D10.1016%2FS0140-6736%2810%2960354-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Skov, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Kater, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shopp, G. M.</span></span> <span> </span><span class="NLM_article-title">Nonclinical Safety of Ziconotide: An Intrathecal Analgesic of a New Pharmaceutical Class</span>. <i>Int. J. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">411</span>– <span class="NLM_lpage">421</span>, <span class="refDoi"> DOI: 10.1080/10915810701582970</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1080%2F10915810701582970" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=17963128" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1WgsbzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=411-421&author=M.+J.+Skovauthor=J.+C.+Beckauthor=A.+W.+de+Katerauthor=G.+M.+Shopp&title=Nonclinical+Safety+of+Ziconotide%3A+An+Intrathecal+Analgesic+of+a+New+Pharmaceutical+Class&doi=10.1080%2F10915810701582970"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Nonclinical Safety of Ziconotide: An Intrathecal Analgesic of a New Pharmaceutical Class</span></div><div class="casAuthors">Skov, Michael J.; Beck, James C.; de Kater, Annelies W.; Shopp, George M.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Toxicology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">411-421</span>CODEN:
                <span class="NLM_cas:coden">IJTOFN</span>;
        ISSN:<span class="NLM_cas:issn">1091-5818</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Ziconotide, a potent, selective, reversible blocker of neuronal N-type voltage-sensitive calcium channels, is approved in the United States for the management of severe chronic pain in patients for whom intrathecal therapy is warranted, and who are intolerant or refractory to other treatment, such as systemic analgesics, adjunctive therapies, or intrathecal morphine.  In the European Union, ziconotide is indicated for the treatment of severe chronic pain in patients who require intrathecal analgesia.  Nonclin. investigations of ziconotide included a comprehensive characterization of its toxicol., incorporating acute and subchronic toxicity studies in rats, dogs, and monkeys; reproductive toxicity assessments in rats and rabbits; and mutagenic, carcinogenic evaluations performed in vivo and in vitro.  Addnl. investigations assessed the potential for cardiotoxicity (rats) and immunogenicity (mice, rats, and guinea pigs), and the presence or absence of intraspinal granuloma formation and local cell proliferation and apoptosis (dogs).  The resulting nonclin. toxicol. profile was predictive of human adverse events reported in clin. trials and consistent with ziconotide's pharmacol. activity.  Frequently obsd. nonclin. behavioral effects included tremoring, shaking, ataxia, and hyperreactivity.  Occurrences were generally transient and reversible upon cessation of treatment, and intolerable effects occurred at doses more than 45 times the max. recommended clin. dose.  Ziconotide was not assocd. with target organ toxicity, teratogenicity, or treatment-related gross or histopathol. changes; it displayed no mutagenic or carcinogenic potential and no propensity to induce local cell proliferation or apoptosis.  Although guinea pigs developed systemic anaphylaxis, antibodies to ziconotide were not detected in mice, rats, or guinea pigs, indicating low immunogenic potential.  No evidence of granuloma formation was obsd. with intrathecal ziconotide treatment.  In summary, the results from these nonclin. safety assessments revealed no significant toxicol. risk to humans treated with ziconotide as recommended.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDNVHfZdQEOrVg90H21EOLACvtfcHk0lgS-5Kx5ZlkqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1WgsbzJ&md5=b5bb75d3d2a25226350003b18437c009</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1080%2F10915810701582970&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10915810701582970%26sid%3Dliteratum%253Aachs%26aulast%3DSkov%26aufirst%3DM.%2BJ.%26aulast%3DBeck%26aufirst%3DJ.%2BC.%26aulast%3Dde%2BKater%26aufirst%3DA.%2BW.%26aulast%3DShopp%26aufirst%3DG.%2BM.%26atitle%3DNonclinical%2520Safety%2520of%2520Ziconotide%253A%2520An%2520Intrathecal%2520Analgesic%2520of%2520a%2520New%2520Pharmaceutical%2520Class%26jtitle%3DInt.%2520J.%2520Toxicol.%26date%3D2007%26volume%3D26%26spage%3D411%26epage%3D421%26doi%3D10.1080%2F10915810701582970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grajny, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durphy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adam, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azher, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molho, E.</span></span> <span> </span><span class="NLM_article-title">Ziconotide-Induced Oro-Lingual Dyskinesia: 3 Cases</span>. <i>Tremor Other Hyperkinet Mov (N Y)</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">37</span>, <span class="refDoi"> DOI: 10.5334/tohm.431</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.5334%2Ftohm.431" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=33101763" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A280%3ADC%252BB3s7lvFKktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2020&pages=37&author=K.+Grajnyauthor=J.+Durphyauthor=O.+Adamauthor=S.+Azherauthor=M.+Guptaauthor=E.+Molho&title=Ziconotide-Induced+Oro-Lingual+Dyskinesia%3A+3+Cases&doi=10.5334%2Ftohm.431"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Ziconotide-Induced Oro-lingual Dyskinesia: 3 Cases</span></div><div class="casAuthors">Grajny Kristopher; Durphy Jennifer; Adam Octavian; Azher Sharmeen; Gupta Megan; Molho Eric</div><div class="citationInfo"><span class="NLM_cas:title">Tremor and other hyperkinetic movements (New York, N.Y.)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">37</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Background:  Ziconotide (ZCN), a nonopioid analgesic, is first-line intrathecal therapy for patients with severe chronic pain refractory to other management options.  We describe three cases of ZCN-induced movement disorders.  Cases:  Case one is a 64-year-old woman who presented with oro-lingual (OL) dyskinesia with dysesthesias and bilateral upper extremity kinetic tremor.  Case two is a 43-year-old man with a 20-month history of ZCN treatment who developed OL dyskinesia with dysesthesias, involuntary left hand and neck movements, hallucinations, dysesthesias on his feet, and gait imbalance.  Case three is a 70-year-old man with a 4-month history of ZCN use who developed OL dyskinesia with dysesthesias.  Conclusions:  Intrathecal treatment of pain with ZCN may be complicated by a drug-induced movement disorder where OL dyskinesia is characteristic.  The movement disorder is likely to be dose related and reversible with ZCN discontinuation, but a chronic movement disorder is also possible.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTh0aBYWtfA2rZpSb_XWfMrfW6udTcc2eYetVtPMajQh7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3s7lvFKktg%253D%253D&md5=e9ddd3b117d39137143999a48e33cf8a</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.5334%2Ftohm.431&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5334%252Ftohm.431%26sid%3Dliteratum%253Aachs%26aulast%3DGrajny%26aufirst%3DK.%26aulast%3DDurphy%26aufirst%3DJ.%26aulast%3DAdam%26aufirst%3DO.%26aulast%3DAzher%26aufirst%3DS.%26aulast%3DGupta%26aufirst%3DM.%26aulast%3DMolho%26aufirst%3DE.%26atitle%3DZiconotide-Induced%2520Oro-Lingual%2520Dyskinesia%253A%25203%2520Cases%26jtitle%3DTremor%2520Other%2520Hyperkinet%2520Mov%2520%2528N%2520Y%2529%26date%3D2020%26volume%3D10%26spage%3D37%26doi%3D10.5334%2Ftohm.431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Remaury, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vita, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gendreau, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnone, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poncelet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Culouscou, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Fur, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soubrié, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caput, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shire, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kopf, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrara, P.</span></span> <span> </span><span class="NLM_article-title">Targeted Inactivation of the Neurotensin Type 1 Receptor Reveals Its Role in Body Temperature Control and Feeding Behavior but Not in Analgesia</span>. <i>Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>953</i></span>,  <span class="NLM_fpage">63</span>– <span class="NLM_lpage">72</span>, <span class="refDoi"> DOI: 10.1016/S0006-8993(02)03271-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2FS0006-8993%2802%2903271-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=12384239" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BD38XnvVOlurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=953&publication_year=2002&pages=63-72&author=A.+Remauryauthor=N.+Vitaauthor=S.+Gendreauauthor=M.+Jungauthor=M.+Arnoneauthor=M.+Ponceletauthor=J.-M.+Culouscouauthor=G.+Le+Furauthor=P.+Soubri%C3%A9author=D.+Caputauthor=D.+Shireauthor=M.+Kopfauthor=P.+Ferrara&title=Targeted+Inactivation+of+the+Neurotensin+Type+1+Receptor+Reveals+Its+Role+in+Body+Temperature+Control+and+Feeding+Behavior+but+Not+in+Analgesia&doi=10.1016%2FS0006-8993%2802%2903271-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted inactivation of the neurotensin type 1 receptor reveals its role in body temperature control and feeding behavior but not in analgesia</span></div><div class="casAuthors">Remaury, Anne; Vita, Natalio; Gendreau, Sylvain; Jung, Mireille; Arnone, Michelle; Poncelet, Martine; Culouscou, Jean-Michel; Le Fur, Gerard; Soubrie, Philippe; Caput, Daniel; Shire, David; Kopf, Manfred; Ferrara, Pascual</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">953</span>
        (<span class="NLM_cas:issue">1,2</span>),
    <span class="NLM_cas:pages">63-72</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Three subtypes of neurotensin receptor have been described, two members of the heptahelical transmembrane domain G protein-coupled receptor superfamily NT-1R and NT-2R, and NT-3R unrelated to this family.  The authors have generated NT-1R deficient (NT-1R-/-) mice.  NT-1R-/- mice were born at the expected Mendelian frequency without obvious abnormalities and they were fertile.  The NT-induced analgesia on the writhing induced by phenyl-p-benzoquinone administration remained at wild-type levels in the NT-1R-/- mice demonstrating that the NT-1R is not implicated in the analgesic effect of NT in this test.  The NT-1R-/- mice were hyperthermic; their body temp. was not affected by intracerebroventricular (i.c.v.) administration of NT, contrasting with the hypothermia induced in NT-1R+/+ mice.  NT-1R-/- mice showed a small significant increase in body wt. compared to the NT-1R+/+ congeners as early as 10 wk after birth, correlated with a higher food intake.  NT-1R-/- mice showed similar spontaneous locomotion to the control littermates, but did not respond to i.c.v. NT-induced hypolocomotion.  I.c.v. injection of NT inhibited feeding in fasted wild-type mice, but had no effect on feeding of the NT-1R-/- mice.  I.c.v. administration of the orexigenic neuropeptide Y (NPY) stimulated feeding to the same extent in both wild-type and NT-1R-/- mice.  This anal. of NT-1R-deficient mice shows that the NT-1R does not play a role in NT-induced analgesia, but that it is clearly implicated in thermal and feeding regulation, wt. control, and NT-induced hypolocomotion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMMGGac-nhAbVg90H21EOLACvtfcHk0liM49GMrpkt2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnvVOlurk%253D&md5=e7421cbc6c3fecfa32ea90c14d144de8</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1016%2FS0006-8993%2802%2903271-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-8993%252802%252903271-7%26sid%3Dliteratum%253Aachs%26aulast%3DRemaury%26aufirst%3DA.%26aulast%3DVita%26aufirst%3DN.%26aulast%3DGendreau%26aufirst%3DS.%26aulast%3DJung%26aufirst%3DM.%26aulast%3DArnone%26aufirst%3DM.%26aulast%3DPoncelet%26aufirst%3DM.%26aulast%3DCulouscou%26aufirst%3DJ.-M.%26aulast%3DLe%2BFur%26aufirst%3DG.%26aulast%3DSoubri%25C3%25A9%26aufirst%3DP.%26aulast%3DCaput%26aufirst%3DD.%26aulast%3DShire%26aufirst%3DD.%26aulast%3DKopf%26aufirst%3DM.%26aulast%3DFerrara%26aufirst%3DP.%26atitle%3DTargeted%2520Inactivation%2520of%2520the%2520Neurotensin%2520Type%25201%2520Receptor%2520Reveals%2520Its%2520Role%2520in%2520Body%2520Temperature%2520Control%2520and%2520Feeding%2520Behavior%2520but%2520Not%2520in%2520Analgesia%26jtitle%3DBrain%2520Res.%26date%3D2002%26volume%3D953%26spage%3D63%26epage%3D72%26doi%3D10.1016%2FS0006-8993%2802%2903271-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pettibone, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hess, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hey, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leviten, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lis, E. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mallorga, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pascarella, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, Z.</span></span> <span> </span><span class="NLM_article-title">The Effects of Deleting the Mouse Neurotensin Receptor Ntr1 on Central and Peripheral Responses to Neurotensin</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>300</i></span>,  <span class="NLM_fpage">305</span>– <span class="NLM_lpage">313</span>, <span class="refDoi"> DOI: 10.1124/jpet.300.1.305</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1124%2Fjpet.300.1.305" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=11752130" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BD38Xht1WltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=300&publication_year=2002&pages=305-313&author=D.+J.+Pettiboneauthor=J.+F.+Hessauthor=P.+J.+Heyauthor=M.+A.+Jacobsonauthor=M.+Levitenauthor=E.+V.+Lisauthor=P.+J.+Mallorgaauthor=D.+M.+Pascarellaauthor=M.+A.+Snyderauthor=J.+B.+Williamsauthor=Z.+Zeng&title=The+Effects+of+Deleting+the+Mouse+Neurotensin+Receptor+Ntr1+on+Central+and+Peripheral+Responses+to+Neurotensin&doi=10.1124%2Fjpet.300.1.305"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">The effects of deleting the mouse neurotensin receptor NTR1 on central and peripheral responses to neurotensin</span></div><div class="casAuthors">Pettibone, Douglas J.; Hess, J. Fred; Hey, Patricia J.; Jacobson, Marlene A.; Leviten, Michael; Lis, Edward V.; Mallorga, Pierre J.; Pascarella, Danette M.; Snyder, Melissa A.; Williams, Jacinta B.; Zeng, Zhizhen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">300</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">305-313</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Mice deficient in the neurotensin (NT)-1 receptor (NTR1) were developed to characterize the NT receptor subtypes that mediate various in vivo responses to NT.  F2 generation (C57BL6/Sv129J) NTR1 knockout (-/-) mice were viable, and showed normal growth and overt behavior.  The -/- mice lacked detectable NTR1 radioligand binding in brain, whereas NTR2 receptor binding d. appeared normal compared with wildtype (+/+) mice.  The gene deletion also resulted in the loss of NTR1 expression as detd. by reverse transcription-polymerase chain reaction and in situ hybridization.  Intracerebroventricular injection of NT (1 μg) to +/+ mice caused a robust hypothermic response (5-6°) and a significant increase in hot-plate latency.  These effects were absent in the -/- mice.  Similar results were obtained with i.p. injections of the brain penetrant NT analog NMe-Arg-Lys-Pro-Trp-Tle-Leu (NT-2, 1 mg/kg i.p.).  NT-2 administration also impaired rotarod performance in wild-type mice, but had no effect on motor coordination in knockout mice.  In vitro, NT and NT-2 at 30 nM caused predominantly contraction and relaxation in isolated distal colon and proximal ileum, resp., from +/+ mice, but no responses were obsd. with tissues from -/- mice.  A similar loss of the contractile effects of NT was obsd. in the isolated stomach fundus from the knockout mice.  In vivo, NT-2 administration reduced colonic propulsion substantially in wild-type mice.  In contrast, NT-2 had no effect in NTR1 null mice, whereas the hypomotility effect of clonidine was intact.  These data indicate that NTR1 mediates several of the central and peripheral effects of NT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpj40U6-QwpfLVg90H21EOLACvtfcHk0liM49GMrpkt2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xht1WltA%253D%253D&md5=50f7e8b5b7d9cc6a047cd29b04b2960b</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1124%2Fjpet.300.1.305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.300.1.305%26sid%3Dliteratum%253Aachs%26aulast%3DPettibone%26aufirst%3DD.%2BJ.%26aulast%3DHess%26aufirst%3DJ.%2BF.%26aulast%3DHey%26aufirst%3DP.%2BJ.%26aulast%3DJacobson%26aufirst%3DM.%2BA.%26aulast%3DLeviten%26aufirst%3DM.%26aulast%3DLis%26aufirst%3DE.%2BV.%26aulast%3DMallorga%26aufirst%3DP.%2BJ.%26aulast%3DPascarella%26aufirst%3DD.%2BM.%26aulast%3DSnyder%26aufirst%3DM.%2BA.%26aulast%3DWilliams%26aufirst%3DJ.%2BB.%26aulast%3DZeng%26aufirst%3DZ.%26atitle%3DThe%2520Effects%2520of%2520Deleting%2520the%2520Mouse%2520Neurotensin%2520Receptor%2520Ntr1%2520on%2520Central%2520and%2520Peripheral%2520Responses%2520to%2520Neurotensin%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2002%26volume%3D300%26spage%3D305%26epage%3D313%26doi%3D10.1124%2Fjpet.300.1.305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mechanic, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutton, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berson, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Button, D. C.</span></span> <span> </span><span class="NLM_article-title">Involvement of the Neurotensin Receptor 1 in the Behavioral Effects of Two Neurotensin Agonists, Nt-2 and Nt69l: Lack of Hypothermic, Antinociceptive and Antipsychotic Actions in Receptor Knockout Mice</span>. <i>Eur. Neuropsychopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">466</span>– <span class="NLM_lpage">475</span>, <span class="refDoi"> DOI: 10.1016/j.euroneuro.2009.01.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2Fj.euroneuro.2009.01.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=19223157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BD1MXms1Krtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=466-475&author=J.+A.+Mechanicauthor=J.+E.+Suttonauthor=A.+E.+Bersonauthor=X.+Wuauthor=J.+Kwanauthor=R.+Schreiberauthor=Z.+Pangauthor=D.+C.+Button&title=Involvement+of+the+Neurotensin+Receptor+1+in+the+Behavioral+Effects+of+Two+Neurotensin+Agonists%2C+Nt-2+and+Nt69l%3A+Lack+of+Hypothermic%2C+Antinociceptive+and+Antipsychotic+Actions+in+Receptor+Knockout+Mice&doi=10.1016%2Fj.euroneuro.2009.01.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Involvement of the neurotensin receptor 1 in the behavioral effects of two neurotensin agonists, NT-2 and NT69L: Lack of hypothermic, antinociceptive and antipsychotic actions in receptor knockout mice</span></div><div class="casAuthors">Mechanic, Jordan A.; Sutton, Janette E.; Berson, Amy E.; Wu, Xiaosu; Kwan, Joyce; Schreiber, Rudy; Pang, Zhen; Button, Donald C.</div><div class="citationInfo"><span class="NLM_cas:title">European Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">466-475</span>CODEN:
                <span class="NLM_cas:coden">EURNE8</span>;
        ISSN:<span class="NLM_cas:issn">0924-977X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Neurotensin (NT) is a neuropeptide implicated in the pathophysiol. of schizophrenia and in mediating the efficacy of antipsychotic drugs.  NT is also involved in the regulation of body temp. and pain sensitivity.  Using neurotensin receptor 1 (NTR1) knockout (KO) and wild-type (WT) mice, these studies evaluated the involvement of NTR1 in the behavioral responses produced by peripheral administration of NT agonists (NT-2 and NT69L).  Animals were characterized in paradigms designed to assess hypothermia, antinociception, and antipsychotic-like effects.  Under basal conditions, there were no phenotypic differences between NTR1 KO and WT mice.  In WT mice, both NTR1 agonists decreased core body temp. (active doses in mg/kg, i.p., for NT-2 and NT69L, resp.: 1 and 3), increased tail withdrawal latencies (1 and 3), produced decreased spontaneous climbing (0.1, 0.3, 1 and 1, 3, 10) and reversed apomorphine-induced climbing (0.3, 1 and 1, 3).  In contrast, none of the effects of either agonist were present in KO mice.  These results suggest that NTR1: (1) does not play a major role in the control of basal thermoregulation, nociception or psychomotor stimulation in mice (barring possible developmental plasticity), (2) does mediate these behavioral responses to NT agonists, and (3) may play a role in the potential antipsychotic effects of these agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8isUICE8pYrVg90H21EOLACvtfcHk0lhOi33xrfk4Kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXms1Krtb8%253D&md5=df8eb4edc51d58652282de58c02466d5</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1016%2Fj.euroneuro.2009.01.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.euroneuro.2009.01.004%26sid%3Dliteratum%253Aachs%26aulast%3DMechanic%26aufirst%3DJ.%2BA.%26aulast%3DSutton%26aufirst%3DJ.%2BE.%26aulast%3DBerson%26aufirst%3DA.%2BE.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DKwan%26aufirst%3DJ.%26aulast%3DSchreiber%26aufirst%3DR.%26aulast%3DPang%26aufirst%3DZ.%26aulast%3DButton%26aufirst%3DD.%2BC.%26atitle%3DInvolvement%2520of%2520the%2520Neurotensin%2520Receptor%25201%2520in%2520the%2520Behavioral%2520Effects%2520of%2520Two%2520Neurotensin%2520Agonists%252C%2520Nt-2%2520and%2520Nt69l%253A%2520Lack%2520of%2520Hypothermic%252C%2520Antinociceptive%2520and%2520Antipsychotic%2520Actions%2520in%2520Receptor%2520Knockout%2520Mice%26jtitle%3DEur.%2520Neuropsychopharmacol.%26date%3D2009%26volume%3D19%26spage%3D466%26epage%3D475%26doi%3D10.1016%2Fj.euroneuro.2009.01.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wehrwein, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joyner, M. J.</span></span> <span> </span><span class="NLM_article-title">Regulation of Blood Pressure by the Arterial Baroreflex and Autonomic Nervous System</span>. <i>Handb. Clin. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">89</span>– <span class="NLM_lpage">102</span>, <span class="refDoi"> DOI: 10.1016/B978-0-444-53491-0.00008-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2FB978-0-444-53491-0.00008-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=24095118" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A280%3ADC%252BC2c%252FmtFSitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2013&pages=89-102&author=E.+A.+Wehrweinauthor=M.+J.+Joyner&title=Regulation+of+Blood+Pressure+by+the+Arterial+Baroreflex+and+Autonomic+Nervous+System&doi=10.1016%2FB978-0-444-53491-0.00008-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of blood pressure by the arterial baroreflex and autonomic nervous system</span></div><div class="casAuthors">Wehrwein Erica A; Joyner Michael J</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of clinical neurology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">89-102</span>
        ISSN:<span class="NLM_cas:issn">0072-9752</span>.
    </div><div class="casAbstract">Mean arterial pressure (MAP) is a critical hemodynamic factor.  The absence of proper regulation of MAP can have important pathophysiological consequences.  Low MAP can cause inadequate blood flow to organs, syncope, and shock.  On the other hand, elevated MAP contributes to increased oxygen demand by the heart, ventricular remodeling, vascular injury, end organ damage, and stroke.  The arterial baroreflex system is a key controller of MAP and is a complex system.  It can be considered in its entirety as an integrative physiological system or in terms of its regulated component parts.  Those component parts include MAP, mechanosensory transduction, afferent pathways, central neural circuits, efferent pathways, receptor pharmacology, integration with other key homeostatic inputs, molecular biology, and/or other elements.  This chapter provides an overview of each of these individual components but stresses the importance of the integrative nature of this reflex.  In addition, this chapter explores common measurement techniques for the baroreflex and explores the baroreflex in diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTAz9I2kswErAyMywPm6HgQfW6udTcc2eYK8XvvlzLYybntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c%252FmtFSitw%253D%253D&md5=e3115865371e315f0a4d28d3150aacd2</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1016%2FB978-0-444-53491-0.00008-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-444-53491-0.00008-0%26sid%3Dliteratum%253Aachs%26aulast%3DWehrwein%26aufirst%3DE.%2BA.%26aulast%3DJoyner%26aufirst%3DM.%2BJ.%26atitle%3DRegulation%2520of%2520Blood%2520Pressure%2520by%2520the%2520Arterial%2520Baroreflex%2520and%2520Autonomic%2520Nervous%2520System%26jtitle%3DHandb.%2520Clin.%2520Neurol.%26date%3D2013%26volume%3D117%26spage%3D89%26epage%3D102%26doi%3D10.1016%2FB978-0-444-53491-0.00008-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mulè, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serio, R.</span></span> <span> </span><span class="NLM_article-title">Mode and Mechanism of Neurotensin Action in Rat Proximal Colon</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>319</i></span>,  <span class="NLM_fpage">269</span>– <span class="NLM_lpage">272</span>, <span class="refDoi"> DOI: 10.1016/S0014-2999(96)00943-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2FS0014-2999%2896%2900943-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=9042600" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADyaK2sXmsVeqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=319&publication_year=1997&pages=269-272&author=F.+Mul%C3%A8author=R.+Serio&title=Mode+and+Mechanism+of+Neurotensin+Action+in+Rat+Proximal+Colon&doi=10.1016%2FS0014-2999%2896%2900943-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Mode and mechanism of neurotensin action in rat proximal colon</span></div><div class="casAuthors">Mule, Flavia; Serio, Rosa</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">319</span>
        (<span class="NLM_cas:issue">2/3</span>),
    <span class="NLM_cas:pages">269-272</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">This study examd. the mechanism of action of neurotensin on intraluminal pressure in rat proximal colon.  The direct and indirect contractile response to neurotensin (100 nM) was abolished in Ca2+-free soln., and was antagonized by nifedipine (1-5-10 nM) and potentiated by Bay K 8644 (Me 1,4-dihydro-2,6-dimethyl-3-nitro-4-(2-trifluoromethylphenyl)-pyridine-5-carboxylate) (10-100-1000 nM).  Neurotensin, in the presence of nifedipine (10 nM) and atropine (1 μM), induced a tetrodotoxin-insensitive inhibitory effect, which was antagonized by SR 48692 (2[(1-(7-chloro-4-quinolinyl)-5-(2,6-dimethoxy-phenyl)pyrazol-3-yl) carbonyl amino]tricyclo(3.3.1.1.3.7)decan-2-carboxylic acid) (300 nM) or apamin (0.1 μM).  The results demonstrate that the neurotensin response is dependent on the influx of Ca2+ via L-type channels and results from summation of excitatory and inhibitory effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoomkwudN0tNrVg90H21EOLACvtfcHk0lhOi33xrfk4Kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmsVeqsg%253D%253D&md5=3d8fedc90bc33fca27700392c44f4dd4</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2896%2900943-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252896%252900943-0%26sid%3Dliteratum%253Aachs%26aulast%3DMul%25C3%25A8%26aufirst%3DF.%26aulast%3DSerio%26aufirst%3DR.%26atitle%3DMode%2520and%2520Mechanism%2520of%2520Neurotensin%2520Action%2520in%2520Rat%2520Proximal%2520Colon%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1997%26volume%3D319%26spage%3D269%26epage%3D272%26doi%3D10.1016%2FS0014-2999%2896%2900943-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pellissier, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eribon, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chabert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gully, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roche, M.</span></span> <span> </span><span class="NLM_article-title">Peripheral Neurotensin Participates in the Modulation of Pre- and Postprandial Intestinal Motility in Rats</span>. <i>Neuropeptides</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">412</span>– <span class="NLM_lpage">419</span>, <span class="refDoi"> DOI: 10.1016/S0143-4179(96)90002-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2FS0143-4179%2896%2990002-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=8923500" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADyaK28XntVOgsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1996&pages=412-419&author=S.+Pellissierauthor=O.+Eribonauthor=J.+Chabertauthor=D.+Gullyauthor=M.+Roche&title=Peripheral+Neurotensin+Participates+in+the+Modulation+of+Pre-+and+Postprandial+Intestinal+Motility+in+Rats&doi=10.1016%2FS0143-4179%2896%2990002-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Peripheral neurotensin participates in the modulation of pre- and postprandial intestinal motility in rats</span></div><div class="casAuthors">Pellissier, S.; Eribon, O.; Chabert, J.; Gully, D.; Roche, M.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropeptides (Edinburgh)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">412-419</span>CODEN:
                <span class="NLM_cas:coden">NRPPDD</span>;
        ISSN:<span class="NLM_cas:issn">0143-4179</span>.
    
            (<span class="NLM_cas:orgname">Churchill Livingstone</span>)
        </div><div class="casAbstract">The present study was undertaken to det. whether neurotensin is involved in the regulation of the intestinal postprandial motor response and, if so, whether the regulatory pathway depends upon peripheral or central neurotensin secretion.  Neurotensin, injected by the i.v. route (5 μg/kg) during the fasting state, induced firstly an increased irregular spiking activity during 30-40 min.  This effect was followed by an increase of frequency of the myoelec. complexes during 60 min.  When injected by the i.c.v. route, neurotensin (0.5 μg/kg) reinforced the fasting motility pattern of the small intestine after a latency of 70 min.  Neurotensin was ineffective on the colon.  The neurotensin receptor antagonist SR 48692 (200 μg/kg i.v) reduced the duration of the postprandial motor response of the small intestine and blocked the late postprandial phase on the proximal colon while it suppressed the early postprandial phase on the distal colon.  When administered i.c.v (20 μg/kg), SR 48692 had no effect.  It is concluded that neurotensin modulates intestinal postprandial motility essentially by a peripheral regulatory pathway.  Endogenous neurotensin is involved in the maintenance of the postprandial motility pattern on the small intestine and the proximal colon while it is involved in the initiation of this response on the distal colon.  This suggests that endogenous neurotensin acts via both endocrine and nervous mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqndBwBPestx7Vg90H21EOLACvtfcHk0lhOi33xrfk4Kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XntVOgsbo%253D&md5=f877f9f251ecd7070a352d7f56bfd7f9</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1016%2FS0143-4179%2896%2990002-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0143-4179%252896%252990002-5%26sid%3Dliteratum%253Aachs%26aulast%3DPellissier%26aufirst%3DS.%26aulast%3DEribon%26aufirst%3DO.%26aulast%3DChabert%26aufirst%3DJ.%26aulast%3DGully%26aufirst%3DD.%26aulast%3DRoche%26aufirst%3DM.%26atitle%3DPeripheral%2520Neurotensin%2520Participates%2520in%2520the%2520Modulation%2520of%2520Pre-%2520and%2520Postprandial%2520Intestinal%2520Motility%2520in%2520Rats%26jtitle%3DNeuropeptides%26date%3D1996%26volume%3D30%26spage%3D412%26epage%3D419%26doi%3D10.1016%2FS0143-4179%2896%2990002-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tyler, B. M.</span>; <span class="NLM_string-name">Douglas, C. L.</span>; <span class="NLM_string-name">Fauq, A.</span>; <span class="NLM_string-name">Pang, Y. P.</span>; <span class="NLM_string-name">Stewart, J. A.</span>; <span class="NLM_string-name">Cusack, B.</span>; <span class="NLM_string-name">MacCormick, D. J.</span>; <span class="NLM_string-name">Richelson, E.</span></span>. <span> </span><span class="NLM_article-title">In Vitro Binding and Cns Effects of Novel Neurotensin Agonists That Cross the Blood-Brain Barrier</span>. In  <i>Vitro Binding and Cns Effects of Novel Neurotensin Agonists That Cross the Blood-Brain Barrier</i>; <span class="NLM_publisher-name">Neuropharmacol</span>, <span class="NLM_year">1999</span>;  <span class="NLM_volume">38</span>, pp.  <span class="NLM_fpage">1027</span>– <span class="NLM_lpage">1034</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2FS0028-3908%2899%2900011-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1999&pages=1027-1034&author=B.+M.+Tyler&author=C.+L.+Douglas&author=A.+Fauq&author=Y.+P.+Pang&author=J.+A.+Stewart&author=B.+Cusack&author=D.+J.+MacCormick&author=E.+Richelson&title=Vitro+Binding+and+Cns+Effects+of+Novel+Neurotensin+Agonists+That+Cross+the+Blood-Brain+Barrier"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1016%2FS0028-3908%2899%2900011-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FS0028-3908%252899%252900011-8%26sid%3Dliteratum%253Aachs%26aulast%3DTyler%26aufirst%3DB.%2BM.%26atitle%3DIn%2520Vitro%2520Binding%2520and%2520Cns%2520Effects%2520of%2520Novel%2520Neurotensin%2520Agonists%2520That%2520Cross%2520the%2520Blood-Brain%2520Barrier%26btitle%3DVitro%2520Binding%2520and%2520Cns%2520Effects%2520of%2520Novel%2520Neurotensin%2520Agonists%2520That%2520Cross%2520the%2520Blood-Brain%2520Barrier%26pub%3DNeuropharmacol%26date%3D1999%26volume%3D38%26spage%3D1027%26epage%3D1034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kilkenny, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Browne, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuthill, I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emerson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altman, D. G.</span></span> <span> </span><span class="NLM_article-title">Improving Bioscience Research Reporting: The Arrive Guidelines for Reporting Animal Research</span>. <i>PLoS Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">e1000412</span> <span class="refDoi"> DOI: 10.1371/journal.pbio.1000412</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1371%2Fjournal.pbio.1000412" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=20613859" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2010&author=C.+Kilkennyauthor=W.+J.+Browneauthor=I.+C.+Cuthillauthor=M.+Emersonauthor=D.+G.+Altman&title=Improving+Bioscience+Research+Reporting%3A+The+Arrive+Guidelines+for+Reporting+Animal+Research&doi=10.1371%2Fjournal.pbio.1000412"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pbio.1000412&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pbio.1000412%26sid%3Dliteratum%253Aachs%26aulast%3DKilkenny%26aufirst%3DC.%26aulast%3DBrowne%26aufirst%3DW.%2BJ.%26aulast%3DCuthill%26aufirst%3DI.%2BC.%26aulast%3DEmerson%26aufirst%3DM.%26aulast%3DAltman%26aufirst%3DD.%2BG.%26atitle%3DImproving%2520Bioscience%2520Research%2520Reporting%253A%2520The%2520Arrive%2520Guidelines%2520for%2520Reporting%2520Animal%2520Research%26jtitle%3DPLoS%2520Biol.%26date%3D2010%26volume%3D8%26doi%3D10.1371%2Fjournal.pbio.1000412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kallina, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grau, J. W.</span></span> <span> </span><span class="NLM_article-title">Tail-Flick Test I: Impact of a Suprathreshold Exposure to Radiant Heat on Pain Reactivity in Rats</span>. <i>Physiol. Behav.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">161</span>– <span class="NLM_lpage">168</span>, <span class="refDoi"> DOI: 10.1016/0031-9384(95)00046-L</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2F0031-9384%2895%2900046-L" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=7667415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADyaK2MXmtFCkt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1995&pages=161-168&author=C.+F.+Kallinaauthor=J.+W.+Grau&title=Tail-Flick+Test+I%3A+Impact+of+a+Suprathreshold+Exposure+to+Radiant+Heat+on+Pain+Reactivity+in+Rats&doi=10.1016%2F0031-9384%2895%2900046-L"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Tail-flick test I: impact of a suprathreshold exposure to radiant heat on pain reactivity in rats</span></div><div class="casAuthors">Kallina, Charles F.; Grau, James W.</div><div class="citationInfo"><span class="NLM_cas:title">Physiology & Behavior</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">161-8</span>CODEN:
                <span class="NLM_cas:coden">PHBHA4</span>;
        ISSN:<span class="NLM_cas:issn">0031-9384</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Radiant heat applied to the tail elicits a vigorous tail-flick response in rats.  This tail-flick reflex is frequently used to measure pain reactivity.  Prior research has shown that a suprathreshold exposure to the radiant heat used to elicit this reflex causes a redn. in tail-flick latencies in pentobarbital anesthetized rats.  Expt. 1 replicated this observation and showed that the effect is not due to a change in tail temp.  Expt. 2 showed that reduced latencies (hyperalgesia) are not obsd. if the spinal cord is transected prior to testing.  Expt. 3 revealed that pentobarbital anesthesia is required to observe thermal-induced hyperalgesia, for this effect is not obsd. in awake subjects.  Expts. 4 and 5 extended this observation by showing that awake rats also fail to exhibit hyperalgesia if others measures of pain reactivity are employed (shock-induced vocalization and motor reactivity).  Implications of the results are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5zOR-_N-MEbVg90H21EOLACvtfcHk0lh1-DD3OVSfXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmtFCkt7w%253D&md5=410c53d8d9f689b51e41319457c0f383</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1016%2F0031-9384%2895%2900046-L&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0031-9384%252895%252900046-L%26sid%3Dliteratum%253Aachs%26aulast%3DKallina%26aufirst%3DC.%2BF.%26aulast%3DGrau%26aufirst%3DJ.%2BW.%26atitle%3DTail-Flick%2520Test%2520I%253A%2520Impact%2520of%2520a%2520Suprathreshold%2520Exposure%2520to%2520Radiant%2520Heat%2520on%2520Pain%2520Reactivity%2520in%2520Rats%26jtitle%3DPhysiol.%2520Behav.%26date%3D1995%26volume%3D58%26spage%3D161%26epage%3D168%26doi%3D10.1016%2F0031-9384%2895%2900046-L" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dubuisson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dennis, S. G.</span></span> <span> </span><span class="NLM_article-title">The Formalin Test: A Quantitative Study of the Analgesic Effects of Morphine, Meperidine, and Brain Stem Stimulation in Rats and Cats</span>. <i>Pain</i> <span class="NLM_year" style="font-weight: bold;">1977</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">161</span>– <span class="NLM_lpage">174</span>, <span class="refDoi"> DOI: 10.1016/0304-3959(77)90130-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2F0304-3959%2877%2990130-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=564014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADyaE1cXhsVGrt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1977&pages=161-174&author=D.+Dubuissonauthor=S.+G.+Dennis&title=The+Formalin+Test%3A+A+Quantitative+Study+of+the+Analgesic+Effects+of+Morphine%2C+Meperidine%2C+and+Brain+Stem+Stimulation+in+Rats+and+Cats&doi=10.1016%2F0304-3959%2877%2990130-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">The formalin test:  a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats</span></div><div class="casAuthors">Dubuisson, David; Dennis, Stephen G.</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">161-74</span>CODEN:
                <span class="NLM_cas:coden">PAINDB</span>;
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    </div><div class="casAbstract">In a procedure to evaluate the analgesic strengths of morphine sulfate  [64-31-3] and meperidine-HCl  [50-13-5], cats or rats, which were pretreated with an appropriate analgesic dose of either drug, were injected with a soln. of formalin  [50-00-0] in the paws and the pain-related behavior was obsd. and compared with that obsd. in the control animals which received formalin but no analgesic.  Pretreatment with either of the 2 analgesics or brain stem stimulation significantly decreased the effect of the pain stimuli.  Morphine and brain stem stimulation provided similar and greater analgesia than meperidine.  The behavioral patterns of the animals seemed to be similar following morphine or the brain stem stimultion.  Thus, formalin injection can be used effectively to evaluate the potencies of analgesics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGod0ErPKDkXGbVg90H21EOLACvtfcHk0lh1-DD3OVSfXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1cXhsVGrt7s%253D&md5=bd26bbc3c46b9c964d0b3aa011580980</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1016%2F0304-3959%2877%2990130-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0304-3959%252877%252990130-0%26sid%3Dliteratum%253Aachs%26aulast%3DDubuisson%26aufirst%3DD.%26aulast%3DDennis%26aufirst%3DS.%2BG.%26atitle%3DThe%2520Formalin%2520Test%253A%2520A%2520Quantitative%2520Study%2520of%2520the%2520Analgesic%2520Effects%2520of%2520Morphine%252C%2520Meperidine%252C%2520and%2520Brain%2520Stem%2520Stimulation%2520in%2520Rats%2520and%2520Cats%26jtitle%3DPain%26date%3D1977%26volume%3D4%26spage%3D161%26epage%3D174%26doi%3D10.1016%2F0304-3959%2877%2990130-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coderre, T. J.</span></span> <span> </span><span class="NLM_article-title">The Role of Excitatory Amino Acid Receptors and Intracellular Messengers in Persistent Nociception after Tissue Injury in Rats</span>. <i>Mol. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">229</span>– <span class="NLM_lpage">246</span>, <span class="refDoi"> DOI: 10.1007/BF02769177</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1007%2FBF02769177" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=7910027" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A280%3ADyaK2c3jsFWrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1993&pages=229-246&author=T.+J.+Coderre&title=The+Role+of+Excitatory+Amino+Acid+Receptors+and+Intracellular+Messengers+in+Persistent+Nociception+after+Tissue+Injury+in+Rats&doi=10.1007%2FBF02769177"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">The role of excitatory amino acid receptors and intracellular messengers in persistent nociception after tissue injury in rats</span></div><div class="casAuthors">Coderre T J</div><div class="citationInfo"><span class="NLM_cas:title">Molecular neurobiology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">229-46</span>
        ISSN:<span class="NLM_cas:issn">0893-7648</span>.
    </div><div class="casAbstract">Increased pain sensitivity (hyperalgesia) and persistent nociception following peripheral tissue injury depends both on an increase in the sensitivity of primary afferent nociceptors at the site of injury (peripheral sensitization), and on an increase in the excitability of neurons in the central nervous system (central sensitization).  We will review evidence that central sensitization, and the persistent nociception it leads to, are dependent on an action of glutamate and aspartate at excitatory amino acid (EAA) receptors.  Additional evidence will be presented implicating a role of various intracellular second messengers that are coupled to EAA receptors (nitric oxide, arachidonic acid, and protein kinase C) to central sensitization and persistent nociception following tissue injury.  Finally, we will examine the evidence for a contribution of molecular events, including noxious stimulus-induced expression of immediate-early genes such as c-fos to persistent nociception.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQn2GXGwDjtSsuCWE5mhx1RfW6udTcc2eb5atFASEUXHLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2c3jsFWrsQ%253D%253D&md5=3281e2d4d3b038f0c5677e11eff034e2</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1007%2FBF02769177&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02769177%26sid%3Dliteratum%253Aachs%26aulast%3DCoderre%26aufirst%3DT.%2BJ.%26atitle%3DThe%2520Role%2520of%2520Excitatory%2520Amino%2520Acid%2520Receptors%2520and%2520Intracellular%2520Messengers%2520in%2520Persistent%2520Nociception%2520after%2520Tissue%2520Injury%2520in%2520Rats%26jtitle%3DMol.%2520Neurobiol.%26date%3D1993%26volume%3D7%26spage%3D229%26epage%3D246%26doi%3D10.1007%2FBF02769177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chaplan, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bach, F. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pogrel, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yaksh, T. L.</span></span> <span> </span><span class="NLM_article-title">Quantitative Assessment of Tactile Allodynia in the Rat Paw</span>. <i>J Neurosci Methods</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">55</span>– <span class="NLM_lpage">63</span>, <span class="refDoi"> DOI: 10.1016/0165-0270(94)90144-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2F0165-0270%2894%2990144-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=7990513" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A280%3ADyaK2M%252Fot1Cjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1994&pages=55-63&author=S.+R.+Chaplanauthor=F.+W.+Bachauthor=J.+W.+Pogrelauthor=J.+M.+Chungauthor=T.+L.+Yaksh&title=Quantitative+Assessment+of+Tactile+Allodynia+in+the+Rat+Paw&doi=10.1016%2F0165-0270%2894%2990144-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative assessment of tactile allodynia in the rat paw</span></div><div class="casAuthors">Chaplan S R; Bach F W; Pogrel J W; Chung J M; Yaksh T L</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neuroscience methods</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">55-63</span>
        ISSN:<span class="NLM_cas:issn">0165-0270</span>.
    </div><div class="casAbstract">We applied and validated a quantitative allodynia assessment technique, using a recently developed rat surgical neuropathy model wherein nocifensive behaviors are evoked by light touch to the paw.  Employing von Frey hairs from 0.41 to 15.1 g, we first characterized the percent response at each stimulus intensity.  A smooth log-linear relationship was observed, with a median 50% threshold at 1.97 g (95% confidence limits, 1.12-3.57 g).  Subsequently, we applied a paradigm using stimulus oscillation around the response threshold, which allowed more rapid, efficient measurements.  Median 50% threshold by this up-down method was 2.4 g (1.81-2.76).  Correlation coefficient between the two methods was 0.91.  In neuropathic rats, good intra- and inter-observer reproducibility was found for the up-down paradigm; some variability was seen in normal rats, attributable to extensive testing.  Thresholds in a sizable group of neuropathic rats showed insignificant variability over 20 days.  After 50 days, 61% still met strict neuropathy criteria, using survival analysis.  Threshold measurement using the up-down paradigm, in combination with the neuropathic pain model, represents a powerful tool for analyzing the effects of manipulations of the neuropathic pain state.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTwRIqb5saCQ8AKB7Fa-xrUfW6udTcc2eb5atFASEUXHLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2M%252Fot1Cjug%253D%253D&md5=6c95ac46cbfc212e26d741f34e347707</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1016%2F0165-0270%2894%2990144-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-0270%252894%252990144-9%26sid%3Dliteratum%253Aachs%26aulast%3DChaplan%26aufirst%3DS.%2BR.%26aulast%3DBach%26aufirst%3DF.%2BW.%26aulast%3DPogrel%26aufirst%3DJ.%2BW.%26aulast%3DChung%26aufirst%3DJ.%2BM.%26aulast%3DYaksh%26aufirst%3DT.%2BL.%26atitle%3DQuantitative%2520Assessment%2520of%2520Tactile%2520Allodynia%2520in%2520the%2520Rat%2520Paw%26jtitle%3DJ%2520Neurosci%2520Methods%26date%3D1994%26volume%3D53%26spage%3D55%26epage%3D63%26doi%3D10.1016%2F0165-0270%2894%2990144-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Curtis, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cirino, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Docherty, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">George, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giembycz, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoyer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Insel, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izzo, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacEwan, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sobey, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanford, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teixeira, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wonnacott, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahluwalia, A.</span></span> <span> </span><span class="NLM_article-title">Experimental Design and Analysis and Their Reporting Ii: Updated and Simplified Guidance for Authors and Peer Reviewers</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>175</i></span>,  <span class="NLM_fpage">987</span>– <span class="NLM_lpage">993</span>, <span class="refDoi"> DOI: 10.1111/bph.14153</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1111%2Fbph.14153" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=29520785" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BC1cXktV2ntbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=175&publication_year=2018&pages=987-993&author=M.+J.+Curtisauthor=S.+Alexanderauthor=G.+Cirinoauthor=J.+R.+Dochertyauthor=C.+H.+Georgeauthor=M.+A.+Giembyczauthor=D.+Hoyerauthor=P.+A.+Inselauthor=A.+A.+Izzoauthor=Y.+Jiauthor=D.+J.+MacEwanauthor=C.+G.+Sobeyauthor=S.+C.+Stanfordauthor=M.+M.+Teixeiraauthor=S.+Wonnacottauthor=A.+Ahluwalia&title=Experimental+Design+and+Analysis+and+Their+Reporting+Ii%3A+Updated+and+Simplified+Guidance+for+Authors+and+Peer+Reviewers&doi=10.1111%2Fbph.14153"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers</span></div><div class="casAuthors">Curtis, Michael J.; Alexander, Steve; Cirino, Giuseppe; Docherty, James R.; George, Christopher H.; Giembycz, Mark A.; Hoyer, Daniel; Insel, Paul A.; Izzo, Angelo A.; Ji, Yong; MacEwan, David J.; Sobey, Christopher G.; Stanford, S. Clare; Teixeira, Mauro M.; Wonnacott, Sue; Ahluwalia, Amrita</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">175</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">987-993</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">This article updates the guidance published in 2015 for authors submitting papers to British Journal of Pharmacol. (Curtis et al., 2015) and is intended to provide the rubric for peer review.  Thus, it is directed towards authors, reviewers and editors.  Explanations for many of the requirements were outlined previously and are not restated here.  The new guidelines are intended to replace those published previously.  The guidelines have been simplified for ease of understanding by authors, to make it more straightforward for peer reviewers to check compliance and to facilitate the curation of the journal's efforts to improve stds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGog90PRcRkrKrVg90H21EOLACvtfcHk0ljgr-Lfox7TmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXktV2ntbs%253D&md5=4dee1eb4b76fe4aa368798bc9ec9087a</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1111%2Fbph.14153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.14153%26sid%3Dliteratum%253Aachs%26aulast%3DCurtis%26aufirst%3DM.%2BJ.%26aulast%3DAlexander%26aufirst%3DS.%26aulast%3DCirino%26aufirst%3DG.%26aulast%3DDocherty%26aufirst%3DJ.%2BR.%26aulast%3DGeorge%26aufirst%3DC.%2BH.%26aulast%3DGiembycz%26aufirst%3DM.%2BA.%26aulast%3DHoyer%26aufirst%3DD.%26aulast%3DInsel%26aufirst%3DP.%2BA.%26aulast%3DIzzo%26aufirst%3DA.%2BA.%26aulast%3DJi%26aufirst%3DY.%26aulast%3DMacEwan%26aufirst%3DD.%2BJ.%26aulast%3DSobey%26aufirst%3DC.%2BG.%26aulast%3DStanford%26aufirst%3DS.%2BC.%26aulast%3DTeixeira%26aufirst%3DM.%2BM.%26aulast%3DWonnacott%26aufirst%3DS.%26aulast%3DAhluwalia%26aufirst%3DA.%26atitle%3DExperimental%2520Design%2520and%2520Analysis%2520and%2520Their%2520Reporting%2520Ii%253A%2520Updated%2520and%2520Simplified%2520Guidance%2520for%2520Authors%2520and%2520Peer%2520Reviewers%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2018%26volume%3D175%26spage%3D987%26epage%3D993%26doi%3D10.1111%2Fbph.14153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 2 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Ragnhild G. Ohm, Mukandila Mulumba, Ramesh M. Chingle, Ahsanullah, Jinqiang Zhang, Sylvain Chemtob, Huy Ong, <span class="NLM_string-name hlFld-ContribAuthor">William D. Lubell</span>. </span><span class="cited-content_cbyCitation_article-title">Diversity-Oriented A3-Macrocyclization for Studying Influences of Ring-Size and Shape of Cyclic Peptides: CD36 Receptor Modulators. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (13)
                                     , 9365-9380. <a href="https://doi.org/10.1021/acs.jmedchem.1c00642" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00642</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00642%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiversity-Oriented%252BA3-Macrocyclization%252Bfor%252BStudying%252BInfluences%252Bof%252BRing-Size%252Band%252BShape%252Bof%252BCyclic%252BPeptides%25253A%252BCD36%252BReceptor%252BModulators%26aulast%3DOhm%26aufirst%3DRagnhild%2BG.%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D07042021%26date%3D23062021%26volume%3D64%26issue%3D13%26spage%3D9365%26epage%3D9380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="NLM_string-name hlFld-ContribAuthor">Philippe Sarret</span>. </span><span class="cited-content_cbyCitation_article-title">Éric Marsault (1971–2021): A Legacy through the Prism of Relationship Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (9)
                                     , 5221-5224. <a href="https://doi.org/10.1021/acs.jmedchem.1c00481" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00481</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00481&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00481%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D%2525C3%252589ric%252BMarsault%252B%2525281971%2525E2%252580%2525932021%252529%25253A%252BA%252BLegacy%252Bthrough%252Bthe%252BPrism%252Bof%252BRelationship%252BChemistry%26aulast%3DSarret%26aufirst%3DPhilippe%26date%3D2021%26date%3D2021%26date%3D24032021%26volume%3D64%26issue%3D9%26spage%3D5221%26epage%3D5224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01726/20210218/images/medium/jm0c01726_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01726/20210218/images/large/jm0c01726_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01726&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01726/20210218/images/medium/jm0c01726_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01726/20210218/images/large/jm0c01726_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Macrocyclic NT(8-13) analogs previously described in the literature. Data taken from ref <a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> (<b>M1</b>, <b>M3</b>, <b>M6</b>, and <b>M7</b>); ref <a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> (<b>M2</b>); ref <a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> (<b>M4</b>); ref <a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> (<b>M5</b>); ref <a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> (<b>M8</b>); ref <a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> (<b>M9</b>), and ref <a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> (<b>M10</b>, <b>M11</b>, and <b>M12</b>). K<sub>i</sub>’s for NTS1 are values reported in the original articles. For NTS2, K<sub>i</sub> values of <b>M9</b> to <b>M12</b> have never been published elsewhere.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01726/20210218/images/large/jm0c01726_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01726&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01726/20210218/images/medium/jm0c01726_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01726/20210218/images/large/jm0c01726_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Solid phase synthesis of the reference compound <b>4</b>. (a) Fmoc-Leu-OH, DIPEA, DCM, rt, 2 h. (b) Piperidine 20% DMF, rt, 2 x 5 min. (c) 1. Fmoc-Tyr(tBu)-OH, DIPEA, DMF, rt, 30 min; 2. Fmoc-AllylGly-OH, DIPEA, DMF, rt, 30 min; 3. Fmoc-Lys(Boc)-OH, DIPEA, DMF, rt, 30 min; 4. Fmoc-Lys(Boc)-OH, DIPEA, DMF, rt, 30 min ;5. Boc-AllylGly-OH, DIPEA, DMF, rt, 30 min. (d) Grubbs–Hoveyda second-generation 0.2 eq, DCE, microwave, 70 °C, 1 h. (e) TFA/TIPS/H<sub>2</sub>O 95/2.5/2.5%, rt, 2 h.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01726/20210218/images/large/jm0c01726_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01726&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01726/20210218/images/medium/jm0c01726_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01726/20210218/images/large/jm0c01726_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Analgesic effects of compound <b>4</b> and morphine on tail-flick latencies in Sprague-Dawley rats. (A) Time course of the analgesic effect of an acute intrathecal injection of <b>4</b> from doses ranging from 10 to 150 μg/kg. (B) Percentage of maximal possible effect (%MPE) calculated at the maximal antinociceptive response for each dose. (C) Determination of the analgesic effective dose (ED<sub>50</sub>). (D) Dose–response curve for s.c. morphine from 1 to 10 mg/kg, (E) %MPE, and (F) ED<sub>50</sub>. (G, H) Naloxone’s ability to antagonize (10 mg/kg, intraperitoneal) the analgesic effect of macrocycle <b>4</b>. Results are expressed as mean ± SEM (<i>N</i> = 5/group). For time courses (A, D, G), comparisons between saline and compounds at different doses were performed using a two-way ANOVA with repeated measures followed by multiple comparisons using Dunnett’s correction. For the %MPE (B, E, H), comparisons were performed using a one-way ANOVA with repeated measures followed by multiple comparisons using Dunnett’s correction between saline and compound <b>4</b> or morphine at different doses and nonlinear regression using four parameters. *<i>p</i> < 0.05, **<i>p</i> < 0.01, ***<i>p</i> < 0.001, ****<i>p</i> < 0.0001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01726/20210218/images/large/jm0c01726_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01726&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01726/20210218/images/medium/jm0c01726_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01726/20210218/images/large/jm0c01726_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Analgesic effect of acute intrathecal injection of 30 to 150 μg/kg compound <b>4</b> or of ziconotide (1 μg/kg) on formalin-evoked pain-related behaviors in Sprague-Dawley rats. The nociceptive response was determined for both acute (A) and inflammatory phases (B). Results are expressed as mean ± SEM (<i>N</i> = 5–6/group). Comparisons between saline, ziconotide, and macrocycle <b>4</b> at different doses were performed using one-way ANOVA with repeated measures followed by multiple comparisons using Dunnett’s correction. *<i>p</i> < 0.05, **<i>p</i> < 0.01.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01726/20210218/images/large/jm0c01726_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01726&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01726/20210218/images/medium/jm0c01726_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01726/20210218/images/large/jm0c01726_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Antiallodynic effect of intrathecal injection of compound <b>4</b> at 150 μg/kg on days 7 and 14 in a model of chronic inflammatory pain induced by intraplantar injection of complete Freund’s adjuvant (CFA) in Sprague-Dawley rats (A). Percentage of antiallodynic effect was determined at the maximal analgesic effect, 10 min post-injection, on day 7 (B) and 14 (C). Results are expressed as mean ± SEM (<i>N</i> = 6/group). For the time course, comparisons between sham animals and CFA rats treated with saline (#) or between CFA rats receiving either saline or compound <b>4</b> (*) were performed on days 3, 7, and 14 using a two-way analysis of variance for repeated measures followed by multiple comparisons using Dunnett’s correction and comparisons. For the % of antiallodynic effect determined on days 7 and 14, comparisons between sham animals and CFA rats treated with saline (#) or CFA rats receiving either saline or <b>4</b> (*) were performed using one-way analysis of variance for repeated measures followed by multiple comparisons using Dunnett’s correction. **<i>p</i> < 0.01, ****<i>p</i> < 0.0001, ####<i>p</i> < 0.0001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01726/20210218/images/large/jm0c01726_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01726&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01726/20210218/images/medium/jm0c01726_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01726/20210218/images/large/jm0c01726_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effect of compound <b>4</b> on blood pressure, body temperature, and smooth muscle contraction. (A) Delta mean arterial blood pressure (ΔMABP) recorded after intravenous injection of NT(8-13) at 0.1 mg/kg or compound <b>4</b> at 0.01, 0.1, or 1 mg/kg to Sprague-Dawley rats. (B) Variation in body temperature measured after intrathecal injection of saline, NTS1-selective PD149163 at 30 μg/kg or compound <b>4</b> at 150 μg/kg. (C) Percentage of ileum relaxation monitored following incubation with increasing concentrations of NT(8-13) or compound <b>4</b> ranging from 10<sup>–11</sup> to 10<sup>–5</sup> M. Results are expressed as mean ± SEM (<i>N</i> = 5–6/group). For body temperature, comparisons between saline and PD149163 or <b>4</b> were performed using a two-way analysis of variance for repeated measures followed by multiple comparisons using Dunnett’s correction. Nonlinear regression using three parameters was performed for % of ileum relaxation. NT(8-13) EC<sub>50</sub> value was obtained from the resulting dose–response curve. ***<i>p</i> < 0.001, ****<i>p</i> < 0.0001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01726/20210218/images/large/jm0c01726_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01726&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i48">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33516" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33516" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 107 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
Leon-Casasola, O. A.</span></span> <span> </span><span class="NLM_article-title">Opioids for Chronic Pain: New Evidence, New Strategies, Safe Prescribing</span>. <i>Am. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>126</i></span>,  <span class="NLM_fpage">S3</span>– <span class="NLM_lpage">S11</span>, <span class="refDoi"> DOI: 10.1016/j.amjmed.2012.11.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2Fj.amjmed.2012.11.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=23414718" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjt1Sgsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2013&pages=S3-S11&author=O.+A.+de%0ALeon-Casasola&title=Opioids+for+Chronic+Pain%3A+New+Evidence%2C+New+Strategies%2C+Safe+Prescribing&doi=10.1016%2Fj.amjmed.2012.11.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Opioids for Chronic Pain: New Evidence, New Strategies, Safe Prescribing</span></div><div class="casAuthors">de Leon-Casasola, Oscar A.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">3, Suppl. 1</span>),
    <span class="NLM_cas:pages">S3-S11</span>CODEN:
                <span class="NLM_cas:coden">AJMEAZ</span>;
        ISSN:<span class="NLM_cas:issn">0002-9343</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  In the United States, the prevalence and burden of chronic pain is large and still growing.  Older adults (aged ≥65 years) make up a large portion of the population with chronic pain, and their presentation, diagnosis, and treatment tends to be more complicated because of age-related physiol. changes and comorbidities.  Guidelines on treating patients with severe back pain recommend opioids as an option for those who do not find adequate pain relief from acetaminophen or nonsteroidal anti-inflammatory drugs (NSAIDs).  For older adult patients at higher risk for NSAID-related adverse effects, such as those who have gastrointestinal or cardiovascular disease, diabetes mellitus, or who are taking low-dose aspirin, opioids are recommended instead.  Opioids may also be an appropriate option for patients with neuropathic pain who have not achieved adequate analgesia from max. doses of first- and second-line antineuropathic agents.  Still, opioids are not appropriate for all patients; rather, a differential diagnosis, consideration of other comorbidities, and the potential for opioid-related adverse effects and substance abuse are required to confirm the value of opioid treatment for each individual.  For nonresponders to opioid therapy, opioid rotation should be considered before discontinuation is pursued.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSKzLJyz7UeLVg90H21EOLACvtfcHk0ljo9FzTc8cdTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjt1Sgsr8%253D&md5=03d6831cc14515153cf4040a31a053a2</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.amjmed.2012.11.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.amjmed.2012.11.011%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BLeon-Casasola%26aufirst%3DO.%2BA.%26atitle%3DOpioids%2520for%2520Chronic%2520Pain%253A%2520New%2520Evidence%252C%2520New%2520Strategies%252C%2520Safe%2520Prescribing%26jtitle%3DAm.%2520J.%2520Med.%26date%3D2013%26volume%3D126%26spage%3DS3%26epage%3DS11%26doi%3D10.1016%2Fj.amjmed.2012.11.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Balch, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trescot, A.</span></span> <span> </span><span class="NLM_article-title">Extended-Release Morphine Sulfate in Treatment of Severe Acute and Chronic Pain</span>. <i>J. Pain. Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">191</span>– <span class="NLM_lpage">200</span>, <span class="refDoi"> DOI: 10.2147/JPR.S6529</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.2147%2FJPR.S6529" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=21197323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1SksLzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2010&pages=191-200&author=R.+J.+Balchauthor=A.+Trescot&title=Extended-Release+Morphine+Sulfate+in+Treatment+of+Severe+Acute+and+Chronic+Pain&doi=10.2147%2FJPR.S6529"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Extended-release morphine sulfate in treatment of severe acute and chronic pain</span></div><div class="casAuthors">Balch, Robert J.; Trescot, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pain Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">191-200</span>CODEN:
                <span class="NLM_cas:coden">JPROEV</span>;
        ISSN:<span class="NLM_cas:issn">1178-7090</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">A review.  Morphine is the archetypal opioid analgesic.  Because it is a short-acting opioid, its use has been limited to the management of acute pain.  The development of extended-release formulations have resulted in the increased utilization of morphine in chronic pain conditions.  This review documents the history of morphine use in pain treatment, and describes the metab., pharmacodynamics, formulations, and efficacy of the currently available extended-release morphine medications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDpi5M0cwDc7Vg90H21EOLACvtfcHk0ljo9FzTc8cdTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1SksLzM&md5=4168f806d9bca0b7511d17102e49ef5c</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.2147%2FJPR.S6529&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FJPR.S6529%26sid%3Dliteratum%253Aachs%26aulast%3DBalch%26aufirst%3DR.%2BJ.%26aulast%3DTrescot%26aufirst%3DA.%26atitle%3DExtended-Release%2520Morphine%2520Sulfate%2520in%2520Treatment%2520of%2520Severe%2520Acute%2520and%2520Chronic%2520Pain%26jtitle%3DJ.%2520Pain.%2520Res.%26date%3D2010%26volume%3D3%26spage%3D191%26epage%3D200%26doi%3D10.2147%2FJPR.S6529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stein, C.</span></span> <span> </span><span class="NLM_article-title">Opioid Analgesia: Recent Developments</span>. <i>Curr. Opin. Supportive Palliative Care</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">112</span>– <span class="NLM_lpage">117</span>, <span class="refDoi"> DOI: 10.1097/SPC.0000000000000495</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1097%2FSPC.0000000000000495" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=32304400" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A280%3ADC%252BB38zms1aruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2020&pages=112-117&author=C.+Stein&title=Opioid+Analgesia%3A+Recent+Developments&doi=10.1097%2FSPC.0000000000000495"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Opioid analgesia: recent developments</span></div><div class="casAuthors">Stein Christoph</div><div class="citationInfo"><span class="NLM_cas:title">Current opinion in supportive and palliative care</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">112-117</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE OF REVIEW:  Opioids are potent drugs for the treatment of severe pain, but they are burdened by detrimental side-effects, such as respiratory depression, addiction, sedation and constipation.  Their clinical application is undisputed in acute (e.g. perioperative) and cancer pain, but their use in chronic nonmalignant pain has met increasing scrutiny and has contributed to the opioid crisis.  Thus, novel analgesics with reduced side-effects are badly needed.  RECENT FINDINGS:  Current research topics include enkephalinase inhibitors, allosteric and multivalent ligands, biased opioid receptor signaling and selective activation of peripheral opioid receptors in injured tissues.  SUMMARY:  Opioids still appear to be most promising among current approaches in the development of analgesics.  Basic knowledge about pathophysiology of clinical pain and novel insights in pharmacology suggest that the most interesting perspectives are augmenting endogenous opioid actions and selectively targeting peripheral opioid receptors.  The latter approach is additionally supported by evidence from clinical studies.  Some biased, multivalent and peripherally selective agonists have advanced to phase III trials, but novel drugs have not become available for clinical application.  Future strategies in analgesic drug development might include public-private partnerships and nonprofit pharmaceutical companies, as exemplified by the AIDS crisis and proposals to combat antibiotic resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcStgl7bjC9fa-vW160gIxP_fW6udTcc2eZ1tyR7IMNJ7rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB38zms1aruw%253D%253D&md5=4b9674952ab21b82a438efc5299af472</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1097%2FSPC.0000000000000495&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FSPC.0000000000000495%26sid%3Dliteratum%253Aachs%26aulast%3DStein%26aufirst%3DC.%26atitle%3DOpioid%2520Analgesia%253A%2520Recent%2520Developments%26jtitle%3DCurr.%2520Opin.%2520Supportive%2520Palliative%2520Care%26date%3D2020%26volume%3D14%26spage%3D112%26epage%3D117%26doi%3D10.1097%2FSPC.0000000000000495" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fornasari, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allegri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerboni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fanelli, G.</span></span> <span> </span><span class="NLM_article-title">A ″Novel″ Association to Treat Pain: Tramadol/Dexketoprofen. The First Drug of a ″New Pharmacological Class″</span>. <i>Acta Biomed.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">17</span>– <span class="NLM_lpage">24</span>, <span class="refDoi"> DOI: 10.23750/abm.v88i1.6361</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.23750%2Fabm.v88i1.6361" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=28467329" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFOku7rP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2017&pages=17-24&author=D.+Fornasariauthor=M.+Allegriauthor=S.+Gerboniauthor=G.+Fanelli&title=A+%E2%80%B3Novel%E2%80%B3+Association+to+Treat+Pain%3A+Tramadol%2FDexketoprofen.+The+First+Drug+of+a+%E2%80%B3New+Pharmacological+Class%E2%80%B3&doi=10.23750%2Fabm.v88i1.6361"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">A "novel" association to treat pain: tramadol/dexketoprofen. The first drug of a "new pharmacological class"</span></div><div class="casAuthors">Fornasari, D.; Allegri, M.; Gerboni, S.; Fanelli, G.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Bio Medica Atenei Parmensis</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17-24</span>CODEN:
                <span class="NLM_cas:coden">ABMAC3</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Mattioli 1885</span>)
        </div><div class="casAbstract">Acute and chronic pain have an important socio-economical impact.  In order to help physicians to choose the appropriate drug, esp. for cancer pain, in 1986 WHO has developed a three-step analgesic "ladder" for cancer pain relief in adults.  Later it has also been used for acute pain and chronic non-cancer pain.  In step I nonsteroidal anti-inflammatory drugs (NSAIDs) are considered with or without adjuvants, in step II the use of weak opioids for mild-moderate pain, with or without NSAIDs and adjuvant, is suggested, while the step III is reserved to strong opioids for moderate-severe pain with or without non-opioids or adjuvants.  In the last two decades, a better pathophysiol. knowledge has improved pain management shifting our view from the pain ladder to a modern pain pyramid, in which drugs are selected not only on the basis of pain intensity, but mainly according to mechanisms underlying pain, including peripheral and spinal sensitization which is the main trigger of chronic pain.  The best pharmacol. approach has become multimodal, in which drugs belonging to different steps should be combined, matching the mechanisms of action with the type of pain.  An important corollary of combining analgesic drugs with different mechanism of action is that proper matching achieves the same effect with lower doses, better outcome and fewer adverse effects.  In this new perspective, fixed-dose pharmaceutical combinations of different drugs are very useful to fulfil pharmacodynamics, pharmacokinetics and adherence criteria, enriching the pain pyramid of half-steps between the first and second step and between the second and third step.  Hence, a new fixed combination of a NSAID with peripheral and central anti-infilammatory activities, such as dexketoprofen, and a weak opioid, such as tramadol, with double analgesic activity in the spinal cord as an opioid and, at the same time, on the descending modulatory pathways, is expected to cover a wide range of acute and recurrent painful conditions, ranging from nociceptive inflammatory pain to neuropathic pain of moderate/severe intensity.  In this review we evaluate the rationale that justifies its use as new class of pharmacol. modality to treat pain accordingly also to a more update view of WHO pain ladder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGQ5T4GXqRV7Vg90H21EOLACvtfcHk0liKKcjmtccuuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFOku7rP&md5=7d30261335f53036ff02f116a1ae649f</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.23750%2Fabm.v88i1.6361&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.23750%252Fabm.v88i1.6361%26sid%3Dliteratum%253Aachs%26aulast%3DFornasari%26aufirst%3DD.%26aulast%3DAllegri%26aufirst%3DM.%26aulast%3DGerboni%26aufirst%3DS.%26aulast%3DFanelli%26aufirst%3DG.%26atitle%3DA%2520%25E2%2580%25B3Novel%25E2%2580%25B3%2520Association%2520to%2520Treat%2520Pain%253A%2520Tramadol%252FDexketoprofen.%2520The%2520First%2520Drug%2520of%2520a%2520%25E2%2580%25B3New%2520Pharmacological%2520Class%25E2%2580%25B3%26jtitle%3DActa%2520Biomed.%26date%3D2017%26volume%3D88%26spage%3D17%26epage%3D24%26doi%3D10.23750%2Fabm.v88i1.6361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Finnerup, N. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Attal, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haroutounian, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNicol, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baron, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dworkin, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilron, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haanpää, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamerman, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lund, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raja, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rice, A. S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowbotham, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sena, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siddall, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallace, M.</span></span> <span> </span><span class="NLM_article-title">Pharmacotherapy for Neuropathic Pain in Adults: A Systematic Review and Meta-Analysis</span>. <i>Lancet Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">162</span>– <span class="NLM_lpage">173</span>, <span class="refDoi"> DOI: 10.1016/S1474-4422(14)70251-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2FS1474-4422%2814%2970251-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=25575710" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BC2MXovFygsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=162-173&author=N.+B.+Finnerupauthor=N.+Attalauthor=S.+Haroutounianauthor=E.+McNicolauthor=R.+Baronauthor=R.+H.+Dworkinauthor=I.+Gilronauthor=M.+Haanp%C3%A4%C3%A4author=P.+Hanssonauthor=T.+S.+Jensenauthor=P.+R.+Kamermanauthor=K.+Lundauthor=A.+Mooreauthor=S.+N.+Rajaauthor=A.+S.+C.+Riceauthor=M.+Rowbothamauthor=E.+Senaauthor=P.+Siddallauthor=B.+H.+Smithauthor=M.+Wallace&title=Pharmacotherapy+for+Neuropathic+Pain+in+Adults%3A+A+Systematic+Review+and+Meta-Analysis&doi=10.1016%2FS1474-4422%2814%2970251-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis</span></div><div class="casAuthors">Finnerup, Nanna B.; Attal, Nadine; Haroutounian, Simon; McNicol, Ewan; Baron, Ralf; Dworkin, Robert H.; Gilron, Ian; Haanpaa, Maija; Hansson, Per; Jensen, Troels S.; Kamerman, Peter R.; Lund, Karen; Moore, Andrew; Raja, Srinivasa N.; Rice, Andrew S. C.; Rowbotham, Michael; Sena, Emily; Siddall, Philip; Smith, Blair H.; Wallace, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">162-173</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">New drug treatments, clin. trials, and stds. of quality for assessment of evidence justify an update of evidence-based recommendations for the pharmacol. treatment of neuropathic pain.  Using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE), we revised the Special Interest Group on Neuropathic Pain (NeuPSIG) recommendations for the pharmacotherapy of neuropathic pain based on the results of a systematic review and meta-anal.  Between Apr., 2013, and Jan., 2014, NeuPSIG of the International Assocn. for the Study of Pain did a systematic review and meta-anal. of randomised, double-blind studies of oral and topical pharmacotherapy for neuropathic pain, including studies published in peer-reviewed journals since Jan., 1966, and unpublished trials retrieved from ClinicalTrials.gov and websites of pharmaceutical companies.  We used no. needed to treat (NNT) for 50% pain relief as a primary measure and assessed publication bias; NNT was calcd. with the fixed-effects Mantel-Haenszel method.229 studies were included in the meta-anal.  Anal. of publication bias suggested a 10% overstatement of treatment effects.  Studies published in peer-reviewed journals reported greater effects than did unpublished studies (r2 9·3%, p=0·009).  Trial outcomes were generally modest: in particular, combined NNTs were 6·4 (95% CI 5·2-8·4) for serotonin-noradrenaline reuptake inhibitors, mainly including duloxetine (nine of 14 studies); 7·7 (6·5-9·4) for pregabalin; 7·2 (5·9-9·21) for gabapentin, including gabapentin extended release and enacarbil; and 10·6 (7·4-19·0) for capsaicin high-concn. patches.  NNTs were lower for tricyclic antidepressants, strong opioids, tramadol, and botulinum toxin A, and undetd. for lidocaine patches.  Based on GRADE, final quality of evidence was moderate or high for all treatments apart from lidocaine patches; tolerability and safety, and values and preferences were higher for topical drugs; and cost was lower for tricyclic antidepressants and tramadol.  These findings permitted a strong recommendation for use and proposal as first-line treatment in neuropathic pain for tricyclic antidepressants, serotonin-noradrenaline reuptake inhibitors, pregabalin, and gabapentin; a weak recommendation for use and proposal as second line for lidocaine patches, capsaicin high-concn. patches, and tramadol; and a weak recommendation for use and proposal as third line for strong opioids and botulinum toxin A.  Topical agents and botulinum toxin A are recommended for peripheral neuropathic pain only.  Our results support a revision of the NeuPSIG recommendations for the pharmacotherapy of neuropathic pain.  Inadequate response to drug treatments constitutes a substantial unmet need in patients with neuropathic pain.  Modest efficacy, large placebo responses, heterogeneous diagnostic criteria, and poor phenotypic profiling probably account for moderate trial outcomes and should be taken into account in future studies.  NeuPSIG of the International Assocn. for the Study of Pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGog3lY2ykFKHrVg90H21EOLACvtfcHk0lj6rgz3D0Xyug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXovFygsw%253D%253D&md5=aaae3dd82ea6896d3977412faedebffd</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2814%2970251-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252814%252970251-0%26sid%3Dliteratum%253Aachs%26aulast%3DFinnerup%26aufirst%3DN.%2BB.%26aulast%3DAttal%26aufirst%3DN.%26aulast%3DHaroutounian%26aufirst%3DS.%26aulast%3DMcNicol%26aufirst%3DE.%26aulast%3DBaron%26aufirst%3DR.%26aulast%3DDworkin%26aufirst%3DR.%2BH.%26aulast%3DGilron%26aufirst%3DI.%26aulast%3DHaanp%25C3%25A4%25C3%25A4%26aufirst%3DM.%26aulast%3DHansson%26aufirst%3DP.%26aulast%3DJensen%26aufirst%3DT.%2BS.%26aulast%3DKamerman%26aufirst%3DP.%2BR.%26aulast%3DLund%26aufirst%3DK.%26aulast%3DMoore%26aufirst%3DA.%26aulast%3DRaja%26aufirst%3DS.%2BN.%26aulast%3DRice%26aufirst%3DA.%2BS.%2BC.%26aulast%3DRowbotham%26aufirst%3DM.%26aulast%3DSena%26aufirst%3DE.%26aulast%3DSiddall%26aufirst%3DP.%26aulast%3DSmith%26aufirst%3DB.%2BH.%26aulast%3DWallace%26aufirst%3DM.%26atitle%3DPharmacotherapy%2520for%2520Neuropathic%2520Pain%2520in%2520Adults%253A%2520A%2520Systematic%2520Review%2520and%2520Meta-Analysis%26jtitle%3DLancet%2520Neurol.%26date%3D2015%26volume%3D14%26spage%3D162%26epage%3D173%26doi%3D10.1016%2FS1474-4422%2814%2970251-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Attal, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouhassira, D.</span></span> <span> </span><span class="NLM_article-title">Pharmacotherapy of Neuropathic Pain: Which Drugs, Which Treatment Algorithms?</span>. <i>Pain</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>156</i></span>,  <span class="NLM_fpage">S104</span>– <span class="NLM_lpage">S114</span>, <span class="refDoi"> DOI: 10.1097/01.j.pain.0000460358.01998.15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1097%2F01.j.pain.0000460358.01998.15" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=25789426" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=2015&pages=S104-S114&author=N.+Attalauthor=D.+Bouhassira&title=Pharmacotherapy+of+Neuropathic+Pain%3A+Which+Drugs%2C+Which+Treatment+Algorithms%3F&doi=10.1097%2F01.j.pain.0000460358.01998.15"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1097%2F01.j.pain.0000460358.01998.15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F01.j.pain.0000460358.01998.15%26sid%3Dliteratum%253Aachs%26aulast%3DAttal%26aufirst%3DN.%26aulast%3DBouhassira%26aufirst%3DD.%26atitle%3DPharmacotherapy%2520of%2520Neuropathic%2520Pain%253A%2520Which%2520Drugs%252C%2520Which%2520Treatment%2520Algorithms%253F%26jtitle%3DPain%26date%3D2015%26volume%3D156%26spage%3DS104%26epage%3DS114%26doi%3D10.1097%2F01.j.pain.0000460358.01998.15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Afsharimani, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kindl, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Good, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardy, J.</span></span> <span> </span><span class="NLM_article-title">Pharmacological Options for the Management of Refractory Cancer Pain-What Is the Evidence?</span>. <i>Support Care Cancer</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1473</span>– <span class="NLM_lpage">1481</span>, <span class="refDoi"> DOI: 10.1007/s00520-015-2678-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1007%2Fs00520-015-2678-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=25749509" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A280%3ADC%252BC2MnitFGktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=1473-1481&author=B.+Afsharimaniauthor=K.+Kindlauthor=P.+Goodauthor=J.+Hardy&title=Pharmacological+Options+for+the+Management+of+Refractory+Cancer+Pain-What+Is+the+Evidence%3F&doi=10.1007%2Fs00520-015-2678-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological options for the management of refractory cancer pain-what is the evidence?</span></div><div class="casAuthors">Afsharimani B; Kindl K; Good P; Hardy J</div><div class="citationInfo"><span class="NLM_cas:title">Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1473-81</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Refractory cancer pain that does not respond to standard opioid and/or co-analgesic therapy occurs in 10-20 % of patients.  Risk factors include young age, neuropathic pain type, incident pain, psychological distress, previous opioid use, high tolerance, a history of addiction and impaired cognition.  The management of patients with refractory pain remains a challenge.  Treatment options include opioid manipulation (parenteral delivery, rotation, combination, methadone and buprenorphine), non-opioids and co-analgesics (paracetamol, non-steroidal anti-inflammatory agents, antidepressants and anticonvulsants), NMDA receptor antagonists, cannabinoids, lignocaine and corticosteroids.  The evidence of benefit for any of these agents is weak, and each additional agent increases the risk of adverse events.  Evidence-based guidelines cannot, therefore, be developed at present.  New approaches are recommended including targeted opioid therapy, multimodal analgesia, a goal-oriented approach to pain management and increasing use of the multidisciplinary team and support services.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS5Ma1donXoAijiVMCqkKxVfW6udTcc2eYhqkJmuQEhWLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MnitFGktg%253D%253D&md5=7a437a90f384fba6f4615d181cd120e2</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1007%2Fs00520-015-2678-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00520-015-2678-9%26sid%3Dliteratum%253Aachs%26aulast%3DAfsharimani%26aufirst%3DB.%26aulast%3DKindl%26aufirst%3DK.%26aulast%3DGood%26aufirst%3DP.%26aulast%3DHardy%26aufirst%3DJ.%26atitle%3DPharmacological%2520Options%2520for%2520the%2520Management%2520of%2520Refractory%2520Cancer%2520Pain-What%2520Is%2520the%2520Evidence%253F%26jtitle%3DSupport%2520Care%2520Cancer%26date%3D2015%26volume%3D23%26spage%3D1473%26epage%3D1481%26doi%3D10.1007%2Fs00520-015-2678-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Benyamin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trescot, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Datta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buenaventura, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adlaka, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sehgal, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glaser, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vallejo, R.</span></span> <span> </span><span class="NLM_article-title">Opioid Complications and Side Effects</span>. <i>Pain Physician</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">S105</span>– <span class="NLM_lpage">S120</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=18443635" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A280%3ADC%252BD1czosVSjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2008&pages=S105-S120&author=R.+Benyaminauthor=A.+M.+Trescotauthor=S.+Dattaauthor=R.+Buenaventuraauthor=R.+Adlakaauthor=N.+Sehgalauthor=S.+E.+Glaserauthor=R.+Vallejo&title=Opioid+Complications+and+Side+Effects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Opioid complications and side effects</span></div><div class="casAuthors">Benyamin Ramsin; Trescot Andrea M; Datta Sukdeb; Buenaventura Ricardo; Adlaka Rajive; Sehgal Nalini; Glaser Scott E; Vallejo Ricardo</div><div class="citationInfo"><span class="NLM_cas:title">Pain physician</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2 Suppl</span>),
    <span class="NLM_cas:pages">S105-20</span>
        ISSN:<span class="NLM_cas:issn">1533-3159</span>.
    </div><div class="casAbstract">Medications which bind to opioid receptors are increasingly being prescribed for the treatment of multiple and diverse chronic painful conditions.  Their use for acute pain or terminal pain is well accepted.  Their role in the long-term treatment of chronic noncancer pain is, however, controversial for many reasons.  One of the primary reasons is the well-known phenomenon of psychological addiction that can occur with the use of these medications.  Abuse and diversion of these medications is a growing problem as the availability of these medications increases and this public health issue confounds their clinical utility.  Also, the extent of their efficacy in the treatment of pain when utilized on a chronic basis has not been definitively proven.  Lastly, the role of opioids in the treatment of chronic pain is also influenced by the fact that these potent analgesics are associated with a significant number of side effects and complications.  It is these phenomena that are the focus of this review.  Common side effects of opioid administration include sedation, dizziness, nausea, vomiting, constipation, physical dependence, tolerance, and respiratory depression.  Physical dependence and addiction are clinical concerns that may prevent proper prescribing and in turn inadequate pain management.  Less common side effects may include delayed gastric emptying, hyperalgesia, immunologic and hormonal dysfunction, muscle rigidity, and myoclonus.  The most common side effects of opioid usage are constipation (which has a very high incidence) and nausea.  These 2 side effects can be difficult to manage and frequently tolerance to them does not develop; this is especially true for constipation.  They may be severe enough to require opioid discontinuation, and contribute to under-dosing and inadequate analgesia.  Several clinical trials are underway to identify adjunct therapies that may mitigate these side effects.  Switching opioids and/or routes of administration may also provide benefits for patients.  Proper patient screening, education, and preemptive treatment of potential side effects may aid in maximizing effectiveness while reducing the severity of side effects and adverse events.  Opioids can be considered broad spectrum analgesic agents, affecting a wide number of organ systems and influencing a large number of body functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRS-eBn7Ppy6vx2phytoz6_fW6udTcc2eYhqkJmuQEhWLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1czosVSjsQ%253D%253D&md5=26196f3cc302b1cad86e32477bb52e18</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBenyamin%26aufirst%3DR.%26aulast%3DTrescot%26aufirst%3DA.%2BM.%26aulast%3DDatta%26aufirst%3DS.%26aulast%3DBuenaventura%26aufirst%3DR.%26aulast%3DAdlaka%26aufirst%3DR.%26aulast%3DSehgal%26aufirst%3DN.%26aulast%3DGlaser%26aufirst%3DS.%2BE.%26aulast%3DVallejo%26aufirst%3DR.%26atitle%3DOpioid%2520Complications%2520and%2520Side%2520Effects%26jtitle%3DPain%2520Physician%26date%3D2008%26volume%3D11%26spage%3DS105%26epage%3DS120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chu, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angst, M. S.</span></span> <span> </span><span class="NLM_article-title">Opioid Tolerance and Hyperalgesia in Chronic Pain Patients after One Month of Oral Morphine Therapy: A Preliminary Prospective Study</span>. <i>J. Pain</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">43</span>– <span class="NLM_lpage">48</span>, <span class="refDoi"> DOI: 10.1016/j.jpain.2005.08.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2Fj.jpain.2005.08.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=16414554" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BD28Xls1Wgtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=43-48&author=L.+F.+Chuauthor=D.+J.+Clarkauthor=M.+S.+Angst&title=Opioid+Tolerance+and+Hyperalgesia+in+Chronic+Pain+Patients+after+One+Month+of+Oral+Morphine+Therapy%3A+A+Preliminary+Prospective+Study&doi=10.1016%2Fj.jpain.2005.08.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Opioid Tolerance and Hyperalgesia in Chronic Pain Patients After One Month of Oral Morphine Therapy: A Preliminary Prospective Study</span></div><div class="casAuthors">Chu, Larry F.; Clark, David J.; Angst, Martin S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pain</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43-48</span>CODEN:
                <span class="NLM_cas:coden">JPOAB5</span>;
        ISSN:<span class="NLM_cas:issn">1526-5900</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">There is accumulating evidence that opioid therapy might not only be assocd. with the development of tolerance but also with an increased sensitivity to pain, a condition referred to as opioid-induced hyperalgesia (OIH).  However, there are no prospective studies documenting the development of opioid tolerance or OIH in patients with chronic pain.  This preliminary study in 6 patients with chronic low back pain prospectively evaluated the development of tolerance and OIH.  Patients were assessed before and 1 mo after initiating oral morphine therapy.  The cold pressor test and exptl. heat pain were used to measure pain sensitivity before and during a target-controlled infusion with the short-acting μ opioid agonist remifentanil.  In the cold pressor test, all patients became hyperalgesic as well as tolerant after 1 mo of oral morphine therapy.  In a model of heat pain, patients exhibited no hyperalgesia, although tolerance could not be evaluated.  These results provide the first prospective evidence for the development of analgesic tolerance and OIH by using exptl. pain in patients with chronic back pain.  This study also validated methodol. for prospectively studying these phenomena in larger populations of pain patients.  Perspective: Exptl. evidence suggests that opioid tolerance and opioid-induced hyperalgesia might limit the clin. utility of opioids in controlling chronic pain.  This study validates a pharmacol. approach to study these phenomena prospectively in chronic pain patients and suggests that both conditions do occur within 1 mo of initiating opioid therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_c1PCwa3EzrVg90H21EOLACvtfcHk0lgGS_8HZ34VVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xls1Wgtg%253D%253D&md5=1aec558cf8dc6754af4dea1370cdcfb0</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.jpain.2005.08.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpain.2005.08.001%26sid%3Dliteratum%253Aachs%26aulast%3DChu%26aufirst%3DL.%2BF.%26aulast%3DClark%26aufirst%3DD.%2BJ.%26aulast%3DAngst%26aufirst%3DM.%2BS.%26atitle%3DOpioid%2520Tolerance%2520and%2520Hyperalgesia%2520in%2520Chronic%2520Pain%2520Patients%2520after%2520One%2520Month%2520of%2520Oral%2520Morphine%2520Therapy%253A%2520A%2520Preliminary%2520Prospective%2520Study%26jtitle%3DJ.%2520Pain%26date%3D2006%26volume%3D7%26spage%3D43%26epage%3D48%26doi%3D10.1016%2Fj.jpain.2005.08.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Munzing, T.</span></span> <span> </span><span class="NLM_article-title">Physician Guide to Appropriate Opioid Prescribing for Noncancer Pain</span>. <i>Perm. J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">16</span>– <span class="NLM_lpage">169</span>, <span class="refDoi"> DOI: 10.7812/TPP/16-169</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.7812%2FTPP%2F16-169" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=28488993" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A280%3ADC%252BC1crlslGrtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2017&pages=16-169&author=T.+Munzing&title=Physician+Guide+to+Appropriate+Opioid+Prescribing+for+Noncancer+Pain&doi=10.7812%2FTPP%2F16-169"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Physician Guide to Appropriate Opioid Prescribing for Noncancer Pain</span></div><div class="casAuthors">Munzing Timothy</div><div class="citationInfo"><span class="NLM_cas:title">The Permanente journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">16-169</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Prescription opioid use for relief of noncancer pain has risen dramatically in the last 15 years, contributing to a quadrupling of opioid overdoses and prescription opioid-related deaths.  This crisis is resulting in heightened attention by health care professionals and organizations, law enforcement, and the government.  In this article, I highlight key topics in the management of patients using opioids (or potentially needing opioids) in outpatient clinical practice; federal and state law enforcement actions regarding physicians' illegal prescribing of opioids; multimodal approaches to pain control; nonmedication management of pain; response strategies when suspecting a patient of diverting or misusing opioids; and warning signs for abuse or diversion.  For those patients for whom opioids are appropriate, I describe key elements for prescribing, including documentation of a detailed history and examination, appropriate evaluation to arrive at a specific diagnosis, individualizing management, and ongoing monitoring (including the use of urine drug screening and a prescription drug monitoring program).  In addition to individual action, when possible, the initiation of systemwide and clinicwide safe prescribing practices supports the physician and patient such that the patient's well-being is at the heart of all pain management decisions.  Physicians are encouraged to further educate themselves to treat pain safely and effectively; to screen patients for opioid use disorder and, when diagnosed, to connect them with evidence-based treatment; and to follow Centers for Disease Control and Prevention guidelines whenever possible.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS_P31OZw-1AS6Ufuk_1xoTfW6udTcc2eY-yV7wRK7bb7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1crlslGrtg%253D%253D&md5=6dae0a55c50da02aa9a36858cefdd746</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.7812%2FTPP%2F16-169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7812%252FTPP%252F16-169%26sid%3Dliteratum%253Aachs%26aulast%3DMunzing%26aufirst%3DT.%26atitle%3DPhysician%2520Guide%2520to%2520Appropriate%2520Opioid%2520Prescribing%2520for%2520Noncancer%2520Pain%26jtitle%3DPerm.%2520J.%26date%3D2017%26volume%3D21%26spage%3D16%26epage%3D169%26doi%3D10.7812%2FTPP%2F16-169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coyle, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pratt, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ocran-Appiah, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Secora, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornegay, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staffa, J.</span></span> <span> </span><span class="NLM_article-title">Opioid Analgesic Dose and the Risk of Misuse, Overdose, and Death: A Narrative Review</span>. <i>Pharmacoepidemiol. Drug. Saf.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">464</span>– <span class="NLM_lpage">472</span>, <span class="refDoi"> DOI: 10.1002/pds.4366</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1002%2Fpds.4366" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=29243305" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A280%3ADC%252BC1MzhslCksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2018&pages=464-472&author=D.+T.+Coyleauthor=C.+Y.+Prattauthor=J.+Ocran-Appiahauthor=A.+Secoraauthor=C.+Kornegayauthor=J.+Staffa&title=Opioid+Analgesic+Dose+and+the+Risk+of+Misuse%2C+Overdose%2C+and+Death%3A+A+Narrative+Review&doi=10.1002%2Fpds.4366"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Opioid analgesic dose and the risk of misuse, overdose, and death: A narrative review</span></div><div class="casAuthors">Coyle David Tyler; Pratt Chih-Ying; Ocran-Appiah Josephine; Secora Alex; Kornegay Cynthia; Staffa Judy</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacoepidemiology and drug safety</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">464-472</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE:  Despite the rise in serious adverse events paralleling increased prescription opioid analgesic use in the United States over the past 2 decades, the association between opioid analgesic dose and the risk of serious adverse health outcomes is incompletely characterized.  We sought to synthesize the medical literature for observational studies examining the association between opioid analgesic dose and the risk of serious adverse health outcomes, with particular attention to the outcomes of misuse, abuse, addiction, overdose, and death.  METHODS:  Searching MEDLINE using PubMed and bibliography review, we identified 22 observational studies published between 2000 and 2015 that assessed the association between opioid analgesic dose and the risk of serious adverse health outcomes.  Some of these studies had significant methodological limitations.  Twelve reviewed studies examined the outcomes of misuse, overdose, or death; no studies examining the risk of addiction or abuse met our criteria for inclusion.  RESULTS:  The results of multiple studies clearly indicate an increasing risk of serious adverse health outcomes associated with increasing opioid analgesic dose.  In particular, the risk of misuse, overdose, and death increases with increasing opioid analgesic dose.  However, there is no opioid dose inflection point beyond which the risk of these adverse health outcomes increases.  No opioid analgesic dose is without risk.  CONCLUSIONS:  The reviewed studies show an increasing risk of serious adverse health outcomes-including misuse, overdose, and death-associated with increasing opioid analgesic dose.  Further research is needed to characterize the relationship between opioid analgesic dose and the risk of addiction and abuse.  This analysis could inform policy actions for regulators and clinical decision making for providers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQM96_mwUR2KtyzdcP07UmufW6udTcc2eY-yV7wRK7bb7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MzhslCksg%253D%253D&md5=5f4018cbcfb30e6fce04293d427d8b79</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1002%2Fpds.4366&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpds.4366%26sid%3Dliteratum%253Aachs%26aulast%3DCoyle%26aufirst%3DD.%2BT.%26aulast%3DPratt%26aufirst%3DC.%2BY.%26aulast%3DOcran-Appiah%26aufirst%3DJ.%26aulast%3DSecora%26aufirst%3DA.%26aulast%3DKornegay%26aufirst%3DC.%26aulast%3DStaffa%26aufirst%3DJ.%26atitle%3DOpioid%2520Analgesic%2520Dose%2520and%2520the%2520Risk%2520of%2520Misuse%252C%2520Overdose%252C%2520and%2520Death%253A%2520A%2520Narrative%2520Review%26jtitle%3DPharmacoepidemiol.%2520Drug.%2520Saf.%26date%3D2018%26volume%3D27%26spage%3D464%26epage%3D472%26doi%3D10.1002%2Fpds.4366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lutfy, K.</span></span> <span> </span><span class="NLM_article-title">Opioid Crisis-an Emphasis on Fentanyl Analogs</span>. <i>Brain Sci.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_fpage">10</span>, <span class="refDoi"> DOI: 10.3390/brainsci10080485</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.3390%2Fbrainsci10080485" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&pages=10&author=K.+Lutfy&title=Opioid+Crisis-an+Emphasis+on+Fentanyl+Analogs&doi=10.3390%2Fbrainsci10080485"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.3390%2Fbrainsci10080485&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fbrainsci10080485%26sid%3Dliteratum%253Aachs%26aulast%3DLutfy%26aufirst%3DK.%26atitle%3DOpioid%2520Crisis-an%2520Emphasis%2520on%2520Fentanyl%2520Analogs%26jtitle%3DBrain%2520Sci.%26date%3D2020%26spage%3D10%26doi%3D10.3390%2Fbrainsci10080485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carraway, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leeman, S. E.</span></span> <span> </span><span class="NLM_article-title">The Isolation of a New Hypotensive Peptide, Neurotensin, from Bovine Hypothalami</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1973</span>,  <span class="NLM_volume"><i>248</i></span>,  <span class="NLM_fpage">6854</span>– <span class="NLM_lpage">6861</span>, <span class="refDoi"> DOI: 10.1016/S0021-9258(19)43429-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2FS0021-9258%2819%2943429-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=4745447" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADyaE2cXps1U%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=248&publication_year=1973&pages=6854-6861&author=R.+Carrawayauthor=S.+E.+Leeman&title=The+Isolation+of+a+New+Hypotensive+Peptide%2C+Neurotensin%2C+from+Bovine+Hypothalami&doi=10.1016%2FS0021-9258%2819%2943429-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami</span></div><div class="casAuthors">Carraway, Robert; Leeman, Susan E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1973</span>),
    <span class="NLM_cas:volume">248</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6854-61</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">A hypotensive peptide, designated neurotensin, was isolated in pure form from acid-Me2CO exts. of bovine hypothalami by column chromatog. and paper electrophoresis.  Amino acid anal. of material recovered after paper electrophoresis at pH 3.5, 6.5, and 8.9 and chromatog. anal. of the dansylated material indicated that the peptide isolated by this procedure was homogenous.  Its amino acid compn. and apparent mol. wt. estd. by chromatog. on Sephadex G-25 indicated that neurotensin is a tridecapeptide composed of Lys, Arg2, Asx, Glx2, Pro2, Ileu, Leu2, Tyr2.  Neurotensin lacks a free N-terminus; however, it possesses a free C-terminus which can be acted upon by carboxypeptidase A.  Neurotensin induced hypotension in the rat and stimulated the contraction of guinea pig ileum and rat uterus; however, it produced relaxation of the rat duodenum.  These pharmacol. properties classify it as a kinin, yet its chem. compn. distinguishes it from any known peptide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGUMbGcmJyBrVg90H21EOLACvtfcHk0limw_QeByh3IQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2cXps1U%253D&md5=717f2fac48338b8403ea764e6e59db00</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2FS0021-9258%2819%2943429-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0021-9258%252819%252943429-7%26sid%3Dliteratum%253Aachs%26aulast%3DCarraway%26aufirst%3DR.%26aulast%3DLeeman%26aufirst%3DS.%2BE.%26atitle%3DThe%2520Isolation%2520of%2520a%2520New%2520Hypotensive%2520Peptide%252C%2520Neurotensin%252C%2520from%2520Bovine%2520Hypothalami%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1973%26volume%3D248%26spage%3D6854%26epage%3D6861%26doi%3D10.1016%2FS0021-9258%2819%2943429-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Granier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Rietschoten, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitabgi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poustis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freychet, P.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Characterization of Neurotensin Analogues for Structure/Activity Relationship Studies. Acetyl-Neurotensin-(8–13) Is the Shortest Analogue with Full Binding and Pharmacological Activities</span>. <i>Eur. J. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>124</i></span>,  <span class="NLM_fpage">117</span>– <span class="NLM_lpage">125</span>, <span class="refDoi"> DOI: 10.1111/j.1432-1033.1982.tb05913.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1111%2Fj.1432-1033.1982.tb05913.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=7084220" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADyaL38XktFOgtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=1982&pages=117-125&author=C.+Granierauthor=J.+Van+Rietschotenauthor=P.+Kitabgiauthor=C.+Poustisauthor=P.+Freychet&title=Synthesis+and+Characterization+of+Neurotensin+Analogues+for+Structure%2FActivity+Relationship+Studies.+Acetyl-Neurotensin-%288%E2%80%9313%29+Is+the+Shortest+Analogue+with+Full+Binding+and+Pharmacological+Activities&doi=10.1111%2Fj.1432-1033.1982.tb05913.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and characterization of neurotensin analogs for structure/activity relationship studies.  Acetyl-neurotensin-(8-13) is the shortest analogue with full binding and pharmacological activities</span></div><div class="casAuthors">Granier, Claude; Van Rietschoten, Jurphaas; Kitabgi, Patrick; Poustis, Claudine; Freychet, Pierre</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">117-24</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    </div><div class="casAbstract">neurotensin  [39379-15-2] And several sequence analogs were synthesized using solid-phase technol. and tested for binding competition with [3H]neurotensin on the specific fixation sites of rat brain synaptosomal membranes and on those of HT 29 cells.  In addn. to these radioreceptor assays on neural and extraneural targets, a pharmacol. test (contraction of guinea pig ileum in the presence of neostigmine) was used to compare the behavior of the synthetic analogs.  A good parallel was obsd. between the degree of fixation and pharmacol. effects for entire neurotensin and for C-terminal region analogs up to the size of neurotensin-(8-13)  [60482-95-3].  The two peptides neurotensin-(6-13)  [60482-94-2] and neurotensin-(4-13)  [60482-93-1] had abnormally high affinities for rat brain synaptic membrane binding sites, combined with relatively low contracting activities.  The C-terminal peptide -Arg-Arg-Pro-Tyr-Ile-Leu fulfills all the structural requirements for mimicking the entire sequence, provided its α-amino end is protected by acetylation.  The guanidinium structure of residues 8 and 9 are not of vital importance, since they could be efficiently replaced by amino groups of lysyl side chains.  xenopsin  [51827-01-1], Which can be considered as a natural analog of neurotensin-(8-13), acts similarly to acetyl-neurotensin-(8-13)  [74853-69-3].  Removal of the phenolic function of residue 11 induces a decrease in neurotensin effects.  The C-terminal isoleucyl and leucyl residues could not be replaced by alanine without complete loss of the 3 activities tested.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZYG17WWqZtLVg90H21EOLACvtfcHk0limw_QeByh3IQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38XktFOgtbg%253D&md5=b48e23ddb8244691644b4b8ae5ceb70c</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1111%2Fj.1432-1033.1982.tb05913.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1432-1033.1982.tb05913.x%26sid%3Dliteratum%253Aachs%26aulast%3DGranier%26aufirst%3DC.%26aulast%3DVan%2BRietschoten%26aufirst%3DJ.%26aulast%3DKitabgi%26aufirst%3DP.%26aulast%3DPoustis%26aufirst%3DC.%26aulast%3DFreychet%26aufirst%3DP.%26atitle%3DSynthesis%2520and%2520Characterization%2520of%2520Neurotensin%2520Analogues%2520for%2520Structure%252FActivity%2520Relationship%2520Studies.%2520Acetyl-Neurotensin-%25288%25E2%2580%259313%2529%2520Is%2520the%2520Shortest%2520Analogue%2520with%2520Full%2520Binding%2520and%2520Pharmacological%2520Activities%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D1982%26volume%3D124%26spage%3D117%26epage%3D125%26doi%3D10.1111%2Fj.1432-1033.1982.tb05913.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guillemette, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dansereau, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaudet, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richelson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarret, P.</span></span> <span> </span><span class="NLM_article-title">Intrathecal Administration of Nts1 Agonists Reverses Nociceptive Behaviors in a Rat Model of Neuropathic Pain</span>. <i>Eur. J. Pain</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">473</span>– <span class="NLM_lpage">484</span>, <span class="refDoi"> DOI: 10.1016/j.ejpain.2011.07.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2Fj.ejpain.2011.07.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=22396077" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BC38XjsVSqt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2012&pages=473-484&author=A.+Guillemetteauthor=M.+A.+Dansereauauthor=N.+Beaudetauthor=E.+Richelsonauthor=P.+Sarret&title=Intrathecal+Administration+of+Nts1+Agonists+Reverses+Nociceptive+Behaviors+in+a+Rat+Model+of+Neuropathic+Pain&doi=10.1016%2Fj.ejpain.2011.07.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Intrathecal administration of NTS1 agonists reverses nociceptive behaviors in a rat model of neuropathic pain</span></div><div class="casAuthors">Guillemette, A.; Dansereau, M. A.; Beaudet, N.; Richelson, E.; Sarret, P.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pain (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">473-484</span>CODEN:
                <span class="NLM_cas:coden">EJPAFJ</span>;
        ISSN:<span class="NLM_cas:issn">1090-3801</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Chronic neuropathic pain arising from peripheral nerve damage is a severe clin. issue where there is a major unmet medical need.  We previously demonstrated that both neurotensin (NT) receptor subtypes 1 (NTS1) and 2 (NTS2) are involved in mediating the naloxone-insensitive antinociceptive effects of neurotensin in different analgesic tests including hotplate, tail-flick, and tonic pain.  However, the role of these receptors in neuropathic pain management has been poorly investigated.  In the present study, we therefore examd. whether intrathecal delivery of NTS1 agonists was effective in reducing neuropathic pain symptoms in rats.  Neuropathy was induced by sciatic nerve constriction (CCI model), and the development of mech. allodynia and thermal hyperalgesia on the ipsi- and contralateral hind paws was examd. 3, 7, 14, 21, and 28 days post-surgery.  CCI-operated rats exhibited significant increases in thermal and mech. hypersensitivities over a 28-day testing period.  Spinal injection of NT to CCI rats alleviated the behavioral responses to radiant heat and mech. stimuli, with a maximal reversal of 91% of allodynia at 6 μg/kg.  Intrathecal administration of the NTS1-selective agonist, PD149163 (30-90 μg/kg) also produced potent anti-allodynic and anti-hyperalgesic effects in nerve-injured rats.  Likewise, heat hyperalgesia and tactile allodynia produced by CCI of the sciatic nerve were fully reversed by the NTS1 agonist, NT69L (5-25 μg/kg).  Altogether, these results support the idea that the NTS1 receptor subtype is involved in pain modulation, and the potential use of NTS1 agonists for the treatment of painful neuropathies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriQDJyQci3e7Vg90H21EOLACvtfcHk0ljwSTcBmVuaEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjsVSqt7w%253D&md5=837122c56b6ee87613fff9b5c10e9797</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.ejpain.2011.07.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejpain.2011.07.008%26sid%3Dliteratum%253Aachs%26aulast%3DGuillemette%26aufirst%3DA.%26aulast%3DDansereau%26aufirst%3DM.%2BA.%26aulast%3DBeaudet%26aufirst%3DN.%26aulast%3DRichelson%26aufirst%3DE.%26aulast%3DSarret%26aufirst%3DP.%26atitle%3DIntrathecal%2520Administration%2520of%2520Nts1%2520Agonists%2520Reverses%2520Nociceptive%2520Behaviors%2520in%2520a%2520Rat%2520Model%2520of%2520Neuropathic%2520Pain%26jtitle%3DEur.%2520J.%2520Pain%26date%3D2012%26volume%3D16%26spage%3D473%26epage%3D484%26doi%3D10.1016%2Fj.ejpain.2011.07.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
Vega, M. J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrer-Montiel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">González-Muñiz, R.</span></span> <span> </span><span class="NLM_article-title">Recent Progress in Non-Opioid Analgesic Peptides</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>660</i></span>,  <span class="NLM_fpage">36</span>– <span class="NLM_lpage">52</span>, <span class="refDoi"> DOI: 10.1016/j.abb.2018.10.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2Fj.abb.2018.10.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=30342013" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=660&publication_year=2018&pages=36-52&author=M.+J.+P.+de%0AVegaauthor=A.+Ferrer-Montielauthor=R.+Gonz%C3%A1lez-Mu%C3%B1iz&title=Recent+Progress+in+Non-Opioid+Analgesic+Peptides&doi=10.1016%2Fj.abb.2018.10.011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.abb.2018.10.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.abb.2018.10.011%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BVega%26aufirst%3DM.%2BJ.%2BP.%26aulast%3DFerrer-Montiel%26aufirst%3DA.%26aulast%3DGonz%25C3%25A1lez-Mu%25C3%25B1iz%26aufirst%3DR.%26atitle%3DRecent%2520Progress%2520in%2520Non-Opioid%2520Analgesic%2520Peptides%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2018%26volume%3D660%26spage%3D36%26epage%3D52%26doi%3D10.1016%2Fj.abb.2018.10.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tétreault, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaudet, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perron, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belleville, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">René, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavelier, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stroh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobi, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behlke, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarret, P.</span></span> <span> </span><span class="NLM_article-title">Spinal Nts2 Receptor Activation Reverses Signs of Neuropathic Pain</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">3741</span>– <span class="NLM_lpage">3752</span>, <span class="refDoi"> DOI: 10.1096/fj.12-225540</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1096%2Ffj.12-225540" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=23756650" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVaitLrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2013&pages=3741-3752&author=P.+T%C3%A9treaultauthor=N.+Beaudetauthor=A.+Perronauthor=K.+Bellevilleauthor=A.+Ren%C3%A9author=F.+Cavelierauthor=J.+Martinezauthor=T.+Strohauthor=A.+M.+Jacobiauthor=S.+D.+Roseauthor=M.+A.+Behlkeauthor=P.+Sarret&title=Spinal+Nts2+Receptor+Activation+Reverses+Signs+of+Neuropathic+Pain&doi=10.1096%2Ffj.12-225540"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Spinal NTS2 receptor activation reverses signs of neuropathic pain</span></div><div class="casAuthors">Tetreault, Pascal; Beaudet, Nicolas; Perron, Amelie; Belleville, Karine; Rene, Adeline; Cavelier, Florine; Martinez, Jean; Stroh, Thomas; Jacobi, Ashley M.; Rose, Scott D.; Behlke, Mark A.; Sarret, Philippe</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3741-3752, 10.1096/fj.12-225540</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">Management of painful peripheral neuropathies remains challenging, since patients with chronic pain respond poorly to the available pharmacopeia.  In recent years, the G-protein-coupled receptor neurotensin (NT) type 2 (NTS2) emerged as an attractive target for treating transitory pain states.  To date, however, there is no evidence for its role in the regulation of chronic peripheral neuropathies.  Here, we found that NTS2 receptors were largely localized to primary afferent fibers and superficial dorsal horns.  Changes in the time course of the gene expression profile of NT, NTS1, and NTS2 were obsd. over a 28-d period following the sciatic nerve constriction [chronic constriction injury (CCI) model].  We next detd. the effects of central delivery of selective-NTS2 agonists to CCI-treated rats on both mech. allodynia (evoked withdrawal responses) and wt.-bearing deficits (discomfort and quality-of-life proxies).  The NTS2 analogs JMV431, levocabastine, and β-lactotensin were all effective in reducing ongoing tactile allodynia in CCI-treated rats.  Likewise, amitriptyline, pregabalin, and morphine significantly attenuated CCI-induced mech. hypersensitivity.  NTS2 agonists were also efficient in reversing wt.-bearing and postural deficits caused by nerve damage, unlike ref. analgesics currently used in the clinic.  Thus, NTS2 agonists may offer new treatment avenues for limiting pain assocd. with peripheral neuropathies and improve functional rehabilitation and well-being.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquJJpzef1xT7Vg90H21EOLACvtfcHk0ljwSTcBmVuaEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVaitLrJ&md5=10a111da88716e123c03c6b89df248a1</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1096%2Ffj.12-225540&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.12-225540%26sid%3Dliteratum%253Aachs%26aulast%3DT%25C3%25A9treault%26aufirst%3DP.%26aulast%3DBeaudet%26aufirst%3DN.%26aulast%3DPerron%26aufirst%3DA.%26aulast%3DBelleville%26aufirst%3DK.%26aulast%3DRen%25C3%25A9%26aufirst%3DA.%26aulast%3DCavelier%26aufirst%3DF.%26aulast%3DMartinez%26aufirst%3DJ.%26aulast%3DStroh%26aufirst%3DT.%26aulast%3DJacobi%26aufirst%3DA.%2BM.%26aulast%3DRose%26aufirst%3DS.%2BD.%26aulast%3DBehlke%26aufirst%3DM.%2BA.%26aulast%3DSarret%26aufirst%3DP.%26atitle%3DSpinal%2520Nts2%2520Receptor%2520Activation%2520Reverses%2520Signs%2520of%2520Neuropathic%2520Pain%26jtitle%3DFASEB%2520J.%26date%3D2013%26volume%3D27%26spage%3D3741%26epage%3D3752%26doi%3D10.1096%2Ffj.12-225540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Behbehani, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pert, A.</span></span> <span> </span><span class="NLM_article-title">A Mechanism for the Analgesic Effect of Neurotensin as Revealed by Behavioral and Electrophysiological Techniques</span>. <i>Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>324</i></span>,  <span class="NLM_fpage">35</span>– <span class="NLM_lpage">42</span>, <span class="refDoi"> DOI: 10.1016/0006-8993(84)90619-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2F0006-8993%2884%2990619-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=6518391" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADyaL2MXptVeiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=324&publication_year=1984&pages=35-42&author=M.+M.+Behbehaniauthor=A.+Pert&title=A+Mechanism+for+the+Analgesic+Effect+of+Neurotensin+as+Revealed+by+Behavioral+and+Electrophysiological+Techniques&doi=10.1016%2F0006-8993%2884%2990619-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">A mechanism for the analgesic effect of neurotensin as revealed by behavioral and electrophysiological techniques</span></div><div class="casAuthors">Behbehani, M. M.; Pert, A.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">324</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">35-42</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    </div><div class="casAbstract">Behavioral and electrophysiol. techniques were used to examine the effects of local injections of neurotensin (NT)  [39379-15-2] into the periaqueductal gray (PAG) of rats.  Injection of NT into the PAG produced dose-dependent analgesia that lasted for as long as 60 min and was not blocked by naloxone.  However, electrolytic lesions of the nucleus raphe magnus (NRM) and its surrounding area abolished the analgesic effect of NT.  Electrophysiol. expts. indicated that micro-pressure application of NT onto neurons in the PAG had a predominantly excitatory effect.  Furthermore, injection of NT into the PAG produced excitation of the NRM neurons.  NT produces its analgesic effect by excitation of PAG neurons which leads to activation of the pain inhibitory system that originates from the NRM and its surrounding areas in the medulla.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoD8Jc99x3wk7Vg90H21EOLACvtfcHk0lgeQ4WkPABltA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXptVeiug%253D%253D&md5=cc6759f013c5fbad15c1f0ab3e1935fe</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2F0006-8993%2884%2990619-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-8993%252884%252990619-X%26sid%3Dliteratum%253Aachs%26aulast%3DBehbehani%26aufirst%3DM.%2BM.%26aulast%3DPert%26aufirst%3DA.%26atitle%3DA%2520Mechanism%2520for%2520the%2520Analgesic%2520Effect%2520of%2520Neurotensin%2520as%2520Revealed%2520by%2520Behavioral%2520and%2520Electrophysiological%2520Techniques%26jtitle%3DBrain%2520Res.%26date%3D1984%26volume%3D324%26spage%3D35%26epage%3D42%26doi%3D10.1016%2F0006-8993%2884%2990619-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bredeloux, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costentin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubuc, I.</span></span> <span> </span><span class="NLM_article-title">Interactions between Nts2 Neurotensin and Opioid Receptors on Two Nociceptive Responses Assessed on the Hot Plate Test in Mice</span>. <i>Behav. Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>175</i></span>,  <span class="NLM_fpage">399</span>– <span class="NLM_lpage">407</span>, <span class="refDoi"> DOI: 10.1016/j.bbr.2006.09.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2Fj.bbr.2006.09.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=17074405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1ersr%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=175&publication_year=2006&pages=399-407&author=P.+Bredelouxauthor=J.+Costentinauthor=I.+Dubuc&title=Interactions+between+Nts2+Neurotensin+and+Opioid+Receptors+on+Two+Nociceptive+Responses+Assessed+on+the+Hot+Plate+Test+in+Mice&doi=10.1016%2Fj.bbr.2006.09.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Interactions between NTS2 neurotensin and opioid receptors on two nociceptive responses assessed on the hot plate test in mice</span></div><div class="casAuthors">Bredeloux, Pierre; Costentin, Jean; Dubuc, Isabelle</div><div class="citationInfo"><span class="NLM_cas:title">Behavioural Brain Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">175</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">399-407</span>CODEN:
                <span class="NLM_cas:coden">BBREDI</span>;
        ISSN:<span class="NLM_cas:issn">0166-4328</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The intracerebroventricular administration of the tridecapeptide neurotensin (NT) produces strong analgesic effects in tests evaluating acute pain.  We investigated whether these effects are mediated by the opioid receptors.  In the hot plate test, the NT receptors agonist NT1 (NαMe-Arg-Lys-Pro-Trp-Tle-Leu), s.c. injected (0.3-3 mg/kg), increased paw licking and jump latencies.  These effects were inhibited by the NTS2 antagonist levocabastine (2.5 mg/kg, i.p.) but not by the selective NTS1 antagonist SR48692 (3 mg/kg, i.p.).  The opioid receptor antagonist naloxone did not modify (up to the dose of 4.5 mg/kg, s.c.) the NT1 effect on licking, but abolished the increase in the jump latency (from the dose of 1.5 mg/kg).  In mice made tolerant to the analgesic effect of morphine (2 mg/kg, s.c.) by previous morphine injections (32 mg/kg, s.c., twice a day, 4 days), NT1 maintained its effect on licking, but its effect on jump latency was suppressed.  Levocabastine (up to the dose of 4.5 mg/kg) failed to antagonize the effects of morphine (2 mg/kg, s.c.) on both licking and jump latencies.  In mice made tolerant to the analgesic effect of NT1 (0.3 mg/kg, s.c.) by previous NT1 injections (3 mg/kg, s.c., twice a day, 4 days) morphine maintained its analgesic effects both on licking and jumping latencies.  We can conclude that neurotensinergic and opioidergic transmissions are functionally independent as regards the licking response.  However, in the jump response, neurotensinergic transmission seems to regulate opioidergic transmission, inducing its stimulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCzDMc2RrThLVg90H21EOLACvtfcHk0lgeQ4WkPABltA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1ersr%252FF&md5=10582997fbcd6fb16bb39de279237205</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.bbr.2006.09.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbr.2006.09.016%26sid%3Dliteratum%253Aachs%26aulast%3DBredeloux%26aufirst%3DP.%26aulast%3DCostentin%26aufirst%3DJ.%26aulast%3DDubuc%26aufirst%3DI.%26atitle%3DInteractions%2520between%2520Nts2%2520Neurotensin%2520and%2520Opioid%2520Receptors%2520on%2520Two%2520Nociceptive%2520Responses%2520Assessed%2520on%2520the%2520Hot%2520Plate%2520Test%2520in%2520Mice%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2006%26volume%3D175%26spage%3D399%26epage%3D407%26doi%3D10.1016%2Fj.bbr.2006.09.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clineschmidt, B. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGuffin, J. C.</span></span> <span> </span><span class="NLM_article-title">Neurotensin Administered Intracisternally Inhibits Responsiveness of Mice to Noxious Stimuli</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1977</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">395</span>– <span class="NLM_lpage">396</span>, <span class="refDoi"> DOI: 10.1016/0014-2999(77)90236-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2F0014-2999%2877%2990236-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=201475" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADyaE1cXhtlWht7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1977&pages=395-396&author=B.+V.+Clineschmidtauthor=J.+C.+McGuffin&title=Neurotensin+Administered+Intracisternally+Inhibits+Responsiveness+of+Mice+to+Noxious+Stimuli&doi=10.1016%2F0014-2999%2877%2990236-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Neurotensin administered intracisternally inhibits responsiveness of mice to noxious stimuli</span></div><div class="casAuthors">Clineschmidt, Bradley V.; McGuffin, Jodie C.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">395-6</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">In female mice, neurotensin (I)  [39379-15-2] injected intracisternally caused a dose-related increase in reaction time upon exposure to a hot plate and a decrease in the frequency of writhing subsequent to the injection of acetic acid.  The minimally ED in the hot plate test was 0.025-0.25 ng/mouse.  In both cases, the max. antinocisponsive effect occurred at 250 ng/mouse, a 10-fold increase in dose caused little, if any addnl. action.  I (2.5 μg) did not have an antinocisponsive effect.  The antinocisponsive effect of I following the max. ED (250 ng/mouse) lasted for ∼ 1 h and for ∼2 h after 10-times this dose.  With dose of I of 25 ng/mouse (hot plate) or 2.5 ng/mouse (writhing), naloxone was not effective as an antagonist of the antinocisponsive action of I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqChpxrp802KrVg90H21EOLACvtfcHk0lgeQ4WkPABltA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1cXhtlWht7Y%253D&md5=c50fa14e8a4d40d4ef72a155508ab302</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2877%2990236-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252877%252990236-9%26sid%3Dliteratum%253Aachs%26aulast%3DClineschmidt%26aufirst%3DB.%2BV.%26aulast%3DMcGuffin%26aufirst%3DJ.%2BC.%26atitle%3DNeurotensin%2520Administered%2520Intracisternally%2520Inhibits%2520Responsiveness%2520of%2520Mice%2520to%2520Noxious%2520Stimuli%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1977%26volume%3D46%26spage%3D395%26epage%3D396%26doi%3D10.1016%2F0014-2999%2877%2990236-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clineschmidt, B. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGuffin, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunting, P. B.</span></span> <span> </span><span class="NLM_article-title">Neurotensin: Antinocisponsive Action in Rodents</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1979</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">129</span>– <span class="NLM_lpage">139</span>, <span class="refDoi"> DOI: 10.1016/0014-2999(79)90415-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2F0014-2999%2879%2990415-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=421735" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADyaE1MXhsVKhsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1979&pages=129-139&author=B.+V.+Clineschmidtauthor=J.+C.+McGuffinauthor=P.+B.+Bunting&title=Neurotensin%3A+Antinocisponsive+Action+in+Rodents&doi=10.1016%2F0014-2999%2879%2990415-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Neurotensin:  antinocisponsive action in rodents</span></div><div class="casAuthors">Clineschmidt, Bradley V.; McGuffin, Jodie C.; Bunting, Patricia A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">129-39</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">Neurotensin  [39379-15-2] administered intracisternally in mice increased reaction time in the hot plate test (min. ED = 25 ng) and decreased writhing induced by acetic acid (min. ED = 0.25 ng).  At the max. ED of 250 ng, the antinocisponsive action of neurotensin lasted for ∼1 h.  In the hot plate test, neurotensin, [Gln4]-neurotensin  [61445-54-3], and [D-Ala2, Met5]enkephalinamide  [61090-95-7] were all equiactive at the 3 dose levels examd., 0.00015, 0.015, and 1.5 nmoles/mouse.  At antinocisponsive doses, mice treated intracisternally with neurotensin also were hypothermic and had decreased locomotor activity.  Neurotensin (2500 ng) administered i.v. did not produce any of the effects described above.  DL-5-Hydroxytryptophan, oxotremorine, and chlorpromazine given systemically caused hypothermia but did not change reaction time in the hot plate procedure.  Neurotensin, even at doses as high as 2500 ng given intracisternally, did not disrupt coordinated motor control or change the current-response relation for electroshock-induced seizures.  The antinocisponsive action of neurotensin in mice (hot plate test) was not antagonized by naloxone, cyproheptadine, methergoline, atropine, benzotropine, mecamylamine, chlorpheniramine, pyribenzamine, cimetidine, BE 2254, propranolol, phenoxybenzamine, haloperidol, or indomethacin.  Neurotensin administered intracisternally was also an effective antinocisponsive agent in rats, as assessed in the hot plate procedure, but not in the tail-flick test.  Naloxone did not antagonize this action of neurotensin in the rat.  The antinocisponsive effect of neurotensin may result from interaction of the peptide with neurotensin-specific receptor sites in the central nervous system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTrJmNLec117Vg90H21EOLACvtfcHk0lgeQ4WkPABltA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1MXhsVKhsrs%253D&md5=c05fcc516f529cfaf3e190a59be2f301</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2879%2990415-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252879%252990415-1%26sid%3Dliteratum%253Aachs%26aulast%3DClineschmidt%26aufirst%3DB.%2BV.%26aulast%3DMcGuffin%26aufirst%3DJ.%2BC.%26aulast%3DBunting%26aufirst%3DP.%2BB.%26atitle%3DNeurotensin%253A%2520Antinocisponsive%2520Action%2520in%2520Rodents%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1979%26volume%3D54%26spage%3D129%26epage%3D139%26doi%3D10.1016%2F0014-2999%2879%2990415-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Osbahr, A. J. D.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nemeroff, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luttinger, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prange, A. J.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Neurotensin-Induced Antinociception in Mice: Antagonism by Thyrotropin-Releasing Hormone</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1981</span>,  <span class="NLM_volume"><i>217</i></span>,  <span class="NLM_fpage">645</span>– <span class="NLM_lpage">651</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=6112261" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADyaL3MXitVeis7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=217&publication_year=1981&pages=645-651&author=A.+J.+D.+Osbahrauthor=C.+B.+Nemeroffauthor=D.+Luttingerauthor=G.+A.+Masonauthor=A.+J.+Prange&title=Neurotensin-Induced+Antinociception+in+Mice%3A+Antagonism+by+Thyrotropin-Releasing+Hormone"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Neurotensin-induced antinociception in mice:  antagonism by thyrotropin-releasing hormone</span></div><div class="casAuthors">Osbahr, Albert J., III; Nemeroff, Charles B.; Luttinger, Daniel; Mason, George A.; Prange, Arthur J., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">217</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">645-51</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">Neurotensin (NT)  [39379-15-2] administered intracisternally to mice produced dose-dependent antinociception in 3 analgesic tests: tail immersion, hot-plate, and acetic acid writhing.  Naloxone, administered i.p. before NT, did not alter NT-induced antinociception in any of these tests but did reverse β-endorphin  [60617-12-1]-induced antinociception.  Centrally and peripherally administered TRH  [24305-27-9] antagonized NT-induced (but not β-endorphin-induced) antinociception.  Equimolar doses of melanostatin  [9083-38-9] did not alter the effects of NT.  NT and TRH apparently are functional antagonists in the central nervous system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJY7ke2pY_WbVg90H21EOLACvtfcHk0lgujf82T1J2TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXitVeis7o%253D&md5=2169b298a15b35041301b74a46a2a36e</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOsbahr%26aufirst%3DA.%2BJ.%2BD.%26aulast%3DNemeroff%26aufirst%3DC.%2BB.%26aulast%3DLuttinger%26aufirst%3DD.%26aulast%3DMason%26aufirst%3DG.%2BA.%26aulast%3DPrange%26aufirst%3DA.%2BJ.%26atitle%3DNeurotensin-Induced%2520Antinociception%2520in%2520Mice%253A%2520Antagonism%2520by%2520Thyrotropin-Releasing%2520Hormone%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1981%26volume%3D217%26spage%3D645%26epage%3D651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wustrow, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akunne, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corbin, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiley, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wise, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heffner, T. G.</span></span> <span> </span><span class="NLM_article-title">Reduced Amide Bond Neurotensin 8-13 Mimetics with Potent in Vivo Activity</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">997</span>– <span class="NLM_lpage">1002</span>, <span class="refDoi"> DOI: 10.1016/0960-894X(95)00155-M</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2F0960-894X%2895%2900155-M" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADyaK2MXlslegu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1995&pages=997-1002&author=D.+J.+Wustrowauthor=M.+D.+Davisauthor=H.+C.+Akunneauthor=A.+E.+Corbinauthor=J.+N.+Wileyauthor=L.+D.+Wiseauthor=T.+G.+Heffner&title=Reduced+Amide+Bond+Neurotensin+8-13+Mimetics+with+Potent+in+Vivo+Activity&doi=10.1016%2F0960-894X%2895%2900155-M"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Reduced amide bond neurotensin 8-13 mimetics with potent in vivo activity</span></div><div class="casAuthors">Wustrow, D. J.; Davis, M. D.; Akunne, H. C.; Corbin, A. E.; Wiley, J. N.; Wise, L. D.; Heffner, T. G.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">997-1002</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Appropriately substituted 8-9 (ψCH2NY) isosteres of neurotensin (NT) 8-13 have been found which are active as NT agonists in vitro and in vivo.  SAR studies suggest that preventing amide bond hydrolysis at the 8-9 and 11-12 positions of NT(8-13) mimetics is important for producing compds. with potent activity in vivo.  Other simplified replacements for the Arg-Arg portion of NT(8-13) are reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolczgZFDR_9rVg90H21EOLACvtfcHk0lgujf82T1J2TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXlslegu7Y%253D&md5=827c72b0a113b17bfcf7594cbf57cef8</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2F0960-894X%2895%2900155-M&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0960-894X%252895%252900155-M%26sid%3Dliteratum%253Aachs%26aulast%3DWustrow%26aufirst%3DD.%2BJ.%26aulast%3DDavis%26aufirst%3DM.%2BD.%26aulast%3DAkunne%26aufirst%3DH.%2BC.%26aulast%3DCorbin%26aufirst%3DA.%2BE.%26aulast%3DWiley%26aufirst%3DJ.%2BN.%26aulast%3DWise%26aufirst%3DL.%2BD.%26aulast%3DHeffner%26aufirst%3DT.%2BG.%26atitle%3DReduced%2520Amide%2520Bond%2520Neurotensin%25208-13%2520Mimetics%2520with%2520Potent%2520in%2520Vivo%2520Activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1995%26volume%3D5%26spage%3D997%26epage%3D1002%26doi%3D10.1016%2F0960-894X%2895%2900155-M" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eiselt, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chartier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Betti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Longpré, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavelier, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tourwé, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gendron, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballet, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarret, P.</span></span> <span> </span><span class="NLM_article-title">Neurotensin Analogues Containing Cyclic Surrogates of Tyrosine at Position 11 Improve Nts2 Selectivity Leading to Analgesia without Hypotension and Hypothermia</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">4535</span>– <span class="NLM_lpage">4544</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.9b00390</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.9b00390" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvFWltLvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=4535-4544&author=E.+Eiseltauthor=S.+Gonzalezauthor=C.+Martinauthor=M.+Chartierauthor=C.+Bettiauthor=J.-M.+Longpr%C3%A9author=F.+Cavelierauthor=D.+Tourw%C3%A9author=L.+Gendronauthor=S.+Balletauthor=P.+Sarret&title=Neurotensin+Analogues+Containing+Cyclic+Surrogates+of+Tyrosine+at+Position+11+Improve+Nts2+Selectivity+Leading+to+Analgesia+without+Hypotension+and+Hypothermia&doi=10.1021%2Facschemneuro.9b00390"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Neurotensin Analogues Containing Cyclic Surrogates of Tyrosine at Position 11 Improve NTS2 Selectivity Leading to Analgesia without Hypotension and Hypothermia</span></div><div class="casAuthors">Eiselt, Emilie; Gonzalez, Simon; Martin, Charlotte; Chartier, Magali; Betti, Cecilia; Longpre, Jean-Michel; Cavelier, Florine; Tourwe, Dirk; Gendron, Louis; Ballet, Steven; Sarret, Philippe</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4535-4544</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Neurotensin (NT) exerts its analgesic effects through activation of the G protein-coupled receptors NTS1 and NTS2.  This opioid-independent antinociception represents a potential alternative for pain management.  While activation of NTS1 also induces a drop in blood pressure and body temp., NTS2 appears to be an analgesic target free of these adverse effects.  Here, we report modifications of NT at Tyr11 to increase selectivity toward NTS2, complemented by modifications at the N-terminus to impair proteolytic degrdn. of the biol. active NT(8-13) sequence.  Replacement of Tyr11 by either 6-OH-Tic or 7-OH-Tic resulted in a significant loss of binding affinity to NTS1 and subsequent NTS2 selectivity.  Incorporation of the unnatural amino acid β3hLys at position 8 increased the half-life to over 24 h in plasma.  Simultaneous integration of both β3hLys8 and 6-OH-Tic11 into NT(8-13) produced a potent and NTS2-selective analog with strong analgesic action after intrathecal delivery in the rat formalin-induced pain model with an ED50 of 1.4 nmol.  Addnl., i.v. administration of this NT analog did not produce persistent hypotension or hypothermia.  These results demonstrate that NT analogs harboring unnatural amino acids at positions 8 and 11 can enhance crucial pharmacokinetic and pharmacodynamic features for NT(8-13) analogs, i.e., proteolytic stability, NTS2 selectivity, and improved analgesic/adverse effect ratio.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1tutNP5uFw7Vg90H21EOLACvtfcHk0lgujf82T1J2TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvFWltLvM&md5=66a2f7f94056744d2d6de0a91314017d</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.9b00390&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.9b00390%26sid%3Dliteratum%253Aachs%26aulast%3DEiselt%26aufirst%3DE.%26aulast%3DGonzalez%26aufirst%3DS.%26aulast%3DMartin%26aufirst%3DC.%26aulast%3DChartier%26aufirst%3DM.%26aulast%3DBetti%26aufirst%3DC.%26aulast%3DLongpr%25C3%25A9%26aufirst%3DJ.-M.%26aulast%3DCavelier%26aufirst%3DF.%26aulast%3DTourw%25C3%25A9%26aufirst%3DD.%26aulast%3DGendron%26aufirst%3DL.%26aulast%3DBallet%26aufirst%3DS.%26aulast%3DSarret%26aufirst%3DP.%26atitle%3DNeurotensin%2520Analogues%2520Containing%2520Cyclic%2520Surrogates%2520of%2520Tyrosine%2520at%2520Position%252011%2520Improve%2520Nts2%2520Selectivity%2520Leading%2520to%2520Analgesia%2520without%2520Hypotension%2520and%2520Hypothermia%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2019%26volume%3D10%26spage%3D4535%26epage%3D4544%26doi%3D10.1021%2Facschemneuro.9b00390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boules, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbut, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richelson, E.</span></span> <span> </span><span class="NLM_article-title">Nt69l, a Novel Analgesic, Shows Synergy with Morphine</span>. <i>Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>1294</i></span>,  <span class="NLM_fpage">22</span>– <span class="NLM_lpage">28</span>, <span class="refDoi"> DOI: 10.1016/j.brainres.2009.07.086</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2Fj.brainres.2009.07.086" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=19651107" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFGlurrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1294&publication_year=2009&pages=22-28&author=M.+Boulesauthor=A.+Shawauthor=Y.+Liangauthor=D.+Barbutauthor=E.+Richelson&title=Nt69l%2C+a+Novel+Analgesic%2C+Shows+Synergy+with+Morphine&doi=10.1016%2Fj.brainres.2009.07.086"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">NT69L, a novel analgesic, shows synergy with morphine</span></div><div class="casAuthors">Boules, M.; Shaw, A.; Liang, Y.; Barbut, D.; Richelson, E.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">1294</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">22-28</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Background: Neurotensin (NT) is a neuropeptide with antinociceptive effects that are mediated through NT receptors, of which there are three known subtypes (NTS1, NTS2, and NTS3).  Morphine is a μ-opioid receptor agonist commonly used for pain treatment but is assocd. with side effects that can be serious.  We hypothesize that selective NT receptor agonists may represent a novel class of analgesics and their use in conjunction with morphine will have synergistic properties which may reduce the dose of morphine administered and its side effects.  Methods: The antinociceptive activity of an NT agonist (NT69L) and morphine was studied in rats using the hot plate test to det. if there is synergism between the two drugs in reducing pain.  The NTS2 receptor antagonist, levocabastine, was used to det. the receptor subtype involved in the analgesic effect of NT69L and morphine.  Results: The administration of both NT69L and morphine resulted in a dose-dependent analgesic effect.  The isobolog. anal. demonstrated that the combination of sub-analgesic doses of NT69L and morphine was synergistic in the hot plate test.  Pretreatment with the NTS2 receptor antagonist, levocabastine attenuated the antinociceptive effect of NT69L and the combined effect of NT69L and morphine in the hot plate test.  Conclusion: The results support the hypothesis that the synergistic combination of NT69L and morphine would improve the pharmacol. treatment of pain while minimizing specific adverse effects of each of the drugs at a higher dose.  NTS2 is important for the antinociceptive effect of NT69L and morphine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrE7jkwCFETorVg90H21EOLACvtfcHk0liFJBgK7P5NpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFGlurrM&md5=15d6faf03877137b20b911f8aa7b6a64</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2009.07.086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2009.07.086%26sid%3Dliteratum%253Aachs%26aulast%3DBoules%26aufirst%3DM.%26aulast%3DShaw%26aufirst%3DA.%26aulast%3DLiang%26aufirst%3DY.%26aulast%3DBarbut%26aufirst%3DD.%26aulast%3DRichelson%26aufirst%3DE.%26atitle%3DNt69l%252C%2520a%2520Novel%2520Analgesic%252C%2520Shows%2520Synergy%2520with%2520Morphine%26jtitle%3DBrain%2520Res.%26date%3D2009%26volume%3D1294%26spage%3D22%26epage%3D28%26doi%3D10.1016%2Fj.brainres.2009.07.086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boules, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnston, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tozy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richelson, E.</span></span> <span> </span><span class="NLM_article-title">Analgesic Synergy of Neurotensin Receptor Subtype 2 Agonist Nt79 and Morphine</span>. <i>Behav. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">573</span>– <span class="NLM_lpage">581</span>, <span class="refDoi"> DOI: 10.1097/FBP.0b013e3283474a3a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1097%2FFBP.0b013e3283474a3a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=21691202" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVWnu7%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2011&pages=573-581&author=M.+Boulesauthor=H.+Johnstonauthor=J.+Tozyauthor=K.+Smithauthor=Z.+Liauthor=E.+Richelson&title=Analgesic+Synergy+of+Neurotensin+Receptor+Subtype+2+Agonist+Nt79+and+Morphine&doi=10.1097%2FFBP.0b013e3283474a3a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Analgesic synergy of neurotensin receptor subtype 2 agonist NT79 and morphine</span></div><div class="casAuthors">Boules, Mona; Johnston, Hannah; Tozy, Jessica; Smith, Kristin; Li, Zhimin; Richelson, Elliott</div><div class="citationInfo"><span class="NLM_cas:title">Behavioural Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">5&6</span>),
    <span class="NLM_cas:pages">573-581</span>CODEN:
                <span class="NLM_cas:coden">BPHAEL</span>;
        ISSN:<span class="NLM_cas:issn">0955-8810</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Neurotensin (NT) is a tridecapeptide with naloxone-independent analgesic action.  NT exerts its effects through three molecularly cloned receptor subtypes, NTS1, NTS2, and NTS3.  The analgesic efficacy of NT agonists depends on their activation of NTS1 and/or NTS2.  NT79 is an NTS2-selective agonist without hypothermic and hypotensive effects, produces analgesic effects in animal models of visceral (writhing), but not thermal (hot plate) pain.  This study extends previous study with NT79 to test its efficacy in an animal model of persistent pain (formalin test) and to det. whether there is analgesic synergy between NT79 and morphine on visceral and persistent pain.  NT79 enhanced the analgesic potency of morphine in the writhing test.  In the persistent pain model, NT79 and morphine attenuated formalin-induced lifting and biting during the inflammatory phase.  NT79 and morphine alone significantly blocked the lifting but not the biting response, which involves the activity of spinal nociceptive circuits.  However, the combination of NT79 and morphine attenuated both lifting and biting responses, results indicating both spinal and supraspinal modulation of persistent nociception.  Isobolog. analyses show analgesic synergism between NT79 and morphine in persistent pain, thus providing a promise of therapy for pain while minimizing adverse effects assocd. with morphine use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRLp-c6yI_KrVg90H21EOLACvtfcHk0liFJBgK7P5NpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVWnu7%252FP&md5=ed83630de3fce2bd7391d16b9f601bf1</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1097%2FFBP.0b013e3283474a3a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FFBP.0b013e3283474a3a%26sid%3Dliteratum%253Aachs%26aulast%3DBoules%26aufirst%3DM.%26aulast%3DJohnston%26aufirst%3DH.%26aulast%3DTozy%26aufirst%3DJ.%26aulast%3DSmith%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DRichelson%26aufirst%3DE.%26atitle%3DAnalgesic%2520Synergy%2520of%2520Neurotensin%2520Receptor%2520Subtype%25202%2520Agonist%2520Nt79%2520and%2520Morphine%26jtitle%3DBehav.%2520Pharmacol.%26date%3D2011%26volume%3D22%26spage%3D573%26epage%3D581%26doi%3D10.1097%2FFBP.0b013e3283474a3a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dobner, P. R.</span></span> <span> </span><span class="NLM_article-title">Neurotensin and Pain Modulation</span>. <i>Peptides</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">2405</span>– <span class="NLM_lpage">2414</span>, <span class="refDoi"> DOI: 10.1016/j.peptides.2006.04.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2Fj.peptides.2006.04.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=16870306" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BD28XpvV2gsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2006&pages=2405-2414&author=P.+R.+Dobner&title=Neurotensin+and+Pain+Modulation&doi=10.1016%2Fj.peptides.2006.04.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Neurotensin and pain modulation</span></div><div class="casAuthors">Dobner, Paul R.</div><div class="citationInfo"><span class="NLM_cas:title">Peptides (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2405-2414</span>CODEN:
                <span class="NLM_cas:coden">PPTDD5</span>;
        ISSN:<span class="NLM_cas:issn">0196-9781</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Neurotensin (NT) can produce a profound analgesia or enhance pain responses, depending on the circumstances.  Recent evidence suggests that this may be due to a dose-dependent recruitment of distinct populations of pain modulatory neurons.  NT knockout mice display defects in both basal nociceptive responses and stress-induced analgesia.  Stress-induced antinociception is absent in these mice and instead stress induces a hyperalgesic response, suggesting that NT plays a key role in the stress-induced suppression of pain.  Cold water swim stress results in increased NT mRNA expression in hypothalamic regions known to project to periaqueductal gray, a key region involved in pain modulation.  Thus, stress-induced increases in NT signaling in pain modulatory regions may be responsible for the transition from pain facilitation to analgesia.  This review focuses on recent advances that have provided insights into the role of NT in pain modulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdK5ae3Tc9lbVg90H21EOLACvtfcHk0liFJBgK7P5NpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpvV2gsro%253D&md5=b36dae07e063430ad827ac3ed489d616</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.peptides.2006.04.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.peptides.2006.04.025%26sid%3Dliteratum%253Aachs%26aulast%3DDobner%26aufirst%3DP.%2BR.%26atitle%3DNeurotensin%2520and%2520Pain%2520Modulation%26jtitle%3DPeptides%26date%3D2006%26volume%3D27%26spage%3D2405%26epage%3D2414%26doi%3D10.1016%2Fj.peptides.2006.04.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Y.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Y.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.-Q.</span></span> <span> </span><span class="NLM_article-title">The Roles of Neurotensin and Its Analogues in Pain</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">840</span>– <span class="NLM_lpage">848</span>, <span class="refDoi"> DOI: 10.2174/1381612820666141027124915</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.2174%2F1381612820666141027124915" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=840-848&author=Y.-P.+Fengauthor=J.+Wangauthor=Y.-L.+Dongauthor=Y.-Y.+Wangauthor=Y.-Q.+Li&title=The+Roles+of+Neurotensin+and+Its+Analogues+in+Pain&doi=10.2174%2F1381612820666141027124915"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.2174%2F1381612820666141027124915&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612820666141027124915%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DY.-P.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DDong%26aufirst%3DY.-L.%26aulast%3DWang%26aufirst%3DY.-Y.%26aulast%3DLi%26aufirst%3DY.-Q.%26atitle%3DThe%2520Roles%2520of%2520Neurotensin%2520and%2520Its%2520Analogues%2520in%2520Pain%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2014%26volume%3D21%26spage%3D840%26epage%3D848%26doi%3D10.2174%2F1381612820666141027124915" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kleczkowska, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lipkowski, A. W.</span></span> <span> </span><span class="NLM_article-title">Neurotensin and Neurotensin Receptors: Characteristic, Structure-Activity Relationship and Pain Modulation--a Review</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>716</i></span>,  <span class="NLM_fpage">54</span>– <span class="NLM_lpage">60</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2013.03.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2Fj.ejphar.2013.03.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=23500196" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BC3sXltVCrsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=716&publication_year=2013&pages=54-60&author=P.+Kleczkowskaauthor=A.+W.+Lipkowski&title=Neurotensin+and+Neurotensin+Receptors%3A+Characteristic%2C+Structure-Activity+Relationship+and+Pain+Modulation%2D%2Da+Review&doi=10.1016%2Fj.ejphar.2013.03.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Neurotensin and neurotensin receptors: Characteristic, structure-activity relationship and pain modulation-A review</span></div><div class="casAuthors">Kleczkowska, Patrycja; Lipkowski, Andrzej W.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">716</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">54-60</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Neurotensin (NT) is a tridecapeptide, which - since its discovery in 1973 - has been demonstrated to be involved in the control of various physiol. activities in both the central nervous system and in the periphery.  Its biol. effects are mediated by four receptor types.  Exogenously administered NT exerts different behavioral effects, including antinociception.  Structure-activity relationship studies performed in recent years resulted in development of several peptidomimetic receptor agonists and non-peptidic receptor antagonists that are useful tools for studies of NT mechanisms in tissue and on cellular level.  This may result in design of new generation of analgesics based on neurotensin.  NT antinociceptive effects are distinct from opioid analgesia.  This creates opportunity of development of hybrid analgesics that may simultaneously activate both opioid and NT antinociceptive pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtIxYXK-5X-bVg90H21EOLACvtfcHk0liUsVmL__3zVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXltVCrsbY%253D&md5=1797d1b66db6924f7bf0bfdc1fe1a1e3</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2013.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2013.03.004%26sid%3Dliteratum%253Aachs%26aulast%3DKleczkowska%26aufirst%3DP.%26aulast%3DLipkowski%26aufirst%3DA.%2BW.%26atitle%3DNeurotensin%2520and%2520Neurotensin%2520Receptors%253A%2520Characteristic%252C%2520Structure-Activity%2520Relationship%2520and%2520Pain%2520Modulation--a%2520Review%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2013%26volume%3D716%26spage%3D54%26epage%3D60%26doi%3D10.1016%2Fj.ejphar.2013.03.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sarret, P.</span>; <span class="NLM_string-name">Cavelier, F.</span></span> <span> </span><span class="NLM_article-title">Neurotensin and Its Receptors</span>. In  <i>Reference Module in Neuroscience and Biobehavioral Psychology</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stein, J.</span></span>, Ed.; <span class="NLM_publisher-name">Elsevier</span>, <span class="NLM_year">2018</span>; pp.  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">17</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&pages=1-17&author=P.+Sarret&author=F.+Cavelierauthor=J.+Stein&title=Reference+Module+in+Neuroscience+and+Biobehavioral+Psychology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DSarret%26aufirst%3DP.%26atitle%3DNeurotensin%2520and%2520Its%2520Receptors%26btitle%3DReference%2520Module%2520in%2520Neuroscience%2520and%2520Biobehavioral%2520Psychology%26aulast%3DStein%26aufirst%3DJ.%26pub%3DElsevier%26date%3D2018%26spage%3D1%26epage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fantegrossi, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, M. C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woods, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richelson, E.</span></span> <span> </span><span class="NLM_article-title">Antinociceptive, Hypothermic, Hypotensive, and Reinforcing Effects of a Novel Neurotensin Receptor Agonist, Nt69l, in Rhesus Monkeys</span>. <i>Pharmacol. Biochem. Behav.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">341</span>– <span class="NLM_lpage">349</span>, <span class="refDoi"> DOI: 10.1016/j.pbb.2004.12.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2Fj.pbb.2004.12.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=15680187" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmvFGrug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2005&pages=341-349&author=W.+E.+Fantegrossiauthor=M.+C.+H.+Koauthor=J.+H.+Woodsauthor=E.+Richelson&title=Antinociceptive%2C+Hypothermic%2C+Hypotensive%2C+and+Reinforcing+Effects+of+a+Novel+Neurotensin+Receptor+Agonist%2C+Nt69l%2C+in+Rhesus+Monkeys&doi=10.1016%2Fj.pbb.2004.12.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Antinociceptive, hypothermic, hypotensive, and reinforcing effects of a novel neurotensin receptor agonist, NT69L, in rhesus monkeys</span></div><div class="casAuthors">Fantegrossi, W. E.; Ko, M. C. H.; Woods, J. H.; Richelson, E.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology, Biochemistry and Behavior</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">341-349</span>CODEN:
                <span class="NLM_cas:coden">PBBHAU</span>;
        ISSN:<span class="NLM_cas:issn">0091-3057</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Neurotensin (NT) is a tridecapeptide found in the nervous system, as well as elsewhere in the body.  It has anatomical and functional relationships to dopaminergic neurons in brain.  NT was implicated in the actions of antipsychotic drugs and psychostimulants, and animal studies suggest that neurotensin directly injected into brain has reinforcing effects.  Previously, the authors showed that 1 of the authors' brain-penetrating analogs of neurotensin, NT69L (N-methyl-L-Arg, L-Lys, L-Pro, L-neo-Trp, L-tert-Leu, L-Leu), has many pharmacol. effects in rats including antinociception, hypothermia, and blockade of the hyperactivity caused by psychostimulants (cocaine, D-amphetamine, and nicotine).  Since these studies in rats suggest that this compd. may have clin. use in humans, the authors were interested to know what effects NT69L had in primates.  NT69L caused a potent antinociceptive effect against capsaicin (0.1 mg)-induced allodynia in 46 °C water in rhesus monkeys, inducing 40% of the maximal possible effect at an i.v. dosage of 0.03 mg/kg; its hypotensive effects precluded evaluation of higher dosages.  Core temp. measured by rectal probe was modestly reduced at 0.01 and 0.03 mg/kg.  In an i.v. self-administration procedure, NT69L was without reinforcing effects at any dose, including those that caused other pharmacol. effects, and did not alter cocaine-maintained behavior when administered as a pretreatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCNrUc_FsYRLVg90H21EOLACvtfcHk0liUsVmL__3zVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmvFGrug%253D%253D&md5=fda03e02c91b0664aa96ab367a95f855</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.pbb.2004.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pbb.2004.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DFantegrossi%26aufirst%3DW.%2BE.%26aulast%3DKo%26aufirst%3DM.%2BC.%2BH.%26aulast%3DWoods%26aufirst%3DJ.%2BH.%26aulast%3DRichelson%26aufirst%3DE.%26atitle%3DAntinociceptive%252C%2520Hypothermic%252C%2520Hypotensive%252C%2520and%2520Reinforcing%2520Effects%2520of%2520a%2520Novel%2520Neurotensin%2520Receptor%2520Agonist%252C%2520Nt69l%252C%2520in%2520Rhesus%2520Monkeys%26jtitle%3DPharmacol.%2520Biochem.%2520Behav.%26date%3D2005%26volume%3D80%26spage%3D341%26epage%3D349%26doi%3D10.1016%2Fj.pbb.2004.12.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Osadchii, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodiwiss, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deftereos, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norton, G.</span></span> <span> </span><span class="NLM_article-title">Neurotensin-Induced Myocardial Noradrenergic Effects in Spontaneously Hypertensive Rats</span>. <i>J. Cardiovasc. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">221</span>– <span class="NLM_lpage">227</span>, <span class="refDoi"> DOI: 10.1097/01.fjc.0000200988.85868.f8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1097%2F01.fjc.0000200988.85868.f8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=16495759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhs12ns78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2006&pages=221-227&author=O.+Osadchiiauthor=A.+Woodiwissauthor=D.+Deftereosauthor=G.+Norton&title=Neurotensin-Induced+Myocardial+Noradrenergic+Effects+in+Spontaneously+Hypertensive+Rats&doi=10.1097%2F01.fjc.0000200988.85868.f8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Neurotensin-Induced Myocardial Noradrenergic Effects in Spontaneously Hypertensive Rats</span></div><div class="casAuthors">Osadchii, Oleg; Woodiwiss, Angela; Deftereos, Dawn; Norton, Gavin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cardiovascular Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">221-227</span>CODEN:
                <span class="NLM_cas:coden">JCPCDT</span>;
        ISSN:<span class="NLM_cas:issn">0160-2446</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Although increases in myocardial synaptic norepinephrine concns. contribute toward the progression to heart failure in hypertension, the stimuli for norepinephrine release are unclear.  In this study we explored whether neurotensin, a neuropeptide found in heart tissue, could modify myocardial norepinephrine release in spontaneously hypertensive rats (SHR).  Prior to the development of cardiac decompensation, baseline coronary effluent norepinephrine concns. were higher in isolated heart prepns. of spontaneously hypertensive rats than in Wistar Kyoto (WKY) control rat hearts.  Neurotensin increased coronary effluent norepinephrine concns. and induced pos. inotropic responses, effects that were enhanced in spontaneously hypertensive rats compared with Wistar Kyoto rats.  Although the neurotensin receptor antagonist, SR 48692, did not modify either baseline coronary effluent norepinephrine concns. or left ventricular systolic function in spontaneously hypertensive rats, it dose dependently abolished neurotensin-induced cardiac norepinephrine release and contractile responses.  Neurotensin-mediated inotropic responses were also abolished by co-administration of the β-adrenoreceptor blockers, propranolol and atenolol.  Inotropic responses to exogenous norepinephrine were similar in SHR and WKY rats.  In summary, in the hypertensive heart there is an increased sensitivity to neurotensin's actions on myocardial norepinephrine release and subsequent contractile changes.  Therefore, neurotensin receptor blockade may represent a novel therapeutic target in preventing the progression to heart failure in hypertension.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJHNV_QfvqebVg90H21EOLACvtfcHk0liUsVmL__3zVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhs12ns78%253D&md5=e5f0720a9cd1e84534f14c089cd9a060</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1097%2F01.fjc.0000200988.85868.f8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F01.fjc.0000200988.85868.f8%26sid%3Dliteratum%253Aachs%26aulast%3DOsadchii%26aufirst%3DO.%26aulast%3DWoodiwiss%26aufirst%3DA.%26aulast%3DDeftereos%26aufirst%3DD.%26aulast%3DNorton%26aufirst%3DG.%26atitle%3DNeurotensin-Induced%2520Myocardial%2520Noradrenergic%2520Effects%2520in%2520Spontaneously%2520Hypertensive%2520Rats%26jtitle%3DJ.%2520Cardiovasc.%2520Pharmacol.%26date%3D2006%26volume%3D47%26spage%3D221%26epage%3D227%26doi%3D10.1097%2F01.fjc.0000200988.85868.f8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Previti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vivancos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rémond, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaulieu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Longpré, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballet, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarret, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavelier, F.</span></span> <span> </span><span class="NLM_article-title">Insightful Backbone Modifications Preventing Proteolytic Degradation of Neurotensin Analogs Improve Nts1-Induced Protective Hypothermia</span>. <i>Front. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">406</span>, <span class="refDoi"> DOI: 10.3389/fchem.2020.00406</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.3389%2Ffchem.2020.00406" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=32582624" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitVWgt7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2020&pages=406&author=S.+Previtiauthor=M.+Vivancosauthor=E.+R%C3%A9mondauthor=S.+Beaulieuauthor=J.+M.+Longpr%C3%A9author=S.+Balletauthor=P.+Sarretauthor=F.+Cavelier&title=Insightful+Backbone+Modifications+Preventing+Proteolytic+Degradation+of+Neurotensin+Analogs+Improve+Nts1-Induced+Protective+Hypothermia&doi=10.3389%2Ffchem.2020.00406"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Insightful backbone modifications preventing proteolytic degradation of neurotensin analogs improve NTS1-induced protective hypothermia</span></div><div class="casAuthors">Previti, Santo; Vivancos, Melanie; Remond, Emmanuelle; Beaulieu, Sabrina; Longpre, Jean-Michel; Ballet, Steven; Sarret, Philippe; Cavelier, Florine</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Chemistry (Lausanne, Switzerland)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">00406</span>CODEN:
                <span class="NLM_cas:coden">FCLSAA</span>;
        ISSN:<span class="NLM_cas:issn">2296-2646</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Therapeutic hypothermia represents a brain-protective strategy for multiple emergency situations, such as stroke or traumatic injury.  Neurotensin (NT), which exerts its effects through activation of two G protein-coupled receptors, namely NTS1 and NTS2, induces a strong and long-lasting decrease in core body temp. after its central administration.  Growing evidence demonstrates that NTS1 is the receptor subtype mediating the hypothermic action of NT.  As such, potent NTS1 agonists designed on the basis of the minimal C-terminal NT(8-13) bioactive fragment have been shown to produce mild hypothermia and exert neuroprotective effects under various clin. relevant conditions.  The high susceptibility of NT(8-13) to protease degrdn. (half-life <2 min) represents, however, a serious limitation for its use in pharmacol. therapy.  In light of this, we report here a structure-activity relationship study in which pairs of NT(8-13) analogs have been developed, based on the incorporation of a reduced Lys8-Lys9 bond.  To further stabilize the peptide bonds, a panel of backbone modifications was also inserted along the peptide sequence, including Sip10, D-Trp11, Dmt11, Tle12, and TMSAla13.  Our results revealed that the combination of appropriate chem. modifications leads to compds. exhibiting improved resistance to proteolytic cleavages (>24 h; 16).  Among them, the NT(8-13) analogs harboring the reduced amine bond combined with the unnatural amino acids TMSAla13 (4) and Sip10 (6) or the di-substitution Lys11 - TMSAla13 (12), D-Trp11-TMSAla13 (14), and Dmt11-Tle12 (16) produced sustained hypothermic effects (-3°C for at least 1 h).  Importantly, we obsd. that hypothermia was mainly driven by the increased stability of the NT(8-13) derivs., instead of the high binding-affinity at NTS1.  Altogether, these results reveal the importance of the reduced amine bond in optimizing the metabolic properties of the NT(8-13) peptide and support the development of stable NTS1 agonists as first drug candidate in neuroprotective hypothermia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotOch_UfGOS7Vg90H21EOLACvtfcHk0lhP5ncgW-3yUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitVWgt7rE&md5=0be0d4fedfa9f73fab18af39aa2c6b41</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.3389%2Ffchem.2020.00406&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffchem.2020.00406%26sid%3Dliteratum%253Aachs%26aulast%3DPreviti%26aufirst%3DS.%26aulast%3DVivancos%26aufirst%3DM.%26aulast%3DR%25C3%25A9mond%26aufirst%3DE.%26aulast%3DBeaulieu%26aufirst%3DS.%26aulast%3DLongpr%25C3%25A9%26aufirst%3DJ.%2BM.%26aulast%3DBallet%26aufirst%3DS.%26aulast%3DSarret%26aufirst%3DP.%26aulast%3DCavelier%26aufirst%3DF.%26atitle%3DInsightful%2520Backbone%2520Modifications%2520Preventing%2520Proteolytic%2520Degradation%2520of%2520Neurotensin%2520Analogs%2520Improve%2520Nts1-Induced%2520Protective%2520Hypothermia%26jtitle%3DFront.%2520Chem.%26date%3D2020%26volume%3D8%26spage%3D406%26doi%3D10.3389%2Ffchem.2020.00406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bissette, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luttinger, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loosen, P. T.</span></span> <span> </span><span class="NLM_article-title">Neurotensin and Thermoregulation</span>. <i>Ann. N. Y. Acad. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>400</i></span>,  <span class="NLM_fpage">268</span>– <span class="NLM_lpage">282</span>, <span class="refDoi"> DOI: 10.1111/j.1749-6632.1982.tb31575.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1111%2Fj.1749-6632.1982.tb31575.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=6820243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADyaL3sXhslehsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=400&publication_year=1982&pages=268-282&author=G.+Bissetteauthor=D.+Luttingerauthor=G.+A.+Masonauthor=D.+E.+Hernandezauthor=P.+T.+Loosen&title=Neurotensin+and+Thermoregulation&doi=10.1111%2Fj.1749-6632.1982.tb31575.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Neurotensin and thermoregulation</span></div><div class="casAuthors">Bissette, Garth; Luttinger, Daniel; Mason, George A.; Hernandez, Daniel E.; Loosen, Peter T.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the New York Academy of Sciences</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">400</span>
        (<span class="NLM_cas:issue">Neurotensin, Brain Gastrointest. Pept.</span>),
    <span class="NLM_cas:pages">268-82</span>CODEN:
                <span class="NLM_cas:coden">ANYAA9</span>;
        ISSN:<span class="NLM_cas:issn">0077-8923</span>.
    </div><div class="casAbstract">A review with 35 refs. on neurotensin  [39379-15-2] and thermoregulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUUchvqZVhyrVg90H21EOLACvtfcHk0lhP5ncgW-3yUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXhslehsrs%253D&md5=6595b225d1f3d3e9bfc47de52e2fe2f1</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1111%2Fj.1749-6632.1982.tb31575.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1749-6632.1982.tb31575.x%26sid%3Dliteratum%253Aachs%26aulast%3DBissette%26aufirst%3DG.%26aulast%3DLuttinger%26aufirst%3DD.%26aulast%3DMason%26aufirst%3DG.%2BA.%26aulast%3DHernandez%26aufirst%3DD.%2BE.%26aulast%3DLoosen%26aufirst%3DP.%2BT.%26atitle%3DNeurotensin%2520and%2520Thermoregulation%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D1982%26volume%3D400%26spage%3D268%26epage%3D282%26doi%3D10.1111%2Fj.1749-6632.1982.tb31575.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pothoulakis, C.</span></span> <span> </span><span class="NLM_article-title">Effects of Nt on Gastrointestinal Motility and Secretion, and Role in Intestinal Inflammation</span>. <i>Peptides</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">2434</span>– <span class="NLM_lpage">2444</span>, <span class="refDoi"> DOI: 10.1016/j.peptides.2005.12.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2Fj.peptides.2005.12.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=16872719" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BD28XpvV2gsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2006&pages=2434-2444&author=D.+Zhaoauthor=C.+Pothoulakis&title=Effects+of+Nt+on+Gastrointestinal+Motility+and+Secretion%2C+and+Role+in+Intestinal+Inflammation&doi=10.1016%2Fj.peptides.2005.12.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of NT on gastrointestinal motility and secretion, and role in intestinal inflammation</span></div><div class="casAuthors">Zhao, Dezheng; Pothoulakis, Charalabos</div><div class="citationInfo"><span class="NLM_cas:title">Peptides (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2434-2444</span>CODEN:
                <span class="NLM_cas:coden">PPTDD5</span>;
        ISSN:<span class="NLM_cas:issn">0196-9781</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  It is well established that interactions of neuropeptides with several cell types at various parts of the intestine are critically involved in intestinal pathophysiol.  Among them, neurotensin has been identified as an important mediator in the development and progress of several gastrointestinal functions and disease conditions, exerting its effects by interacting with specific receptors that exert direct and indirect effects on nerves, epithelial cells, and cells of the immune and inflammatory systems.  This review summarizes our recent understanding on the participation of neurotensin in the physiol. and pathophysiol. of the small and large intestine, and discusses various mechanisms that could be involved in these actions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCfvwYdNLG37Vg90H21EOLACvtfcHk0lhP5ncgW-3yUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpvV2gsrk%253D&md5=64c00c033c59f7c0aa72c1cdaec0a82b</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.peptides.2005.12.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.peptides.2005.12.016%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DD.%26aulast%3DPothoulakis%26aufirst%3DC.%26atitle%3DEffects%2520of%2520Nt%2520on%2520Gastrointestinal%2520Motility%2520and%2520Secretion%252C%2520and%2520Role%2520in%2520Intestinal%2520Inflammation%26jtitle%3DPeptides%26date%3D2006%26volume%3D27%26spage%3D2434%26epage%3D2444%26doi%3D10.1016%2Fj.peptides.2005.12.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Asselin, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubuc, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coquerel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costentin, J.</span></span> <span> </span><span class="NLM_article-title">Localization of Neurotensin Nts2 Receptors in Rat Brain, Using [3h]Levocabastine</span>. <i>Neuroreport</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1087</span>– <span class="NLM_lpage">1091</span>, <span class="refDoi"> DOI: 10.1097/00001756-200104170-00044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1097%2F00001756-200104170-00044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=11303751" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjtVWgsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2001&pages=1087-1091&author=M.+L.+Asselinauthor=I.+Dubucauthor=A.+Coquerelauthor=J.+Costentin&title=Localization+of+Neurotensin+Nts2+Receptors+in+Rat+Brain%2C+Using+%5B3h%5DLevocabastine&doi=10.1097%2F00001756-200104170-00044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Localization of neurotensin NTS2 receptors in rat brain, using [3H]levocabastine</span></div><div class="casAuthors">Asselin, Marie-Liesse; Dubuc, Isabelle; Coquerel, Antoine; Costentin, Jean</div><div class="citationInfo"><span class="NLM_cas:title">NeuroReport</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1087-1091</span>CODEN:
                <span class="NLM_cas:coden">NERPEZ</span>;
        ISSN:<span class="NLM_cas:issn">0959-4965</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">The brain localization of the neurotensin receptor NTS2 was studied with [3H]levocabastine, using an autoradiog. procedure.  This study suggests that NTS2 receptors are mainly intracellular.  High densities of binding sites were obsd. in the cingulate, insular, temporal, occipital, entorhinal cortex, amygdaloid complex, septohippocampal nuclei, medial thalamus, mammillary bodies and superior colliculi; a moderate labeling was obsd. in the anterior and medial hippocampus, olfactory tubercle, hypothalamus, periaqueductal gray matter, caudate putamen, nucleus accumbens, septum, lateral thalamus, dorsal raphe nucleus and cerebellum; finally, a low labeling was apparent in the ventral tegmentum area and substantia nigra.  Thus it appears that NTS2 receptors are particularly abundant in the cerebral cortex, the limbic areas and some areas involved in pain perception.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKospzSy6FeLVg90H21EOLACvtfcHk0lhP5ncgW-3yUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjtVWgsLw%253D&md5=dcf68024e457bb6e687babb2a5fb7021</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1097%2F00001756-200104170-00044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00001756-200104170-00044%26sid%3Dliteratum%253Aachs%26aulast%3DAsselin%26aufirst%3DM.%2BL.%26aulast%3DDubuc%26aufirst%3DI.%26aulast%3DCoquerel%26aufirst%3DA.%26aulast%3DCostentin%26aufirst%3DJ.%26atitle%3DLocalization%2520of%2520Neurotensin%2520Nts2%2520Receptors%2520in%2520Rat%2520Brain%252C%2520Using%2520%255B3h%255DLevocabastine%26jtitle%3DNeuroreport%26date%3D2001%26volume%3D12%26spage%3D1087%26epage%3D1091%26doi%3D10.1097%2F00001756-200104170-00044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sarret, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaudet, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazella, J.</span></span> <span> </span><span class="NLM_article-title">Regional and Cellular Distribution of Low Affinity Neurotensin Receptor Mrna in Adult and Developing Mouse Brain</span>. <i>J. Comp. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>394</i></span>,  <span class="NLM_fpage">344</span>– <span class="NLM_lpage">356</span>, <span class="refDoi"> DOI: 10.1002/(SICI)1096-9861(19980511)394:3<344::AID-CNE6>3.0.CO;2-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1002%2F%28SICI%291096-9861%2819980511%29394%3A3%3C344%3A%3AAID-CNE6%3E3.0.CO%3B2-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=9579398" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADyaK1cXjt1KjsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=394&publication_year=1998&pages=344-356&author=P.+Sarretauthor=A.+Beaudetauthor=J.+P.+Vincentauthor=J.+Mazella&title=Regional+and+Cellular+Distribution+of+Low+Affinity+Neurotensin+Receptor+Mrna+in+Adult+and+Developing+Mouse+Brain&doi=10.1002%2F%28SICI%291096-9861%2819980511%29394%3A3%3C344%3A%3AAID-CNE6%3E3.0.CO%3B2-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Regional and cellular distribution of low affinity neurotensin receptor mRNA in adult and developing mouse brain</span></div><div class="casAuthors">Sarret, Philippe; Beaudet, Alain; Vincent, Jean-Pierre; Mazellai, Jean</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Comparative Neurology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">394</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">344-356</span>CODEN:
                <span class="NLM_cas:coden">JCNEAM</span>;
        ISSN:<span class="NLM_cas:issn">0021-9967</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Levocabastine-sensitive neurotensin receptor (NTRL) mRNAs were localized by in situ hybridization in adult and developing mouse brain.  NTRL hybridization signal was widely distributed throughout the neuraxis.  The highest concns. of NTRL mRNA were detected in the olfactory system, olfactory tubercle, cerebral and cerebellar cortices, hippocampal formation, and selective hypothalamic nuclei.  Moderate to dense hybridization signal was also obsd. in assocn. with a variety of auditory, visual, and somatosensory relay nuclei, suggesting that the NTRL might be involved in a widespread modulation of primary afferent pathways.  Finally a high expression of NTRL was evident in brainstem structures implicated in descending antinociceptive influences (e.g., the periaqueductal gray, nucleus raphe magnus, gigantocellular reticular nucleus, pars alpha, and lateral paragigantocellular nucleus) consistent with the proposed mediation of NT-induced analgesia by the NTRL.  Although most of the regions found here to express NTRL mRNA were previously reported to be devoid of mRNA encoding the high affinity NT receptor (NTRH), a few areas (e.g., the anterior olfactory nucleus, medial septum, diagonal band of Broca, reticular thalamic nucleus, suprachiasmatic hypothalamic nucleus, and pontine nucleus) were enriched in both receptor subtypes, suggesting a possible coexpression of these receptors by the same cells.  Ontogenic studies revealed that in the mouse brain, NTRL mRNA was detected only from postnatal day 14 and did not reach adulthood concns. before day 30.  In cerebral cortex, the developmental increase in NTRL expression was correlated over time with the decrease in NTRH expression previously documented in the rat, suggesting a progressive takeover of the latter by the former for transduction of the effects of NT in this structure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo750VMxJ8UfrVg90H21EOLACvtfcHk0lgkAGC9RsbZIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjt1KjsbY%253D&md5=08e46a043a96e0d2e48ff9ecc5596d7b</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291096-9861%2819980511%29394%3A3%3C344%3A%3AAID-CNE6%3E3.0.CO%3B2-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291096-9861%252819980511%2529394%253A3%253C344%253A%253AAID-CNE6%253E3.0.CO%253B2-1%26sid%3Dliteratum%253Aachs%26aulast%3DSarret%26aufirst%3DP.%26aulast%3DBeaudet%26aufirst%3DA.%26aulast%3DVincent%26aufirst%3DJ.%2BP.%26aulast%3DMazella%26aufirst%3DJ.%26atitle%3DRegional%2520and%2520Cellular%2520Distribution%2520of%2520Low%2520Affinity%2520Neurotensin%2520Receptor%2520Mrna%2520in%2520Adult%2520and%2520Developing%2520Mouse%2520Brain%26jtitle%3DJ.%2520Comp.%2520Neurol.%26date%3D1998%26volume%3D394%26spage%3D344%26epage%3D356%26doi%3D10.1002%2F%28SICI%291096-9861%2819980511%29394%3A3%3C344%3A%3AAID-CNE6%3E3.0.CO%3B2-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sarret, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perron, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stroh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaudet, A.</span></span> <span> </span><span class="NLM_article-title">Immunohistochemical Distribution of Nts2 Neurotensin Receptors in the Rat Central Nervous System</span>. <i>J. Comp. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>461</i></span>,  <span class="NLM_fpage">520</span>– <span class="NLM_lpage">538</span>, <span class="refDoi"> DOI: 10.1002/cne.10718</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1002%2Fcne.10718" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=12746866" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BD3sXltFGlurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=461&publication_year=2003&pages=520-538&author=P.+Sarretauthor=A.+Perronauthor=T.+Strohauthor=A.+Beaudet&title=Immunohistochemical+Distribution+of+Nts2+Neurotensin+Receptors+in+the+Rat+Central+Nervous+System&doi=10.1002%2Fcne.10718"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Immunohistochemical distribution of NTS2 neurotensin receptors in the rat central nervous system</span></div><div class="casAuthors">Sarret, Philippe; Perron, Amelie; Stroh, Thomas; Beaudet, Alain</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Comparative Neurology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">461</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">520-538</span>CODEN:
                <span class="NLM_cas:coden">JCNEAM</span>;
        ISSN:<span class="NLM_cas:issn">0021-9967</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">We localized the levocabastine-sensitive neurotensin receptor (NTS2) protein in adult rat brain by using an N-terminally-directed antibody.  NTS2-like immunoreactivity was broadly distributed throughout the rat brain.  At the cellular level, the reaction product was exclusively assocd. with neurons and predominantly, although not exclusively, with their dendritic arbors.  No NTS2 signal was obsd. over astrocytes, as confirmed by dual confocal microscopic immunofluorescence studies using the astrocytic marker S100β.  High densities of NTS2-like immunoreactive nerve cell bodies and/or processes were detected in many regions documented to receive a dense neurotensinergic innervation, such as the olfactory bulb, bed nucleus of the stria terminalis, magnocellular preoptic nucleus, amygdaloid complex, anterodorsal thalamic nucleus, substantia nigra, ventral tegmental area, and several brainstem nuclei.  Most conspicuous among the latter were structures implicated in the descending control of nociceptive inputs (e.g., the periaqueductal gray, dorsal raphe, gigantocellular reticular nucleus, pars alpha, lateral paragigantocellular, and raphe magnus), in keeping with the postulated role of NTS2 receptors in the mediation of neurotensin's supraspinal antinociceptive actions.  However, the distribution of NTS2-like immunoreactivity largely exceeded that of neurotensin terminal fields, and some of the highest concns. of the receptor were found in areas devoid of neurotensinergic inputs such as the cerebral cortex, hippocampus, and cerebellum, suggesting that neurotensin may not be the exclusive endogenous ligand for this receptor subtype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsW0j3O468YLVg90H21EOLACvtfcHk0lgkAGC9RsbZIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXltFGlurg%253D&md5=2ffe69b294f8ccc75ef2a5d3ea8d108b</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1002%2Fcne.10718&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcne.10718%26sid%3Dliteratum%253Aachs%26aulast%3DSarret%26aufirst%3DP.%26aulast%3DPerron%26aufirst%3DA.%26aulast%3DStroh%26aufirst%3DT.%26aulast%3DBeaudet%26aufirst%3DA.%26atitle%3DImmunohistochemical%2520Distribution%2520of%2520Nts2%2520Neurotensin%2520Receptors%2520in%2520the%2520Rat%2520Central%2520Nervous%2520System%26jtitle%3DJ.%2520Comp.%2520Neurol.%26date%3D2003%26volume%3D461%26spage%3D520%26epage%3D538%26doi%3D10.1002%2Fcne.10718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lépée-Lorgeoux, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Betancur, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rostène, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pélaprat, D.</span></span> <span> </span><span class="NLM_article-title">Differential Ontogenetic Patterns of Levocabastine-Sensitive Neurotensin Nt2 Receptors and of Nt1 Receptors in the Rat Brain Revealed by in Situ Hybridization</span>. <i>Brain Res. Dev. Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">115</span>– <span class="NLM_lpage">131</span>, <span class="refDoi"> DOI: 10.1016/S0165-3806(99)00009-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2FS0165-3806%2899%2900009-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10064881" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADyaK1MXht1OhtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=1999&pages=115-131&author=I.+L%C3%A9p%C3%A9e-Lorgeouxauthor=C.+Betancurauthor=W.+Rost%C3%A8neauthor=D.+P%C3%A9laprat&title=Differential+Ontogenetic+Patterns+of+Levocabastine-Sensitive+Neurotensin+Nt2+Receptors+and+of+Nt1+Receptors+in+the+Rat+Brain+Revealed+by+in+Situ+Hybridization&doi=10.1016%2FS0165-3806%2899%2900009-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Differential ontogenetic patterns of levocabastine-sensitive neurotensin NT2 receptors and of NT1 receptors in the rat brain revealed by in situ hybridization</span></div><div class="casAuthors">Lepee-Lorgeoux, Isabelle; Betancur, Catalina; Rostene, William; Pelaprat, Didier</div><div class="citationInfo"><span class="NLM_cas:title">Developmental Brain Research</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">1,2</span>),
    <span class="NLM_cas:pages">115-131</span>CODEN:
                <span class="NLM_cas:coden">DBRRDB</span>;
        ISSN:<span class="NLM_cas:issn">0165-3806</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The postnatal ontogeny of the levocabastine-sensitive neurotensin receptor (NT2) mRNA was studied by in situ hybridization in the rat brain and compared with the distribution of the levocabastine-insensitive NT1 receptor.  NT2 receptor mRNA was absent at birth from all brain structures except the ependymal cell layer lining the ventricles.  The development of NT2 receptor mRNA followed three ontogenetic patterns.  The first pattern, involving the majority of the cerebral gray matter, was characterized by a continuous increase from postnatal day 5 (P5) to P30.  The second one, involving regions rich in myelinated fibers such as the corpus callosum and lacunosum moleculare layer of the hippocampus, exhibited a pronounced increase between P5 and P10, peaked at P15 and was followed by a plateau or a slight decrease.  The third pattern was obsd. in the ependymal cell layer lining the olfactory and lateral ventricles, where the high labeling already present at birth continued to increase during development.  These different developmental patterns could reflect the variety of cells expressing NT2 receptor mRNA, including neurons, protoplasmic astrocytes in gray matter, fibrous astrocytes present in myelinated fibers tracts, and ependymal cells.  In contrast, NT1 receptor mRNA, which seems to be assocd. only with neurons, was highly and transiently expressed during the perinatal period in the cerebral cortex, hippocampus and striatal neuroepithelium.  Other regions, notably the ventral tegmental area and substantia nigra compacta, exhibited a gradual increase in NT1 receptor signal, reaching adult levels by P21.  Both the differential localization and ontogenetic profiles of NT1 and NT2 receptor mRNAs suggest different involvement of these two receptors in brain functions and development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUfer4c8glILVg90H21EOLACvtfcHk0lgkAGC9RsbZIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXht1OhtbY%253D&md5=a17ff07d795f5953642b572f1ef8e3b3</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2FS0165-3806%2899%2900009-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0165-3806%252899%252900009-7%26sid%3Dliteratum%253Aachs%26aulast%3DL%25C3%25A9p%25C3%25A9e-Lorgeoux%26aufirst%3DI.%26aulast%3DBetancur%26aufirst%3DC.%26aulast%3DRost%25C3%25A8ne%26aufirst%3DW.%26aulast%3DP%25C3%25A9laprat%26aufirst%3DD.%26atitle%3DDifferential%2520Ontogenetic%2520Patterns%2520of%2520Levocabastine-Sensitive%2520Neurotensin%2520Nt2%2520Receptors%2520and%2520of%2520Nt1%2520Receptors%2520in%2520the%2520Rat%2520Brain%2520Revealed%2520by%2520in%2520Situ%2520Hybridization%26jtitle%3DBrain%2520Res.%2520Dev.%2520Brain%2520Res.%26date%3D1999%26volume%3D113%26spage%3D115%26epage%3D131%26doi%3D10.1016%2FS0165-3806%2899%2900009-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Munk, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mutt, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isberg, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolajsen, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bibbe, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flock, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deupi, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gloriam, D. E.</span></span> <span> </span><span class="NLM_article-title">An Online Resource for Gpcr Structure Determination and Analysis</span>. <i>Nat. Methods</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">151</span>– <span class="NLM_lpage">162</span>, <span class="refDoi"> DOI: 10.1038/s41592-018-0302-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1038%2Fs41592-018-0302-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=30664776" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BC1MXmtFGru74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2019&pages=151-162&author=C.+Munkauthor=E.+Muttauthor=V.+Isbergauthor=L.+F.+Nikolajsenauthor=J.+M.+Bibbeauthor=T.+Flockauthor=M.+A.+Hansonauthor=R.+C.+Stevensauthor=X.+Deupiauthor=D.+E.+Gloriam&title=An+Online+Resource+for+Gpcr+Structure+Determination+and+Analysis&doi=10.1038%2Fs41592-018-0302-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">An online resource for GPCR structure determination and analysis</span></div><div class="casAuthors">Munk, Christian; Mutt, Eshita; Isberg, Vignir; Nikolajsen, Louise F.; Bibbe, Janne M.; Flock, Tilman; Hanson, Michael A.; Stevens, Raymond C.; Deupi, Xavier; Gloriam, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Methods</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">151-162</span>CODEN:
                <span class="NLM_cas:coden">NMAEA3</span>;
        ISSN:<span class="NLM_cas:issn">1548-7091</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">G-protein-coupled receptors (GPCRs) transduce physiol. and sensory stimuli into appropriate cellular responses and mediate the actions of one-third of drugs.  GPCR structural studies have revealed the general bases of receptor activation, signaling, drug action and allosteric modulation, but so far cover only 13% of nonolfactory receptors.  We broadly surveyed the receptor modifications/engineering and methods used to produce all available GPCR crystal and cryo-electron microscopy (cryo-EM) structures, and present an interactive resource integrated in GPCRdb (http://www.gpcrdb.org) to assist users in designing constructs and browsing appropriate exptl. conditions for structure studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnhlg2FyHfTLVg90H21EOLACvtfcHk0lhkHS1Jq0CE3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXmtFGru74%253D&md5=a0e1ffb48671b58a63764ed4cff86901</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1038%2Fs41592-018-0302-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41592-018-0302-x%26sid%3Dliteratum%253Aachs%26aulast%3DMunk%26aufirst%3DC.%26aulast%3DMutt%26aufirst%3DE.%26aulast%3DIsberg%26aufirst%3DV.%26aulast%3DNikolajsen%26aufirst%3DL.%2BF.%26aulast%3DBibbe%26aufirst%3DJ.%2BM.%26aulast%3DFlock%26aufirst%3DT.%26aulast%3DHanson%26aufirst%3DM.%2BA.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DDeupi%26aufirst%3DX.%26aulast%3DGloriam%26aufirst%3DD.%2BE.%26atitle%3DAn%2520Online%2520Resource%2520for%2520Gpcr%2520Structure%2520Determination%2520and%2520Analysis%26jtitle%3DNat.%2520Methods%26date%3D2019%26volume%3D16%26spage%3D151%26epage%3D162%26doi%3D10.1038%2Fs41592-018-0302-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krumm, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Botos, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaidehi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grisshammer, R.</span></span> <span> </span><span class="NLM_article-title">Structure and Dynamics of a Constitutively Active Neurotensin Receptor</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">38564</span>, <span class="refDoi"> DOI: 10.1038/srep38564</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1038%2Fsrep38564" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=27924846" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFCqtbbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=38564&author=B.+E.+Krummauthor=S.+Leeauthor=S.+Bhattacharyaauthor=I.+Botosauthor=C.+F.+Whiteauthor=H.+Duauthor=N.+Vaidehiauthor=R.+Grisshammer&title=Structure+and+Dynamics+of+a+Constitutively+Active+Neurotensin+Receptor&doi=10.1038%2Fsrep38564"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and dynamics of a constitutively active neurotensin receptor</span></div><div class="casAuthors">Krumm, Brian E.; Lee, Sangbae; Bhattacharya, Supriyo; Botos, Istvan; White, Courtney F.; Du, Haijuan; Vaidehi, Nagarajan; Grisshammer, Reinhard</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">38564</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Many G protein-coupled receptors show constitutive activity, resulting in the prodn. of a second messenger in the absence of an agonist; and naturally occurring constitutively active mutations in receptors have been implicated in diseases.  To gain insight into mechanistic aspects of constitutive activity, we report here the 3.3 Å crystal structure of a constitutively active, agonist-bound neurotensin receptor (NTSR1) and mol. dynamics simulations of agonist-occupied and ligand-free receptor.  Comparison with the structure of a NTSR1 variant that has little constitutive activity reveals uncoupling of the ligand-binding domain from conserved connector residues, that effect conformational changes during GPCR activation.  Furthermore, mol. dynamics simulations show strong contacts between connector residue side chains and increased flexibility at the intracellular receptor face as features that coincide with robust signalling in cells.  The loss of correlation between the binding pocket and conserved connector residues, combined with altered receptor dynamics, possibly explains the reduced neurotensin efficacy in the constitutively active NTSR1 and a facilitated initial engagement with G protein in the absence of agonist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1DeeNHmoaMLVg90H21EOLACvtfcHk0lhkHS1Jq0CE3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFCqtbbI&md5=c14f5ada49ba23c241dc547a0c502ba8</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1038%2Fsrep38564&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep38564%26sid%3Dliteratum%253Aachs%26aulast%3DKrumm%26aufirst%3DB.%2BE.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DBhattacharya%26aufirst%3DS.%26aulast%3DBotos%26aufirst%3DI.%26aulast%3DWhite%26aufirst%3DC.%2BF.%26aulast%3DDu%26aufirst%3DH.%26aulast%3DVaidehi%26aufirst%3DN.%26aulast%3DGrisshammer%26aufirst%3DR.%26atitle%3DStructure%2520and%2520Dynamics%2520of%2520a%2520Constitutively%2520Active%2520Neurotensin%2520Receptor%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D38564%26doi%3D10.1038%2Fsrep38564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Egloff, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hillenbrand, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klenk, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batyuk, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heine, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balada, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlinkmann, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schütz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plückthun, A.</span></span> <span> </span><span class="NLM_article-title">Structure of Signaling-Competent Neurotensin Receptor 1 Obtained by Directed Evolution in Escherichia Coli</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">E655</span>– <span class="NLM_lpage">E662</span>, <span class="refDoi"> DOI: 10.1073/pnas.1317903111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1073%2Fpnas.1317903111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=24453215" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisFOntrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=E655-E662&author=P.+Egloffauthor=M.+Hillenbrandauthor=C.+Klenkauthor=A.+Batyukauthor=P.+Heineauthor=S.+Baladaauthor=K.+M.+Schlinkmannauthor=D.+J.+Scottauthor=M.+Sch%C3%BCtzauthor=A.+Pl%C3%BCckthun&title=Structure+of+Signaling-Competent+Neurotensin+Receptor+1+Obtained+by+Directed+Evolution+in+Escherichia+Coli&doi=10.1073%2Fpnas.1317903111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of signaling-competent neurotensin receptor 1 obtained by directed evolution in Escherichia coli</span></div><div class="casAuthors">Egloff, Pascal; Hillenbrand, Matthias; Klenk, Christoph; Batyuk, Alexander; Heine, Philipp; Balada, Stefanie; Schlinkmann, Karola M.; Scott, Daniel J.; Schutz, Marco; Pluckthun, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">E655-E662</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Crystallog. has advanced our understanding of G protein-coupled receptors, but low expression levels and instability in soln. have limited structural insights to very few selected members of this large protein family.  Using neurotensin receptor 1 (NTR1) as a proof of principle, we show that two directed evolution technologies that we recently developed have the potential to overcome these problems.  We purified three neurotensin-bound NTR1 variants from Escherichia coli and detd. their x-ray structures at up to 2.75 Å resoln. using vapor diffusion crystn. expts.  A crystd. construct was pharmacol. characterized and exhibited ligand-dependent signaling, internalization, and wild-type-like agonist and antagonist affinities.  Our structures are fully consistent with all biochem. defined ligand-contacting residues, and they represent an inactive NTR1 state at the cytosolic side.  They exhibit significant differences to a previously detd. NTR1 structure (Protein Data Bank ID code 4GRV) in the ligand-binding pocket and by the presence of the amphipathic helix 8.  A comparison of helix 8 stability determinants between NTR1 and other crystd. G protein-coupled receptors suggests that the occupancy of the canonical position of the amphipathic helix is reduced to various extents in many receptors, and we have elucidated the sequence determinants for a stable helix 8.  Our anal. also provides a structural rationale for the long-known effects of C-terminal palmitoylation reactions on G protein-coupled receptor signaling, receptor maturation, and desensitization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEqfddVgyHFLVg90H21EOLACvtfcHk0lhkHS1Jq0CE3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisFOntrc%253D&md5=036230389cacc05a6462cf7b6a55278b</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1317903111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1317903111%26sid%3Dliteratum%253Aachs%26aulast%3DEgloff%26aufirst%3DP.%26aulast%3DHillenbrand%26aufirst%3DM.%26aulast%3DKlenk%26aufirst%3DC.%26aulast%3DBatyuk%26aufirst%3DA.%26aulast%3DHeine%26aufirst%3DP.%26aulast%3DBalada%26aufirst%3DS.%26aulast%3DSchlinkmann%26aufirst%3DK.%2BM.%26aulast%3DScott%26aufirst%3DD.%2BJ.%26aulast%3DSch%25C3%25BCtz%26aufirst%3DM.%26aulast%3DPl%25C3%25BCckthun%26aufirst%3DA.%26atitle%3DStructure%2520of%2520Signaling-Competent%2520Neurotensin%2520Receptor%25201%2520Obtained%2520by%2520Directed%2520Evolution%2520in%2520Escherichia%2520Coli%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26spage%3DE655%26epage%3DE662%26doi%3D10.1073%2Fpnas.1317903111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">White, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noinaj, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Love, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kloss, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gvozdenovic-Jeremic, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiloach, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grisshammer, R.</span></span> <span> </span><span class="NLM_article-title">Structure of the Agonist-Bound Neurotensin Receptor</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>490</i></span>,  <span class="NLM_fpage">508</span>– <span class="NLM_lpage">513</span>, <span class="refDoi"> DOI: 10.1038/nature11558</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1038%2Fnature11558" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=23051748" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVykt7%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=490&publication_year=2012&pages=508-513&author=J.+F.+Whiteauthor=N.+Noinajauthor=Y.+Shibataauthor=J.+Loveauthor=B.+Klossauthor=F.+Xuauthor=J.+Gvozdenovic-Jeremicauthor=P.+Shahauthor=J.+Shiloachauthor=C.+G.+Tateauthor=R.+Grisshammer&title=Structure+of+the+Agonist-Bound+Neurotensin+Receptor&doi=10.1038%2Fnature11558"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the agonist-bound neurotensin receptor</span></div><div class="casAuthors">White, Jim F.; Noinaj, Nicholas; Shibata, Yoko; Love, James; Kloss, Brian; Xu, Feng; Gvozdenovic-Jeremic, Jelena; Shah, Priyanka; Shiloach, Joseph; Tate, Christopher G.; Grisshammer, Reinhard</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">490</span>
        (<span class="NLM_cas:issue">7421</span>),
    <span class="NLM_cas:pages">508-513</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Neurotensin (NTS) is a 13-amino-acid peptide that functions as both a neurotransmitter and a hormone through the activation of the neurotensin receptor NTSR1, a G-protein-coupled receptor (GPCR).  In the brain, NTS modulates the activity of dopaminergic systems, opioid-independent analgesia, and the inhibition of food intake; in the gut, NTS regulates a range of digestive processes.  Here we present the structure at 2.8 Å resoln. of Rattus norvegicus NTSR1 in an active-like state, bound to NTS8-13, the carboxy-terminal portion of NTS responsible for agonist-induced activation of the receptor.  The peptide agonist binds to NTSR1 in an extended conformation nearly perpendicular to the membrane plane, with the C terminus oriented towards the receptor core.  Our findings provide, to our knowledge, the first insight into the binding mode of a peptide agonist to a GPCR and may support the development of non-peptide ligands that could be useful in the treatment of neurol. disorders, cancer and obesity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMGexg96PiObVg90H21EOLACvtfcHk0lhhHhpTjRfFVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVykt7%252FP&md5=c55a071640dec7edae7a69d715bea675</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1038%2Fnature11558&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11558%26sid%3Dliteratum%253Aachs%26aulast%3DWhite%26aufirst%3DJ.%2BF.%26aulast%3DNoinaj%26aufirst%3DN.%26aulast%3DShibata%26aufirst%3DY.%26aulast%3DLove%26aufirst%3DJ.%26aulast%3DKloss%26aufirst%3DB.%26aulast%3DXu%26aufirst%3DF.%26aulast%3DGvozdenovic-Jeremic%26aufirst%3DJ.%26aulast%3DShah%26aufirst%3DP.%26aulast%3DShiloach%26aufirst%3DJ.%26aulast%3DTate%26aufirst%3DC.%2BG.%26aulast%3DGrisshammer%26aufirst%3DR.%26atitle%3DStructure%2520of%2520the%2520Agonist-Bound%2520Neurotensin%2520Receptor%26jtitle%3DNature%26date%3D2012%26volume%3D490%26spage%3D508%26epage%3D513%26doi%3D10.1038%2Fnature11558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krumm, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grisshammer, R.</span></span> <span> </span><span class="NLM_article-title">Structural Prerequisites for G-Protein Activation by the Neurotensin Receptor</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">7895</span>, <span class="refDoi"> DOI: 10.1038/ncomms8895</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1038%2Fncomms8895" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=26205105" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlWgsr%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=7895&author=B.+E.+Krummauthor=J.+F.+Whiteauthor=P.+Shahauthor=R.+Grisshammer&title=Structural+Prerequisites+for+G-Protein+Activation+by+the+Neurotensin+Receptor&doi=10.1038%2Fncomms8895"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Structural prerequisites for G-protein activation by the neurotensin receptor</span></div><div class="casAuthors">Krumm, Brian E.; White, Jim F.; Shah, Priyanka; Grisshammer, Reinhard</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">7895</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We previously detd. the structure of neurotensin receptor NTSR1 in an active-like conformation with six thermostabilizing mutations bound to the peptide agonist neurotensin.  This receptor was unable to activate G proteins, indicating that the mutations restricted NTSR1 to relate agonist binding to G-protein activation.  Here we analyze the effect of three of those mutations (E166A3.49, L310A6.37, F358A7.42) and present two structures of NTSR1 able to catalyze nucleotide exchange at Gα.  The presence of F3587.42 causes the conserved W3216.48 to adopt a side chain orientation parallel to the lipid bilayer sealing the collapsed Na+ ion pocket and linking the agonist with residues in the lower receptor part implicated in GPCR activation.  In the intracellular receptor half, the bulkier L3106.37 side chain dictates the position of R1673.50 of the highly conserved D/ERY motif.  These residues, together with the presence of E1663.49 provide determinants for G-protein activation by NTSR1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCIT6IdiZypLVg90H21EOLACvtfcHk0lhhHhpTjRfFVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlWgsr%252FP&md5=d190d8d1194ec776c628729c7c7ad368</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1038%2Fncomms8895&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms8895%26sid%3Dliteratum%253Aachs%26aulast%3DKrumm%26aufirst%3DB.%2BE.%26aulast%3DWhite%26aufirst%3DJ.%2BF.%26aulast%3DShah%26aufirst%3DP.%26aulast%3DGrisshammer%26aufirst%3DR.%26atitle%3DStructural%2520Prerequisites%2520for%2520G-Protein%2520Activation%2520by%2520the%2520Neurotensin%2520Receptor%26jtitle%3DNat.%2520Commun.%26date%3D2015%26volume%3D6%26spage%3D7895%26doi%3D10.1038%2Fncomms8895" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yin, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Waal, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pal, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melcher, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edward Zhou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eric Xu, H.</span></span> <span> </span><span class="NLM_article-title">A Complex Structure of Arrestin-2 Bound to a G Protein-Coupled Receptor</span>. <i>Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">971</span>– <span class="NLM_lpage">983</span>, <span class="refDoi"> DOI: 10.1038/s41422-019-0256-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1038%2Fs41422-019-0256-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=31776446" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlOmsbjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2019&pages=971-983&author=W.+Yinauthor=Z.+Liauthor=M.+Jinauthor=Y.+L.+Yinauthor=P.+W.+de+Waalauthor=K.+Palauthor=Y.+Yinauthor=X.+Gaoauthor=Y.+Heauthor=J.+Gaoauthor=X.+Wangauthor=Y.+Zhangauthor=H.+Zhouauthor=K.+Melcherauthor=Y.+Jiangauthor=Y.+Congauthor=X.+Edward+Zhouauthor=X.+Yuauthor=H.+Eric+Xu&title=A+Complex+Structure+of+Arrestin-2+Bound+to+a+G+Protein-Coupled+Receptor&doi=10.1038%2Fs41422-019-0256-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">A complex structure of arrestin-2 bound to a G protein-coupled receptor</span></div><div class="casAuthors">Yin, Wanchao; Li, Zhihai; Jin, Mingliang; Yin, Yu-Ling; de Waal, Parker W.; Pal, Kuntal; Yin, Yanting; Gao, Xiang; He, Yuanzheng; Gao, Jing; Wang, Xiaoxi; Zhang, Yan; Zhou, Hu; Melcher, Karsten; Jiang, Yi; Cong, Yao; Edward Zhou, X.; Yu, Xuekui; Eric Xu, H.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">971-983</span>CODEN:
                <span class="NLM_cas:coden">CREEB6</span>;
        ISSN:<span class="NLM_cas:issn">1001-0602</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Arrestins comprise a family of signal regulators of G-protein-coupled receptors (GPCRs), which include arrestins 1 to 4.  While arrestins 1 and 4 are visual arrestins dedicated to rhodopsin, arrestins 2 and 3 (Arr2 and Arr3) are β-arrestins known to regulate many nonvisual GPCRs.  The dynamic and promiscuous coupling of Arr2 to nonvisual GPCRs has posed tech. challenges to tackle the basis of arrestin binding to GPCRs.  Here we report the structure of Arr2 in complex with neurotensin receptor 1 (NTSR1), which reveals an overall assembly that is strikingly different from the visual arrestin-rhodopsin complex by a 90° rotation of Arr2 relative to the receptor.  In this new configuration, intracellular loop 3 (ICL3) and transmembrane helix 6 (TM6) of the receptor are oriented toward the N-terminal domain of the arrestin, making it possible for GPCRs that lack the C-terminal tail to couple Arr2 through their ICL3.  Mol. dynamics simulation and crosslinking data further support the assembly of the Arr2-NTSR1 complex.  Sequence anal. and homol. modeling suggest that the Arr2-NTSR1 complex structure may provide an alternative template for modeling arrestin-GPCR interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOGw5ZDnRsp7Vg90H21EOLACvtfcHk0lhhHhpTjRfFVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlOmsbjL&md5=4083a3c2c00ad32fe37bda69c61aa0c0</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1038%2Fs41422-019-0256-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41422-019-0256-2%26sid%3Dliteratum%253Aachs%26aulast%3DYin%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DJin%26aufirst%3DM.%26aulast%3DYin%26aufirst%3DY.%2BL.%26aulast%3Dde%2BWaal%26aufirst%3DP.%2BW.%26aulast%3DPal%26aufirst%3DK.%26aulast%3DYin%26aufirst%3DY.%26aulast%3DGao%26aufirst%3DX.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DMelcher%26aufirst%3DK.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DCong%26aufirst%3DY.%26aulast%3DEdward%2BZhou%26aufirst%3DX.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DEric%2BXu%26aufirst%3DH.%26atitle%3DA%2520Complex%2520Structure%2520of%2520Arrestin-2%2520Bound%2520to%2520a%2520G%2520Protein-Coupled%2520Receptor%26jtitle%3DCell%2520Res.%26date%3D2019%26volume%3D29%26spage%3D971%26epage%3D983%26doi%3D10.1038%2Fs41422-019-0256-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masureel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janetzko, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glenn, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skiniotis, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobilka, B. K.</span></span> <span> </span><span class="NLM_article-title">Structure of the Neurotensin Receptor 1 in Complex with β-Arrestin 1</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>579</i></span>,  <span class="NLM_fpage">303</span>– <span class="NLM_lpage">308</span>, <span class="refDoi"> DOI: 10.1038/s41586-020-1953-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1038%2Fs41586-020-1953-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=31945771" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BB3cXjvFygu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=579&publication_year=2020&pages=303-308&author=W.+Huangauthor=M.+Masureelauthor=Q.+Quauthor=J.+Janetzkoauthor=A.+Inoueauthor=H.+E.+Katoauthor=M.+J.+Robertsonauthor=K.+C.+Nguyenauthor=J.+S.+Glennauthor=G.+Skiniotisauthor=B.+K.+Kobilka&title=Structure+of+the+Neurotensin+Receptor+1+in+Complex+with+%CE%B2-Arrestin+1&doi=10.1038%2Fs41586-020-1953-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the neurotensin receptor 1 in complex with β-arrestin 1</span></div><div class="casAuthors">Huang, Weijiao; Masureel, Matthieu; Qu, Qianhui; Janetzko, John; Inoue, Asuka; Kato, Hideaki E.; Robertson, Michael J.; Nguyen, Khanh C.; Glenn, Jeffrey S.; Skiniotis, Georgios; Kobilka, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">579</span>
        (<span class="NLM_cas:issue">7798</span>),
    <span class="NLM_cas:pages">303-308</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Arrestin proteins bind to active, phosphorylated G-protein-coupled receptors (GPCRs), thereby preventing G-protein coupling, triggering receptor internalization and affecting various downstream signaling pathways.  Although there is a wealth of structural information detailing the interactions between GPCRs and G proteins, less is known about how arrestins engage GPCRs.  Here we report a cryo-electron microscopy structure of full-length human neurotensin receptor 1 (NTSR1) in complex with truncated human β-arrestin 1 (βarr1(ΔCT)).  We find that phosphorylation of NTSR1 is crit. for the formation of a stable complex with βarr1(ΔCT), and identify phosphorylated sites in both the third intracellular loop and the C terminus that may promote this interaction.  In addn., we observe a phosphatidylinositol-4,5-bisphosphate mol. forming a bridge between the membrane side of NTSR1 transmembrane segments 1 and 4 and the C-lobe of arrestin.  Compared with a structure of a rhodopsin-arrestin-1 complex, in our structure arrestin is rotated by approx. 85° relative to the receptor.  These findings highlight both conserved aspects and plasticity among arrestin-receptor interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOIs9dTKOA37Vg90H21EOLACvtfcHk0ljn33rNUV5tgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXjvFygu7w%253D&md5=1c0c8f151295a59694dd27bec054495d</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1038%2Fs41586-020-1953-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41586-020-1953-1%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DMasureel%26aufirst%3DM.%26aulast%3DQu%26aufirst%3DQ.%26aulast%3DJanetzko%26aufirst%3DJ.%26aulast%3DInoue%26aufirst%3DA.%26aulast%3DKato%26aufirst%3DH.%2BE.%26aulast%3DRobertson%26aufirst%3DM.%2BJ.%26aulast%3DNguyen%26aufirst%3DK.%2BC.%26aulast%3DGlenn%26aufirst%3DJ.%2BS.%26aulast%3DSkiniotis%26aufirst%3DG.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26atitle%3DStructure%2520of%2520the%2520Neurotensin%2520Receptor%25201%2520in%2520Complex%2520with%2520%25CE%25B2-Arrestin%25201%26jtitle%3DNature%26date%3D2020%26volume%3D579%26spage%3D303%26epage%3D308%26doi%3D10.1038%2Fs41586-020-1953-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kato, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suomivuori, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kadji, F. M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishna
Kumar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fonseca, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hilger, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Latorraca, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dror, R. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobilka, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skiniotis, G.</span></span> <span> </span><span class="NLM_article-title">Conformational Transitions of a Neurotensin Receptor 1-Gi1 Complex</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>572</i></span>,  <span class="NLM_fpage">80</span>– <span class="NLM_lpage">85</span>, <span class="refDoi"> DOI: 10.1038/s41586-019-1337-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1038%2Fs41586-019-1337-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=31243364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BC1MXht1yktL%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=572&publication_year=2019&pages=80-85&author=H.+E.+Katoauthor=Y.+Zhangauthor=H.+Huauthor=C.+M.+Suomivuoriauthor=F.+M.+N.+Kadjiauthor=J.+Aokiauthor=K.+Krishna%0AKumarauthor=R.+Fonsecaauthor=D.+Hilgerauthor=W.+Huangauthor=N.+R.+Latorracaauthor=A.+Inoueauthor=R.+O.+Drorauthor=B.+K.+Kobilkaauthor=G.+Skiniotis&title=Conformational+Transitions+of+a+Neurotensin+Receptor+1-Gi1+Complex&doi=10.1038%2Fs41586-019-1337-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Conformational transitions of a neurotensin receptor 1-Gi1 complex</span></div><div class="casAuthors">Kato, Hideaki E.; Zhang, Yan; Hu, Hongli; Suomivuori, Carl-Mikael; Kadji, Francois Marie Ngako; Aoki, Junken; Krishna Kumar, Kaavya; Fonseca, Rasmus; Hilger, Daniel; Huang, Weijiao; Latorraca, Naomi R.; Inoue, Asuka; Dror, Ron O.; Kobilka, Brian K.; Skiniotis, Georgios</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">572</span>
        (<span class="NLM_cas:issue">7767</span>),
    <span class="NLM_cas:pages">80-85</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Neurotensin receptor 1 (NTSR1) is a G-protein-coupled receptor (GPCR) that engages multiple subtypes of G protein, and is involved in the regulation of blood pressure, body temp., wt. and the response to pain.  Here we present structures of human NTSR1 in complex with the agonist JMV449 and the heterotrimeric Gi1 protein, at a resoln. of 3 Å.  We identify two conformations: a canonical-state complex that is similar to recently reported GPCR-Gi/o complexes (in which the nucleotide-binding pocket adopts more flexible conformations that may facilitate nucleotide exchange), and a non-canonical state in which the G protein is rotated by about 45 degrees relative to the receptor and exhibits a more rigid nucleotide-binding pocket.  In the non-canonical state, NTSR1 exhibits features of both active and inactive conformations, which suggests that the structure may represent an intermediate form along the activation pathway of G proteins.  This structural information, complemented by mol. dynamics simulations and functional studies, provides insights into the complex process of G-protein activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7W5VFHU7QCbVg90H21EOLACvtfcHk0ljn33rNUV5tgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXht1yktL%252FL&md5=0ce265e5a9dc353e69d2c04032803399</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1038%2Fs41586-019-1337-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41586-019-1337-6%26sid%3Dliteratum%253Aachs%26aulast%3DKato%26aufirst%3DH.%2BE.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DHu%26aufirst%3DH.%26aulast%3DSuomivuori%26aufirst%3DC.%2BM.%26aulast%3DKadji%26aufirst%3DF.%2BM.%2BN.%26aulast%3DAoki%26aufirst%3DJ.%26aulast%3DKrishna%2BKumar%26aufirst%3DK.%26aulast%3DFonseca%26aufirst%3DR.%26aulast%3DHilger%26aufirst%3DD.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DLatorraca%26aufirst%3DN.%2BR.%26aulast%3DInoue%26aufirst%3DA.%26aulast%3DDror%26aufirst%3DR.%2BO.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26aulast%3DSkiniotis%26aufirst%3DG.%26atitle%3DConformational%2520Transitions%2520of%2520a%2520Neurotensin%2520Receptor%25201-Gi1%2520Complex%26jtitle%3DNature%26date%3D2019%26volume%3D572%26spage%3D80%26epage%3D85%26doi%3D10.1038%2Fs41586-019-1337-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fanelli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Floquet, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besserer-Offroy, É.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delort, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vivancos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Longpré, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renault, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarret, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavelier, F.</span></span> <span> </span><span class="NLM_article-title">Use of Molecular Modeling to Design Selective Nts2 Neurotensin Analogues</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">3303</span>– <span class="NLM_lpage">3313</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01848</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01848" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlsVyntrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=3303-3313&author=R.+Fanelliauthor=N.+Floquetauthor=%C3%89.+Besserer-Offroyauthor=B.+Delortauthor=M.+Vivancosauthor=J.+M.+Longpr%C3%A9author=P.+Renaultauthor=J.+Martinezauthor=P.+Sarretauthor=F.+Cavelier&title=Use+of+Molecular+Modeling+to+Design+Selective+Nts2+Neurotensin+Analogues&doi=10.1021%2Facs.jmedchem.6b01848"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Use of Molecular Modeling to Design Selective NTS2 Neurotensin Analogues</span></div><div class="casAuthors">Fanelli, Roberto; Floquet, Nicolas; Besserer-Offroy, Elie; Delort, Bartholome; Vivancos, Melanie; Longpre, Jean-Michel; Renault, Pedro; Martinez, Jean; Sarret, Philippe; Cavelier, Florine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3303-3313</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Neurotensin exerts potent analgesia by acting at both NTS1 and NTS2 receptors, whereas NTS1 activation also results in other physiol. effects such as hypotension and hypothermia.  Here, we used mol. modeling approach to design highly selective NTS2 ligands by investigating the docking of novel NT[8-13] compds. at both NTS1 and NTS2 sites.  Mol. dynamics simulations revealed an interaction of the Tyr11 residue of NT[8-13] with an acidic residue (Glu179) located in the ECL2 of hNTS2 or with a basic residue (Arg212) at the same position in hNTS1.  The importance of the residue at position 11 for NTS1/NTS2 selectivity was further demonstrated by the design of new NT analogs bearing basic (Lys, Orn) or acid (Asp or Glu) function.  As predicted by the mol. dynamics simulations, binding of NT[8-13] analogs harboring a Lys11 exhibited higher affinity toward the hNTS1-R212E mutant receptor, in which Arg212 was substituted by the neg. charged Glu residue.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIqa126BbiC7Vg90H21EOLACvtfcHk0ljn33rNUV5tgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlsVyntrg%253D&md5=32fc41daeb4c5f0f8219765a7c1e9c12</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01848&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01848%26sid%3Dliteratum%253Aachs%26aulast%3DFanelli%26aufirst%3DR.%26aulast%3DFloquet%26aufirst%3DN.%26aulast%3DBesserer-Offroy%26aufirst%3D%25C3%2589.%26aulast%3DDelort%26aufirst%3DB.%26aulast%3DVivancos%26aufirst%3DM.%26aulast%3DLongpr%25C3%25A9%26aufirst%3DJ.%2BM.%26aulast%3DRenault%26aufirst%3DP.%26aulast%3DMartinez%26aufirst%3DJ.%26aulast%3DSarret%26aufirst%3DP.%26aulast%3DCavelier%26aufirst%3DF.%26atitle%3DUse%2520of%2520Molecular%2520Modeling%2520to%2520Design%2520Selective%2520Nts2%2520Neurotensin%2520Analogues%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D3303%26epage%3D3313%26doi%3D10.1021%2Facs.jmedchem.6b01848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boules, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briody, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fauq, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliveros, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khaniyev, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katovich, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richelson, E.</span></span> <span> </span><span class="NLM_article-title">Nt79: A Novel Neurotensin Analog with Selective Behavioral Effects</span>. <i>Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1308</i></span>,  <span class="NLM_fpage">35</span>– <span class="NLM_lpage">46</span>, <span class="refDoi"> DOI: 10.1016/j.brainres.2009.10.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2Fj.brainres.2009.10.050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=19874804" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFanu7vO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1308&publication_year=2010&pages=35-46&author=M.+Boulesauthor=Y.+Liangauthor=S.+Briodyauthor=T.+Miuraauthor=I.+Fauqauthor=A.+Oliverosauthor=M.+Wilsonauthor=S.+Khaniyevauthor=K.+Williamsauthor=Z.+Liauthor=Y.+Qiauthor=M.+Katovichauthor=E.+Richelson&title=Nt79%3A+A+Novel+Neurotensin+Analog+with+Selective+Behavioral+Effects&doi=10.1016%2Fj.brainres.2009.10.050"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">NT79: A novel neurotensin analog with selective behavioral effects</span></div><div class="casAuthors">Boules, Mona; Liang, Yanqi; Briody, Siobhan; Miura, Tomofumi; Fauq, Irfan; Oliveros, Alfredo; Wilson, Mina; Khaniyev, Shaheen; Williams, Katrina; Li, Zhimin; Qi, Yanfei; Katovich, Michael; Richelson, Elliott</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1308</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">35-46</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Neurotensin, a tridecapeptide, is widely distributed in the brain and gastrointestinal tract.  It possesses analgesic, hypothermic, and antipsychotic-like properties.  Neurotensin's effects are mediated mainly through two receptor subtypes, NTS1 and NTS2.  Activation of NTS1 has been implicated in most of the pharmacol. effects of neurotensin but is assocd. with hypothermia and hypotension.  The authors report on a novel neurotensin analog with higher selectivity to NTS2, namely, NT79, which exhibits selective behavioral effects.  NT79 was tested in animal models for pain (thermal-hot plate test; visceral-acetic acid-induced writhing test), and in animal models that are predictive of antipsychotic-like effects (apomorphine-induced climbing; d-amphetamine-induced hyperactivity; disruption of prepulse inhibition).  Its effects on body temp. and on blood pressure were also detd.  Neurochem. changes in extracellular neurotransmitters were measured using in vivo microdialysis while the rats were simultaneously evaluated for acetic acid-induced writhing with and without pretreatment with NT79.  Binding data at molecularly cloned hNTS1 and hNTS2 suggest selectivity for hNTS2.  NT79 blocked the acetic acid-induced writhing with an ED50 of 0.14 μg/kg while having no effect on thermal nociception.  The writhing was paralleled by an increase in 5-HT which was attenuated by NT79.  NT79 demonstrated antipsychotic-like effects by blocking apomorphine-induced climbing, d-amphetamine-induced hyperactivity, and reducing d-amphetamine- and DOI-induced disruption of prepulse inhibition.  Uniquely, it caused no significant hypothermia and was without effect on blood pressure.  NT79, with its higher selectivity to NTS2, may be potentially useful to treat visceral pain, and psychosis without concomitant side effects of hypothermia or hypotension.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvdV6rKFt287Vg90H21EOLACvtfcHk0ljNJ38rTVJA1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFanu7vO&md5=212ac7646f691aeec397282b1782876a</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2009.10.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2009.10.050%26sid%3Dliteratum%253Aachs%26aulast%3DBoules%26aufirst%3DM.%26aulast%3DLiang%26aufirst%3DY.%26aulast%3DBriody%26aufirst%3DS.%26aulast%3DMiura%26aufirst%3DT.%26aulast%3DFauq%26aufirst%3DI.%26aulast%3DOliveros%26aufirst%3DA.%26aulast%3DWilson%26aufirst%3DM.%26aulast%3DKhaniyev%26aufirst%3DS.%26aulast%3DWilliams%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DQi%26aufirst%3DY.%26aulast%3DKatovich%26aufirst%3DM.%26aulast%3DRichelson%26aufirst%3DE.%26atitle%3DNt79%253A%2520A%2520Novel%2520Neurotensin%2520Analog%2520with%2520Selective%2520Behavioral%2520Effects%26jtitle%3DBrain%2520Res.%26date%3D2010%26volume%3D1308%26spage%3D35%26epage%3D46%26doi%3D10.1016%2Fj.brainres.2009.10.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Einsiedel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Held, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hervet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plomer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tschammer, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span> <span> </span><span class="NLM_article-title">Discovery of Highly Potent and Neurotensin Receptor 2 Selective Neurotensin Mimetics</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">2915</span>– <span class="NLM_lpage">2923</span>, <span class="refDoi"> DOI: 10.1021/jm200006c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200006c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvV2hurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2915-2923&author=J.+Einsiedelauthor=C.+Heldauthor=M.+Hervetauthor=M.+Plomerauthor=N.+Tschammerauthor=H.+H%C3%BCbnerauthor=P.+Gmeiner&title=Discovery+of+Highly+Potent+and+Neurotensin+Receptor+2+Selective+Neurotensin+Mimetics&doi=10.1021%2Fjm200006c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Highly Potent and Neurotensin Receptor 2 Selective Neurotensin Mimetics</span></div><div class="casAuthors">Einsiedel, Jurgen; Held, Cornelia; Hervet, Maud; Plomer, Manuel; Tschammer, Nuska; Hubner, Harald; Gmeiner, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2915-2923</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The neurotensin receptor subtype 2 (NTS2) is involved in the modulation of tonic pain sensitivity and psychiatric diseases and is, therefore, regarded as a highly attractive pharmacol. target protein.  Aiming to discover NTS2 selective ligands, we herein describe the identification of screening hits and the chem. synthesis of structural variants leading to the highly potent and NTS2 selective peptide-peptoid hybrids of type 3.  The neurotensin mimetics 3a and 3e-g incorporating an N-(4-hydroxyphenethyl)glycine substructure exhibit single digit nanomolar affinity (Ki = 4.3-8.8 nM) and 1900-12000 fold selectivity over the neurotensin receptor subtype 1 (NTS1).  According to functional expts., the test compds. 3a and 3e-g displayed an inhibition of constitutive mitogen-activated protein kinase (MAPK) activity exceeding 2.6-4.6 times the inverse agonist activity of the endogenous ligand neurotensin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgosdwSBrpXbVg90H21EOLACvtfcHk0ljNJ38rTVJA1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvV2hurc%253D&md5=d6b755f092b2073e6c38f6663c8b81b4</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fjm200006c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200006c%26sid%3Dliteratum%253Aachs%26aulast%3DEinsiedel%26aufirst%3DJ.%26aulast%3DHeld%26aufirst%3DC.%26aulast%3DHervet%26aufirst%3DM.%26aulast%3DPlomer%26aufirst%3DM.%26aulast%3DTschammer%26aufirst%3DN.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DDiscovery%2520of%2520Highly%2520Potent%2520and%2520Neurotensin%2520Receptor%25202%2520Selective%2520Neurotensin%2520Mimetics%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2915%26epage%3D2923%26doi%3D10.1021%2Fjm200006c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Richard, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barroso, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labbé-Jullié, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitabgi, P.</span></span> <span> </span><span class="NLM_article-title">Agonism, Inverse Agonism, and Neutral Antagonism at the Constitutively Active Human Neurotensin Receptor 2</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1392</span>– <span class="NLM_lpage">1398</span>, <span class="refDoi"> DOI: 10.1124/mol.60.6.1392</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1124%2Fmol.60.6.1392" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=11723247" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BD3MXovVOitLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2001&pages=1392-1398&author=F.+Richardauthor=S.+Barrosoauthor=J.+Martinezauthor=C.+Labb%C3%A9-Julli%C3%A9author=P.+Kitabgi&title=Agonism%2C+Inverse+Agonism%2C+and+Neutral+Antagonism+at+the+Constitutively+Active+Human+Neurotensin+Receptor+2&doi=10.1124%2Fmol.60.6.1392"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Agonism, inverse agonism, and neutral antagonism at the constitutively active human neurotensin receptor 2</span></div><div class="casAuthors">Richard, Francoise; Barroso, Severine; Martinez, Jean; Labbe-Jullie, Catherine; Kitabgi, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1392-1398</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Two G protein-coupled neurotensin (NT) receptors, termed NTR1 and NTR2, have been identified so far.  In contrast to the NTR1, which has been extensively studied, little is known about the pharmacol. and biol. properties of the NTR2.  In the course of characterizing NT analogs that exhibited binding selectivity for the NTR2, the authors discovered that this receptor constitutively activated inositol phosphate (IP) prodn.  Here, the authors report on the constitutive activity of the human NTR2 (hNTR2) transfected in COS cells and on compds. that exhibit agonism, inverse agonism, and neutral antagonism at this receptor.  IP levels increased linearly with time, whereas they remained const. in mock-transfected cells.  Furthermore, IP prodn. was proportional to the amt. of hNTR2 present at the cell membrane.  SR 48692, a nonpeptide antagonist of the NTR1, stimulated IP prodn., whereas levocabastine, a nonpeptide histamine H1 antagonist that binds the NTR2 but not the NTR1, behaved as a weak partial inverse agonist.  NT analogs modified at position 11 of the NT mol., in particular by the introduction of bulky arom. D amino acids, exhibited binding selectivity at the hNTR2 and also behaved as partial inverse agonists, reversing constitutive IP prodn. up to 50%.  Finally, NT barely affected constitutive IP prodn. but antagonized the effects of both agonist and inverse agonist compds., thus behaving as a neutral antagonist.  The unique pharmacol. profile of the hNTR2 is discussed in the light of its sequence similarity with the NTR1 and the known binding site topol. of NT and SR 48692 in the NTR1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPUX-dsvlE67Vg90H21EOLACvtfcHk0ljNJ38rTVJA1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXovVOitLY%253D&md5=da4ffe26782a9a0d0ec9c6d6a76de91f</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1124%2Fmol.60.6.1392&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.60.6.1392%26sid%3Dliteratum%253Aachs%26aulast%3DRichard%26aufirst%3DF.%26aulast%3DBarroso%26aufirst%3DS.%26aulast%3DMartinez%26aufirst%3DJ.%26aulast%3DLabb%25C3%25A9-Julli%25C3%25A9%26aufirst%3DC.%26aulast%3DKitabgi%26aufirst%3DP.%26atitle%3DAgonism%252C%2520Inverse%2520Agonism%252C%2520and%2520Neutral%2520Antagonism%2520at%2520the%2520Constitutively%2520Active%2520Human%2520Neurotensin%2520Receptor%25202%26jtitle%3DMol.%2520Pharmacol.%26date%3D2001%26volume%3D60%26spage%3D1392%26epage%3D1398%26doi%3D10.1124%2Fmol.60.6.1392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dubuc, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarret, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labbé-Jullié, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Botto, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honoré, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourdel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costentin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitabgi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazella, J.</span></span> <span> </span><span class="NLM_article-title">Identification of the Receptor Subtype Involved in the Analgesic Effect of Neurotensin</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">503</span>– <span class="NLM_lpage">510</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.19-01-00503.1999</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1523%2FJNEUROSCI.19-01-00503.1999" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=9870978" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADyaK1MXltVWitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1999&pages=503-510&author=I.+Dubucauthor=P.+Sarretauthor=C.+Labb%C3%A9-Julli%C3%A9author=J.-M.+Bottoauthor=E.+Honor%C3%A9author=E.+Bourdelauthor=J.+Martinezauthor=J.+Costentinauthor=J.-P.+Vincentauthor=P.+Kitabgiauthor=J.+Mazella&title=Identification+of+the+Receptor+Subtype+Involved+in+the+Analgesic+Effect+of+Neurotensin&doi=10.1523%2FJNEUROSCI.19-01-00503.1999"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of the receptor subtype involved in the analgesic effect of neurotensin</span></div><div class="casAuthors">Dubuc, Isabelle; Sarret, Philippe; Labbe-Jullie, Catherine; Botto, Jean-Marie; Honore, Eric; Bourdel, Elisabeth; Martinez, Jean; Costentin, Jean; Vincent, Jean-Pierre; Kitabgi, Patrick; Mazella, Jean</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">503-510</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The neuropeptide neurotensin (NT) elicits hypothermic and naloxone-insensitive analgesic responses after brain injection.  Recent pharmacol. evidence obtained with NT agonists and antagonists suggests that these effects are mediated by a receptor distinct from the initially cloned high-affinity NT receptor (NTR1).  The recent cloning of a second NT receptor (NTR2) prompted the authors to evaluate its role in NT-induced analgesia.  Intracerebroventricular injections in mice of two different antisense oligodeoxynucleotides from the NTR2 markedly decreased NTR2 mRNA and protein and reduced NT-induced analgesia.  This effect was specific, because NTR1 levels were unaffected, and sense or scramble oligodeoxynucleotides had no effect.  Structure-activity studies revealed a close correlation between the analgesic potency of NT analogs and their affinity for the NTR2 and disclosed potent and selective agonists of this receptor.  These data confirm that NTR1 is involved in the NT-elicited turning behavior and demonstrate that the NTR2 mediates NT-induced analgesia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIvLUmowYy_bVg90H21EOLACvtfcHk0lipG42A0zKMvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXltVWitQ%253D%253D&md5=5c95936473e8adb8566bfe72bcea5668</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.19-01-00503.1999&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.19-01-00503.1999%26sid%3Dliteratum%253Aachs%26aulast%3DDubuc%26aufirst%3DI.%26aulast%3DSarret%26aufirst%3DP.%26aulast%3DLabb%25C3%25A9-Julli%25C3%25A9%26aufirst%3DC.%26aulast%3DBotto%26aufirst%3DJ.-M.%26aulast%3DHonor%25C3%25A9%26aufirst%3DE.%26aulast%3DBourdel%26aufirst%3DE.%26aulast%3DMartinez%26aufirst%3DJ.%26aulast%3DCostentin%26aufirst%3DJ.%26aulast%3DVincent%26aufirst%3DJ.-P.%26aulast%3DKitabgi%26aufirst%3DP.%26aulast%3DMazella%26aufirst%3DJ.%26atitle%3DIdentification%2520of%2520the%2520Receptor%2520Subtype%2520Involved%2520in%2520the%2520Analgesic%2520Effect%2520of%2520Neurotensin%26jtitle%3DJ.%2520Neurosci.%26date%3D1999%26volume%3D19%26spage%3D503%26epage%3D510%26doi%3D10.1523%2FJNEUROSCI.19-01-00503.1999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Held, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plomer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meltretter, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pischetsrieder, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span> <span> </span><span class="NLM_article-title">Development of a Metabolically Stable Neurotensin Receptor 2 (Nts2) Ligand</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">75</span>– <span class="NLM_lpage">81</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201200376</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1002%2Fcmdc.201200376" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=23097347" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFGqu7%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=75-81&author=C.+Heldauthor=M.+Plomerauthor=H.+H%C3%BCbnerauthor=J.+Meltretterauthor=M.+Pischetsriederauthor=P.+Gmeiner&title=Development+of+a+Metabolically+Stable+Neurotensin+Receptor+2+%28Nts2%29+Ligand&doi=10.1002%2Fcmdc.201200376"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a Metabolically Stable Neurotensin Receptor 2 (NTS2) Ligand</span></div><div class="casAuthors">Held, Cornelia; Plomer, Manuel; Huebner, Harald; Meltretter, Jasmin; Pischetsrieder, Monika; Gmeiner, Peter</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">75-81</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Subtype-selective neurotensin receptor 2 (NTS2) ligands can be used as mol. probes to investigate the physiol. role of neurotensinergic systems and serve as lead compds. to initiate the development of drugs for the treatment of tonic pain.  Starting from the authors' recently described NTS2 ligand (I, H-Arg-Arg-Pro-(N-homo-Tyr)-Ile-Leu-OH), structural variants of type (II, H-X-Y-Pro-(N-homo-Tyr)-Ile-Leu-OH where X = N-Me-Arg or Nlys and Y = Arg or Lys) were synthesized to further improve binding affinity and selectivity to gain metabolic stability.  The peptide-peptoid hybrid (III, N-Me-Arg-Arg-Pro-(N-homo-Tyr)-Ile-Leu-OH) showed excellent NTS2 binding affinity (Ki=2.8 nM) and 22,000-fold selectivity over NTS1, as well as metabolic stability over 32 h in a serum degrdn. assay.  Employing a MAPK-driven luciferase reporter gene assay and an IP accumulation assay, the neurotensin mimetic (III) displayed resp. inhibitions of constitutive activity exceeding 4.3- and 3.9-fold that of the inverse agonist activity of the endogenous ligand neurotensin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFWayShMb1J7Vg90H21EOLACvtfcHk0lipG42A0zKMvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFGqu7%252FN&md5=c7f08d11405351b2dc5a81dfc81bff35</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201200376&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201200376%26sid%3Dliteratum%253Aachs%26aulast%3DHeld%26aufirst%3DC.%26aulast%3DPlomer%26aufirst%3DM.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DMeltretter%26aufirst%3DJ.%26aulast%3DPischetsrieder%26aufirst%3DM.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DDevelopment%2520of%2520a%2520Metabolically%2520Stable%2520Neurotensin%2520Receptor%25202%2520%2528Nts2%2529%2520Ligand%26jtitle%3DChemMedChem%26date%3D2013%26volume%3D8%26spage%3D75%26epage%3D81%26doi%3D10.1002%2Fcmdc.201200376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pratsch, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unfried, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Einsiedel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plomer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinrich, M. R.</span></span> <span> </span><span class="NLM_article-title">Radical Arylation of Tyrosine and Its Application in the Synthesis of a Highly Selective Neurotensin Receptor 2 Ligand</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">3746</span>– <span class="NLM_lpage">3752</span>, <span class="refDoi"> DOI: 10.1039/c1ob05292f</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1039%2Fc1ob05292f" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=21472182" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlt1Ght7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2011&pages=3746-3752&author=G.+Pratschauthor=J.+F.+Unfriedauthor=J.+Einsiedelauthor=M.+Plomerauthor=H.+H%C3%BCbnerauthor=P.+Gmeinerauthor=M.+R.+Heinrich&title=Radical+Arylation+of+Tyrosine+and+Its+Application+in+the+Synthesis+of+a+Highly+Selective+Neurotensin+Receptor+2+Ligand&doi=10.1039%2Fc1ob05292f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Radical arylation of tyrosine and its application in the synthesis of a highly selective neurotensin receptor 2 ligand</span></div><div class="casAuthors">Pratsch, Gerald; Unfried, Johannes F.; Einsiedel, Juergen; Plomer, Manuel; Huebner, Harald; Gmeiner, Peter; Heinrich, Markus R.</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3746-3752</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A small library of Fmoc-protected 3-arylated tyrosines was created by radical arylation.  The new building blocks were successfully applied in the synthesis of two novel neurotensin receptor ligands, H-Arg-Arg-Pro-FPTyr-Ile-Leu-OH [FPTyr = (S)- and (R)-3-(4-fluorophenyl)tyrosine].  Both isomers showed high affinity for the human NTS2 receptor with Ki values in the nanomolar range.  Interestingly, subtype selectivity strongly depends on the configuration of the peptide in position 11.  Peptide contg. (R)-3-(4-fluorophenyl)tyrosine displayed an excellent preference for NTS2 compared to NTS1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrY1iBZYuIrkrVg90H21EOLACvtfcHk0lipG42A0zKMvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlt1Ght7c%253D&md5=a7d9030ecc421c22ae1c343fd8f2c04e</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1039%2Fc1ob05292f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc1ob05292f%26sid%3Dliteratum%253Aachs%26aulast%3DPratsch%26aufirst%3DG.%26aulast%3DUnfried%26aufirst%3DJ.%2BF.%26aulast%3DEinsiedel%26aufirst%3DJ.%26aulast%3DPlomer%26aufirst%3DM.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DGmeiner%26aufirst%3DP.%26aulast%3DHeinrich%26aufirst%3DM.%2BR.%26atitle%3DRadical%2520Arylation%2520of%2520Tyrosine%2520and%2520Its%2520Application%2520in%2520the%2520Synthesis%2520of%2520a%2520Highly%2520Selective%2520Neurotensin%2520Receptor%25202%2520Ligand%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2011%26volume%3D9%26spage%3D3746%26epage%3D3752%26doi%3D10.1039%2Fc1ob05292f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Simeth, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bause, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobmeier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kling, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lachmann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Einsiedel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">König, B.</span></span> <span> </span><span class="NLM_article-title">Nts2-Selective Neurotensin Mimetics with Tetrahydrofuran Amino Acids</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">350</span>– <span class="NLM_lpage">359</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2016.10.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2Fj.bmc.2016.10.039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=27842797" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVGgtrjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=350-359&author=N.+A.+Simethauthor=M.+Bauseauthor=M.+Dobmeierauthor=R.+C.+Klingauthor=D.+Lachmannauthor=H.+H%C3%BCbnerauthor=J.+Einsiedelauthor=P.+Gmeinerauthor=B.+K%C3%B6nig&title=Nts2-Selective+Neurotensin+Mimetics+with+Tetrahydrofuran+Amino+Acids&doi=10.1016%2Fj.bmc.2016.10.039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">NTS2-selective neurotensin mimetics with tetrahydrofuran amino acids</span></div><div class="casAuthors">Simeth, Nadja A.; Bause, Manuel; Dobmeier, Michael; Kling, Ralf C.; Lachmann, Daniel; Huebner, Harald; Einsiedel, Juergen; Gmeiner, Peter; Koenig, Burkhard</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">350-359</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Stimulation of the NTS2 neurotensin receptor causes antipsychotic effects and leads to a promotion of the μ-opioid-independent antinociception, which is important in the modulation of tonic pain sensitivity.  We report the synthesis and properties of a small library of peptidic agonists based on the active neurotensin fragment NT(8-13).  Two THF amino acid derivs. were synthesized to replace Tyr11 in NT(8-13).  Addnl., Arg8, Arg9, and Ile12 of the lead peptide were exchanged by Lys, Lys, and Gly, resp.  The new compds. showed substantial NTS2 binding affinity and up to 1000-fold selectivity over NTS1.  The highest selectivity (Ki(NTS2): 29 nM, Ki(NTS1): 35,000 nM) was obsd. for the peptide analog 17Rtrans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNyZX8W7v-TbVg90H21EOLACvtfcHk0liX-qVZwv6NQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVGgtrjJ&md5=071e1b20ff943a826abedadebab5851a</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.10.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.10.039%26sid%3Dliteratum%253Aachs%26aulast%3DSimeth%26aufirst%3DN.%2BA.%26aulast%3DBause%26aufirst%3DM.%26aulast%3DDobmeier%26aufirst%3DM.%26aulast%3DKling%26aufirst%3DR.%2BC.%26aulast%3DLachmann%26aufirst%3DD.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DEinsiedel%26aufirst%3DJ.%26aulast%3DGmeiner%26aufirst%3DP.%26aulast%3DK%25C3%25B6nig%26aufirst%3DB.%26atitle%3DNts2-Selective%2520Neurotensin%2520Mimetics%2520with%2520Tetrahydrofuran%2520Amino%2520Acids%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2017%26volume%3D25%26spage%3D350%26epage%3D359%26doi%3D10.1016%2Fj.bmc.2016.10.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bumbak, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noonan-Williams, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaid, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitehead, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kocan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bathgate, R. A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chalmers, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gooley, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, D. J.</span></span> <span> </span><span class="NLM_article-title">Conformational Changes in Tyrosine 11 of Neurotensin Are Required to Activate the Neurotensin Receptor 1</span>. <i>ACS Pharmacol. Trans. l Sci.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">690</span>– <span class="NLM_lpage">705</span>, <span class="refDoi"> DOI: 10.1021/acsptsci.0c00026</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsptsci.0c00026" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2020&pages=690-705&author=F.+Bumbakauthor=T.+Thomasauthor=B.+J.+Noonan-Williamsauthor=T.+M.+Vaidauthor=F.+Yanauthor=A.+R.+Whiteheadauthor=S.+Bruellauthor=M.+Kocanauthor=X.+Tanauthor=M.+A.+Johnsonauthor=R.+A.+D.+Bathgateauthor=D.+K.+Chalmersauthor=P.+R.+Gooleyauthor=D.+J.+Scott&title=Conformational+Changes+in+Tyrosine+11+of+Neurotensin+Are+Required+to+Activate+the+Neurotensin+Receptor+1&doi=10.1021%2Facsptsci.0c00026"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Facsptsci.0c00026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsptsci.0c00026%26sid%3Dliteratum%253Aachs%26aulast%3DBumbak%26aufirst%3DF.%26aulast%3DThomas%26aufirst%3DT.%26aulast%3DNoonan-Williams%26aufirst%3DB.%2BJ.%26aulast%3DVaid%26aufirst%3DT.%2BM.%26aulast%3DYan%26aufirst%3DF.%26aulast%3DWhitehead%26aufirst%3DA.%2BR.%26aulast%3DBruell%26aufirst%3DS.%26aulast%3DKocan%26aufirst%3DM.%26aulast%3DTan%26aufirst%3DX.%26aulast%3DJohnson%26aufirst%3DM.%2BA.%26aulast%3DBathgate%26aufirst%3DR.%2BA.%2BD.%26aulast%3DChalmers%26aufirst%3DD.%2BK.%26aulast%3DGooley%26aufirst%3DP.%2BR.%26aulast%3DScott%26aufirst%3DD.%2BJ.%26atitle%3DConformational%2520Changes%2520in%2520Tyrosine%252011%2520of%2520Neurotensin%2520Are%2520Required%2520to%2520Activate%2520the%2520Neurotensin%2520Receptor%25201%26jtitle%3DACS%2520Pharmacol.%2520Trans.%2520l%2520Sci.%26date%3D2020%26volume%3D3%26spage%3D690%26epage%3D705%26doi%3D10.1021%2Facsptsci.0c00026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marsault, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, M. L.</span></span> <span> </span><span class="NLM_article-title">Macrocycles Are Great Cycles: Applications, Opportunities, and Challenges of Synthetic Macrocycles in Drug Discovery</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">1961</span>– <span class="NLM_lpage">2004</span>, <span class="refDoi"> DOI: 10.1021/jm1012374</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1012374" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BC3MXivVSjtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1961-2004&author=E.+Marsaultauthor=M.+L.+Peterson&title=Macrocycles+Are+Great+Cycles%3A+Applications%2C+Opportunities%2C+and+Challenges+of+Synthetic+Macrocycles+in+Drug+Discovery&doi=10.1021%2Fjm1012374"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Macrocycles Are Great Cycles: Applications, Opportunities, and Challenges of Synthetic Macrocycles in Drug Discovery</span></div><div class="casAuthors">Marsault, Eric; Peterson, Mark L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1961-2004</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Macrocycles occupy a unique segment of chem. space.  In the past decade, their chem. diversity expanded significantly, supported by advances in bioinformatics and synthetic methodol.  As a consequence, this structural type has now been successfully tested on most biol. target classes.  The goal of this article is to put into perspective the current applications, opportunities, and challenges assocd. with synthetic macrocycles in drug discovery.  Accordingly, the first part of this article is dedicated to the drug discovery aspects of macrocycles and highlights salient features of their medicinal chem.  This section is organized by target class, a choice aimed at providing the reader an appreciation of the structural diversity generated for each class.  To give the reader an appreciation of the tools available to construct macrocyclic scaffolds, the site and method of the pivotal macrocyclization step are indicated in the figures.  Readers are referred to the source articles for further details.  In the second part, the technologies and synthetic approaches that already have demonstrated utility or possess a high potential for macrocycle-based drug discovery are discussed.  Finally, a perspective on the future of synthetic macrocycles in medicinal chem. is offered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrygQLE6JraHrVg90H21EOLACvtfcHk0lheb3cqWvxMWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXivVSjtbo%253D&md5=97c1120896e90a85790a9ac1274259f3</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fjm1012374&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1012374%26sid%3Dliteratum%253Aachs%26aulast%3DMarsault%26aufirst%3DE.%26aulast%3DPeterson%26aufirst%3DM.%2BL.%26atitle%3DMacrocycles%2520Are%2520Great%2520Cycles%253A%2520Applications%252C%2520Opportunities%252C%2520and%2520Challenges%2520of%2520Synthetic%2520Macrocycles%2520in%2520Drug%2520Discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1961%26epage%3D2004%26doi%3D10.1021%2Fjm1012374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marsault, E.</span>; <span class="NLM_string-name">Peterson, M. L.</span></span> <i>Practical Medicinal Chemistry with Macrocycles: Design, Synthesis, and Case Studies</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsault, E.</span>; <span class="NLM_string-name">Peterson, M. L.</span></span>, Eds.; <span class="NLM_publisher-name">John Wiley & Sons, Incorporated</span>, <span class="NLM_year">2017</span>; p  <span class="NLM_fpage">624</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1002%2F9781119092599" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&pages=624&author=E.+Marsault&author=M.+L.+Petersonauthor=E.+Marsault&author=M.+L.+Peterson&title=Practical+Medicinal+Chemistry+with+Macrocycles%3A+Design%2C+Synthesis%2C+and+Case+Studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1002%2F9781119092599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9781119092599%26sid%3Dliteratum%253Aachs%26aulast%3DMarsault%26aufirst%3DE.%26btitle%3DPractical%2520Medicinal%2520Chemistry%2520with%2520Macrocycles%253A%2520Design%252C%2520Synthesis%252C%2520and%2520Case%2520Studies%26aulast%3DMarsault%26aufirst%3DE.%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Incorporated%26date%3D2017%26spage%3D624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mallinson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, I.</span></span> <span> </span><span class="NLM_article-title">Macrocycles in New Drug Discovery</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1409</span>– <span class="NLM_lpage">1438</span>, <span class="refDoi"> DOI: 10.4155/fmc.12.93</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.4155%2Ffmc.12.93" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=22857532" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFCht7rO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=1409-1438&author=J.+Mallinsonauthor=I.+Collins&title=Macrocycles+in+New+Drug+Discovery&doi=10.4155%2Ffmc.12.93"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Macrocycles in new drug discovery</span></div><div class="casAuthors">Mallinson, Jamie; Collins, Ian</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1409-1438</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  The use of drug-like macrocycles is emerging as an exciting area of medicinal chem., with several recent examples highlighting the favorable changes in biol. and physicochem. properties that macrocyclization can afford.  Natural product macrocycles and their synthetic derivs. have long been clin. useful and attention is now being focused on the wider use of macrocyclic scaffolds in medicinal chem. in the search for new drugs for increasingly challenging targets.  With the increasing awareness of concepts of drug-likeness and the dangers of mol. obesity', functionalized macrocyclic scaffolds could provide a way to generate ligand-efficient mols. with enhanced properties.  In this review we will sep. discuss the effects of macrocyclization upon potency, selectivity and physicochem. properties, concg. on recent case histories in oncol. drug discovery.  Addnl., we will highlight selected advances in the synthesis of macrocycles and provide an outlook on the future use of macrocyclic scaffolds in medicinal chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSrzcbKW7Tc7Vg90H21EOLACvtfcHk0lheb3cqWvxMWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFCht7rO&md5=63ad275af92ac89ae6b36c5071b578f8</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.4155%2Ffmc.12.93&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.12.93%26sid%3Dliteratum%253Aachs%26aulast%3DMallinson%26aufirst%3DJ.%26aulast%3DCollins%26aufirst%3DI.%26atitle%3DMacrocycles%2520in%2520New%2520Drug%2520Discovery%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2012%26volume%3D4%26spage%3D1409%26epage%3D1438%26doi%3D10.4155%2Ffmc.12.93" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sefler, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawyer, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holub, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Omecinsky, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reily, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thanabal, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akunne, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cody, W. L.</span></span> <span> </span><span class="NLM_article-title">Design and Structure-Activity Relationships of C-Terminal Cyclic Neurotensin Fragment Analogues</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">249</span>– <span class="NLM_lpage">257</span>, <span class="refDoi"> DOI: 10.1021/jm00002a006</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00002a006" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADyaK2MXivFOqtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1995&pages=249-257&author=A.+M.+Seflerauthor=J.+X.+Heauthor=T.+K.+Sawyerauthor=K.+E.+Holubauthor=D.+O.+Omecinskyauthor=M.+D.+Reilyauthor=V.+Thanabalauthor=H.+C.+Akunneauthor=W.+L.+Cody&title=Design+and+Structure-Activity+Relationships+of+C-Terminal+Cyclic+Neurotensin+Fragment+Analogues&doi=10.1021%2Fjm00002a006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Structure-Activity Relationships of C-Terminal Cyclic Neurotensin Fragment Analogs</span></div><div class="casAuthors">Sefler, Andrea M.; He, John X.; Sawyer, Tomi K.; Holub, Katherine E.; Omecinsky, Diana O.; Reily, Michael D.; Thanabal, Venkataraman; Akunne, Hyacinth C.; Cody, Wayne L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">249-57</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Neurotensin (NT) is a linear tridecapeptide with a broad range of central and peripheral pharmacol. effects.  The C-terminal hexapeptide of NT (NT8-13) has been shown to possess similar properties to NT itself, and in fact, an analog of NT8-13 (NαMeArg8-Lys-Pro-Trp-Tle-Leu13, Tle = tert-leucine) has been reported to possess central activity after peripheral administration.  Cyclic derivs. of this hexapeptide were synthesized by a combination of soln. and solid-phase peptide synthetic methodologies, and several analogs had low nanomolar binding affinity for the NT receptor.  In particular, cyclo[Arg-Lys-Pro-Trp-Glu]-Leu (cyclized between the α amine of Arg and the γ carboxylate of Glu) possessed 16 nM NT receptor affinity and was detd. to be an agonist in vitro.  1H-NMR and 13C-edited 1H-NMR spectroscopy were performed on this and related cyclic analogs to help identify structural properties which may be important for receptor recognition.  These cyclic peptides represent novel mol. probes to further investigate NT receptor pharmacol., as well as to advance the authors understanding of the structural/conformational relationships of NT and to help establish a working basis for addnl. pharmacophore mapping studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_fpGulb0q87Vg90H21EOLACvtfcHk0lhf7tVaxo84HA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXivFOqtLw%253D&md5=65c62b9e868acaab3fa75954891c119d</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1021%2Fjm00002a006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00002a006%26sid%3Dliteratum%253Aachs%26aulast%3DSefler%26aufirst%3DA.%2BM.%26aulast%3DHe%26aufirst%3DJ.%2BX.%26aulast%3DSawyer%26aufirst%3DT.%2BK.%26aulast%3DHolub%26aufirst%3DK.%2BE.%26aulast%3DOmecinsky%26aufirst%3DD.%2BO.%26aulast%3DReily%26aufirst%3DM.%2BD.%26aulast%3DThanabal%26aufirst%3DV.%26aulast%3DAkunne%26aufirst%3DH.%2BC.%26aulast%3DCody%26aufirst%3DW.%2BL.%26atitle%3DDesign%2520and%2520Structure-Activity%2520Relationships%2520of%2520C-Terminal%2520Cyclic%2520Neurotensin%2520Fragment%2520Analogues%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1995%26volume%3D38%26spage%3D249%26epage%3D257%26doi%3D10.1021%2Fjm00002a006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Akunne, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zoski, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sefler, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawyer, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pugsley, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cody, W. L.</span></span> <span> </span><span class="NLM_article-title">Functional Activity of New C-Terminal Cyclic-Neurotensin Fragment Analogs</span>. <i>Neuropeptides</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">213</span>– <span class="NLM_lpage">218</span>, <span class="refDoi"> DOI: 10.1016/S0143-4179(96)90066-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2FS0143-4179%2896%2990066-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=8819144" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADyaK28XksFSltrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1996&pages=213-218&author=H.+C.+Akunneauthor=S.+Darlingauthor=K.+Zoskiauthor=A.+M.+Seflerauthor=J.+X.+Heauthor=T.+K.+Sawyerauthor=T.+A.+Pugsleyauthor=W.+L.+Cody&title=Functional+Activity+of+New+C-Terminal+Cyclic-Neurotensin+Fragment+Analogs&doi=10.1016%2FS0143-4179%2896%2990066-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Functional activity of new C-terminal cyclic-neurotensin fragment analogs</span></div><div class="casAuthors">Akunne, H. C.; Darling, S.; Zoski, K.; Sefler, A. M.; He, J. X.; Sawyer, T. K.; Pugsley, T. A.; Cody, W. L.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropeptides (Edinburgh)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">213-218</span>CODEN:
                <span class="NLM_cas:coden">NRPPDD</span>;
        ISSN:<span class="NLM_cas:issn">0143-4179</span>.
    
            (<span class="NLM_cas:orgname">Churchill Livingstone</span>)
        </div><div class="casAbstract">Neurotensin (NT, pGlu-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Tyr-Ile-Leu) is a tridecapeptide that displays a wide spectrum of biol. actions.  Cyclic derivs. of a hexapeptide NT [(8-13)] (NαMeArg-Lys-Pro-Trp-Tle-Leu, Tle = tert-leucine) were designed and prepd. by a combination of soln. and solid-phase peptide synthetic methodologies.  As reported previously, several analogs possessed nanomolar binding affinities for NT receptors in newborn (10-day-old) mouse brain membrane prepns.  In this study, the authors detd. the functional ability of these analogs to mobilize intracellular free calcium, [Ca2+]i, in HT-29 cells (human colonic adenocarcinoma).  Of greatest interest were the cyclic compds. 2, 6 and 9 that had Ki values of 0.19, 3.50 and 4.18 μM for [3H]NT-labeled receptors in the HT-29 cell membrane assay, resp.  In the functional assay, compds. 2 and 6 mobilized [Ca2+]i with EC50 values of 0.13 and 20 μM, resp.  In comparison, Compd. 9 blocked the NT-induced mobilization of [Ca2+]i, with an IC50 of 1.70 μM.  The present findings indicate that small mol. cyclic analogs, that possess functional activity, can be designed and may have therapeutic utility in the treatment of schizophrenia and possibly other neurol. disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocKbW8FBlwMLVg90H21EOLACvtfcHk0lhf7tVaxo84HA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XksFSltrg%253D&md5=479a060eb7bead57ce3155d118e6e91e</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2FS0143-4179%2896%2990066-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0143-4179%252896%252990066-9%26sid%3Dliteratum%253Aachs%26aulast%3DAkunne%26aufirst%3DH.%2BC.%26aulast%3DDarling%26aufirst%3DS.%26aulast%3DZoski%26aufirst%3DK.%26aulast%3DSefler%26aufirst%3DA.%2BM.%26aulast%3DHe%26aufirst%3DJ.%2BX.%26aulast%3DSawyer%26aufirst%3DT.%2BK.%26aulast%3DPugsley%26aufirst%3DT.%2BA.%26aulast%3DCody%26aufirst%3DW.%2BL.%26atitle%3DFunctional%2520Activity%2520of%2520New%2520C-Terminal%2520Cyclic-Neurotensin%2520Fragment%2520Analogs%26jtitle%3DNeuropeptides%26date%3D1996%26volume%3D30%26spage%3D213%26epage%3D218%26doi%3D10.1016%2FS0143-4179%2896%2990066-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Van
Kemmel, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubuc, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourdel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fehrentz, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costentin, J.</span></span> <span> </span><span class="NLM_article-title">A C-Terminal Cyclic 8-13 Neurotensin Fragment Analog Appears Less Exposed to Neprilysin When It Crosses the Blood-Brain Barrier Than the Cerebrospinal Fluid-Brain Barrier in Mice</span>. <i>Neurosci. Lett.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>217</i></span>,  <span class="NLM_fpage">58</span>– <span class="NLM_lpage">60</span>, <span class="refDoi"> DOI: 10.1016/0304-3940(96)13074-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2F0304-3940%2896%2913074-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=8905739" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADyaK28XmsFGltrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=217&publication_year=1996&pages=58-60&author=F.+M.+Van%0AKemmelauthor=I.+Dubucauthor=E.+Bourdelauthor=J.+A.+Fehrentzauthor=J.+Martinezauthor=J.+Costentin&title=A+C-Terminal+Cyclic+8-13+Neurotensin+Fragment+Analog+Appears+Less+Exposed+to+Neprilysin+When+It+Crosses+the+Blood-Brain+Barrier+Than+the+Cerebrospinal+Fluid-Brain+Barrier+in+Mice&doi=10.1016%2F0304-3940%2896%2913074-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">A C-terminal cyclic 8-13 neurotensin fragment analog appears less exposed to neprilysin when it crosses the blood-brain barrier than the cerebrospinal fluid-brain barrier in mice</span></div><div class="casAuthors">Van Kemmel, F.-M.; Dubuc, I.; Bourdel, E.; Fehrentz, J.-A.; Martinez, J.; Costentin, J.</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience Letters</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">217</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">58-60</span>CODEN:
                <span class="NLM_cas:coden">NELED5</span>;
        ISSN:<span class="NLM_cas:issn">0304-3940</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A C-terminal cyclic 8-13 neurotensin fragment analog, JMV 1193, a direct agonist of central neurotensin receptors, is able to cross both the cerebrospinal fluid-brain barrier and the blood-brain barrier.  When administered intracerebroventricularly (i.c.v.), its hypothermic effect was potentiated by the enkephalinase inhibition induced either by thiorphan (simultaneous intracerebroventricular administration of 10 μg) or by the thiorphan prodrug, acetorphan (10 mg/kg, i.v.).  Such a potentiation was not obsd. with both JMV 1193 and acetorphan were administered i.v.  Therefore it appears that the sensitivity of JMV 1193 to enkephalinase depends on its route of administration.  It is exposed to this peptidase after i.c.v. injection (when crossing the cerebrospinal fluid-brain barrier), while it is not after i.v. administration (when crossing the blood-brain barrier).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowxyL91WEvvbVg90H21EOLACvtfcHk0lhsVJe-4puqeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XmsFGltrY%253D&md5=e5d4de8c2099863ca865722a0cef7c28</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2F0304-3940%2896%2913074-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0304-3940%252896%252913074-3%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BKemmel%26aufirst%3DF.%2BM.%26aulast%3DDubuc%26aufirst%3DI.%26aulast%3DBourdel%26aufirst%3DE.%26aulast%3DFehrentz%26aufirst%3DJ.%2BA.%26aulast%3DMartinez%26aufirst%3DJ.%26aulast%3DCostentin%26aufirst%3DJ.%26atitle%3DA%2520C-Terminal%2520Cyclic%25208-13%2520Neurotensin%2520Fragment%2520Analog%2520Appears%2520Less%2520Exposed%2520to%2520Neprilysin%2520When%2520It%2520Crosses%2520the%2520Blood-Brain%2520Barrier%2520Than%2520the%2520Cerebrospinal%2520Fluid-Brain%2520Barrier%2520in%2520Mice%26jtitle%3DNeurosci.%2520Lett.%26date%3D1996%26volume%3D217%26spage%3D58%26epage%3D60%26doi%3D10.1016%2F0304-3940%2896%2913074-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lundquist, J. T.,  IV</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dix, T. A.</span></span> <span> </span><span class="NLM_article-title">Preparation and Receptor Binding Affinities of Cyclic C-Terminal Neurotensin (8-13) and (9-13) Analogues</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">2579</span>– <span class="NLM_lpage">2582</span>, <span class="refDoi"> DOI: 10.1016/S0960-894X(99)00420-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2FS0960-894X%2899%2900420-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10498212" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADyaK1MXmtFCitr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1999&pages=2579-2582&author=J.+T.+Lundquistauthor=T.+A.+Dix&title=Preparation+and+Receptor+Binding+Affinities+of+Cyclic+C-Terminal+Neurotensin+%288-13%29+and+%289-13%29+Analogues&doi=10.1016%2FS0960-894X%2899%2900420-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation and receptor binding affinities of cyclic C-terminal neurotensin (8-13) and (9-13) analogues</span></div><div class="casAuthors">Lundquist, Joseph T., IV; Dix, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2579-2582</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Cyclic analogs of neurotensin (NT) C-terminal fragments NT(8-13) and NT(9-13) were produced via intramol. nucleophilic substitution of the Tyr(11) phenoxide anion on a 6-bromohexanoyl side chain substituted at position 8 or 9 and tested for NT receptor binding affinity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSuH8va3kk_rVg90H21EOLACvtfcHk0lhsVJe-4puqeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmtFCitr4%253D&md5=418fde68195607c0d0048b41ebe612ef</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2899%2900420-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252899%252900420-5%26sid%3Dliteratum%253Aachs%26aulast%3DLundquist%26aufirst%3DJ.%2BT.%26aulast%3DDix%26aufirst%3DT.%2BA.%26atitle%3DPreparation%2520and%2520Receptor%2520Binding%2520Affinities%2520of%2520Cyclic%2520C-Terminal%2520Neurotensin%2520%25288-13%2529%2520and%2520%25289-13%2529%2520Analogues%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1999%26volume%3D9%26spage%3D2579%26epage%3D2582%26doi%3D10.1016%2FS0960-894X%2899%2900420-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bredeloux, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavelier, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubuc, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vivet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costentin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, J.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Biological Effects of C(Lys-Lys-Pro-Tyr-Ile-Leu-Lys-Lys-Pro-Tyr-Ile-Leu) (Jmv2012), a New Analogue of Neurotensin That Crosses the Blood-Brain Barrier</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">1610</span>– <span class="NLM_lpage">1616</span>, <span class="refDoi"> DOI: 10.1021/jm700925k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm700925k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BD1cXivV2gsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=1610-1616&author=P.+Bredelouxauthor=F.+Cavelierauthor=I.+Dubucauthor=B.+Vivetauthor=J.+Costentinauthor=J.+Martinez&title=Synthesis+and+Biological+Effects+of+C%28Lys-Lys-Pro-Tyr-Ile-Leu-Lys-Lys-Pro-Tyr-Ile-Leu%29+%28Jmv2012%29%2C+a+New+Analogue+of+Neurotensin+That+Crosses+the+Blood-Brain+Barrier&doi=10.1021%2Fjm700925k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological effects of c(Lys-Lys-Pro-Tyr-Ile-Leu-Lys-Lys-Pro-Tyr-Ile-Leu) (JMV2012), a new analogue of neurotensin that crosses the blood-brain barrier</span></div><div class="casAuthors">Bredeloux, Pierre; Cavelier, Florine; Dubuc, Isabelle; Vivet, Bertrand; Costentin, Jean; Martinez, Jean</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1610-1616</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The central administration of neurotensin (NT) or of its C-terminal hexapeptide fragment NT(8-13), produces strong analgesic effects in tests evaluating acute pain.  The use of NT-derived peptides as pharmaceutical agents to relief severe pain in patients could be of great interest.  Unfortunately, peptides do not readily penetrate the blood-brain barrier.  It was obsd. that the cyclic NT(8-13) analog, c(Lys-Lys-Pro-Tyr-Ile-Leu-Lys-Lys-Pro-Tyr-Ile-Leu) (JMV2012), when peripherally administered to mice produced analgesic and hypothermic effects, suggesting the peptide penetrates the blood-brain barrier and functions effectively like a drug.  Moreover, dimeric compds. show increased potency compared to their corresponding monomer.  The synthesis of the cyclic dimer JMV2012 is reported.  In mice, JMV2012 induced a profound hypothermia and a potent analgesia, even when peripherally administered.  JMV2012 appears to be an ideal lead compd. for the development of bioactive NT analogs as analgesics drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC6JSqhCBUzrVg90H21EOLACvtfcHk0lhsVJe-4puqeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXivV2gsLk%253D&md5=cfc20f6b9efea2d1be988eccfdef4c92</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Fjm700925k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm700925k%26sid%3Dliteratum%253Aachs%26aulast%3DBredeloux%26aufirst%3DP.%26aulast%3DCavelier%26aufirst%3DF.%26aulast%3DDubuc%26aufirst%3DI.%26aulast%3DVivet%26aufirst%3DB.%26aulast%3DCostentin%26aufirst%3DJ.%26aulast%3DMartinez%26aufirst%3DJ.%26atitle%3DSynthesis%2520and%2520Biological%2520Effects%2520of%2520C%2528Lys-Lys-Pro-Tyr-Ile-Leu-Lys-Lys-Pro-Tyr-Ile-Leu%2529%2520%2528Jmv2012%2529%252C%2520a%2520New%2520Analogue%2520of%2520Neurotensin%2520That%2520Crosses%2520the%2520Blood-Brain%2520Barrier%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D1610%26epage%3D1616%26doi%3D10.1021%2Fjm700925k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sousbie, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besserer-Offroy, É.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brouillette, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Longpré, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leduc, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarret, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsault, É.</span></span> <span> </span><span class="NLM_article-title">In Search of the Optimal Macrocyclization Site for Neurotensin</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">227</span>– <span class="NLM_lpage">232</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.7b00500</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.7b00500" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslyqsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=227-232&author=M.+Sousbieauthor=%C3%89.+Besserer-Offroyauthor=R.+L.+Brouilletteauthor=J.-M.+Longpr%C3%A9author=R.+Leducauthor=P.+Sarretauthor=%C3%89.+Marsault&title=In+Search+of+the+Optimal+Macrocyclization+Site+for+Neurotensin&doi=10.1021%2Facsmedchemlett.7b00500"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">In Search of the Optimal Macrocyclization Site for Neurotensin</span></div><div class="casAuthors">Sousbie, Marc; Besserer-Offroy, Elie; Brouillette, Rebecca L.; Longpre, Jean-Michel; Leduc, Richard; Sarret, Philippe; Marsault, Eric</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">227-232</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Neurotensin exerts potent analgesic effects following activation of its cognate GPCRs.  In this study, the authors describe a systematic exploration, using structure-based design, of conformationally constraining neurotensin (8-13) with the help of macrocyclization and the resulting impacts on binding affinity, signaling, and proteolytic stability.  This exploratory study led to a macrocyclic scaffold with submicromolar binding affinity, agonist activity, and greatly improved plasma stability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKgRzZ0YvF3LVg90H21EOLACvtfcHk0lgCTUX3sSet1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslyqsbg%253D&md5=7a81d21142ea26f1b85b4f43283ed509</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.7b00500&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.7b00500%26sid%3Dliteratum%253Aachs%26aulast%3DSousbie%26aufirst%3DM.%26aulast%3DBesserer-Offroy%26aufirst%3D%25C3%2589.%26aulast%3DBrouillette%26aufirst%3DR.%2BL.%26aulast%3DLongpr%25C3%25A9%26aufirst%3DJ.-M.%26aulast%3DLeduc%26aufirst%3DR.%26aulast%3DSarret%26aufirst%3DP.%26aulast%3DMarsault%26aufirst%3D%25C3%2589.%26atitle%3DIn%2520Search%2520of%2520the%2520Optimal%2520Macrocyclization%2520Site%2520for%2520Neurotensin%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D9%26spage%3D227%26epage%3D232%26doi%3D10.1021%2Facsmedchemlett.7b00500" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sousbie, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vivancos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brouillette, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besserer-Offroy, É.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Longpré, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leduc, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarret, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsault, É.</span></span> <span> </span><span class="NLM_article-title">Structural Optimization and Characterization of Potent Analgesic Macrocyclic Analogues of Neurotensin (8-13)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">7103</span>– <span class="NLM_lpage">7115</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00175</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00175" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlKms7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=7103-7115&author=M.+Sousbieauthor=M.+Vivancosauthor=R.+L.+Brouilletteauthor=%C3%89.+Besserer-Offroyauthor=J.-M.+Longpr%C3%A9author=R.+Leducauthor=P.+Sarretauthor=%C3%89.+Marsault&title=Structural+Optimization+and+Characterization+of+Potent+Analgesic+Macrocyclic+Analogues+of+Neurotensin+%288-13%29&doi=10.1021%2Facs.jmedchem.8b00175"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Optimization and Characterization of Potent Analgesic Macrocyclic Analogues of Neurotensin (8-13)</span></div><div class="casAuthors">Sousbie, Marc; Vivancos, Melanie; Brouillette, Rebecca L.; Besserer-Offroy, Elie; Longpre, Jean-Michel; Leduc, Richard; Sarret, Philippe; Marsault, Eric</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7103-7115</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The neurotensin receptors are attractive targets for the development of new analgesic compds.  They represent potential alternatives or adjuvants to opioids.  Herein, we report the structural optimization of our recently reported macrocyclic peptide analogs of NT (8-13).  The macrocycle was formed via ring-closing metathesis (RCM) between an ortho allylated tyrosine residue in position 11 and the side chain of alkene-functionalized amino acid in position 8 of NT (8-13).  Minute modifications led to significant binding affinity improvement (Ki improved from 5600 nM to 15 nM) with greatly improved plasma stability compared to NT (8-13).  This study also delineates the structural features influencing these parameters.  The signaling profiles of the new macrocycles were detd. on the NTS1 receptor and the physiol. effects of the two most potent and stable analogs were assessed in vivo using rodent models.  Both compds. displayed strong analgesic effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiJNnGkZ2klrVg90H21EOLACvtfcHk0lgCTUX3sSet1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlKms7fK&md5=0dc826bb5712cb3910ecb51f7bf88d28</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00175&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00175%26sid%3Dliteratum%253Aachs%26aulast%3DSousbie%26aufirst%3DM.%26aulast%3DVivancos%26aufirst%3DM.%26aulast%3DBrouillette%26aufirst%3DR.%2BL.%26aulast%3DBesserer-Offroy%26aufirst%3D%25C3%2589.%26aulast%3DLongpr%25C3%25A9%26aufirst%3DJ.-M.%26aulast%3DLeduc%26aufirst%3DR.%26aulast%3DSarret%26aufirst%3DP.%26aulast%3DMarsault%26aufirst%3D%25C3%2589.%26atitle%3DStructural%2520Optimization%2520and%2520Characterization%2520of%2520Potent%2520Analgesic%2520Macrocyclic%2520Analogues%2520of%2520Neurotensin%2520%25288-13%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D7103%26epage%3D7115%26doi%3D10.1021%2Facs.jmedchem.8b00175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, J. A.</span></span> <span> </span><span class="NLM_article-title">High-Resolution Epitope Mapping of Hgh-Receptor Interactions by Alanine-Scanning Mutagenesis</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>244</i></span>,  <span class="NLM_fpage">1081</span>– <span class="NLM_lpage">1085</span>, <span class="refDoi"> DOI: 10.1126/science.2471267</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1126%2Fscience.2471267" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=2471267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADyaL1MXltV2it7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=244&publication_year=1989&pages=1081-1085&author=B.+C.+Cunninghamauthor=J.+A.+Wells&title=High-Resolution+Epitope+Mapping+of+Hgh-Receptor+Interactions+by+Alanine-Scanning+Mutagenesis&doi=10.1126%2Fscience.2471267"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">High-resolution epitope mapping of hGH-receptor interactions by alanine-scanning mutagenesis</span></div><div class="casAuthors">Cunningham, Brian C.; Wells, James A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">244</span>
        (<span class="NLM_cas:issue">4908</span>),
    <span class="NLM_cas:pages">1081-5</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">A strategy, called alanine-scanning mutagenesis, was used to identify specific side chains in human growth hormone (hGH) that strongly modulate binding to the hGH receptor cloned from human liver.  Single alanine mutations (62 in total) were introduced at every residue contained within the 3 discontinuous segments of hGH (residues 2-19, 54-74, and 167-191) that have been implicated in receptor recognition.  The alanine scan revealed a cluster of a dozen large side chains that when mutated to alanine each showed >4-fold lower binding affinity to the hGH receptor.  Many of these residues that promote binding to the hGH receptor are altered in homologs of hGH (such as placental lactogens and prolactins) that do not bind tightly to the hGH receptor.  The overall folding of these mutant proteins was indistinguishable from that of the wild-type hGH, as detd. by strong cross-reactivities with 7 different conformationally sensitive monoclonal antibodies.  The alanine scan also identified at least one side chain, Glu174, that hindered binding because when it was mutated to alanine the receptor affinity increased by >4-fold.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6zoDe8YESIrVg90H21EOLACvtfcHk0ljo1AYRYDMwgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXltV2it7c%253D&md5=b88aa28886f1716c85f8beb76e7e7100</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1126%2Fscience.2471267&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.2471267%26sid%3Dliteratum%253Aachs%26aulast%3DCunningham%26aufirst%3DB.%2BC.%26aulast%3DWells%26aufirst%3DJ.%2BA.%26atitle%3DHigh-Resolution%2520Epitope%2520Mapping%2520of%2520Hgh-Receptor%2520Interactions%2520by%2520Alanine-Scanning%2520Mutagenesis%26jtitle%3DScience%26date%3D1989%26volume%3D244%26spage%3D1081%26epage%3D1085%26doi%3D10.1126%2Fscience.2471267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">St-Pierre, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lalonde, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gendreau, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quirion, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regoli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rioux, F.</span></span> <span> </span><span class="NLM_article-title">Synthesis of peptides by the solid-phase method. 6. Neurotensin, fragments, and analogs</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1981</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">370</span>– <span class="NLM_lpage">376</span>, <span class="refDoi"> DOI: 10.1021/jm00136a004</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00136a004" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADyaL3MXhtlarsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1981&pages=370-376&author=S.+St-Pierreauthor=J.+M.+Lalondeauthor=M.+Gendreauauthor=R.+Quirionauthor=D.+Regoliauthor=F.+Rioux&title=Synthesis+of+peptides+by+the+solid-phase+method.+6.+Neurotensin%2C+fragments%2C+and+analogs&doi=10.1021%2Fjm00136a004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of peptides by the solid-phase method.  6.  Neurotensin, fragments, and analogs</span></div><div class="casAuthors">St-Pierre, S.; Lalonde, J. M.; Gendreau, M.; Quirion, R.; Regoli, D.; Rioux, F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">370-6</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">Neurotensin acetate  [76398-90-8] and 24 related compds., including fragments or analogs modified at the C-terminal end of the parent mol., have been prepd. by the solid-phase method.  After purifn. by cation-exchange chromatog., the compds. were characterized by thin-layer chromatog., amino acid anal., elemental anal., and high-pressure liq. chromatog.  The stimulating effects of the peptides were evaluated in rat stomach strips, in isolated spontaneously beating atria of guinea pigs, and in the coronaries of perfused rat hearts.  9-13-Neurotensin acetate  [76381-84-5] was the smallest C-terminal fragment possessing full intrinsic activity in all 3 assays.  The 11-tyrosine residue was important for biol. activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKtkueJKmzxLVg90H21EOLACvtfcHk0ljo1AYRYDMwgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXhtlarsL8%253D&md5=a2ab2e0b743c5ad17b713c8a2f83693e</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1021%2Fjm00136a004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00136a004%26sid%3Dliteratum%253Aachs%26aulast%3DSt-Pierre%26aufirst%3DS.%26aulast%3DLalonde%26aufirst%3DJ.%2BM.%26aulast%3DGendreau%26aufirst%3DM.%26aulast%3DQuirion%26aufirst%3DR.%26aulast%3DRegoli%26aufirst%3DD.%26aulast%3DRioux%26aufirst%3DF.%26atitle%3DSynthesis%2520of%2520peptides%2520by%2520the%2520solid-phase%2520method.%25206.%2520Neurotensin%252C%2520fragments%252C%2520and%2520analogs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1981%26volume%3D24%26spage%3D370%26epage%3D376%26doi%3D10.1021%2Fjm00136a004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Henry, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horwell, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meecham, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, D. C.</span></span> <span> </span><span class="NLM_article-title">A Structure-Affinity Study of the Amino Acid Side-Chains in Neurotensin: N and C Terminal Deletions and Ala-Scan</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">949</span>– <span class="NLM_lpage">952</span>, <span class="refDoi"> DOI: 10.1016/S0960-894X(00)80698-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2FS0960-894X%2800%2980698-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADyaK3sXlslCgs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1993&pages=949-952&author=J.+A.+Henryauthor=D.+C.+Horwellauthor=K.+G.+Meechamauthor=D.+C.+Rees&title=A+Structure-Affinity+Study+of+the+Amino+Acid+Side-Chains+in+Neurotensin%3A+N+and+C+Terminal+Deletions+and+Ala-Scan&doi=10.1016%2FS0960-894X%2800%2980698-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">A structure-affinity study of the amino acid side-chains in neurotensin: N and C terminal deletions and Ala-scan</span></div><div class="casAuthors">Henry, Jenny A.; Horwell, David C.; Meecham, Kenneth G.; Rees, David C.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">949-52</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    </div><div class="casAbstract">A systematic N- and C-terminal deletion and Ala-scan (sequential replacement of amino acid moieties in active peptide fragment with Ala) study was used to quantify the involvement of each neurotensin amino acid side-chain for the in vitro binding interaction with the neurotensin receptor.  The hexapeptide neurotensin-(8-13) retained receptor binding affinity similar to that of the intact hormone, indicating that neither the amino acid side-chains on residues 1-7 nor their amide backbone contributed to receptor binding.  Tyr11 and Leu13 were the most important residues, and there appeared to be some synergy between the binding interactions of these two side-chains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCeNxU4Tuos7Vg90H21EOLACvtfcHk0lhyToyfA2MgKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXlslCgs7w%253D&md5=143e3b4b4ccd74a7db6175e14e42531b</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2800%2980698-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252800%252980698-8%26sid%3Dliteratum%253Aachs%26aulast%3DHenry%26aufirst%3DJ.%2BA.%26aulast%3DHorwell%26aufirst%3DD.%2BC.%26aulast%3DMeecham%26aufirst%3DK.%2BG.%26aulast%3DRees%26aufirst%3DD.%2BC.%26atitle%3DA%2520Structure-Affinity%2520Study%2520of%2520the%2520Amino%2520Acid%2520Side-Chains%2520in%2520Neurotensin%253A%2520N%2520and%2520C%2520Terminal%2520Deletions%2520and%2520Ala-Scan%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1993%26volume%3D3%26spage%3D949%26epage%3D952%26doi%3D10.1016%2FS0960-894X%2800%2980698-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prusoff, W. H.</span></span> <span> </span><span class="NLM_article-title">Relationship between the Inhibition Constant (K1) and the Concentration of Inhibitor Which Causes 50 Per Cent Inhibition (I50) of an Enzymatic Reaction</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1973</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">3099</span>– <span class="NLM_lpage">3108</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(73)90196-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2F0006-2952%2873%2990196-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=4202581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADyaE2cXhtVGgs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1973&pages=3099-3108&author=Y.+Chengauthor=W.+H.+Prusoff&title=Relationship+between+the+Inhibition+Constant+%28K1%29+and+the+Concentration+of+Inhibitor+Which+Causes+50+Per+Cent+Inhibition+%28I50%29+of+an+Enzymatic+Reaction&doi=10.1016%2F0006-2952%2873%2990196-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Relation between the inhibition constant K1) and the concentration of inhibitor which causes fifty per cent inhibition (I50) of an enzymic reaction</span></div><div class="casAuthors">Cheng, Yung-Chi; Prusoff, William H.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1973</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">3099-108</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">The Ki and I50 values are equal where the kinetics are non- or uncompetitive, but not where they are competitive.  The relation between the 2 values was analyzed for non- and uncompetitive bi- and monosubstrate reactions and for competitive bisubstrate reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqodFY_8msz57Vg90H21EOLACvtfcHk0lhyToyfA2MgKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2cXhtVGgs7c%253D&md5=fe7175ca300d8f4085df87af37f8656c</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2873%2990196-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252873%252990196-2%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DPrusoff%26aufirst%3DW.%2BH.%26atitle%3DRelationship%2520between%2520the%2520Inhibition%2520Constant%2520%2528K1%2529%2520and%2520the%2520Concentration%2520of%2520Inhibitor%2520Which%2520Causes%252050%2520Per%2520Cent%2520Inhibition%2520%2528I50%2529%2520of%2520an%2520Enzymatic%2520Reaction%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1973%26volume%3D22%26spage%3D3099%26epage%3D3108%26doi%3D10.1016%2F0006-2952%2873%2990196-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">MacArthur, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thornton, J. M.</span></span> <span> </span><span class="NLM_article-title">Influence of Proline Residues on Protein Conformation</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>218</i></span>,  <span class="NLM_fpage">397</span>– <span class="NLM_lpage">412</span>, <span class="refDoi"> DOI: 10.1016/0022-2836(91)90721-H</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2F0022-2836%2891%2990721-H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=2010917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADyaK3MXit1eru7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=218&publication_year=1991&pages=397-412&author=M.+W.+MacArthurauthor=J.+M.+Thornton&title=Influence+of+Proline+Residues+on+Protein+Conformation&doi=10.1016%2F0022-2836%2891%2990721-H"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Influence of proline residues on protein conformation</span></div><div class="casAuthors">MacArthur, Malcolm W.; Thornton, Janet M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">218</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">397-412</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    </div><div class="casAbstract">To study the influence of proline residues on three-dimensional structure, an anal. has been made of all proline residues and their local conformations extd. from the Brookhaven Protein Data bank.  The conformation of the proline itself, the relative occurrence of cis and trans peptides preceding proline residues, the influence of proline on the conformation of the preceding residue and the conformations of various proline patters (Pro-Pro, Pro-X-Pro, etc.) were considered.  The results highlight the unique role of proline in detg. local conformation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9BHG_P_K9ubVg90H21EOLACvtfcHk0lhyToyfA2MgKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXit1eru7g%253D&md5=65644520cd10a3ef7e68ebbe6d8a2cf7</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2F0022-2836%2891%2990721-H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0022-2836%252891%252990721-H%26sid%3Dliteratum%253Aachs%26aulast%3DMacArthur%26aufirst%3DM.%2BW.%26aulast%3DThornton%26aufirst%3DJ.%2BM.%26atitle%3DInfluence%2520of%2520Proline%2520Residues%2520on%2520Protein%2520Conformation%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1991%26volume%3D218%26spage%3D397%26epage%3D412%26doi%3D10.1016%2F0022-2836%2891%2990721-H" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uttenthal, L. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bloom, S. R.</span></span> <span> </span><span class="NLM_article-title">In Vitro Degradation of Neurotensin in Human Plasma</span>. <i>Peptides</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">383</span>– <span class="NLM_lpage">387</span>, <span class="refDoi"> DOI: 10.1016/0196-9781(86)90002-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2F0196-9781%2886%2990002-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=3774585" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADyaL28Xls1Grt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1986&pages=383-387&author=Y.+C.+Leeauthor=L.+O.+Uttenthalauthor=H.+A.+Smithauthor=S.+R.+Bloom&title=In+Vitro+Degradation+of+Neurotensin+in+Human+Plasma&doi=10.1016%2F0196-9781%2886%2990002-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro degradation of neurotensin in human plasma</span></div><div class="casAuthors">Lee, Y. C.; Uttenthal, L. O.; Smith, H. A.; Bloom, S. R.</div><div class="citationInfo"><span class="NLM_cas:title">Peptides (New York, NY, United States)</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">383-7</span>CODEN:
                <span class="NLM_cas:coden">PPTDD5</span>;
        ISSN:<span class="NLM_cas:issn">0196-9781</span>.
    </div><div class="casAbstract">Fresh human plasma was incubated with neurotensin  [39379-15-2] in the presence and absence of the peptidase  [9031-96-3] inhibitors pepstatin A, EDTA  [60-00-4], phenylmethylsulfonylfluoride, and aprotinin.  The half-time of disappearance of neurotensin at 37° was 226 min in vitro as opposed to 1.4 min in vivo when measured by RIA with a C-terminally directed neurotensin antiserum.  Both gel filtration and reversed-phase HPLC showed that the main degrdn. product of neurotensin in human plasma in vitro was chromatog. and immunol. identical to neurotensin 1-8  [80887-44-1] and HPLC also demonstrated the formation of neurotensin 1-11  [74032-89-6].  The loss of neurotensin incubated in human plasma in vitro was greatly reduced by EDTA but not by the other peptidase inhibitors tested.  In this respect peptidase(s) responsible for the degrdn. of neurotensin in plasma differ from those present in brain homogenates.  EDTA may be of importance in the preservation of neurotensin in plasma samples.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0PLTSBw-bb7Vg90H21EOLACvtfcHk0liI0NtZHeNJUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28Xls1Grt7Y%253D&md5=24cda7de23fcd0b1c755ab9782967696</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1016%2F0196-9781%2886%2990002-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0196-9781%252886%252990002-1%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DY.%2BC.%26aulast%3DUttenthal%26aufirst%3DL.%2BO.%26aulast%3DSmith%26aufirst%3DH.%2BA.%26aulast%3DBloom%26aufirst%3DS.%2BR.%26atitle%3DIn%2520Vitro%2520Degradation%2520of%2520Neurotensin%2520in%2520Human%2520Plasma%26jtitle%3DPeptides%26date%3D1986%26volume%3D7%26spage%3D383%26epage%3D387%26doi%3D10.1016%2F0196-9781%2886%2990002-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stern, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cullen, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barber, V. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richer, R.</span></span> <span> </span><span class="NLM_article-title">Peptidases in the Cerebrospinal Fluid</span>. <i>Can. Med. Assoc. J.</i> <span class="NLM_year" style="font-weight: bold;">1950</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">473</span>– <span class="NLM_lpage">475</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=14778097" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADyaG38XhsFagsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1950&pages=473-475&author=K.+Sternauthor=A.+M.+Cullenauthor=V.+T.+Barberauthor=R.+Richer&title=Peptidases+in+the+Cerebrospinal+Fluid"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Peptidases in the cerebrospinal fluid</span></div><div class="casAuthors">Stern, Karl; Cullen, Andrea M.; Barber, Virginia T.; Richer, Ruth</div><div class="citationInfo"><span class="NLM_cas:title">Canadian Medical Association Journal</span>
        (<span class="NLM_cas:date">1950</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">473-5</span>CODEN:
                <span class="NLM_cas:coden">CMAJAX</span>;
        ISSN:<span class="NLM_cas:issn">0008-4409</span>.
    </div><div class="casAbstract">Cerebrospinal fluid, obtained from 21 patients suffering from various pathol. conditions, generally had considerably less peptidase activity than blood serum.  Those spinal fluids with high peptidase activity also contained numerous leucocytes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpX9dtVNy_wPbVg90H21EOLACvtfcHk0liI0NtZHeNJUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG38XhsFagsA%253D%253D&md5=48436da2324c08180a6f61bde20b7ab0</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStern%26aufirst%3DK.%26aulast%3DCullen%26aufirst%3DA.%2BM.%26aulast%3DBarber%26aufirst%3DV.%2BT.%26aulast%3DRicher%26aufirst%3DR.%26atitle%3DPeptidases%2520in%2520the%2520Cerebrospinal%2520Fluid%26jtitle%3DCan.%2520Med.%2520Assoc.%2520J.%26date%3D1950%26volume%3D63%26spage%3D473%26epage%3D475" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tyndall, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nall, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlie, D. P.</span></span> <span> </span><span class="NLM_article-title">Proteases Universally Recognize Beta Strands in Their Active Sites</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">973</span>– <span class="NLM_lpage">1000</span>, <span class="refDoi"> DOI: 10.1021/cr040669e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr040669e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlSqtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2005&pages=973-1000&author=J.+D.+Tyndallauthor=T.+Nallauthor=D.+P.+Fairlie&title=Proteases+Universally+Recognize+Beta+Strands+in+Their+Active+Sites&doi=10.1021%2Fcr040669e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Proteases universally recognize beta strands in their active sites</span></div><div class="casAuthors">Tyndall, Joel D. A.; Nall, Tessa; Fairlie, David P.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">973-999</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Proteases account for a significant proportion (∼2%) of the human genome with >550 defined members and a further ∼100 predicted human proteases.  Proteases also represent 1-5% of the genomes of infectious organisms such as bacteria, parasites, and viruses.  They are categorized by the nature of their active site catalytic residue(s) as metallo (34%), serine (30%), cysteine (26%), aspartic (4%), and the less characterized threonine (5%).  Mammalian proteases, of which ∼20% are membrane-bound, are aberrantly expressed or underregulated during many disease conditions, suggesting that inhibitors of specific proteases might be able to control irregular mammalian physiol.  Alternatively, since there are now >50 human proteases where one or more genetic mutations have been found to lead to hereditary diseases, gene therapy may be a useful approach when it eventually becomes technol. feasible.  The goal of protease inhibitor design is to develop potent inhibitors of the offending or mammalian protease but with accompanying selectivity to avoid inhibiting very similar host proteases required for normal host physiol.  This review summarizes an anal. of >1500 3-dimensional crystal (x-ray) and soln. (NMR) structures from the Protein Data Bank of substrates, products, and inhibitors bound in the active sites of all 5 protease classes.  Most of the active sites, with few exceptions, have been found to recognize peptidic and non-peptidic ligands in an extended β-strand conformation.  Such conformational selection of ligands explains the resistance of folded/structured regions of proteins to proteolytic degrdn., the susceptibility of denatured proteins to processing, and the higher affinity of conformationally constrained 'extended' inhibitors/substrates for proteases.  On the basis of the results presented by the authors, one would predict that the use of various approaches to fix an extended β-strand ligand conformation should produce high-affinity inhibitors even for proteases of unknown structure, provided that the substrate specificity and protease type is known.  This inference should be extremely valuable, particularly when the structure of a protease is not known and inhibitor design has to be based solely on substrate preferences.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8uFIrmHewBrVg90H21EOLACvtfcHk0liIZX9zpWzOug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlSqtLo%253D&md5=67da540a9c260f7c80d9a2f7128dfc15</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1021%2Fcr040669e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr040669e%26sid%3Dliteratum%253Aachs%26aulast%3DTyndall%26aufirst%3DJ.%2BD.%26aulast%3DNall%26aufirst%3DT.%26aulast%3DFairlie%26aufirst%3DD.%2BP.%26atitle%3DProteases%2520Universally%2520Recognize%2520Beta%2520Strands%2520in%2520Their%2520Active%2520Sites%26jtitle%3DChem.%2520Rev.%26date%3D2005%26volume%3D105%26spage%3D973%26epage%3D1000%26doi%3D10.1021%2Fcr040669e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McDermott, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwardson, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffiths, E. C.</span></span> <span> </span><span class="NLM_article-title">Mechanism of Neurotensin Degradation by Rat Brain Peptidases</span>. <i>Regul. Pept.</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">397</span>– <span class="NLM_lpage">404</span>, <span class="refDoi"> DOI: 10.1016/0167-0115(82)90062-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2F0167-0115%2882%2990062-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=7051196" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADyaL38Xlt1Wju70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1982&pages=397-404&author=J.+R.+McDermottauthor=A.+I.+Smithauthor=J.+A.+Edwardsonauthor=E.+C.+Griffiths&title=Mechanism+of+Neurotensin+Degradation+by+Rat+Brain+Peptidases&doi=10.1016%2F0167-0115%2882%2990062-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of neurotensin degradation by rat brain peptidases</span></div><div class="casAuthors">McDermott, J. R.; Smith, A. I.; Edwardson, J. A.; Griffiths, E. C.</div><div class="citationInfo"><span class="NLM_cas:title">Regulatory Peptides</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5-6</span>),
    <span class="NLM_cas:pages">397-404</span>CODEN:
                <span class="NLM_cas:coden">REPPDY</span>;
        ISSN:<span class="NLM_cas:issn">0167-0115</span>.
    </div><div class="casAbstract">neurotensin  [39379-15-2] Is degraded by peptidases present in sol. and particulate (25,000 × g) fractions of rat hypothalamus, thalamus, cortex, and pituitary, the sol. fraction of the hypothalamus having the highest activity.  High performance liq. chromatog. and amino acid anal. were used to identify the degrdn. pathway.  The main product in both fractions was neurotensin  [80887-44-1] and the corresponding C-terminal fragment [9-13]neurotensin  [60482-96-4] was identified.  [1-10]neurotensin  [63524-00-5] Was also identified, proportionately more of this peptide being produced by the particulate rather than the sol. fraction.  In the presence of dithiothreitol, neurotensin  [82882-13-1] and [1-10]neurotensin were major products particularly in the sol. fraction.  Results suggest that the main sites of cleavage of neurotensin by rat brain peptidases are the Arg8-Arg9, Pro10-Tyr11, and Pro7-Arg8 bonds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdUOHHs82TCbVg90H21EOLACvtfcHk0liIZX9zpWzOug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38Xlt1Wju70%253D&md5=e947215b328ec497f4e849b50bfbf632</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1016%2F0167-0115%2882%2990062-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0167-0115%252882%252990062-3%26sid%3Dliteratum%253Aachs%26aulast%3DMcDermott%26aufirst%3DJ.%2BR.%26aulast%3DSmith%26aufirst%3DA.%2BI.%26aulast%3DEdwardson%26aufirst%3DJ.%2BA.%26aulast%3DGriffiths%26aufirst%3DE.%2BC.%26atitle%3DMechanism%2520of%2520Neurotensin%2520Degradation%2520by%2520Rat%2520Brain%2520Peptidases%26jtitle%3DRegul.%2520Pept.%26date%3D1982%26volume%3D3%26spage%3D397%26epage%3D404%26doi%3D10.1016%2F0167-0115%2882%2990062-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lugrin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vecchini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doulut, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitabgi, P.</span></span> <span> </span><span class="NLM_article-title">Reduced Peptide Bond Pseudopeptide Analogues of Neurotensin: Binding and Biological Activities, and in Vitro Metabolic Stability</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>205</i></span>,  <span class="NLM_fpage">191</span>– <span class="NLM_lpage">198</span>, <span class="refDoi"> DOI: 10.1016/0014-2999(91)90819-C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2F0014-2999%2891%2990819-C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1812009" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADyaK38XpvFCksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=205&publication_year=1991&pages=191-198&author=D.+Lugrinauthor=F.+Vecchiniauthor=S.+Doulutauthor=M.+Rodriguezauthor=J.+Martinezauthor=P.+Kitabgi&title=Reduced+Peptide+Bond+Pseudopeptide+Analogues+of+Neurotensin%3A+Binding+and+Biological+Activities%2C+and+in+Vitro+Metabolic+Stability&doi=10.1016%2F0014-2999%2891%2990819-C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Reduced peptide bond pseudopeptide analogs of neurotensin:  binding and biological activities, and in vitro metabolic stability</span></div><div class="casAuthors">Lugrin, Didier; Vecchini, Francoise; Doulut, Sylvie; Rodriguez, Marc; Martinez, Jean; Kitabgi, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">205</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">191-8</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">A series of pseudopeptide analogs of neurotensin was produced by systematically replacing the 5 peptide bonds in neurotensin-(8-13) with CH2NH (ψ, reduced) bonds.  All these analogs were synthesized with a free amino terminus (H derivs.) and with a N-terminal tert-butyloxycarbonyl group (Boc derivs.).  The compds. were screened in vitro for agonist or antagonist activity and for metabolic stability by testing their ability to inhibit the binding of radiolabeled neurotensin to homogenates of newborn mouse brain; their ability to contract isolated guinea pig ileum prepns.; and their degrdn. in the presence of rat brain homogenates.  All the analogs bound to the mouse brain neurotensin receptor and all exhibited agonist activity in the guinea pig ileum assay.  Only the H- and Boc[ψ8,9] derivs. were at least as potent as their parent compds. neurotensin (8-13) and Boc-neurotensin-(8-13) in the binding and biol. assays.  All the other pseudopeptide analogs with reduced bonds at position 9-10, 10-11, 11-12 and 12-13 showed a marked redn. in potency ranging from 2 to 4 orders of magnitude.  All the derivs. that were protected at their N terminus either by the presence of a Boc group or by the presence of a reduced bond at position 8-9 and 9-10 were slowly degraded by rat brain homogenates.  The other derivs. were, in contrast, quite rapidly degraded.  There was a good correlation between binding and biol. potencies for those analogs that were resistant to degrdn.  Interestingly, the degrdn.-resistant H-[ψ8,9] compd. exhibited higher binding and biol. potency than neurotensin.  It is therefore expected that this analog will produce highly potent and long-lasting neurotensin-like effects in vivo, and preliminary expts. indicate that this is indeed the case.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMrU2Z_xnLOrVg90H21EOLACvtfcHk0li6keNWQSoh8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XpvFCksg%253D%253D&md5=de57511a94a2224ce09f8624fdda79ac</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2891%2990819-C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252891%252990819-C%26sid%3Dliteratum%253Aachs%26aulast%3DLugrin%26aufirst%3DD.%26aulast%3DVecchini%26aufirst%3DF.%26aulast%3DDoulut%26aufirst%3DS.%26aulast%3DRodriguez%26aufirst%3DM.%26aulast%3DMartinez%26aufirst%3DJ.%26aulast%3DKitabgi%26aufirst%3DP.%26atitle%3DReduced%2520Peptide%2520Bond%2520Pseudopeptide%2520Analogues%2520of%2520Neurotensin%253A%2520Binding%2520and%2520Biological%2520Activities%252C%2520and%2520in%2520Vitro%2520Metabolic%2520Stability%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1991%26volume%3D205%26spage%3D191%26epage%3D198%26doi%3D10.1016%2F0014-2999%2891%2990819-C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seebach, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lukaszuk, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patora-Komisarska, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Podwysocka, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardiner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebert, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reubi, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cescato, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waser, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rougeot, C.</span></span> <span> </span><span class="NLM_article-title">On the Terminal Homologation of Physiologically Active Peptides as a Means of Increasing Stability in Human Serum--Neurotensin, Opiorphin, B27-Kk10 Epitope, Npy</span>. <i>Chem. Biodivers.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">711</span>– <span class="NLM_lpage">739</span>, <span class="refDoi"> DOI: 10.1002/cbdv.201100093</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1002%2Fcbdv.201100093" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=21560227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A280%3ADC%252BC3MrgtVGmug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2011&pages=711-739&author=D.+Seebachauthor=A.+Lukaszukauthor=K.+Patora-Komisarskaauthor=D.+Podwysockaauthor=J.+Gardinerauthor=M.+O.+Ebertauthor=J.+C.+Reubiauthor=R.+Cescatoauthor=B.+Waserauthor=P.+Gmeinerauthor=H.+H%C3%BCbnerauthor=C.+Rougeot&title=On+the+Terminal+Homologation+of+Physiologically+Active+Peptides+as+a+Means+of+Increasing+Stability+in+Human+Serum%2D%2DNeurotensin%2C+Opiorphin%2C+B27-Kk10+Epitope%2C+Npy&doi=10.1002%2Fcbdv.201100093"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">On the terminal homologation of physiologically active peptides as a means of increasing stability in human serum--neurotensin, opiorphin, B27-KK10 epitope, NPY</span></div><div class="casAuthors">Seebach Dieter; Lukaszuk Aneta; Patora-Komisarska Krystyna; Podwysocka Dominika; Gardiner James; Ebert Marc-Olivier; Reubi Jean Claude; Cescato Renzo; Waser Beatrice; Gmeiner Peter; Hubner Harald; Rougeot Catherine</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & biodiversity</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">711-39</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The terminal homologation by CH(2) insertion into the peptides mentioned in the title is described.  This involves replacement of the N-terminal amino acid residue by a β(2) - and of the C-terminal amino acid residue by a β(3) -homo-amino acid moiety (β(2) hXaa and β(3) hXaa, resp.; Fig. 1).  In this way, the structure of the peptide chain from the N-terminal to the C-terminal stereogenic center is identical, and the modified peptide is protected against cleavage by exopeptidases (Figs. 2 and 3).  Neurotensin (NT; 1) and its C-terminal fragment NT(8-13) are ligands of the G-protein-coupled receptors (GPCR) NT1, NT2, NT3, and NT analogs are promising tools to be used in cancer diagnostics and therapy.  The affinities of homologated NT analogs, 2b-2e, for NT1 and NT2 receptors were determined by using cell homogenates and tumor tissues (Table 1); in the latter experiments, the affinities for the NT1 receptor are more or less the same as those of NT (0.5-1.3 vs. 0.6 nM).  At the same time, one of the homologated NT analogs, 2c, survives in human plasma for 7 days at 37° (Fig. 6).  An NMR analysis of NT(8-13) (Tables 2 and 4, and Fig. 8) reveals that this N-terminal NT fragment folds to a turn in CD(3) OH. - In the case of the human analgesic opiorphin (3a), a pentapeptide, and of the HIV-derived B27-KK10 (4a), a decapeptide, terminal homologation (→3b and 4b, resp.) led to a 7- and 70-fold half-life increase in plasma (Fig. 9).  With N-terminally homologated NPY, 5c, we were not able to determine serum stability; the peptide consisting of 36 amino acid residues is subject to cleavage by endopetidases.  Three of the homologated compounds, 2b, 2c, and 5c, were shown to be agonists (Fig. 7 and 11).  A comparison of terminal homologation with other stability-increasing terminal modifications of peptides is performed (Fig. 5), and possible applications of the neurotensin analogs, described herein, are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTXSIxo7OLTmbjnyZkbE8yXfW6udTcc2eYDT9E6yKX0x7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MrgtVGmug%253D%253D&md5=9280069bdab6a3f7a034f917241e0c81</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1002%2Fcbdv.201100093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbdv.201100093%26sid%3Dliteratum%253Aachs%26aulast%3DSeebach%26aufirst%3DD.%26aulast%3DLukaszuk%26aufirst%3DA.%26aulast%3DPatora-Komisarska%26aufirst%3DK.%26aulast%3DPodwysocka%26aufirst%3DD.%26aulast%3DGardiner%26aufirst%3DJ.%26aulast%3DEbert%26aufirst%3DM.%2BO.%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26aulast%3DCescato%26aufirst%3DR.%26aulast%3DWaser%26aufirst%3DB.%26aulast%3DGmeiner%26aufirst%3DP.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DRougeot%26aufirst%3DC.%26atitle%3DOn%2520the%2520Terminal%2520Homologation%2520of%2520Physiologically%2520Active%2520Peptides%2520as%2520a%2520Means%2520of%2520Increasing%2520Stability%2520in%2520Human%2520Serum--Neurotensin%252C%2520Opiorphin%252C%2520B27-Kk10%2520Epitope%252C%2520Npy%26jtitle%3DChem.%2520Biodivers.%26date%3D2011%26volume%3D8%26spage%3D711%26epage%3D739%26doi%3D10.1002%2Fcbdv.201100093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Einsiedel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hervet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Härterich, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koschatzky, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span> <span> </span><span class="NLM_article-title">Peptide Backbone Modifications on the C-Terminal Hexapeptide of Neurotensin</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">2013</span>– <span class="NLM_lpage">2018</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2008.01.110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2Fj.bmcl.2008.01.110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=18276136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjtlymtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=2013-2018&author=J.+Einsiedelauthor=H.+H%C3%BCbnerauthor=M.+Hervetauthor=S.+H%C3%A4rterichauthor=S.+Koschatzkyauthor=P.+Gmeiner&title=Peptide+Backbone+Modifications+on+the+C-Terminal+Hexapeptide+of+Neurotensin&doi=10.1016%2Fj.bmcl.2008.01.110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Peptide backbone modifications on the C-terminal hexapeptide of neurotensin</span></div><div class="casAuthors">Einsiedel, Juergen; Huebner, Harald; Hervet, Maud; Haerterich, Steffen; Koschatzky, Susanne; Gmeiner, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2013-2018</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">To compare backbone-induced susceptibilities with affinity changes that are caused by side-chain modifications in the resp. positions, structure activity relationship studies on a series of NT(8-13) analogs were performed providing valuable insights into the major requirement for neurotensin receptor recognition and activation.  The data led the authors to highly potent NTR1 ligands and the generation of a pharmacophore model that will be helpful for the discovery of therapeutically relevant non-peptidic NTR1 agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDAmdNBALiOrVg90H21EOLACvtfcHk0li6keNWQSoh8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjtlymtr8%253D&md5=279fe25841915ac7da128234fb412083</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.01.110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.01.110%26sid%3Dliteratum%253Aachs%26aulast%3DEinsiedel%26aufirst%3DJ.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DHervet%26aufirst%3DM.%26aulast%3DH%25C3%25A4rterich%26aufirst%3DS.%26aulast%3DKoschatzky%26aufirst%3DS.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DPeptide%2520Backbone%2520Modifications%2520on%2520the%2520C-Terminal%2520Hexapeptide%2520of%2520Neurotensin%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D2013%26epage%3D2018%26doi%3D10.1016%2Fj.bmcl.2008.01.110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Checler, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emson, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitabgi, P.</span></span> <span> </span><span class="NLM_article-title">Inactivation of Neurotensin by Rat Brain Synaptic Membranes. Cleavage at the Pro10-Tyr11 Bond by Endopeptidase 24.11 (Enkephalinase) and a Peptidase Different from Proline-Endopeptidase</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">1295</span>– <span class="NLM_lpage">1301</span>, <span class="refDoi"> DOI: 10.1111/j.1471-4159.1984.tb05386.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1111%2Fj.1471-4159.1984.tb05386.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=6387047" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADyaL2MXhtVyk" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1984&pages=1295-1301&author=F.+Checlerauthor=P.+C.+Emsonauthor=J.+P.+Vincentauthor=P.+Kitabgi&title=Inactivation+of+Neurotensin+by+Rat+Brain+Synaptic+Membranes.+Cleavage+at+the+Pro10-Tyr11+Bond+by+Endopeptidase+24.11+%28Enkephalinase%29+and+a+Peptidase+Different+from+Proline-Endopeptidase&doi=10.1111%2Fj.1471-4159.1984.tb05386.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Inactivation of neurotensin by rat brain synaptic membranes.  Cleavage at the Pro10-Tyr11 bond by endopeptidase 24.11 (enkephalinase) and a peptidase different from proline-endopeptidase</span></div><div class="casAuthors">Checler, Frederic; Emson, P. C.; Vincent, J. P.; Kitabgi, P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1295-301</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    </div><div class="casAbstract">It was shown previously that the tridecapeptide neurotensin (NT)  [55508-42-4] is inactivated by rat brain synaptic membranes, with one of the primary inactivating cleavages occurring at the Pro10-Tyr11 peptide bond and leading to the formation of NT1-10  [63524-00-5] and NT11-13  [60482-98-6].  A study was designed to investigate the possibility that this cleavage was catalyzed by proline endopeptidase  [72162-84-6] and(or) endopeptidase 24.11 (enkephalinase)  [82707-54-8].  The cleavage of neurotensin at the Pro10-Tyr11 bond by synaptic membranes was not affected by an inhibitor of proline endopeptidase or an antiserum to this enzyme, and thiorphan (a potent endopeptidase 24.11 inhibitor only partially decreased the formation of NT1-10 and NT11-13 by synaptic membranes.  Thus, proline endopeptidase (although it is present in synaptic membranes) is not involved in the cleavage of neurotensin at the Pro10-Tyr11 bond, and endopeptidase 24.11 only partially contributes to this cleavage.  Apparently, there exists in rat brain synaptic membranes a peptidase  [9031-96-3] different from proline endopeptidase and endopeptidase 24.11 that is mainly responsible for inactivating neurotensin by cleaving at the Pro10-Tyr11 bond.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9F4TCRFk_2rVg90H21EOLACvtfcHk0lhU25zy_U22QQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXhtVyk&md5=785137dffca396859ffd6cd5dd3c64ea</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.1984.tb05386.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.1984.tb05386.x%26sid%3Dliteratum%253Aachs%26aulast%3DChecler%26aufirst%3DF.%26aulast%3DEmson%26aufirst%3DP.%2BC.%26aulast%3DVincent%26aufirst%3DJ.%2BP.%26aulast%3DKitabgi%26aufirst%3DP.%26atitle%3DInactivation%2520of%2520Neurotensin%2520by%2520Rat%2520Brain%2520Synaptic%2520Membranes.%2520Cleavage%2520at%2520the%2520Pro10-Tyr11%2520Bond%2520by%2520Endopeptidase%252024.11%2520%2528Enkephalinase%2529%2520and%2520a%2520Peptidase%2520Different%2520from%2520Proline-Endopeptidase%26jtitle%3DJ.%2520Neurochem.%26date%3D1984%26volume%3D43%26spage%3D1295%26epage%3D1301%26doi%3D10.1111%2Fj.1471-4159.1984.tb05386.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Checler, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitabgi, P.</span></span> <span> </span><span class="NLM_article-title">Inactivation of Neurotensin by Rat Brain Synaptic Membranes Partly Occurs through Cleavage at the Arg8-Arg9 Peptide Bond by a Metalloendopeptidase</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">1509</span>– <span class="NLM_lpage">1513</span>, <span class="refDoi"> DOI: 10.1111/j.1471-4159.1985.tb07220.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1111%2Fj.1471-4159.1985.tb07220.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=3900293" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADyaL2MXmtVOgt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1985&pages=1509-1513&author=F.+Checlerauthor=J.+P.+Vincentauthor=P.+Kitabgi&title=Inactivation+of+Neurotensin+by+Rat+Brain+Synaptic+Membranes+Partly+Occurs+through+Cleavage+at+the+Arg8-Arg9+Peptide+Bond+by+a+Metalloendopeptidase&doi=10.1111%2Fj.1471-4159.1985.tb07220.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Inactivation of neurotensin by rat brain synaptic membranes partly occurs through cleavage at the Arg8-Arg9 peptide bond by a metalloendopeptidase</span></div><div class="casAuthors">Checler, Frederic; Vincent, J. P.; Kitabgi, P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1509-13</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    </div><div class="casAbstract">One of the primary inactivating cleavages of neurotensin (NT)  [39379-15-2] by rat brain synaptic membranes occurs at the Arg8-Arg9 peptide bond, leading to the formation of NT1-8 and NT9-13.  The involvement at this site of a metalloendopeptidase  [149371-24-4] was demonstrated by the use of its specific inhibitor, N-[1(R,S)-carboxy-2-phenylethyl]-alanylalanylphenylalanine-p-aminobenzoate  [90991-75-6], which exerts an inhibition on NT1-8 formation with a concn. for half maximal inhibition of 0.6 μM, close to its Ki for the purified metalloendopeptidase (1.94 μM).  Furthermore, the role of a postproline dipeptidyl-aminopeptidase  [54249-88-6] in the secondary processing of NT9-13 formation was established.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovxsOWtXge67Vg90H21EOLACvtfcHk0lhU25zy_U22QQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXmtVOgt7Y%253D&md5=b1b7fca2bd7117b2de9ee02ce44fe002</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.1985.tb07220.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.1985.tb07220.x%26sid%3Dliteratum%253Aachs%26aulast%3DChecler%26aufirst%3DF.%26aulast%3DVincent%26aufirst%3DJ.%2BP.%26aulast%3DKitabgi%26aufirst%3DP.%26atitle%3DInactivation%2520of%2520Neurotensin%2520by%2520Rat%2520Brain%2520Synaptic%2520Membranes%2520Partly%2520Occurs%2520through%2520Cleavage%2520at%2520the%2520Arg8-Arg9%2520Peptide%2520Bond%2520by%2520a%2520Metalloendopeptidase%26jtitle%3DJ.%2520Neurochem.%26date%3D1985%26volume%3D45%26spage%3D1509%26epage%3D1513%26doi%3D10.1111%2Fj.1471-4159.1985.tb07220.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Checler, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitabgi, P.</span></span> <span> </span><span class="NLM_article-title">Purification and Characterization of a Novel Neurotensin-Degrading Peptidase from Rat Brain Synaptic Membranes</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>261</i></span>,  <span class="NLM_fpage">11274</span>– <span class="NLM_lpage">11281</span>, <span class="refDoi"> DOI: 10.1016/S0021-9258(18)67379-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2FS0021-9258%2818%2967379-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=3525564" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADyaL28XlvVKgu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=261&publication_year=1986&pages=11274-11281&author=F.+Checlerauthor=J.+P.+Vincentauthor=P.+Kitabgi&title=Purification+and+Characterization+of+a+Novel+Neurotensin-Degrading+Peptidase+from+Rat+Brain+Synaptic+Membranes&doi=10.1016%2FS0021-9258%2818%2967379-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Purification and characterization of a novel neurotensin-degrading peptidase from rat brain synaptic membranes</span></div><div class="casAuthors">Checler, Frederic; Vincent, Jean Pierre; Kitabgi, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">261</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">11274-81</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">A peptidase that cleaved neurotensin at the Pro10-Tyr11 peptide bond, leading to the formation of neurotensin-(1-10) and neurotensin-(11-13), was purified nearly to homogeneity from rat brain synaptic membranes.  The enzyme appeared to be monomeric with a mol. wt. of ∼70,000-75,000 as detd. by SDS-PAGE and HPLC.  Isoelectrofocusing indicated a pI of 5.9-6.  The purified peptidase could be classified as a neutral metallopeptidase with respect to its sensitivity to pH and metal chelators.  SH group-blocking agents and acidic and serine protease inhibitors had no effect.  Studies with specific peptidase inhibitors clearly indicated that the purified enzyme was distinct from enzymes capable of cleaving neurotensin at the Pro10-Tyr11 bond, such as proline endopeptidase and endopeptidase 24-11.  The enzyme was also distinct from other neurotensin-degrading peptidases, such as angiotensin-converting enzyme and a recently purified rat brain sol. metalloendopeptidase.  The peptidase displayed a high affinity for neurotensin (Km = 2.6 μM).  Studies on its specificity revealed that neurotensin-(9-13) was the shortest neurotensin partial sequence that was able to fully inhibit [3H]neurotensin degrdn.  Shortening the C-terminal end of the neurotensin mol. as well as substitutions in positions 8, 9, and 11 by D-amino acids strongly decreased the inhibitory potency of neurotensin.  Among 20 natural peptides, only angiotensin I and the neurotensin-related peptides xenopsin and neuromedin N were found as potent as unlabeled neurotensin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKlR1_uEkky7Vg90H21EOLACvtfcHk0lh9fI8wfA5ugg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XlvVKgu74%253D&md5=209457f889b7d8f9c90270160b136be3</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1016%2FS0021-9258%2818%2967379-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0021-9258%252818%252967379-X%26sid%3Dliteratum%253Aachs%26aulast%3DChecler%26aufirst%3DF.%26aulast%3DVincent%26aufirst%3DJ.%2BP.%26aulast%3DKitabgi%26aufirst%3DP.%26atitle%3DPurification%2520and%2520Characterization%2520of%2520a%2520Novel%2520Neurotensin-Degrading%2520Peptidase%2520from%2520Rat%2520Brain%2520Synaptic%2520Membranes%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1986%26volume%3D261%26spage%3D11274%26epage%3D11281%26doi%3D10.1016%2FS0021-9258%2818%2967379-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sarret, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esdaile, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perron, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stroh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaudet, A.</span></span> <span> </span><span class="NLM_article-title">Potent Spinal Analgesia Elicited through Stimulation of Nts2 Neurotensin Receptors</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">8188</span>– <span class="NLM_lpage">8196</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.0810-05.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1523%2FJNEUROSCI.0810-05.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=16148226" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVaktL%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=8188-8196&author=P.+Sarretauthor=M.+J.+Esdaileauthor=A.+Perronauthor=J.+Martinezauthor=T.+Strohauthor=A.+Beaudet&title=Potent+Spinal+Analgesia+Elicited+through+Stimulation+of+Nts2+Neurotensin+Receptors&doi=10.1523%2FJNEUROSCI.0810-05.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Potent spinal analgesia elicited through stimulation of NTS2 neurotensin receptors</span></div><div class="casAuthors">Sarret, Philippe; Esdaile, Michael J.; Perron, Amelie; Martinez, Jean; Stroh, Thomas; Beaudet, Alain</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">8188-8196</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Intrathecal administration of the neuropeptide neurotensin (NT) was shown previously to exert antinociceptive effects in a variety of acute spinal pain paradigms including hot-plate, tail-flick, and writhing tests.  In the present study, we sought to det. whether some of these antinociceptive effects might be elicited via stimulation of low-affinity NTS2 receptors.  We first established, using immunoblotting and immunohistochem. techniques, that NTS2 receptors were extensively assocd. with putative spinal nociceptive pathways, both at the level of the dorsal root ganglia and of the superficial layers of the dorsal horn of the spinal cord.  We then examd. the effects of intrathecal administration of NT or selective NTS2 agonists on acute thermal pain.  Both NT and NTS2 agonists, levocabastine and JMV-431, induced dose-dependent antinociceptive responses in the tail-flick test.  The effects of levocabastine and of JMV-431 were unaffected by coadministration of the NTS1-specific antagonist SR 48692, confirming that they were NTS2 mediated.  In contrast, the antinociceptive effects of NT were partly abolished by coadministration of SR 48692, indicating that NTS1 and NTS2 receptors were both involved.  These results suggest that NTS2 receptors play a role in the regulation of spinal nociceptive inputs and that selective NTS2 agonists may offer new avenues for the treatment of acute pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFtoMm6lyDKrVg90H21EOLACvtfcHk0lh9fI8wfA5ugg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVaktL%252FK&md5=1cf6d25f21e5c86e87b14a40f219a9fd</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.0810-05.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.0810-05.2005%26sid%3Dliteratum%253Aachs%26aulast%3DSarret%26aufirst%3DP.%26aulast%3DEsdaile%26aufirst%3DM.%2BJ.%26aulast%3DPerron%26aufirst%3DA.%26aulast%3DMartinez%26aufirst%3DJ.%26aulast%3DStroh%26aufirst%3DT.%26aulast%3DBeaudet%26aufirst%3DA.%26atitle%3DPotent%2520Spinal%2520Analgesia%2520Elicited%2520through%2520Stimulation%2520of%2520Nts2%2520Neurotensin%2520Receptors%26jtitle%3DJ.%2520Neurosci.%26date%3D2005%26volume%3D25%26spage%3D8188%26epage%3D8196%26doi%3D10.1523%2FJNEUROSCI.0810-05.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vivancos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giddings, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiethe, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warner, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murza, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besserer-Offroy, É.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Longpré, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Runyon, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decker, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilmour, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarret, P.</span></span> <span> </span><span class="NLM_article-title">Identification of 2-({[1-(4-Fluorophenyl)-5-(2-Methoxyphenyl)-1h-Pyrazol-3-Yl]Carbonyl}Amino)Tricyc Lo[3.3.1.13,7]Decane-2-Carboxylic Acid (Ntrc-844) as a Selective Antagonist for the Rat Neurotensin Receptor Type 2</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1225</span>– <span class="NLM_lpage">1231</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.6b00097</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.6b00097" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVyitrfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=1225-1231&author=J.+B.+Thomasauthor=M.+Vivancosauthor=A.+M.+Giddingsauthor=R.+W.+Wietheauthor=K.+R.+Warnerauthor=A.+Murzaauthor=%C3%89.+Besserer-Offroyauthor=J.-M.+Longpr%C3%A9author=S.+P.+Runyonauthor=A.+M.+Deckerauthor=B.+P.+Gilmourauthor=P.+Sarret&title=Identification+of+2-%28%7B%5B1-%284-Fluorophenyl%29-5-%282-Methoxyphenyl%29-1h-Pyrazol-3-Yl%5DCarbonyl%7DAmino%29Tricyc+Lo%5B3.3.1.13%2C7%5DDecane-2-Carboxylic+Acid+%28Ntrc-844%29+as+a+Selective+Antagonist+for+the+Rat+Neurotensin+Receptor+Type+2&doi=10.1021%2Facschemneuro.6b00097"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of 2-({[1-(4-Fluorophenyl)-5-(2-methoxyphenyl)-1H-pyrazol-3-yl]carbonyl}amino)tricyclo[3.3.1.13,7]decane-2-carboxylic Acid (NTRC-844) as a Selective Antagonist for the Rat Neurotensin Receptor Type 2</span></div><div class="casAuthors">Thomas, James B.; Vivancos, Melanie; Giddings, Angela M.; Wiethe, Robert W.; Warner, Keith R.; Murza, Alexandre; Besserer-Offroy, Elie; Longpre, Jean-Michel; Runyon, Scott P.; Decker, Ann M.; Gilmour, Brian P.; Sarret, Philippe</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1225-1231</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Neurotensin receptor type 2 (NTS2) compds. display analgesic activity in animal pain models.  We have identified the first high-affinity NTS2-selective antagonist (8) that is active in vivo.  This study also revealed that the NTS2 FLIPR assay designation for a compd., agonist, partial agonist, and so forth, did not correlate with its in vivo activity as obsd. in the thermal tail-flick acute model of pain.  This suggests that calcium mobilization is not the signaling pathway involved in NTS2-mediated analgesia as assessed by the thermal tail-flick model.  Finally, we found a significant bias between rat and human for compd. 9 in the NTS2 binding assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmiVSjAuzSlbVg90H21EOLACvtfcHk0lijGVd0Vxqkug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVyitrfP&md5=f2e3c54fc60f9a905588d16ba7381323</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.6b00097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.6b00097%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DJ.%2BB.%26aulast%3DVivancos%26aufirst%3DM.%26aulast%3DGiddings%26aufirst%3DA.%2BM.%26aulast%3DWiethe%26aufirst%3DR.%2BW.%26aulast%3DWarner%26aufirst%3DK.%2BR.%26aulast%3DMurza%26aufirst%3DA.%26aulast%3DBesserer-Offroy%26aufirst%3D%25C3%2589.%26aulast%3DLongpr%25C3%25A9%26aufirst%3DJ.-M.%26aulast%3DRunyon%26aufirst%3DS.%2BP.%26aulast%3DDecker%26aufirst%3DA.%2BM.%26aulast%3DGilmour%26aufirst%3DB.%2BP.%26aulast%3DSarret%26aufirst%3DP.%26atitle%3DIdentification%2520of%25202-%2528%257B%255B1-%25284-Fluorophenyl%2529-5-%25282-Methoxyphenyl%2529-1h-Pyrazol-3-Yl%255DCarbonyl%257DAmino%2529Tricyc%2520Lo%255B3.3.1.13%252C7%255DDecane-2-Carboxylic%2520Acid%2520%2528Ntrc-844%2529%2520as%2520a%2520Selective%2520Antagonist%2520for%2520the%2520Rat%2520Neurotensin%2520Receptor%2520Type%25202%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2016%26volume%3D7%26spage%3D1225%26epage%3D1231%26doi%3D10.1021%2Facschemneuro.6b00097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coquerel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubuc, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitaegi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costentin, J.</span></span> <span> </span><span class="NLM_article-title">Potentiation by Thiorphan and Bestatin of the Naloxone-Insensitive Analgesic Effects of Neurotensin and Neuromedin N</span>. <i>Neurochem. Int.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">361</span>– <span class="NLM_lpage">366</span>, <span class="refDoi"> DOI: 10.1016/0197-0186(88)90175-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2F0197-0186%2888%2990175-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=20501239" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADyaL1cXktFOgsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1988&pages=361-366&author=A.+Coquerelauthor=I.+Dubucauthor=P.+Kitaegiauthor=J.+Costentin&title=Potentiation+by+Thiorphan+and+Bestatin+of+the+Naloxone-Insensitive+Analgesic+Effects+of+Neurotensin+and+Neuromedin+N&doi=10.1016%2F0197-0186%2888%2990175-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Potentiation by thiorphan and bestatin of the naloxone-insensitive analgesic effects of neurotensin and neuromedin N</span></div><div class="casAuthors">Coquerel, A.; Dubuc, I.; Kitabgi, P.; Costentin, J.</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemistry International</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">361-6</span>CODEN:
                <span class="NLM_cas:coden">NEUIDS</span>;
        ISSN:<span class="NLM_cas:issn">0197-0186</span>.
    </div><div class="casAbstract">Neurotensin induced antinociceptive activity as measured in a variety of nociceptive tests 10 and 30 min following intracerebroventricular (i.c.v.) injection in mice.  The lowest effective peptide doses were 25 ng in the writhing test, 25-50 ng in the tail-flick test, 50-100 ng in the hot-plate test, and 2000 ng in the tail elec. stimulation test.  The neurotensin-related hexapeptide neuromedin N also displayed antinociceptive properties but only in the writhing and tail-flick tests.  Furthermore, as compared to neurotensin, the neuromedin effects required higher doses.  The 50% EDs for neurotensin and neuromedin in the writhing test were 70 and 1070 ng, resp.  Sep. or combined injections of the endopeptidase 24.11 (enkephalinase) inhibitor thiorphan (10 μg) and the aminopeptidase inhibitor bestatin (50 μg) did not affect tail-flick latencies.  In contrast i.c.v. injection or thiorphan together with an ineffective dose of neurotensin (25 ng) resulted in an antinociceptive effect.  Bestatin did not modify tail-flick latencies in neurotensin-treated mice whether in the absence or presence of thiorphan.  On the contrary, each of these peptidase inhibitors promoted antinociceptive effects of subthreshold doses of neuromedin (1 μg) in the tail-flick test.  Maximal antinociception was obtained by combining both inhibitors, thus conferring antinociceptive effects to neuromedin doses that were as low as 10 ng.  Naloxone (0.5-2 mg/kg, s.c.) did not reduced the antinociceptive effects of combinations of neurotensin and thiorphan and of neuromedin, thiorphan, and bestatin.  Both neurotensin and neuromedin elicit analgesia in mice through an opiate-independent mechanism.  Furthermore, like enkephalin, neuromedin is readily degraded by brain endopeptidase 24.11 and bestatin sensitive aminopeptidase(s), whereas the resistance of neurotensin to aminopeptidase attack confers to this peptide a broader spectrum and longer duration of action than its congener neuromedin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvycSr-IkCzbVg90H21EOLACvtfcHk0lijGVd0Vxqkug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXktFOgsLg%253D&md5=b902afe03f7e7c6c75e9a485f9c67149</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1016%2F0197-0186%2888%2990175-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0197-0186%252888%252990175-1%26sid%3Dliteratum%253Aachs%26aulast%3DCoquerel%26aufirst%3DA.%26aulast%3DDubuc%26aufirst%3DI.%26aulast%3DKitaegi%26aufirst%3DP.%26aulast%3DCostentin%26aufirst%3DJ.%26atitle%3DPotentiation%2520by%2520Thiorphan%2520and%2520Bestatin%2520of%2520the%2520Naloxone-Insensitive%2520Analgesic%2520Effects%2520of%2520Neurotensin%2520and%2520Neuromedin%2520N%26jtitle%3DNeurochem.%2520Int.%26date%3D1988%26volume%3D12%26spage%3D361%26epage%3D366%26doi%3D10.1016%2F0197-0186%2888%2990175-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tjølsen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berge, O. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunskaar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosland, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hole, K.</span></span> <span> </span><span class="NLM_article-title">The Formalin Test: An Evaluation of the Method</span>. <i>Pain</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">5</span>– <span class="NLM_lpage">17</span>, <span class="refDoi"> DOI: 10.1016/0304-3959(92)90003-T</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2F0304-3959%2892%2990003-T" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1454405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A280%3ADyaK3s%252FoslSnsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1992&pages=5-17&author=A.+Tj%C3%B8lsenauthor=O.+G.+Bergeauthor=S.+Hunskaarauthor=J.+H.+Roslandauthor=K.+Hole&title=The+Formalin+Test%3A+An+Evaluation+of+the+Method&doi=10.1016%2F0304-3959%2892%2990003-T"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">The formalin test: an evaluation of the method</span></div><div class="casAuthors">Tjolsen Arne; Berge Odd-Geir; Hunskaar Steinar; Rosland Jan Henrik; Hole Kjell</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5-17</span>
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    </div><div class="casAbstract">The formalin test for nociception, which is predominantly used with rats and mice, involves moderate, continuous pain generated by injured tissue.  In this way it differs from most traditional tests of nociception which rely upon brief stimuli of threshold intensity.  In this article we describe the main features of the formalin test, including the characteristics of the stimulus and how changes in nociceptive behaviour may be measured and interpreted.  The response to formalin shows an early and a late phase.  The early phase seems to be caused predominantly by C-fibre activation due to the peripheral stimulus, while the late phase appears to be dependent on the combination of an inflammatory reaction in the peripheral tissue and functional changes in the dorsal horn of the spinal cord.  These functional changes seem to be initiated by the C-fibre barrage during the early phase.  In mice, the behavioural response in the late phase depends on the ambient temperature.  We argue that the peripheral tissue temperature as well as other factors influencing the peripheral inflammation may affect the response, possibly confounding the results obtained with the test.  Furthermore, we discuss the methods of recording the response and the value of observing more than one aspect of behaviour.  Scoring of several behavioural variables provides a means of assessing motor or sensorimotor function as possible causes for changes in behaviour.  In conclusion, the formalin test is a valuable addition to the battery of methods available to study nociception.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSEPstJUQcfvkEksK8CslK8fW6udTcc2eZPBrMKl_5JNrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3s%252FoslSnsA%253D%253D&md5=d56dc5eb88d109dd30d319dcf580c781</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1016%2F0304-3959%2892%2990003-T&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0304-3959%252892%252990003-T%26sid%3Dliteratum%253Aachs%26aulast%3DTj%25C3%25B8lsen%26aufirst%3DA.%26aulast%3DBerge%26aufirst%3DO.%2BG.%26aulast%3DHunskaar%26aufirst%3DS.%26aulast%3DRosland%26aufirst%3DJ.%2BH.%26aulast%3DHole%26aufirst%3DK.%26atitle%3DThe%2520Formalin%2520Test%253A%2520An%2520Evaluation%2520of%2520the%2520Method%26jtitle%3DPain%26date%3D1992%26volume%3D51%26spage%3D5%26epage%3D17%26doi%3D10.1016%2F0304-3959%2892%2990003-T" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roussy, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dansereau, M.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baudisson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ezzoubaa, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belleville, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaudet, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richelson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarret, P.</span></span> <span> </span><span class="NLM_article-title">Evidence for a Role of Nts2 Receptors in the Modulation of Tonic Pain Sensitivity</span>. <i>Mol. Pain</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1744-8069-5-38</span>, <span class="refDoi"> DOI: 10.1186/1744-8069-5-38</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1186%2F1744-8069-5-38" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=1744-8069-5-38&author=G.+Roussyauthor=M.-A.+Dansereauauthor=S.+Baudissonauthor=F.+Ezzoubaaauthor=K.+Bellevilleauthor=N.+Beaudetauthor=J.+Martinezauthor=E.+Richelsonauthor=P.+Sarret&title=Evidence+for+a+Role+of+Nts2+Receptors+in+the+Modulation+of+Tonic+Pain+Sensitivity&doi=10.1186%2F1744-8069-5-38"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1186%2F1744-8069-5-38&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1744-8069-5-38%26sid%3Dliteratum%253Aachs%26aulast%3DRoussy%26aufirst%3DG.%26aulast%3DDansereau%26aufirst%3DM.-A.%26aulast%3DBaudisson%26aufirst%3DS.%26aulast%3DEzzoubaa%26aufirst%3DF.%26aulast%3DBelleville%26aufirst%3DK.%26aulast%3DBeaudet%26aufirst%3DN.%26aulast%3DMartinez%26aufirst%3DJ.%26aulast%3DRichelson%26aufirst%3DE.%26aulast%3DSarret%26aufirst%3DP.%26atitle%3DEvidence%2520for%2520a%2520Role%2520of%2520Nts2%2520Receptors%2520in%2520the%2520Modulation%2520of%2520Tonic%2520Pain%2520Sensitivity%26jtitle%3DMol.%2520Pain%26date%3D2009%26volume%3D5%26spage%3D1744-8069-5-38%26doi%3D10.1186%2F1744-8069-5-38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brouillette, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besserer-Offroy, É.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mona, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chartier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavenus, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sousbie, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belleville, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Longpré, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsault, É.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grandbois, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarret, P.</span></span> <span> </span><span class="NLM_article-title">Cell-Penetrating Pepducins Targeting the Neurotensin Receptor Type 1 Relieve Pain</span>. <i>Pharmacol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>155</i></span>,  <span class="NLM_fpage">104750</span>, <span class="refDoi"> DOI: 10.1016/j.phrs.2020.104750</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2Fj.phrs.2020.104750" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=32151680" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BB3cXlsFaqtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=155&publication_year=2020&pages=104750&author=R.+L.+Brouilletteauthor=%C3%89.+Besserer-Offroyauthor=C.+E.+Monaauthor=M.+Chartierauthor=S.+Lavenusauthor=M.+Sousbieauthor=K.+Bellevilleauthor=J.+M.+Longpr%C3%A9author=%C3%89.+Marsaultauthor=M.+Grandboisauthor=P.+Sarret&title=Cell-Penetrating+Pepducins+Targeting+the+Neurotensin+Receptor+Type+1+Relieve+Pain&doi=10.1016%2Fj.phrs.2020.104750"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Cell-penetrating pepducins targeting the neurotensin receptor type 1 relieve pain</span></div><div class="casAuthors">Brouillette, Rebecca L.; Besserer-Offroy, Elie; Mona, Christine E.; Chartier, Magali; Lavenus, Sandrine; Sousbie, Marc; Belleville, Karine; Longpre, Jean-Michel; Marsault, Eric; Grandbois, Michel; Sarret, Philippe</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">155</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">104750</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Pepducins are cell-penetrating, membrane-tethered lipopeptides designed to target the intracellular region of a G protein-coupled receptor (GPCR) in order to allosterically modulate the receptor's signaling output.  In this proof-of-concept study, we explored the pain-relief potential of a pepducin series derived from the first intracellular loop of neurotensin receptor type 1 (NTS1), a class A GPCR that mediates many of the effects of the neurotensin (NT) tridecapeptide, including hypothermia, hypotension and analgesia.  We used BRET-based biosensors to det. the pepducins' ability to engage G protein signaling pathways assocd. with NTS1 activation.  We obsd. partial Gαq and Gα13 activation at a 10 μM concn., indicating that these pepducins may act as allosteric agonists of NTS1.  Addnl., we used surface plasmon resonance (SPR) as a label-free assay to monitor pepducin-induced responses in CHO-K1 cells stably expressing hNTS1.  This whole-cell integrated assay enabled us to subdivide our pepducin series into three profile response groups.  In order to det. the pepducins' antinociceptive potential, we then screened the series in an acute pain model (tail-flick test) by measuring tail withdrawal latencies to a thermal nociceptive stimulus, following intrathecal (i.t.) pepducin administration (275 nmol/kg).  We further evaluated promising pepducins in a tonic pain model (formalin test), as well as in neuropathic (Chronic Constriction Injury) and inflammatory (Complete Freund's Adjuvant) chronic pain models.  We report one pepducin, PP-001, that consistently reduced rat nociceptive behaviors, even in chronic pain paradigms.  Finally, we designed a TAMRA-tagged version of PP-001 and found by confocal microscopy that the pepducin reached the rat dorsal root ganglia post i.t. injection, thus potentially modulating the activity of NTS1 at this location to produce its analgesic effect.  Altogether, these results suggest that NTS1-derived pepducins may represent a promising strategy in pain-relief.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquiZ7ZgL1QoLVg90H21EOLACvtfcHk0lifNNHfvIdX8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXlsFaqtbw%253D&md5=7ac6b5b2c35737f185a963e75c882af1</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2020.104750&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2020.104750%26sid%3Dliteratum%253Aachs%26aulast%3DBrouillette%26aufirst%3DR.%2BL.%26aulast%3DBesserer-Offroy%26aufirst%3D%25C3%2589.%26aulast%3DMona%26aufirst%3DC.%2BE.%26aulast%3DChartier%26aufirst%3DM.%26aulast%3DLavenus%26aufirst%3DS.%26aulast%3DSousbie%26aufirst%3DM.%26aulast%3DBelleville%26aufirst%3DK.%26aulast%3DLongpr%25C3%25A9%26aufirst%3DJ.%2BM.%26aulast%3DMarsault%26aufirst%3D%25C3%2589.%26aulast%3DGrandbois%26aufirst%3DM.%26aulast%3DSarret%26aufirst%3DP.%26atitle%3DCell-Penetrating%2520Pepducins%2520Targeting%2520the%2520Neurotensin%2520Receptor%2520Type%25201%2520Relieve%2520Pain%26jtitle%3DPharmacol.%2520Res.%26date%3D2020%26volume%3D155%26spage%3D104750%26doi%3D10.1016%2Fj.phrs.2020.104750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roussy, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dansereau, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doré-Savard, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belleville, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaudet, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richelson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarret, P.</span></span> <span> </span><span class="NLM_article-title">Spinal Nts1 Receptors Regulate Nociceptive Signaling in a Rat Formalin Tonic Pain Model</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">1100</span>– <span class="NLM_lpage">1114</span>, <span class="refDoi"> DOI: 10.1111/j.1471-4159.2007.05205.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1111%2Fj.1471-4159.2007.05205.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=18182046" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmsVOlsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=1100-1114&author=G.+Roussyauthor=M.+A.+Dansereauauthor=L.+Dor%C3%A9-Savardauthor=K.+Bellevilleauthor=N.+Beaudetauthor=E.+Richelsonauthor=P.+Sarret&title=Spinal+Nts1+Receptors+Regulate+Nociceptive+Signaling+in+a+Rat+Formalin+Tonic+Pain+Model&doi=10.1111%2Fj.1471-4159.2007.05205.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Spinal NTS1 receptors regulate nociceptive signaling in a rat formalin tonic pain model</span></div><div class="casAuthors">Roussy, Genevieve; Dansereau, Marc-Andre; Dore-Savard, Louis; Belleville, Karine; Beaudet, Nicolas; Richelson, Elliott; Sarret, Philippe</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1100-1114</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Central administration of the neuropeptide neurotensin (NT) was shown to induce antinociceptive responses both spinally and supraspinally.  Although NTS2 receptors play an important role in modulating the activity of spinal neurons, we have recently implicated NTS1 receptors in NT's analgesic effects in acute spinal pain paradigms.  The current expts. were thus designed to examine the antinociceptive effects of intrathecal administration of NTS1 agonists in formalin-induced tonic pain in rats.  We first established, using immunoblotting and immunohistochem. approaches, that NTS1 receptors were present in small- and medium-sized dorsal root ganglion cells and localized in the superficial layers of the dorsal horn of the spinal cord.  We then examd. the effects of intrathecal injection of NT (1-15 μg/kg) or NTS1 preferring agonists on the nocifensive response to intraplantar formalin.  Both NTS1-agonists, PD149163 (10-120 μg/kg) and NT69L (1-100 μg/kg), dose-dependently attenuated the formalin-induced behaviors.  Accordingly, NTS1 agonists markedly suppressed pain-evoked c-fos expression in the superficial, nucleus proprius and neck regions of the spinal dorsal horn.  The concomitant administration of PD149163 with the NTS1 antagonist SR48692 (3 μg/kg) significantly reversed PD149163-induced antinociception, confirming the implication of NTS1 in tonic pain.  In contrast, NT69L's analgesic effects were partly abolished by co-administration of SR48692, indicating that NT69L-induced effects may also be exerted through interaction with NTS2.  These results demonstrate that NTS1 receptors play a key role in the mediation of the analgesic effects of NT in persistent pain and suggest that NTS1-selective agonists may represent a new line of analgesic compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrD9lHFE_J6YLVg90H21EOLACvtfcHk0lgkcUmV2hUbWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmsVOlsrk%253D&md5=f1b36a2cb157800ef7b98f628517c73c</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2007.05205.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2007.05205.x%26sid%3Dliteratum%253Aachs%26aulast%3DRoussy%26aufirst%3DG.%26aulast%3DDansereau%26aufirst%3DM.%2BA.%26aulast%3DDor%25C3%25A9-Savard%26aufirst%3DL.%26aulast%3DBelleville%26aufirst%3DK.%26aulast%3DBeaudet%26aufirst%3DN.%26aulast%3DRichelson%26aufirst%3DE.%26aulast%3DSarret%26aufirst%3DP.%26atitle%3DSpinal%2520Nts1%2520Receptors%2520Regulate%2520Nociceptive%2520Signaling%2520in%2520a%2520Rat%2520Formalin%2520Tonic%2520Pain%2520Model%26jtitle%3DJ.%2520Neurochem.%26date%3D2008%26volume%3D105%26spage%3D1100%26epage%3D1114%26doi%3D10.1111%2Fj.1471-4159.2007.05205.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Williams, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heavner, J. E.</span></span> <span> </span><span class="NLM_article-title">Ziconotide: An Update and Review</span>. <i>Expert Opin. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1575</span>– <span class="NLM_lpage">1583</span>, <span class="refDoi"> DOI: 10.1517/14656566.9.9.1575</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1517%2F14656566.9.9.1575" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=18518786" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BD1cXms1Wlu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=1575-1583&author=J.+A.+Williamsauthor=M.+Dayauthor=J.+E.+Heavner&title=Ziconotide%3A+An+Update+and+Review&doi=10.1517%2F14656566.9.9.1575"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Ziconotide: an update and review</span></div><div class="casAuthors">Williams, Jason A.; Day, Miles; Heavner, James E.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Pharmacotherapy</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1575-1583</span>CODEN:
                <span class="NLM_cas:coden">EOPHF7</span>;
        ISSN:<span class="NLM_cas:issn">1465-6566</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Background: Ziconotide is the only N-type calcium channel blocker approved by the US FDA for the treatment of chronic pain.  The approved indication is for the management of severe chronic pain in patients for whom intrathecal therapy is warranted and who are intolerant of or refractory to other treatments such as systemic analgesics, adjunctive therapies or intrathecal morphine.  Objective: The purpose of this article was to review the available safety, efficacy and dosing information for ziconotide.  Methods: The sources searched for literature from 1980 to Jan. 2008 included Pub Med, MEDLINE and PREMEDLINE using the words ziconotide, conotoxins and pain.  Results/conclusion: Ziconotide is administered intrathecally by infusion pump to block nociceptive signal transmission in the spinal cord.  It is a synthetic neuroactive peptide equiv. to the omega conotoxin MVIIA, a constituent of the venom of the fish-hunting marine snail Conus magus.  It is highly potent, has a steep dose-response curve, a slow onset of action and a narrow margin of safety and responses to dose adjustments are slow.  Patients receiving ziconotide should be under the care of physicians experienced in the management of intrathecal infusion therapy for pain control and should have convenient access to medical facilities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6JGTrlDxukbVg90H21EOLACvtfcHk0lgkcUmV2hUbWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXms1Wlu78%253D&md5=9b652d1492d000acfb2db5aff1039ae5</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1517%2F14656566.9.9.1575&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14656566.9.9.1575%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DJ.%2BA.%26aulast%3DDay%26aufirst%3DM.%26aulast%3DHeavner%26aufirst%3DJ.%2BE.%26atitle%3DZiconotide%253A%2520An%2520Update%2520and%2520Review%26jtitle%3DExpert%2520Opin.%2520Pharmacother.%26date%3D2008%26volume%3D9%26spage%3D1575%26epage%3D1583%26doi%3D10.1517%2F14656566.9.9.1575" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deer, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pope, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanes, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDowell, G. C.</span></span> <span> </span><span class="NLM_article-title">Intrathecal Therapy for Chronic Pain: A Review of Morphine and Ziconotide as Firstline Options</span>. <i>Pain Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">784</span>– <span class="NLM_lpage">798</span>, <span class="refDoi"> DOI: 10.1093/pm/pny132</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1093%2Fpm%2Fpny132" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=30137539" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A280%3ADC%252BB3c3htVOgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2019&pages=784-798&author=T.+R.+Deerauthor=J.+E.+Popeauthor=M.+C.+Hanesauthor=G.+C.+McDowell&title=Intrathecal+Therapy+for+Chronic+Pain%3A+A+Review+of+Morphine+and+Ziconotide+as+Firstline+Options&doi=10.1093%2Fpm%2Fpny132"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Intrathecal Therapy for Chronic Pain: A Review of Morphine and Ziconotide as Firstline Options</span></div><div class="casAuthors">Deer Timothy R; Pope Jason E; Hanes Michael C; McDowell Gladstone C</div><div class="citationInfo"><span class="NLM_cas:title">Pain medicine (Malden, Mass.)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">784-798</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVES:  To evaluate the evidence for morphine and ziconotide as firstline intrathecal (IT) analgesia agents for patients with chronic pain.  METHODS:  Medline was searched (through July 2017) for "ziconotide" or "morphine" AND "intrathecal" AND "chronic pain," with results limited to studies in human populations.  RESULTS:  The literature supports the use of morphine (based primarily on noncontrolled, prospective, and retrospective studies) and ziconotide (based on randomized controlled trials and prospective observational studies) as first-choice IT therapies.  The 2016 Polyanalgesic Consensus Conference (PACC) guidelines recommended both morphine and ziconotide as firstline IT monotherapy for localized and diffuse chronic pain of cancer-related and non-cancer-related etiologies; however, one consensus point emphasized ziconotide use, unless contraindicated, as firstline IT therapy in patients with chronic non-cancer-related pain.  Initial IT therapy choice should take into consideration individual patient characteristics (e.g., pain location, response to previous therapies, comorbid medical conditions, psychiatric history).  Trialing is recommended to assess medication efficacy and tolerability.  For both morphine and ziconotide, the PACC guidelines recommend conservative initial dosing strategies.  Due to its narrow therapeutic window, ziconotide requires careful dose titration.  Ziconotide is contraindicated in patients with a history of psychosis.  IT morphine administration may be associated with serious side effects (e.g., respiratory depression, catheter tip granuloma), require dose increases, and cause dependence over time.  CONCLUSION:  Based on the available evidence, morphine and ziconotide are recommended as firstline IT monotherapy for cancer-related and non-cancer-related pain.  The choice of first-in-pump therapy should take into consideration patient characteristics and the advantages and disadvantages of each medication.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQSR0OHYEK4ucuCWE5mhx1RfW6udTcc2eb9BwYD5LFbMLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c3htVOgtw%253D%253D&md5=79f97446d9bd1b18da18549d58ac9466</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1093%2Fpm%2Fpny132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fpm%252Fpny132%26sid%3Dliteratum%253Aachs%26aulast%3DDeer%26aufirst%3DT.%2BR.%26aulast%3DPope%26aufirst%3DJ.%2BE.%26aulast%3DHanes%26aufirst%3DM.%2BC.%26aulast%3DMcDowell%26aufirst%3DG.%2BC.%26atitle%3DIntrathecal%2520Therapy%2520for%2520Chronic%2520Pain%253A%2520A%2520Review%2520of%2520Morphine%2520and%2520Ziconotide%2520as%2520Firstline%2520Options%26jtitle%3DPain%2520Med.%26date%3D2019%26volume%3D20%26spage%3D784%26epage%3D798%26doi%3D10.1093%2Fpm%2Fpny132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Báckryd, E.</span></span> <span> </span><span class="NLM_article-title">Do the Potential Benefits Outweigh the Risks? An Update on the Use of Ziconotide in Clinical Practice</span>. <i>Eur. J. Pain</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1193</span>– <span class="NLM_lpage">1202</span>, <span class="refDoi"> DOI: 10.1002/ejp.1229</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1002%2Fejp.1229" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=29635804" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A280%3ADC%252BC1MjgslCqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2018&pages=1193-1202&author=E.+B%C3%A1ckryd&title=Do+the+Potential+Benefits+Outweigh+the+Risks%3F+An+Update+on+the+Use+of+Ziconotide+in+Clinical+Practice&doi=10.1002%2Fejp.1229"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Do the potential benefits outweigh the risks? An update on the use of ziconotide in clinical practice</span></div><div class="casAuthors">Backryd E</div><div class="citationInfo"><span class="NLM_cas:title">European journal of pain (London, England)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1193-1202</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Ziconotide is a selective and potent blocker of N-type voltage-gated calcium channels.  It was approved by the Food and Drug Administration in 2004 and by the European Medicines Agency in 2005 for the treatment of severe chronic pain in patients needing intrathecal analgesia (ITA).  The aim of this paper is to provide a practitioner-oriented, educational, narrative, up-to-date review on the use of ziconotide in clinical pain medicine.  Of special concern regarding safety is the partial incongruity between dosing statements in the Summary of Product Characteristics and novel low-dosage, slow uptitration recommendations.  Even though ziconotide has obvious advantages compared to opioids, pain practitioners pondering the use of ziconotide nonetheless have to balance its proved potential analgesic effect against its neurological side effects, with special consideration being given to dosing and neuropsychiatric dangers.  Using a seesaw analogy, the paper discusses what factors pain physicians should weigh in when considering ziconotide as ITA drug, the non-opioid advantages of ziconotide being counterbalanced by its potential psychiatric side effects.  Ziconotide is an important part of the armamentarium of modern interventional pain medicine.  If ITA is deemed necessary, ziconotide is a rational alternative, at least in chronic (neuropathic) non-cancer pain.  However, in many European countries, ziconotide treatment is only available in a few (if any) centres.  The safety profile of ziconotide is not fundamentally more worrying than that of opioids or cannabinoids; it is just different.  This paper provides a concise, up-to-date and clinically-oriented summary of the use of ziconotide in clinical practice, not least concerning safety and dosage issues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTsBIVt11XjsUh5eUSa2oe_fW6udTcc2eb9BwYD5LFbMLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MjgslCqsQ%253D%253D&md5=4b2cb469a3048d1de7021b44619409aa</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1002%2Fejp.1229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fejp.1229%26sid%3Dliteratum%253Aachs%26aulast%3DB%25C3%25A1ckryd%26aufirst%3DE.%26atitle%3DDo%2520the%2520Potential%2520Benefits%2520Outweigh%2520the%2520Risks%253F%2520An%2520Update%2520on%2520the%2520Use%2520of%2520Ziconotide%2520in%2520Clinical%2520Practice%26jtitle%3DEur.%2520J.%2520Pain%26date%3D2018%26volume%3D22%26spage%3D1193%26epage%3D1202%26doi%3D10.1002%2Fejp.1229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schmidtko, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lótsch, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freynhagen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geisslinger, G.</span></span> <span> </span><span class="NLM_article-title">Ziconotide for Treatment of Severe Chronic Pain</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>375</i></span>,  <span class="NLM_fpage">1569</span>– <span class="NLM_lpage">1577</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(10)60354-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2FS0140-6736%2810%2960354-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=20413151" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsVOnt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=375&publication_year=2010&pages=1569-1577&author=A.+Schmidtkoauthor=J.+L%C3%B3tschauthor=R.+Freynhagenauthor=G.+Geisslinger&title=Ziconotide+for+Treatment+of+Severe+Chronic+Pain&doi=10.1016%2FS0140-6736%2810%2960354-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Ziconotide for treatment of severe chronic pain</span></div><div class="casAuthors">Schmidtko, Achim; Loetsch, Joern; Freynhagen, Rainer; Geisslinger, Gerd</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">375</span>
        (<span class="NLM_cas:issue">9725</span>),
    <span class="NLM_cas:pages">1569-1577</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Summary: Pharmacol. management of severe chronic pain is difficult to achieve with currently available analgesic drugs, and remains a large unmet therapeutic need.  The synthetic peptide ziconotide has been approved by the US Food and Drug Administration and the European Medicines Agency for intrathecal treatment of patients with severe chronic pain that is refractory to other treatment modalities.  Ziconotide is the first member in the new drug class of selective N-type voltage-sensitive calcium-channel blockers.  The ziconotide-induced blockade of N-type calcium channels in the spinal cord inhibits release of pain-relevant neurotransmitters from central terminals of primary afferent neurons.  By this mechanism, ziconotide can effectively reduce pain.  However, ziconotide has a narrow therapeutic window because of substantial CNS side-effects, and thus treatment with ziconotide is appropriate for only a small subset of patients with severe chronic pain.  We provide an overview of the benefits and limitations of intrathecal ziconotide treatment and review potential future developments in this new drug class.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpp8ap2seTMHbVg90H21EOLACvtfcHk0ljSga5r6F4akg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsVOnt7w%253D&md5=3823cf9b9116bb02f898a3bf01848dc2</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2810%2960354-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252810%252960354-6%26sid%3Dliteratum%253Aachs%26aulast%3DSchmidtko%26aufirst%3DA.%26aulast%3DL%25C3%25B3tsch%26aufirst%3DJ.%26aulast%3DFreynhagen%26aufirst%3DR.%26aulast%3DGeisslinger%26aufirst%3DG.%26atitle%3DZiconotide%2520for%2520Treatment%2520of%2520Severe%2520Chronic%2520Pain%26jtitle%3DLancet%26date%3D2010%26volume%3D375%26spage%3D1569%26epage%3D1577%26doi%3D10.1016%2FS0140-6736%2810%2960354-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Skov, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Kater, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shopp, G. M.</span></span> <span> </span><span class="NLM_article-title">Nonclinical Safety of Ziconotide: An Intrathecal Analgesic of a New Pharmaceutical Class</span>. <i>Int. J. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">411</span>– <span class="NLM_lpage">421</span>, <span class="refDoi"> DOI: 10.1080/10915810701582970</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1080%2F10915810701582970" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=17963128" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1WgsbzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=411-421&author=M.+J.+Skovauthor=J.+C.+Beckauthor=A.+W.+de+Katerauthor=G.+M.+Shopp&title=Nonclinical+Safety+of+Ziconotide%3A+An+Intrathecal+Analgesic+of+a+New+Pharmaceutical+Class&doi=10.1080%2F10915810701582970"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Nonclinical Safety of Ziconotide: An Intrathecal Analgesic of a New Pharmaceutical Class</span></div><div class="casAuthors">Skov, Michael J.; Beck, James C.; de Kater, Annelies W.; Shopp, George M.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Toxicology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">411-421</span>CODEN:
                <span class="NLM_cas:coden">IJTOFN</span>;
        ISSN:<span class="NLM_cas:issn">1091-5818</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Ziconotide, a potent, selective, reversible blocker of neuronal N-type voltage-sensitive calcium channels, is approved in the United States for the management of severe chronic pain in patients for whom intrathecal therapy is warranted, and who are intolerant or refractory to other treatment, such as systemic analgesics, adjunctive therapies, or intrathecal morphine.  In the European Union, ziconotide is indicated for the treatment of severe chronic pain in patients who require intrathecal analgesia.  Nonclin. investigations of ziconotide included a comprehensive characterization of its toxicol., incorporating acute and subchronic toxicity studies in rats, dogs, and monkeys; reproductive toxicity assessments in rats and rabbits; and mutagenic, carcinogenic evaluations performed in vivo and in vitro.  Addnl. investigations assessed the potential for cardiotoxicity (rats) and immunogenicity (mice, rats, and guinea pigs), and the presence or absence of intraspinal granuloma formation and local cell proliferation and apoptosis (dogs).  The resulting nonclin. toxicol. profile was predictive of human adverse events reported in clin. trials and consistent with ziconotide's pharmacol. activity.  Frequently obsd. nonclin. behavioral effects included tremoring, shaking, ataxia, and hyperreactivity.  Occurrences were generally transient and reversible upon cessation of treatment, and intolerable effects occurred at doses more than 45 times the max. recommended clin. dose.  Ziconotide was not assocd. with target organ toxicity, teratogenicity, or treatment-related gross or histopathol. changes; it displayed no mutagenic or carcinogenic potential and no propensity to induce local cell proliferation or apoptosis.  Although guinea pigs developed systemic anaphylaxis, antibodies to ziconotide were not detected in mice, rats, or guinea pigs, indicating low immunogenic potential.  No evidence of granuloma formation was obsd. with intrathecal ziconotide treatment.  In summary, the results from these nonclin. safety assessments revealed no significant toxicol. risk to humans treated with ziconotide as recommended.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDNVHfZdQEOrVg90H21EOLACvtfcHk0ljSga5r6F4akg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1WgsbzJ&md5=b5bb75d3d2a25226350003b18437c009</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1080%2F10915810701582970&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10915810701582970%26sid%3Dliteratum%253Aachs%26aulast%3DSkov%26aufirst%3DM.%2BJ.%26aulast%3DBeck%26aufirst%3DJ.%2BC.%26aulast%3Dde%2BKater%26aufirst%3DA.%2BW.%26aulast%3DShopp%26aufirst%3DG.%2BM.%26atitle%3DNonclinical%2520Safety%2520of%2520Ziconotide%253A%2520An%2520Intrathecal%2520Analgesic%2520of%2520a%2520New%2520Pharmaceutical%2520Class%26jtitle%3DInt.%2520J.%2520Toxicol.%26date%3D2007%26volume%3D26%26spage%3D411%26epage%3D421%26doi%3D10.1080%2F10915810701582970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grajny, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durphy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adam, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azher, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molho, E.</span></span> <span> </span><span class="NLM_article-title">Ziconotide-Induced Oro-Lingual Dyskinesia: 3 Cases</span>. <i>Tremor Other Hyperkinet Mov (N Y)</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">37</span>, <span class="refDoi"> DOI: 10.5334/tohm.431</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.5334%2Ftohm.431" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=33101763" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A280%3ADC%252BB3s7lvFKktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2020&pages=37&author=K.+Grajnyauthor=J.+Durphyauthor=O.+Adamauthor=S.+Azherauthor=M.+Guptaauthor=E.+Molho&title=Ziconotide-Induced+Oro-Lingual+Dyskinesia%3A+3+Cases&doi=10.5334%2Ftohm.431"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Ziconotide-Induced Oro-lingual Dyskinesia: 3 Cases</span></div><div class="casAuthors">Grajny Kristopher; Durphy Jennifer; Adam Octavian; Azher Sharmeen; Gupta Megan; Molho Eric</div><div class="citationInfo"><span class="NLM_cas:title">Tremor and other hyperkinetic movements (New York, N.Y.)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">37</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Background:  Ziconotide (ZCN), a nonopioid analgesic, is first-line intrathecal therapy for patients with severe chronic pain refractory to other management options.  We describe three cases of ZCN-induced movement disorders.  Cases:  Case one is a 64-year-old woman who presented with oro-lingual (OL) dyskinesia with dysesthesias and bilateral upper extremity kinetic tremor.  Case two is a 43-year-old man with a 20-month history of ZCN treatment who developed OL dyskinesia with dysesthesias, involuntary left hand and neck movements, hallucinations, dysesthesias on his feet, and gait imbalance.  Case three is a 70-year-old man with a 4-month history of ZCN use who developed OL dyskinesia with dysesthesias.  Conclusions:  Intrathecal treatment of pain with ZCN may be complicated by a drug-induced movement disorder where OL dyskinesia is characteristic.  The movement disorder is likely to be dose related and reversible with ZCN discontinuation, but a chronic movement disorder is also possible.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTh0aBYWtfA2rZpSb_XWfMrfW6udTcc2ebXhx9Af_Kzfrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3s7lvFKktg%253D%253D&md5=e9ddd3b117d39137143999a48e33cf8a</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.5334%2Ftohm.431&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5334%252Ftohm.431%26sid%3Dliteratum%253Aachs%26aulast%3DGrajny%26aufirst%3DK.%26aulast%3DDurphy%26aufirst%3DJ.%26aulast%3DAdam%26aufirst%3DO.%26aulast%3DAzher%26aufirst%3DS.%26aulast%3DGupta%26aufirst%3DM.%26aulast%3DMolho%26aufirst%3DE.%26atitle%3DZiconotide-Induced%2520Oro-Lingual%2520Dyskinesia%253A%25203%2520Cases%26jtitle%3DTremor%2520Other%2520Hyperkinet%2520Mov%2520%2528N%2520Y%2529%26date%3D2020%26volume%3D10%26spage%3D37%26doi%3D10.5334%2Ftohm.431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Remaury, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vita, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gendreau, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnone, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poncelet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Culouscou, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Fur, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soubrié, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caput, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shire, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kopf, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrara, P.</span></span> <span> </span><span class="NLM_article-title">Targeted Inactivation of the Neurotensin Type 1 Receptor Reveals Its Role in Body Temperature Control and Feeding Behavior but Not in Analgesia</span>. <i>Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>953</i></span>,  <span class="NLM_fpage">63</span>– <span class="NLM_lpage">72</span>, <span class="refDoi"> DOI: 10.1016/S0006-8993(02)03271-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2FS0006-8993%2802%2903271-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=12384239" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BD38XnvVOlurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=953&publication_year=2002&pages=63-72&author=A.+Remauryauthor=N.+Vitaauthor=S.+Gendreauauthor=M.+Jungauthor=M.+Arnoneauthor=M.+Ponceletauthor=J.-M.+Culouscouauthor=G.+Le+Furauthor=P.+Soubri%C3%A9author=D.+Caputauthor=D.+Shireauthor=M.+Kopfauthor=P.+Ferrara&title=Targeted+Inactivation+of+the+Neurotensin+Type+1+Receptor+Reveals+Its+Role+in+Body+Temperature+Control+and+Feeding+Behavior+but+Not+in+Analgesia&doi=10.1016%2FS0006-8993%2802%2903271-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted inactivation of the neurotensin type 1 receptor reveals its role in body temperature control and feeding behavior but not in analgesia</span></div><div class="casAuthors">Remaury, Anne; Vita, Natalio; Gendreau, Sylvain; Jung, Mireille; Arnone, Michelle; Poncelet, Martine; Culouscou, Jean-Michel; Le Fur, Gerard; Soubrie, Philippe; Caput, Daniel; Shire, David; Kopf, Manfred; Ferrara, Pascual</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">953</span>
        (<span class="NLM_cas:issue">1,2</span>),
    <span class="NLM_cas:pages">63-72</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Three subtypes of neurotensin receptor have been described, two members of the heptahelical transmembrane domain G protein-coupled receptor superfamily NT-1R and NT-2R, and NT-3R unrelated to this family.  The authors have generated NT-1R deficient (NT-1R-/-) mice.  NT-1R-/- mice were born at the expected Mendelian frequency without obvious abnormalities and they were fertile.  The NT-induced analgesia on the writhing induced by phenyl-p-benzoquinone administration remained at wild-type levels in the NT-1R-/- mice demonstrating that the NT-1R is not implicated in the analgesic effect of NT in this test.  The NT-1R-/- mice were hyperthermic; their body temp. was not affected by intracerebroventricular (i.c.v.) administration of NT, contrasting with the hypothermia induced in NT-1R+/+ mice.  NT-1R-/- mice showed a small significant increase in body wt. compared to the NT-1R+/+ congeners as early as 10 wk after birth, correlated with a higher food intake.  NT-1R-/- mice showed similar spontaneous locomotion to the control littermates, but did not respond to i.c.v. NT-induced hypolocomotion.  I.c.v. injection of NT inhibited feeding in fasted wild-type mice, but had no effect on feeding of the NT-1R-/- mice.  I.c.v. administration of the orexigenic neuropeptide Y (NPY) stimulated feeding to the same extent in both wild-type and NT-1R-/- mice.  This anal. of NT-1R-deficient mice shows that the NT-1R does not play a role in NT-induced analgesia, but that it is clearly implicated in thermal and feeding regulation, wt. control, and NT-induced hypolocomotion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMMGGac-nhAbVg90H21EOLACvtfcHk0liFK_ISiN1IAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnvVOlurk%253D&md5=e7421cbc6c3fecfa32ea90c14d144de8</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1016%2FS0006-8993%2802%2903271-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-8993%252802%252903271-7%26sid%3Dliteratum%253Aachs%26aulast%3DRemaury%26aufirst%3DA.%26aulast%3DVita%26aufirst%3DN.%26aulast%3DGendreau%26aufirst%3DS.%26aulast%3DJung%26aufirst%3DM.%26aulast%3DArnone%26aufirst%3DM.%26aulast%3DPoncelet%26aufirst%3DM.%26aulast%3DCulouscou%26aufirst%3DJ.-M.%26aulast%3DLe%2BFur%26aufirst%3DG.%26aulast%3DSoubri%25C3%25A9%26aufirst%3DP.%26aulast%3DCaput%26aufirst%3DD.%26aulast%3DShire%26aufirst%3DD.%26aulast%3DKopf%26aufirst%3DM.%26aulast%3DFerrara%26aufirst%3DP.%26atitle%3DTargeted%2520Inactivation%2520of%2520the%2520Neurotensin%2520Type%25201%2520Receptor%2520Reveals%2520Its%2520Role%2520in%2520Body%2520Temperature%2520Control%2520and%2520Feeding%2520Behavior%2520but%2520Not%2520in%2520Analgesia%26jtitle%3DBrain%2520Res.%26date%3D2002%26volume%3D953%26spage%3D63%26epage%3D72%26doi%3D10.1016%2FS0006-8993%2802%2903271-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pettibone, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hess, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hey, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leviten, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lis, E. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mallorga, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pascarella, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, Z.</span></span> <span> </span><span class="NLM_article-title">The Effects of Deleting the Mouse Neurotensin Receptor Ntr1 on Central and Peripheral Responses to Neurotensin</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>300</i></span>,  <span class="NLM_fpage">305</span>– <span class="NLM_lpage">313</span>, <span class="refDoi"> DOI: 10.1124/jpet.300.1.305</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1124%2Fjpet.300.1.305" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=11752130" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BD38Xht1WltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=300&publication_year=2002&pages=305-313&author=D.+J.+Pettiboneauthor=J.+F.+Hessauthor=P.+J.+Heyauthor=M.+A.+Jacobsonauthor=M.+Levitenauthor=E.+V.+Lisauthor=P.+J.+Mallorgaauthor=D.+M.+Pascarellaauthor=M.+A.+Snyderauthor=J.+B.+Williamsauthor=Z.+Zeng&title=The+Effects+of+Deleting+the+Mouse+Neurotensin+Receptor+Ntr1+on+Central+and+Peripheral+Responses+to+Neurotensin&doi=10.1124%2Fjpet.300.1.305"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">The effects of deleting the mouse neurotensin receptor NTR1 on central and peripheral responses to neurotensin</span></div><div class="casAuthors">Pettibone, Douglas J.; Hess, J. Fred; Hey, Patricia J.; Jacobson, Marlene A.; Leviten, Michael; Lis, Edward V.; Mallorga, Pierre J.; Pascarella, Danette M.; Snyder, Melissa A.; Williams, Jacinta B.; Zeng, Zhizhen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">300</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">305-313</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Mice deficient in the neurotensin (NT)-1 receptor (NTR1) were developed to characterize the NT receptor subtypes that mediate various in vivo responses to NT.  F2 generation (C57BL6/Sv129J) NTR1 knockout (-/-) mice were viable, and showed normal growth and overt behavior.  The -/- mice lacked detectable NTR1 radioligand binding in brain, whereas NTR2 receptor binding d. appeared normal compared with wildtype (+/+) mice.  The gene deletion also resulted in the loss of NTR1 expression as detd. by reverse transcription-polymerase chain reaction and in situ hybridization.  Intracerebroventricular injection of NT (1 μg) to +/+ mice caused a robust hypothermic response (5-6°) and a significant increase in hot-plate latency.  These effects were absent in the -/- mice.  Similar results were obtained with i.p. injections of the brain penetrant NT analog NMe-Arg-Lys-Pro-Trp-Tle-Leu (NT-2, 1 mg/kg i.p.).  NT-2 administration also impaired rotarod performance in wild-type mice, but had no effect on motor coordination in knockout mice.  In vitro, NT and NT-2 at 30 nM caused predominantly contraction and relaxation in isolated distal colon and proximal ileum, resp., from +/+ mice, but no responses were obsd. with tissues from -/- mice.  A similar loss of the contractile effects of NT was obsd. in the isolated stomach fundus from the knockout mice.  In vivo, NT-2 administration reduced colonic propulsion substantially in wild-type mice.  In contrast, NT-2 had no effect in NTR1 null mice, whereas the hypomotility effect of clonidine was intact.  These data indicate that NTR1 mediates several of the central and peripheral effects of NT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpj40U6-QwpfLVg90H21EOLACvtfcHk0lhqaAO93yqWZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xht1WltA%253D%253D&md5=50f7e8b5b7d9cc6a047cd29b04b2960b</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1124%2Fjpet.300.1.305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.300.1.305%26sid%3Dliteratum%253Aachs%26aulast%3DPettibone%26aufirst%3DD.%2BJ.%26aulast%3DHess%26aufirst%3DJ.%2BF.%26aulast%3DHey%26aufirst%3DP.%2BJ.%26aulast%3DJacobson%26aufirst%3DM.%2BA.%26aulast%3DLeviten%26aufirst%3DM.%26aulast%3DLis%26aufirst%3DE.%2BV.%26aulast%3DMallorga%26aufirst%3DP.%2BJ.%26aulast%3DPascarella%26aufirst%3DD.%2BM.%26aulast%3DSnyder%26aufirst%3DM.%2BA.%26aulast%3DWilliams%26aufirst%3DJ.%2BB.%26aulast%3DZeng%26aufirst%3DZ.%26atitle%3DThe%2520Effects%2520of%2520Deleting%2520the%2520Mouse%2520Neurotensin%2520Receptor%2520Ntr1%2520on%2520Central%2520and%2520Peripheral%2520Responses%2520to%2520Neurotensin%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2002%26volume%3D300%26spage%3D305%26epage%3D313%26doi%3D10.1124%2Fjpet.300.1.305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mechanic, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutton, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berson, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Button, D. C.</span></span> <span> </span><span class="NLM_article-title">Involvement of the Neurotensin Receptor 1 in the Behavioral Effects of Two Neurotensin Agonists, Nt-2 and Nt69l: Lack of Hypothermic, Antinociceptive and Antipsychotic Actions in Receptor Knockout Mice</span>. <i>Eur. Neuropsychopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">466</span>– <span class="NLM_lpage">475</span>, <span class="refDoi"> DOI: 10.1016/j.euroneuro.2009.01.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2Fj.euroneuro.2009.01.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=19223157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BD1MXms1Krtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=466-475&author=J.+A.+Mechanicauthor=J.+E.+Suttonauthor=A.+E.+Bersonauthor=X.+Wuauthor=J.+Kwanauthor=R.+Schreiberauthor=Z.+Pangauthor=D.+C.+Button&title=Involvement+of+the+Neurotensin+Receptor+1+in+the+Behavioral+Effects+of+Two+Neurotensin+Agonists%2C+Nt-2+and+Nt69l%3A+Lack+of+Hypothermic%2C+Antinociceptive+and+Antipsychotic+Actions+in+Receptor+Knockout+Mice&doi=10.1016%2Fj.euroneuro.2009.01.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Involvement of the neurotensin receptor 1 in the behavioral effects of two neurotensin agonists, NT-2 and NT69L: Lack of hypothermic, antinociceptive and antipsychotic actions in receptor knockout mice</span></div><div class="casAuthors">Mechanic, Jordan A.; Sutton, Janette E.; Berson, Amy E.; Wu, Xiaosu; Kwan, Joyce; Schreiber, Rudy; Pang, Zhen; Button, Donald C.</div><div class="citationInfo"><span class="NLM_cas:title">European Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">466-475</span>CODEN:
                <span class="NLM_cas:coden">EURNE8</span>;
        ISSN:<span class="NLM_cas:issn">0924-977X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Neurotensin (NT) is a neuropeptide implicated in the pathophysiol. of schizophrenia and in mediating the efficacy of antipsychotic drugs.  NT is also involved in the regulation of body temp. and pain sensitivity.  Using neurotensin receptor 1 (NTR1) knockout (KO) and wild-type (WT) mice, these studies evaluated the involvement of NTR1 in the behavioral responses produced by peripheral administration of NT agonists (NT-2 and NT69L).  Animals were characterized in paradigms designed to assess hypothermia, antinociception, and antipsychotic-like effects.  Under basal conditions, there were no phenotypic differences between NTR1 KO and WT mice.  In WT mice, both NTR1 agonists decreased core body temp. (active doses in mg/kg, i.p., for NT-2 and NT69L, resp.: 1 and 3), increased tail withdrawal latencies (1 and 3), produced decreased spontaneous climbing (0.1, 0.3, 1 and 1, 3, 10) and reversed apomorphine-induced climbing (0.3, 1 and 1, 3).  In contrast, none of the effects of either agonist were present in KO mice.  These results suggest that NTR1: (1) does not play a major role in the control of basal thermoregulation, nociception or psychomotor stimulation in mice (barring possible developmental plasticity), (2) does mediate these behavioral responses to NT agonists, and (3) may play a role in the potential antipsychotic effects of these agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8isUICE8pYrVg90H21EOLACvtfcHk0lhqaAO93yqWZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXms1Krtb8%253D&md5=df8eb4edc51d58652282de58c02466d5</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1016%2Fj.euroneuro.2009.01.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.euroneuro.2009.01.004%26sid%3Dliteratum%253Aachs%26aulast%3DMechanic%26aufirst%3DJ.%2BA.%26aulast%3DSutton%26aufirst%3DJ.%2BE.%26aulast%3DBerson%26aufirst%3DA.%2BE.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DKwan%26aufirst%3DJ.%26aulast%3DSchreiber%26aufirst%3DR.%26aulast%3DPang%26aufirst%3DZ.%26aulast%3DButton%26aufirst%3DD.%2BC.%26atitle%3DInvolvement%2520of%2520the%2520Neurotensin%2520Receptor%25201%2520in%2520the%2520Behavioral%2520Effects%2520of%2520Two%2520Neurotensin%2520Agonists%252C%2520Nt-2%2520and%2520Nt69l%253A%2520Lack%2520of%2520Hypothermic%252C%2520Antinociceptive%2520and%2520Antipsychotic%2520Actions%2520in%2520Receptor%2520Knockout%2520Mice%26jtitle%3DEur.%2520Neuropsychopharmacol.%26date%3D2009%26volume%3D19%26spage%3D466%26epage%3D475%26doi%3D10.1016%2Fj.euroneuro.2009.01.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wehrwein, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joyner, M. J.</span></span> <span> </span><span class="NLM_article-title">Regulation of Blood Pressure by the Arterial Baroreflex and Autonomic Nervous System</span>. <i>Handb. Clin. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">89</span>– <span class="NLM_lpage">102</span>, <span class="refDoi"> DOI: 10.1016/B978-0-444-53491-0.00008-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2FB978-0-444-53491-0.00008-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=24095118" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A280%3ADC%252BC2c%252FmtFSitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2013&pages=89-102&author=E.+A.+Wehrweinauthor=M.+J.+Joyner&title=Regulation+of+Blood+Pressure+by+the+Arterial+Baroreflex+and+Autonomic+Nervous+System&doi=10.1016%2FB978-0-444-53491-0.00008-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of blood pressure by the arterial baroreflex and autonomic nervous system</span></div><div class="casAuthors">Wehrwein Erica A; Joyner Michael J</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of clinical neurology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">89-102</span>
        ISSN:<span class="NLM_cas:issn">0072-9752</span>.
    </div><div class="casAbstract">Mean arterial pressure (MAP) is a critical hemodynamic factor.  The absence of proper regulation of MAP can have important pathophysiological consequences.  Low MAP can cause inadequate blood flow to organs, syncope, and shock.  On the other hand, elevated MAP contributes to increased oxygen demand by the heart, ventricular remodeling, vascular injury, end organ damage, and stroke.  The arterial baroreflex system is a key controller of MAP and is a complex system.  It can be considered in its entirety as an integrative physiological system or in terms of its regulated component parts.  Those component parts include MAP, mechanosensory transduction, afferent pathways, central neural circuits, efferent pathways, receptor pharmacology, integration with other key homeostatic inputs, molecular biology, and/or other elements.  This chapter provides an overview of each of these individual components but stresses the importance of the integrative nature of this reflex.  In addition, this chapter explores common measurement techniques for the baroreflex and explores the baroreflex in diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTAz9I2kswErAyMywPm6HgQfW6udTcc2eY--P6okUU9Kbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c%252FmtFSitw%253D%253D&md5=e3115865371e315f0a4d28d3150aacd2</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1016%2FB978-0-444-53491-0.00008-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-444-53491-0.00008-0%26sid%3Dliteratum%253Aachs%26aulast%3DWehrwein%26aufirst%3DE.%2BA.%26aulast%3DJoyner%26aufirst%3DM.%2BJ.%26atitle%3DRegulation%2520of%2520Blood%2520Pressure%2520by%2520the%2520Arterial%2520Baroreflex%2520and%2520Autonomic%2520Nervous%2520System%26jtitle%3DHandb.%2520Clin.%2520Neurol.%26date%3D2013%26volume%3D117%26spage%3D89%26epage%3D102%26doi%3D10.1016%2FB978-0-444-53491-0.00008-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mulè, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serio, R.</span></span> <span> </span><span class="NLM_article-title">Mode and Mechanism of Neurotensin Action in Rat Proximal Colon</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>319</i></span>,  <span class="NLM_fpage">269</span>– <span class="NLM_lpage">272</span>, <span class="refDoi"> DOI: 10.1016/S0014-2999(96)00943-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2FS0014-2999%2896%2900943-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=9042600" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADyaK2sXmsVeqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=319&publication_year=1997&pages=269-272&author=F.+Mul%C3%A8author=R.+Serio&title=Mode+and+Mechanism+of+Neurotensin+Action+in+Rat+Proximal+Colon&doi=10.1016%2FS0014-2999%2896%2900943-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Mode and mechanism of neurotensin action in rat proximal colon</span></div><div class="casAuthors">Mule, Flavia; Serio, Rosa</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">319</span>
        (<span class="NLM_cas:issue">2/3</span>),
    <span class="NLM_cas:pages">269-272</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">This study examd. the mechanism of action of neurotensin on intraluminal pressure in rat proximal colon.  The direct and indirect contractile response to neurotensin (100 nM) was abolished in Ca2+-free soln., and was antagonized by nifedipine (1-5-10 nM) and potentiated by Bay K 8644 (Me 1,4-dihydro-2,6-dimethyl-3-nitro-4-(2-trifluoromethylphenyl)-pyridine-5-carboxylate) (10-100-1000 nM).  Neurotensin, in the presence of nifedipine (10 nM) and atropine (1 μM), induced a tetrodotoxin-insensitive inhibitory effect, which was antagonized by SR 48692 (2[(1-(7-chloro-4-quinolinyl)-5-(2,6-dimethoxy-phenyl)pyrazol-3-yl) carbonyl amino]tricyclo(3.3.1.1.3.7)decan-2-carboxylic acid) (300 nM) or apamin (0.1 μM).  The results demonstrate that the neurotensin response is dependent on the influx of Ca2+ via L-type channels and results from summation of excitatory and inhibitory effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoomkwudN0tNrVg90H21EOLACvtfcHk0lhYNIFddVNnTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmsVeqsg%253D%253D&md5=3d8fedc90bc33fca27700392c44f4dd4</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2896%2900943-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252896%252900943-0%26sid%3Dliteratum%253Aachs%26aulast%3DMul%25C3%25A8%26aufirst%3DF.%26aulast%3DSerio%26aufirst%3DR.%26atitle%3DMode%2520and%2520Mechanism%2520of%2520Neurotensin%2520Action%2520in%2520Rat%2520Proximal%2520Colon%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1997%26volume%3D319%26spage%3D269%26epage%3D272%26doi%3D10.1016%2FS0014-2999%2896%2900943-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pellissier, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eribon, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chabert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gully, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roche, M.</span></span> <span> </span><span class="NLM_article-title">Peripheral Neurotensin Participates in the Modulation of Pre- and Postprandial Intestinal Motility in Rats</span>. <i>Neuropeptides</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">412</span>– <span class="NLM_lpage">419</span>, <span class="refDoi"> DOI: 10.1016/S0143-4179(96)90002-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2FS0143-4179%2896%2990002-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=8923500" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADyaK28XntVOgsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1996&pages=412-419&author=S.+Pellissierauthor=O.+Eribonauthor=J.+Chabertauthor=D.+Gullyauthor=M.+Roche&title=Peripheral+Neurotensin+Participates+in+the+Modulation+of+Pre-+and+Postprandial+Intestinal+Motility+in+Rats&doi=10.1016%2FS0143-4179%2896%2990002-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Peripheral neurotensin participates in the modulation of pre- and postprandial intestinal motility in rats</span></div><div class="casAuthors">Pellissier, S.; Eribon, O.; Chabert, J.; Gully, D.; Roche, M.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropeptides (Edinburgh)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">412-419</span>CODEN:
                <span class="NLM_cas:coden">NRPPDD</span>;
        ISSN:<span class="NLM_cas:issn">0143-4179</span>.
    
            (<span class="NLM_cas:orgname">Churchill Livingstone</span>)
        </div><div class="casAbstract">The present study was undertaken to det. whether neurotensin is involved in the regulation of the intestinal postprandial motor response and, if so, whether the regulatory pathway depends upon peripheral or central neurotensin secretion.  Neurotensin, injected by the i.v. route (5 μg/kg) during the fasting state, induced firstly an increased irregular spiking activity during 30-40 min.  This effect was followed by an increase of frequency of the myoelec. complexes during 60 min.  When injected by the i.c.v. route, neurotensin (0.5 μg/kg) reinforced the fasting motility pattern of the small intestine after a latency of 70 min.  Neurotensin was ineffective on the colon.  The neurotensin receptor antagonist SR 48692 (200 μg/kg i.v) reduced the duration of the postprandial motor response of the small intestine and blocked the late postprandial phase on the proximal colon while it suppressed the early postprandial phase on the distal colon.  When administered i.c.v (20 μg/kg), SR 48692 had no effect.  It is concluded that neurotensin modulates intestinal postprandial motility essentially by a peripheral regulatory pathway.  Endogenous neurotensin is involved in the maintenance of the postprandial motility pattern on the small intestine and the proximal colon while it is involved in the initiation of this response on the distal colon.  This suggests that endogenous neurotensin acts via both endocrine and nervous mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqndBwBPestx7Vg90H21EOLACvtfcHk0lhYNIFddVNnTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XntVOgsbo%253D&md5=f877f9f251ecd7070a352d7f56bfd7f9</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1016%2FS0143-4179%2896%2990002-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0143-4179%252896%252990002-5%26sid%3Dliteratum%253Aachs%26aulast%3DPellissier%26aufirst%3DS.%26aulast%3DEribon%26aufirst%3DO.%26aulast%3DChabert%26aufirst%3DJ.%26aulast%3DGully%26aufirst%3DD.%26aulast%3DRoche%26aufirst%3DM.%26atitle%3DPeripheral%2520Neurotensin%2520Participates%2520in%2520the%2520Modulation%2520of%2520Pre-%2520and%2520Postprandial%2520Intestinal%2520Motility%2520in%2520Rats%26jtitle%3DNeuropeptides%26date%3D1996%26volume%3D30%26spage%3D412%26epage%3D419%26doi%3D10.1016%2FS0143-4179%2896%2990002-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tyler, B. M.</span>; <span class="NLM_string-name">Douglas, C. L.</span>; <span class="NLM_string-name">Fauq, A.</span>; <span class="NLM_string-name">Pang, Y. P.</span>; <span class="NLM_string-name">Stewart, J. A.</span>; <span class="NLM_string-name">Cusack, B.</span>; <span class="NLM_string-name">MacCormick, D. J.</span>; <span class="NLM_string-name">Richelson, E.</span></span>. <span> </span><span class="NLM_article-title">In Vitro Binding and Cns Effects of Novel Neurotensin Agonists That Cross the Blood-Brain Barrier</span>. In  <i>Vitro Binding and Cns Effects of Novel Neurotensin Agonists That Cross the Blood-Brain Barrier</i>; <span class="NLM_publisher-name">Neuropharmacol</span>, <span class="NLM_year">1999</span>;  <span class="NLM_volume">38</span>, pp.  <span class="NLM_fpage">1027</span>– <span class="NLM_lpage">1034</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2FS0028-3908%2899%2900011-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1999&pages=1027-1034&author=B.+M.+Tyler&author=C.+L.+Douglas&author=A.+Fauq&author=Y.+P.+Pang&author=J.+A.+Stewart&author=B.+Cusack&author=D.+J.+MacCormick&author=E.+Richelson&title=Vitro+Binding+and+Cns+Effects+of+Novel+Neurotensin+Agonists+That+Cross+the+Blood-Brain+Barrier"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1016%2FS0028-3908%2899%2900011-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FS0028-3908%252899%252900011-8%26sid%3Dliteratum%253Aachs%26aulast%3DTyler%26aufirst%3DB.%2BM.%26atitle%3DIn%2520Vitro%2520Binding%2520and%2520Cns%2520Effects%2520of%2520Novel%2520Neurotensin%2520Agonists%2520That%2520Cross%2520the%2520Blood-Brain%2520Barrier%26btitle%3DVitro%2520Binding%2520and%2520Cns%2520Effects%2520of%2520Novel%2520Neurotensin%2520Agonists%2520That%2520Cross%2520the%2520Blood-Brain%2520Barrier%26pub%3DNeuropharmacol%26date%3D1999%26volume%3D38%26spage%3D1027%26epage%3D1034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kilkenny, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Browne, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuthill, I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emerson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altman, D. G.</span></span> <span> </span><span class="NLM_article-title">Improving Bioscience Research Reporting: The Arrive Guidelines for Reporting Animal Research</span>. <i>PLoS Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">e1000412</span> <span class="refDoi"> DOI: 10.1371/journal.pbio.1000412</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1371%2Fjournal.pbio.1000412" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=20613859" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2010&author=C.+Kilkennyauthor=W.+J.+Browneauthor=I.+C.+Cuthillauthor=M.+Emersonauthor=D.+G.+Altman&title=Improving+Bioscience+Research+Reporting%3A+The+Arrive+Guidelines+for+Reporting+Animal+Research&doi=10.1371%2Fjournal.pbio.1000412"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pbio.1000412&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pbio.1000412%26sid%3Dliteratum%253Aachs%26aulast%3DKilkenny%26aufirst%3DC.%26aulast%3DBrowne%26aufirst%3DW.%2BJ.%26aulast%3DCuthill%26aufirst%3DI.%2BC.%26aulast%3DEmerson%26aufirst%3DM.%26aulast%3DAltman%26aufirst%3DD.%2BG.%26atitle%3DImproving%2520Bioscience%2520Research%2520Reporting%253A%2520The%2520Arrive%2520Guidelines%2520for%2520Reporting%2520Animal%2520Research%26jtitle%3DPLoS%2520Biol.%26date%3D2010%26volume%3D8%26doi%3D10.1371%2Fjournal.pbio.1000412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kallina, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grau, J. W.</span></span> <span> </span><span class="NLM_article-title">Tail-Flick Test I: Impact of a Suprathreshold Exposure to Radiant Heat on Pain Reactivity in Rats</span>. <i>Physiol. Behav.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">161</span>– <span class="NLM_lpage">168</span>, <span class="refDoi"> DOI: 10.1016/0031-9384(95)00046-L</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2F0031-9384%2895%2900046-L" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=7667415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADyaK2MXmtFCkt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1995&pages=161-168&author=C.+F.+Kallinaauthor=J.+W.+Grau&title=Tail-Flick+Test+I%3A+Impact+of+a+Suprathreshold+Exposure+to+Radiant+Heat+on+Pain+Reactivity+in+Rats&doi=10.1016%2F0031-9384%2895%2900046-L"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Tail-flick test I: impact of a suprathreshold exposure to radiant heat on pain reactivity in rats</span></div><div class="casAuthors">Kallina, Charles F.; Grau, James W.</div><div class="citationInfo"><span class="NLM_cas:title">Physiology & Behavior</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">161-8</span>CODEN:
                <span class="NLM_cas:coden">PHBHA4</span>;
        ISSN:<span class="NLM_cas:issn">0031-9384</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Radiant heat applied to the tail elicits a vigorous tail-flick response in rats.  This tail-flick reflex is frequently used to measure pain reactivity.  Prior research has shown that a suprathreshold exposure to the radiant heat used to elicit this reflex causes a redn. in tail-flick latencies in pentobarbital anesthetized rats.  Expt. 1 replicated this observation and showed that the effect is not due to a change in tail temp.  Expt. 2 showed that reduced latencies (hyperalgesia) are not obsd. if the spinal cord is transected prior to testing.  Expt. 3 revealed that pentobarbital anesthesia is required to observe thermal-induced hyperalgesia, for this effect is not obsd. in awake subjects.  Expts. 4 and 5 extended this observation by showing that awake rats also fail to exhibit hyperalgesia if others measures of pain reactivity are employed (shock-induced vocalization and motor reactivity).  Implications of the results are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5zOR-_N-MEbVg90H21EOLACvtfcHk0lgWWHkzxh8UdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmtFCkt7w%253D&md5=410c53d8d9f689b51e41319457c0f383</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1016%2F0031-9384%2895%2900046-L&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0031-9384%252895%252900046-L%26sid%3Dliteratum%253Aachs%26aulast%3DKallina%26aufirst%3DC.%2BF.%26aulast%3DGrau%26aufirst%3DJ.%2BW.%26atitle%3DTail-Flick%2520Test%2520I%253A%2520Impact%2520of%2520a%2520Suprathreshold%2520Exposure%2520to%2520Radiant%2520Heat%2520on%2520Pain%2520Reactivity%2520in%2520Rats%26jtitle%3DPhysiol.%2520Behav.%26date%3D1995%26volume%3D58%26spage%3D161%26epage%3D168%26doi%3D10.1016%2F0031-9384%2895%2900046-L" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dubuisson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dennis, S. G.</span></span> <span> </span><span class="NLM_article-title">The Formalin Test: A Quantitative Study of the Analgesic Effects of Morphine, Meperidine, and Brain Stem Stimulation in Rats and Cats</span>. <i>Pain</i> <span class="NLM_year" style="font-weight: bold;">1977</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">161</span>– <span class="NLM_lpage">174</span>, <span class="refDoi"> DOI: 10.1016/0304-3959(77)90130-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2F0304-3959%2877%2990130-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=564014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADyaE1cXhsVGrt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1977&pages=161-174&author=D.+Dubuissonauthor=S.+G.+Dennis&title=The+Formalin+Test%3A+A+Quantitative+Study+of+the+Analgesic+Effects+of+Morphine%2C+Meperidine%2C+and+Brain+Stem+Stimulation+in+Rats+and+Cats&doi=10.1016%2F0304-3959%2877%2990130-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">The formalin test:  a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats</span></div><div class="casAuthors">Dubuisson, David; Dennis, Stephen G.</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">161-74</span>CODEN:
                <span class="NLM_cas:coden">PAINDB</span>;
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    </div><div class="casAbstract">In a procedure to evaluate the analgesic strengths of morphine sulfate  [64-31-3] and meperidine-HCl  [50-13-5], cats or rats, which were pretreated with an appropriate analgesic dose of either drug, were injected with a soln. of formalin  [50-00-0] in the paws and the pain-related behavior was obsd. and compared with that obsd. in the control animals which received formalin but no analgesic.  Pretreatment with either of the 2 analgesics or brain stem stimulation significantly decreased the effect of the pain stimuli.  Morphine and brain stem stimulation provided similar and greater analgesia than meperidine.  The behavioral patterns of the animals seemed to be similar following morphine or the brain stem stimultion.  Thus, formalin injection can be used effectively to evaluate the potencies of analgesics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGod0ErPKDkXGbVg90H21EOLACvtfcHk0lgYL3r9-9fwIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1cXhsVGrt7s%253D&md5=bd26bbc3c46b9c964d0b3aa011580980</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1016%2F0304-3959%2877%2990130-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0304-3959%252877%252990130-0%26sid%3Dliteratum%253Aachs%26aulast%3DDubuisson%26aufirst%3DD.%26aulast%3DDennis%26aufirst%3DS.%2BG.%26atitle%3DThe%2520Formalin%2520Test%253A%2520A%2520Quantitative%2520Study%2520of%2520the%2520Analgesic%2520Effects%2520of%2520Morphine%252C%2520Meperidine%252C%2520and%2520Brain%2520Stem%2520Stimulation%2520in%2520Rats%2520and%2520Cats%26jtitle%3DPain%26date%3D1977%26volume%3D4%26spage%3D161%26epage%3D174%26doi%3D10.1016%2F0304-3959%2877%2990130-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coderre, T. J.</span></span> <span> </span><span class="NLM_article-title">The Role of Excitatory Amino Acid Receptors and Intracellular Messengers in Persistent Nociception after Tissue Injury in Rats</span>. <i>Mol. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">229</span>– <span class="NLM_lpage">246</span>, <span class="refDoi"> DOI: 10.1007/BF02769177</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1007%2FBF02769177" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=7910027" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A280%3ADyaK2c3jsFWrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1993&pages=229-246&author=T.+J.+Coderre&title=The+Role+of+Excitatory+Amino+Acid+Receptors+and+Intracellular+Messengers+in+Persistent+Nociception+after+Tissue+Injury+in+Rats&doi=10.1007%2FBF02769177"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">The role of excitatory amino acid receptors and intracellular messengers in persistent nociception after tissue injury in rats</span></div><div class="casAuthors">Coderre T J</div><div class="citationInfo"><span class="NLM_cas:title">Molecular neurobiology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">229-46</span>
        ISSN:<span class="NLM_cas:issn">0893-7648</span>.
    </div><div class="casAbstract">Increased pain sensitivity (hyperalgesia) and persistent nociception following peripheral tissue injury depends both on an increase in the sensitivity of primary afferent nociceptors at the site of injury (peripheral sensitization), and on an increase in the excitability of neurons in the central nervous system (central sensitization).  We will review evidence that central sensitization, and the persistent nociception it leads to, are dependent on an action of glutamate and aspartate at excitatory amino acid (EAA) receptors.  Additional evidence will be presented implicating a role of various intracellular second messengers that are coupled to EAA receptors (nitric oxide, arachidonic acid, and protein kinase C) to central sensitization and persistent nociception following tissue injury.  Finally, we will examine the evidence for a contribution of molecular events, including noxious stimulus-induced expression of immediate-early genes such as c-fos to persistent nociception.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQn2GXGwDjtSsuCWE5mhx1RfW6udTcc2eaLpb_0oS5x47ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2c3jsFWrsQ%253D%253D&md5=3281e2d4d3b038f0c5677e11eff034e2</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1007%2FBF02769177&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02769177%26sid%3Dliteratum%253Aachs%26aulast%3DCoderre%26aufirst%3DT.%2BJ.%26atitle%3DThe%2520Role%2520of%2520Excitatory%2520Amino%2520Acid%2520Receptors%2520and%2520Intracellular%2520Messengers%2520in%2520Persistent%2520Nociception%2520after%2520Tissue%2520Injury%2520in%2520Rats%26jtitle%3DMol.%2520Neurobiol.%26date%3D1993%26volume%3D7%26spage%3D229%26epage%3D246%26doi%3D10.1007%2FBF02769177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chaplan, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bach, F. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pogrel, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yaksh, T. L.</span></span> <span> </span><span class="NLM_article-title">Quantitative Assessment of Tactile Allodynia in the Rat Paw</span>. <i>J Neurosci Methods</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">55</span>– <span class="NLM_lpage">63</span>, <span class="refDoi"> DOI: 10.1016/0165-0270(94)90144-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1016%2F0165-0270%2894%2990144-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=7990513" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A280%3ADyaK2M%252Fot1Cjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1994&pages=55-63&author=S.+R.+Chaplanauthor=F.+W.+Bachauthor=J.+W.+Pogrelauthor=J.+M.+Chungauthor=T.+L.+Yaksh&title=Quantitative+Assessment+of+Tactile+Allodynia+in+the+Rat+Paw&doi=10.1016%2F0165-0270%2894%2990144-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative assessment of tactile allodynia in the rat paw</span></div><div class="casAuthors">Chaplan S R; Bach F W; Pogrel J W; Chung J M; Yaksh T L</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neuroscience methods</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">55-63</span>
        ISSN:<span class="NLM_cas:issn">0165-0270</span>.
    </div><div class="casAbstract">We applied and validated a quantitative allodynia assessment technique, using a recently developed rat surgical neuropathy model wherein nocifensive behaviors are evoked by light touch to the paw.  Employing von Frey hairs from 0.41 to 15.1 g, we first characterized the percent response at each stimulus intensity.  A smooth log-linear relationship was observed, with a median 50% threshold at 1.97 g (95% confidence limits, 1.12-3.57 g).  Subsequently, we applied a paradigm using stimulus oscillation around the response threshold, which allowed more rapid, efficient measurements.  Median 50% threshold by this up-down method was 2.4 g (1.81-2.76).  Correlation coefficient between the two methods was 0.91.  In neuropathic rats, good intra- and inter-observer reproducibility was found for the up-down paradigm; some variability was seen in normal rats, attributable to extensive testing.  Thresholds in a sizable group of neuropathic rats showed insignificant variability over 20 days.  After 50 days, 61% still met strict neuropathy criteria, using survival analysis.  Threshold measurement using the up-down paradigm, in combination with the neuropathic pain model, represents a powerful tool for analyzing the effects of manipulations of the neuropathic pain state.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTwRIqb5saCQ8AKB7Fa-xrUfW6udTcc2eaLpb_0oS5x47ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2M%252Fot1Cjug%253D%253D&md5=6c95ac46cbfc212e26d741f34e347707</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1016%2F0165-0270%2894%2990144-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-0270%252894%252990144-9%26sid%3Dliteratum%253Aachs%26aulast%3DChaplan%26aufirst%3DS.%2BR.%26aulast%3DBach%26aufirst%3DF.%2BW.%26aulast%3DPogrel%26aufirst%3DJ.%2BW.%26aulast%3DChung%26aufirst%3DJ.%2BM.%26aulast%3DYaksh%26aufirst%3DT.%2BL.%26atitle%3DQuantitative%2520Assessment%2520of%2520Tactile%2520Allodynia%2520in%2520the%2520Rat%2520Paw%26jtitle%3DJ%2520Neurosci%2520Methods%26date%3D1994%26volume%3D53%26spage%3D55%26epage%3D63%26doi%3D10.1016%2F0165-0270%2894%2990144-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Curtis, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cirino, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Docherty, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">George, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giembycz, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoyer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Insel, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izzo, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacEwan, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sobey, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanford, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teixeira, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wonnacott, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahluwalia, A.</span></span> <span> </span><span class="NLM_article-title">Experimental Design and Analysis and Their Reporting Ii: Updated and Simplified Guidance for Authors and Peer Reviewers</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>175</i></span>,  <span class="NLM_fpage">987</span>– <span class="NLM_lpage">993</span>, <span class="refDoi"> DOI: 10.1111/bph.14153</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=10.1111%2Fbph.14153" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=29520785" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;key=1%3ACAS%3A528%3ADC%252BC1cXktV2ntbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=175&publication_year=2018&pages=987-993&author=M.+J.+Curtisauthor=S.+Alexanderauthor=G.+Cirinoauthor=J.+R.+Dochertyauthor=C.+H.+Georgeauthor=M.+A.+Giembyczauthor=D.+Hoyerauthor=P.+A.+Inselauthor=A.+A.+Izzoauthor=Y.+Jiauthor=D.+J.+MacEwanauthor=C.+G.+Sobeyauthor=S.+C.+Stanfordauthor=M.+M.+Teixeiraauthor=S.+Wonnacottauthor=A.+Ahluwalia&title=Experimental+Design+and+Analysis+and+Their+Reporting+Ii%3A+Updated+and+Simplified+Guidance+for+Authors+and+Peer+Reviewers&doi=10.1111%2Fbph.14153"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers</span></div><div class="casAuthors">Curtis, Michael J.; Alexander, Steve; Cirino, Giuseppe; Docherty, James R.; George, Christopher H.; Giembycz, Mark A.; Hoyer, Daniel; Insel, Paul A.; Izzo, Angelo A.; Ji, Yong; MacEwan, David J.; Sobey, Christopher G.; Stanford, S. Clare; Teixeira, Mauro M.; Wonnacott, Sue; Ahluwalia, Amrita</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">175</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">987-993</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">This article updates the guidance published in 2015 for authors submitting papers to British Journal of Pharmacol. (Curtis et al., 2015) and is intended to provide the rubric for peer review.  Thus, it is directed towards authors, reviewers and editors.  Explanations for many of the requirements were outlined previously and are not restated here.  The new guidelines are intended to replace those published previously.  The guidelines have been simplified for ease of understanding by authors, to make it more straightforward for peer reviewers to check compliance and to facilitate the curation of the journal's efforts to improve stds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGog90PRcRkrKrVg90H21EOLACvtfcHk0ljvYunzOZ_wnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXktV2ntbs%253D&md5=4dee1eb4b76fe4aa368798bc9ec9087a</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1111%2Fbph.14153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.14153%26sid%3Dliteratum%253Aachs%26aulast%3DCurtis%26aufirst%3DM.%2BJ.%26aulast%3DAlexander%26aufirst%3DS.%26aulast%3DCirino%26aufirst%3DG.%26aulast%3DDocherty%26aufirst%3DJ.%2BR.%26aulast%3DGeorge%26aufirst%3DC.%2BH.%26aulast%3DGiembycz%26aufirst%3DM.%2BA.%26aulast%3DHoyer%26aufirst%3DD.%26aulast%3DInsel%26aufirst%3DP.%2BA.%26aulast%3DIzzo%26aufirst%3DA.%2BA.%26aulast%3DJi%26aufirst%3DY.%26aulast%3DMacEwan%26aufirst%3DD.%2BJ.%26aulast%3DSobey%26aufirst%3DC.%2BG.%26aulast%3DStanford%26aufirst%3DS.%2BC.%26aulast%3DTeixeira%26aufirst%3DM.%2BM.%26aulast%3DWonnacott%26aufirst%3DS.%26aulast%3DAhluwalia%26aufirst%3DA.%26atitle%3DExperimental%2520Design%2520and%2520Analysis%2520and%2520Their%2520Reporting%2520Ii%253A%2520Updated%2520and%2520Simplified%2520Guidance%2520for%2520Authors%2520and%2520Peer%2520Reviewers%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2018%26volume%3D175%26spage%3D987%26epage%3D993%26doi%3D10.1111%2Fbph.14153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes4"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i41"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01726">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_01458"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c01726?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01726</a>. <ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">SMILES list of compounds NST1 and NST2 (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01726/suppl_file/jm0c01726_si_001.csv">CSV</a>)</p></li><li><p class="inline">(Table S1) Sequences, molecular formula strings, and characterization data of neurotensin analogs; (Figure S1) displacement curves of [<sup>125</sup>I]-Neurotensin for the alascan NT(8-13) peptides on hNTS1 and hNTS2; (Figure S2) displacement curves of [<sup>125</sup>I]-Neurotensin by macrocyclic NT peptides on hNTS1 and hNTS2; and (Figure S3) stability of NT(8-13) and macrocycle <b>4</b> in rat plasma and cerebrospinal fluid (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01726/suppl_file/jm0c01726_si_002.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01726/suppl_file/jm0c01726_si_001.csv">jm0c01726_si_001.csv (6.83 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01726/suppl_file/jm0c01726_si_002.pdf">jm0c01726_si_002.pdf (1.9 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c01726&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2021.64.issue-4%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c01726%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c01726" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67993ddc9f763c6a","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
